Prefix(:=<http://purl.obolibrary.org/obo/cto.owl#>)
Prefix(dc:=<http://purl.org/dc/elements/1.1/>)
Prefix(obo:=<http://purl.obolibrary.org/obo/>)
Prefix(owl:=<http://www.w3.org/2002/07/owl#>)
Prefix(rdf:=<http://www.w3.org/1999/02/22-rdf-syntax-ns#>)
Prefix(xml:=<http://www.w3.org/XML/1998/namespace>)
Prefix(xsd:=<http://www.w3.org/2001/XMLSchema#>)
Prefix(foaf:=<http://xmlns.com/foaf/0.1/>)
Prefix(rdfs:=<http://www.w3.org/2000/01/rdf-schema#>)
Prefix(terms:=<http://purl.org/dc/terms/>)
Prefix(protege:=<http://protege.stanford.edu/plugins/owl/protege#>)
Prefix(oboInOwl:=<http://www.geneontology.org/formats/oboInOwl#>)
Prefix(statistics:=<http://purl.org/net/OCRe/statistics.owl#>)
Prefix(study_protocol:=<http://purl.org/net/OCRe/study_protocol.owl#>)


Ontology(<http://purl.obolibrary.org/obo/cto.owl>
Annotation(obo:IAO_0000116 "BFO 2 Reference: BFO does not claim to provide complete coverage of entities of all types. It seeks only to provide coverage of those entities studied by empirical science together with those entities which affect or are involved in human activities such as data processing and planning - coverage that is sufficiently broad to provide assistance to those engaged in building domain ontologies for purposes of data annotation."@en)
Annotation(obo:IAO_0000116 "BFO 2 Reference: BFO's treatment of continuants and occurrents - as also its treatment of regions, rests on a dichotomy between space and time, and on the view that there are two perspectives on reality - earlier called the 'SNAP' and 'SPAN' perspectives, both of which are essential to the non-reductionist representation of reality as we understand it from the best available science.")
Annotation(obo:IAO_0000116 "BFO 2 Reference: For both terms and relational expressions in BFO, we distinguish between primitive and defined. 'Entity' is an example of a  primitive term. Primitive terms in a highest-level ontology such as BFO are terms that are so basic to our understanding of reality that there is no way of defining them in a non-circular fashion. For these, therefore, we can provide only elucidations, supplemented by examples and by axioms.")
Annotation(dc:contributor "Alan Ruttenberg")
Annotation(dc:contributor "Albert Goldfain")
Annotation(dc:contributor "Asiyah Yu Lin (CDRH, Food and Drug Administration)")
Annotation(dc:contributor "Astghik Sargsyan (Fraunhofer SCAI)")
Annotation(dc:contributor "Barry Smith")
Annotation(dc:contributor "Bill Duncan")
Annotation(dc:contributor "Bjoern Peters")
Annotation(dc:contributor "Chris Mungall")
Annotation(dc:contributor "David Osumi-Sutherland")
Annotation(dc:contributor "Fabian Neuhaus")
Annotation(dc:contributor "Geena Mariya Jose (Causality Biomodels)")
Annotation(dc:contributor "Holger Stenzhorn")
Annotation(dc:contributor "James A. Overton")
Annotation(dc:contributor "Janna Hastings")
Annotation(dc:contributor "Jie Zheng")
Annotation(dc:contributor "Jonathan Bona")
Annotation(dc:contributor "Larry Hunter")
Annotation(dc:contributor "Leon Li (NIH)")
Annotation(dc:contributor "Leonard Jacuzzo")
Annotation(dc:contributor "Ludger Jansen")
Annotation(dc:contributor "Mark Ressler")
Annotation(dc:contributor "Mathias Brochhausen")
Annotation(dc:contributor "Mauricio Almeida")
Annotation(dc:contributor "Melanie Courtot")
Annotation(dc:contributor "Oliver He (University of Michigan)")
Annotation(dc:contributor "Pierre Grenon")
Annotation(dc:contributor "Randall Dipert")
Annotation(dc:contributor "Ron Rudnicki")
Annotation(dc:contributor "Selja Seppälä")
Annotation(dc:contributor "Shounak Baksi (Causality Biomodels)")
Annotation(dc:contributor "Stefan Schulz")
Annotation(dc:contributor "Thomas Bittner")
Annotation(dc:contributor "Werner Ceusters")
Annotation(dc:contributor "Yongqun \"Oliver\" He")
Annotation(dc:description "The core Ontology of Clinical Trials (CTO) will serve as a structured resource integrating basic terms and concepts in the context of clinical trials. Thereby covering clinicaltrails.gov. CoreCTO will serve as a basic ontology to generate extended versions for specific applications such as annotation of variables in study documents from clinical trials.")
Annotation(terms:creator "Alpha Tom Kodamullil (Fraunhofer SCAI)")
Annotation(terms:creator "Johannes Darms (Fraunhofer SCAI)")
Annotation(terms:creator "Stephan Gebel (Fraunhofer SCAI)")
Annotation(terms:creator "Sumit Madan (Fraunhofer SCAI)")
Annotation(terms:license <http://creativecommons.org/licenses/by/4.0/>)
Annotation(terms:license "http://creativecommons.org/licenses/by/4.0")
Annotation(terms:title "CTO: Core Ontology of Clinical Trials")
Annotation(rdfs:comment "Please see the project site https://github.com/BFO-ontology/BFO, the bfo2 owl discussion group http://groups.google.com/group/bfo-owl-devel, the bfo2 discussion group http://groups.google.com/group/bfo-devel, the tracking google doc http://goo.gl/IlrEE, and the current version of the bfo2 reference http://purl.obolibrary.org/obo/bfo/dev/bfo2-reference.docx. This ontology is generated from a specification at https://github.com/BFO-ontology/BFO/tree/master/src/ontology/owl-group/specification/ and with the code that generates the OWL version in https://github.com/BFO-ontology/BFO/tree/master/src/tools/. A very early version of BFO version 2 in CLIF is at http://purl.obolibrary.org/obo/bfo/dev/bfo.clif."@en)
Annotation(rdfs:comment "The BSD license on the BFO project site refers to code used to build BFO."@en)
Annotation(rdfs:comment "This BFO 2.0 version represents a major update to BFO and is not strictly backwards compatible with BFO 1.1. The previous OWL version of BFO, version 1.1.1 will remain available at http://ifomis.org/bfo/1.1 and will no longer be updated. The BFO 2.0 OWL is a classes-only specification. The incorporation of core relations has been held over for a later version.")
Annotation(rdfs:isDefinedBy <http://purl.obolibrary.org/obo/bfo/dev/bfo.clif>)
Annotation(rdfs:isDefinedBy <https://github.com/BFO-ontology/BFO/tree/master/src/ontology/owl-group/specification/>)
Annotation(rdfs:seeAlso <http://groups.google.com/group/bfo-devel>)
Annotation(rdfs:seeAlso <http://groups.google.com/group/bfo-discuss>)
Annotation(rdfs:seeAlso <http://groups.google.com/group/bfo-owl-devel>)
Annotation(rdfs:seeAlso <http://purl.obolibrary.org/obo/bfo/dev/owl>)
Annotation(rdfs:seeAlso <https://github.com/BFO-ontology/BFO/tree/master/src/tools/>)
Annotation(owl:versionInfo "Version Release: 1.0.0")
Annotation(foaf:homepage <http://basic-formal-ontology.org/>)
Annotation(foaf:homepage <http://ifomis.org/bfo>)
Annotation(foaf:homepage <https://github.com/BFO-ontology/BFO>)
Annotation(foaf:mbox <mailto:bfo-owl-devel@googlegroups.com>)

Declaration(Class(obo:BFO_0000001))
Declaration(Class(obo:BFO_0000002))
Declaration(Class(obo:BFO_0000003))
Declaration(Class(obo:BFO_0000004))
Declaration(Class(obo:BFO_0000006))
Declaration(Class(obo:BFO_0000008))
Declaration(Class(obo:BFO_0000009))
Declaration(Class(obo:BFO_0000011))
Declaration(Class(obo:BFO_0000015))
Declaration(Class(obo:BFO_0000016))
Declaration(Class(obo:BFO_0000017))
Declaration(Class(obo:BFO_0000018))
Declaration(Class(obo:BFO_0000019))
Declaration(Class(obo:BFO_0000020))
Declaration(Class(obo:BFO_0000023))
Declaration(Class(obo:BFO_0000024))
Declaration(Class(obo:BFO_0000026))
Declaration(Class(obo:BFO_0000027))
Declaration(Class(obo:BFO_0000028))
Declaration(Class(obo:BFO_0000029))
Declaration(Class(obo:BFO_0000030))
Declaration(Class(obo:BFO_0000031))
Declaration(Class(obo:BFO_0000034))
Declaration(Class(obo:BFO_0000035))
Declaration(Class(obo:BFO_0000038))
Declaration(Class(obo:BFO_0000040))
Declaration(Class(obo:BFO_0000140))
Declaration(Class(obo:BFO_0000141))
Declaration(Class(obo:BFO_0000142))
Declaration(Class(obo:BFO_0000144))
Declaration(Class(obo:BFO_0000145))
Declaration(Class(obo:BFO_0000146))
Declaration(Class(obo:BFO_0000147))
Declaration(Class(obo:BFO_0000148))
Declaration(Class(obo:BFO_0000182))
Declaration(Class(obo:CHEBI_23367))
Declaration(Class(obo:CHEBI_24431))
Declaration(Class(obo:CTO_0000001))
Declaration(Class(obo:CTO_0000002))
Declaration(Class(obo:CTO_0000003))
Declaration(Class(obo:CTO_0000004))
Declaration(Class(obo:CTO_0000005))
Declaration(Class(obo:CTO_0000006))
Declaration(Class(obo:CTO_0000007))
Declaration(Class(obo:CTO_0000008))
Declaration(Class(obo:CTO_0000009))
Declaration(Class(obo:CTO_0000010))
Declaration(Class(obo:CTO_0000011))
Declaration(Class(obo:CTO_0000012))
Declaration(Class(obo:CTO_0000013))
Declaration(Class(obo:CTO_0000014))
Declaration(Class(obo:CTO_0000015))
Declaration(Class(obo:CTO_0000016))
Declaration(Class(obo:CTO_0000017))
Declaration(Class(obo:CTO_0000018))
Declaration(Class(obo:CTO_0000019))
Declaration(Class(obo:CTO_0000020))
Declaration(Class(obo:CTO_0000022))
Declaration(Class(obo:CTO_0000023))
Declaration(Class(obo:CTO_0000024))
Declaration(Class(obo:CTO_0000025))
Declaration(Class(obo:CTO_0000026))
Declaration(Class(obo:CTO_0000028))
Declaration(Class(obo:CTO_0000030))
Declaration(Class(obo:CTO_0000031))
Declaration(Class(obo:CTO_0000032))
Declaration(Class(obo:CTO_0000033))
Declaration(Class(obo:CTO_0000034))
Declaration(Class(obo:CTO_0000035))
Declaration(Class(obo:CTO_0000036))
Declaration(Class(obo:CTO_0000037))
Declaration(Class(obo:CTO_0000038))
Declaration(Class(obo:CTO_0000039))
Declaration(Class(obo:CTO_0000040))
Declaration(Class(obo:CTO_0000041))
Declaration(Class(obo:CTO_0000043))
Declaration(Class(obo:CTO_0000044))
Declaration(Class(obo:CTO_0000045))
Declaration(Class(obo:CTO_0000046))
Declaration(Class(obo:CTO_0000047))
Declaration(Class(obo:CTO_0000048))
Declaration(Class(obo:CTO_0000049))
Declaration(Class(obo:CTO_0000050))
Declaration(Class(obo:CTO_0000051))
Declaration(Class(obo:CTO_0000052))
Declaration(Class(obo:CTO_0000053))
Declaration(Class(obo:CTO_0000054))
Declaration(Class(obo:CTO_0000055))
Declaration(Class(obo:CTO_0000056))
Declaration(Class(obo:CTO_0000073))
Declaration(Class(obo:CTO_0000074))
Declaration(Class(obo:CTO_0000075))
Declaration(Class(obo:CTO_0000076))
Declaration(Class(obo:CTO_0000077))
Declaration(Class(obo:CTO_0000099))
Declaration(Class(obo:CTO_0000100))
Declaration(Class(obo:CTO_0000101))
Declaration(Class(obo:CTO_0000102))
Declaration(Class(obo:CTO_0000103))
Declaration(Class(obo:CTO_0000104))
Declaration(Class(obo:CTO_0000105))
Declaration(Class(obo:CTO_0000106))
Declaration(Class(obo:CTO_0000107))
Declaration(Class(obo:CTO_0000108))
Declaration(Class(obo:CTO_0000109))
Declaration(Class(obo:CTO_0000110))
Declaration(Class(obo:CTO_0000111))
Declaration(Class(obo:CTO_0000112))
Declaration(Class(obo:CTO_0000113))
Declaration(Class(obo:CTO_0000114))
Declaration(Class(obo:CTO_0000115))
Declaration(Class(obo:CTO_0000116))
Declaration(Class(obo:CTO_0000117))
Declaration(Class(obo:CTO_0000118))
Declaration(Class(obo:CTO_0000119))
Declaration(Class(obo:CTO_0000120))
Declaration(Class(obo:CTO_0000132))
Declaration(Class(obo:CTO_0000200))
Declaration(Class(obo:CTO_0000201))
Declaration(Class(obo:CTO_0000202))
Declaration(Class(obo:CTO_0000203))
Declaration(Class(obo:CTO_0000204))
Declaration(Class(obo:CTO_0000205))
Declaration(Class(obo:CTO_0000206))
Declaration(Class(obo:CTO_0000207))
Declaration(Class(obo:CTO_0000208))
Declaration(Class(obo:CTO_0000209))
Declaration(Class(obo:CTO_0000210))
Declaration(Class(obo:CTO_0000211))
Declaration(Class(obo:CTO_0000212))
Declaration(Class(obo:CTO_0000213))
Declaration(Class(obo:CTO_0000214))
Declaration(Class(obo:CTO_0000215))
Declaration(Class(obo:CTO_0000216))
Declaration(Class(obo:CTO_0000217))
Declaration(Class(obo:CTO_0000218))
Declaration(Class(obo:CTO_0000219))
Declaration(Class(obo:CTO_0000220))
Declaration(Class(obo:DRON_00000005))
Declaration(Class(obo:ERO_0000017))
Declaration(Class(obo:ERO_0001092))
Declaration(Class(obo:ERO_0001402))
Declaration(Class(obo:ERO_0001843))
Declaration(Class(obo:IAO_0000005))
Declaration(Class(obo:IAO_0000007))
Declaration(Class(obo:IAO_0000027))
Declaration(Class(obo:IAO_0000030))
Declaration(Class(obo:IAO_0000033))
Declaration(Class(obo:IAO_0000078))
Declaration(Class(obo:IAO_0000088))
Declaration(Class(obo:IAO_0000102))
Declaration(Class(obo:IAO_0000104))
Declaration(Class(obo:IAO_0000300))
Declaration(Class(obo:IAO_0000310))
Declaration(Class(obo:IAO_0000422))
Declaration(Class(obo:IAO_0000429))
Declaration(Class(obo:IAO_0000578))
Declaration(Class(obo:MS_1000590))
Declaration(Class(obo:NCBITaxon_1))
Declaration(Class(obo:NCBITaxon_131567))
Declaration(Class(obo:NCBITaxon_2759))
Declaration(Class(obo:NCBITaxon_40674))
Declaration(Class(obo:NCBITaxon_7742))
Declaration(Class(obo:NCBITaxon_9606))
Declaration(Class(obo:NCIT_C115575))
Declaration(Class(obo:NCIT_C129000))
Declaration(Class(obo:NCIT_C139174))
Declaration(Class(obo:NCIT_C142175))
Declaration(Class(obo:NCIT_C142660))
Declaration(Class(obo:NCIT_C147141))
Declaration(Class(obo:NCIT_C15238))
Declaration(Class(obo:NCIT_C15245))
Declaration(Class(obo:NCIT_C15329))
Declaration(Class(obo:NCIT_C15600))
Declaration(Class(obo:NCIT_C15601))
Declaration(Class(obo:NCIT_C15602))
Declaration(Class(obo:NCIT_C15603))
Declaration(Class(obo:NCIT_C15693))
Declaration(Class(obo:NCIT_C15694))
Declaration(Class(obo:NCIT_C15714))
Declaration(Class(obo:NCIT_C16084))
Declaration(Class(obo:NCIT_C161319))
Declaration(Class(obo:NCIT_C19332))
Declaration(Class(obo:NCIT_C25150))
Declaration(Class(obo:NCIT_C25320))
Declaration(Class(obo:NCIT_C48355))
Declaration(Class(obo:NCIT_C49653))
Declaration(Class(obo:NCIT_C49656))
Declaration(Class(obo:NCIT_C49657))
Declaration(Class(obo:NCIT_C49692))
Declaration(Class(obo:NCIT_C52580))
Declaration(Class(obo:NCIT_C60776))
Declaration(Class(obo:NCIT_C70793))
Declaration(Class(obo:NCIT_C70817))
Declaration(Class(obo:NCIT_C70840))
Declaration(Class(obo:NCIT_C71485))
Declaration(Class(obo:NCIT_C71486))
Declaration(Class(obo:NCIT_C82638))
Declaration(Class(obo:NCIT_C84336))
Declaration(Class(obo:NCIT_C90467))
Declaration(Class(obo:NCIT_C90468))
Declaration(Class(obo:NCIT_C90469))
Declaration(Class(obo:NCIT_C93360))
Declaration(Class(obo:NCIT_C98388))
Declaration(Class(obo:NCIT_C98714))
Declaration(Class(obo:NCIT_C98722))
Declaration(Class(obo:NCIT_C98747))
Declaration(Class(obo:NCIT_C98772))
Declaration(Class(obo:NCIT_C98781))
Declaration(Class(obo:OAE_0000001))
Declaration(Class(obo:OAE_0000002))
Declaration(Class(obo:OAE_0000011))
Declaration(Class(obo:OAE_0000094))
Declaration(Class(obo:OAE_0002807))
Declaration(Class(obo:OBI_0000011))
Declaration(Class(obo:OBI_0000066))
Declaration(Class(obo:OBI_0000070))
Declaration(Class(obo:OBI_0000102))
Declaration(Class(obo:OBI_0000115))
Declaration(Class(obo:OBI_0000202))
Declaration(Class(obo:OBI_0000243))
Declaration(Class(obo:OBI_0000245))
Declaration(Class(obo:OBI_0000272))
Declaration(Class(obo:OBI_0000810))
Declaration(Class(obo:OBI_0000968))
Declaration(Class(obo:OBI_0001627))
Declaration(Class(obo:OBI_0001755))
Declaration(Class(obo:OBI_0001928))
Declaration(Class(obo:OBI_0001933))
Declaration(Class(obo:OBI_0002555))
Declaration(Class(obo:OBI_0002556))
Declaration(Class(obo:OBI_0002557))
Declaration(Class(obo:OBI_0002561))
Declaration(Class(obo:OBI_0002624))
Declaration(Class(obo:OBI_0300311))
Declaration(Class(obo:OBI_0500000))
Declaration(Class(obo:OBI_0500002))
Declaration(Class(obo:OBI_0500003))
Declaration(Class(obo:OBI_0500004))
Declaration(Class(obo:OBI_0500006))
Declaration(Class(obo:OBI_0500014))
Declaration(Class(obo:OBI_0500026))
Declaration(Class(obo:OBI_0500027))
Declaration(Class(obo:OBI_0500028))
Declaration(Class(obo:OBI_0600004))
Declaration(Class(obo:OGMS_0000014))
Declaration(Class(obo:OGMS_0000015))
Declaration(Class(obo:OGMS_0000019))
Declaration(Class(obo:OGMS_0000031))
Declaration(Class(obo:OGMS_0000060))
Declaration(Class(obo:OGMS_0000061))
Declaration(Class(obo:OGMS_0000073))
Declaration(Class(obo:OMIABIS_0001019))
Declaration(Class(obo:OMIABIS_0001020))
Declaration(Class(obo:OMRSE_00000024))
Declaration(Class(obo:OMRSE_00000038))
Declaration(Class(obo:OPMI_0000112))
Declaration(Class(obo:OPMI_0000223))
Declaration(Class(obo:OPMI_0000282))
Declaration(Class(obo:OPMI_0000293))
Declaration(Class(obo:OPMI_0000294))
Declaration(Class(obo:OPMI_0000296))
Declaration(Class(obo:OPMI_0000297))
Declaration(Class(obo:OPMI_0000302))
Declaration(Class(obo:OPMI_0000304))
Declaration(Class(obo:OPMI_0000326))
Declaration(Class(obo:OPMI_0000327))
Declaration(Class(obo:OPMI_0000365))
Declaration(Class(obo:OPMI_0000376))
Declaration(Class(obo:OPMI_0000381))
Declaration(Class(obo:OPMI_0000383))
Declaration(Class(obo:OPMI_0000384))
Declaration(Class(obo:OPMI_0000389))
Declaration(Class(obo:OPMI_0000390))
Declaration(Class(obo:OPMI_0000391))
Declaration(Class(obo:OPMI_0000393))
Declaration(Class(obo:OPMI_0000395))
Declaration(Class(obo:OPMI_0000397))
Declaration(Class(obo:OPMI_0000398))
Declaration(Class(obo:OPMI_0000399))
Declaration(Class(obo:OPMI_0000400))
Declaration(Class(obo:OPMI_0000401))
Declaration(Class(obo:OPMI_0000402))
Declaration(Class(obo:OPMI_0000418))
Declaration(Class(obo:PATO_0000047))
Declaration(Class(obo:PATO_0000383))
Declaration(Class(obo:PATO_0000384))
Declaration(Class(obo:PATO_0001236))
Declaration(Class(obo:PATO_0001241))
Declaration(Class(obo:PATO_0001894))
Declaration(Class(obo:PATO_0001995))
Declaration(Class(obo:PDRO_0000129))
Declaration(Class(obo:VO_0000002))
Declaration(Class(obo:VO_0000427))
Declaration(Class(obo:VO_0000428))
Declaration(Class(obo:VO_0000429))
Declaration(Class(obo:VO_0000430))
Declaration(Class(obo:VO_0000596))
Declaration(ObjectProperty(obo:BFO_0000051))
Declaration(ObjectProperty(obo:BFO_0000055))
Declaration(ObjectProperty(obo:BFO_0000062))
Declaration(ObjectProperty(obo:CTO_0000126))
Declaration(ObjectProperty(obo:CTO_0000127))
Declaration(ObjectProperty(obo:CTO_0000128))
Declaration(ObjectProperty(obo:CTO_0000129))
Declaration(ObjectProperty(obo:CTO_0000130))
Declaration(ObjectProperty(obo:CTO_0000131))
Declaration(ObjectProperty(obo:IAO_0000136))
Declaration(ObjectProperty(obo:OBI_0000293))
Declaration(ObjectProperty(obo:OPMI_0000366))
Declaration(ObjectProperty(obo:RO_0000057))
Declaration(ObjectProperty(obo:RO_0000059))
Declaration(ObjectProperty(obo:RO_0000087))
Declaration(ObjectProperty(obo:RO_0002248))
Declaration(ObjectProperty(obo:RO_0002249))
Declaration(ObjectProperty(rdfs:subClassOf))
Declaration(NamedIndividual(obo:IAO_0000122))
Declaration(NamedIndividual(obo:IAO_0000123))
Declaration(NamedIndividual(obo:IAO_0000125))
Declaration(NamedIndividual(obo:iao.owl))
Declaration(NamedIndividual(obo:obi.owl))
Declaration(AnnotationProperty(protege:readOnly))
Declaration(AnnotationProperty(obo:BFO_0000179))
Declaration(AnnotationProperty(obo:BFO_0000180))
Declaration(AnnotationProperty(obo:CTO_0000121))
Declaration(AnnotationProperty(obo:CTO_0000122))
Declaration(AnnotationProperty(obo:CTO_0000123))
Declaration(AnnotationProperty(obo:CTO_0000124))
Declaration(AnnotationProperty(obo:CTO_0000125))
Declaration(AnnotationProperty(obo:IAO_0000111))
Declaration(AnnotationProperty(obo:IAO_0000112))
Declaration(AnnotationProperty(obo:IAO_0000114))
Declaration(AnnotationProperty(obo:IAO_0000115))
Declaration(AnnotationProperty(obo:IAO_0000116))
Declaration(AnnotationProperty(obo:IAO_0000117))
Declaration(AnnotationProperty(obo:IAO_0000118))
Declaration(AnnotationProperty(obo:IAO_0000119))
Declaration(AnnotationProperty(obo:IAO_0000232))
Declaration(AnnotationProperty(obo:IAO_0000233))
Declaration(AnnotationProperty(obo:IAO_0000412))
Declaration(AnnotationProperty(obo:IAO_0000600))
Declaration(AnnotationProperty(obo:IAO_0000601))
Declaration(AnnotationProperty(obo:IAO_0000602))
Declaration(AnnotationProperty(obo:IAO_0010000))
Declaration(AnnotationProperty(obo:NCIT_A11))
Declaration(AnnotationProperty(obo:NCIT_NHC0))
Declaration(AnnotationProperty(obo:NCIT_P106))
Declaration(AnnotationProperty(obo:NCIT_P107))
Declaration(AnnotationProperty(obo:NCIT_P108))
Declaration(AnnotationProperty(obo:NCIT_P207))
Declaration(AnnotationProperty(obo:NCIT_P208))
Declaration(AnnotationProperty(obo:NCIT_P322))
Declaration(AnnotationProperty(obo:NCIT_P325))
Declaration(AnnotationProperty(obo:NCIT_P366))
Declaration(AnnotationProperty(obo:NCIT_P371))
Declaration(AnnotationProperty(obo:NCIT_P375))
Declaration(AnnotationProperty(obo:NCIT_P98))
Declaration(AnnotationProperty(obo:OBI_0001847))
Declaration(AnnotationProperty(obo:OBI_0001886))
Declaration(AnnotationProperty(obo:OBI_9991118))
Declaration(AnnotationProperty(obo:OPMI_0000364))
Declaration(AnnotationProperty(<http://purl.obolibrary.org/obo/ncbitaxon#has_rank>))
Declaration(AnnotationProperty(dc:contributor))
Declaration(AnnotationProperty(dc:creator))
Declaration(AnnotationProperty(dc:date))
Declaration(AnnotationProperty(dc:description))
Declaration(AnnotationProperty(dc:member))
Declaration(AnnotationProperty(dc:source))
Declaration(AnnotationProperty(terms:creator))
Declaration(AnnotationProperty(terms:license))
Declaration(AnnotationProperty(terms:title))
Declaration(AnnotationProperty(oboInOwl:hasAlternativeId))
Declaration(AnnotationProperty(oboInOwl:hasDbXref))
Declaration(AnnotationProperty(oboInOwl:hasExactSynonym))
Declaration(AnnotationProperty(oboInOwl:hasNarrowSynonym))
Declaration(AnnotationProperty(oboInOwl:hasOBONamespace))
Declaration(AnnotationProperty(oboInOwl:hasRelatedSynonym))
Declaration(AnnotationProperty(oboInOwl:id))
Declaration(AnnotationProperty(oboInOwl:inSubset))
Declaration(AnnotationProperty(oboInOwl:is_metadata_tag))
Declaration(AnnotationProperty(oboInOwl:shorthand))
Declaration(AnnotationProperty(rdf:type))
Declaration(AnnotationProperty(rdfs:comment))
Declaration(AnnotationProperty(rdfs:isDefinedBy))
Declaration(AnnotationProperty(rdfs:label))
Declaration(AnnotationProperty(rdfs:seeAlso))
Declaration(AnnotationProperty(foaf:homepage))
Declaration(AnnotationProperty(foaf:mbox))
Declaration(Datatype(obo:NCIT_Contributing_Source-enum))
Declaration(Datatype(obo:NCIT_Semantic_Type-enum))
Declaration(Datatype(obo:NCIT_textArea))
Declaration(Datatype(rdf:langString))
############################
#   Annotation Properties
############################

# Annotation Property: protege:readOnly (protege:readOnly)

AnnotationPropertyRange(protege:readOnly xsd:boolean)

# Annotation Property: obo:BFO_0000179 (BFO OWL specification label)

AnnotationAssertion(obo:IAO_0000111 obo:BFO_0000179 "BFO OWL specification label"@en)
AnnotationAssertion(obo:IAO_0000115 obo:BFO_0000179 "Relates an entity in the ontology to the name of the variable that is used to represent it in the code that generates the BFO OWL file from the lispy specification."@en)
AnnotationAssertion(obo:IAO_0000232 obo:BFO_0000179 "Really of interest to developers only"@en)
AnnotationAssertion(rdfs:label obo:BFO_0000179 "BFO OWL specification label")
AnnotationAssertion(rdfs:label obo:BFO_0000179 "BFO OWL specification label"@en)
SubAnnotationPropertyOf(obo:BFO_0000179 rdfs:label)

# Annotation Property: obo:BFO_0000180 (BFO CLIF specification label)

AnnotationAssertion(obo:IAO_0000111 obo:BFO_0000180 "BFO CLIF specification label"@en)
AnnotationAssertion(obo:IAO_0000115 obo:BFO_0000180 "Relates an entity in the ontology to the term that is used to represent it in the the CLIF specification of BFO2"@en)
AnnotationAssertion(obo:IAO_0000119 obo:BFO_0000180 "Person:Alan Ruttenberg")
AnnotationAssertion(obo:IAO_0000232 obo:BFO_0000180 "Really of interest to developers only"@en)
AnnotationAssertion(rdfs:label obo:BFO_0000180 "BFO CLIF specification label")
AnnotationAssertion(rdfs:label obo:BFO_0000180 "BFO CLIF specification label"@en)
SubAnnotationPropertyOf(obo:BFO_0000180 rdfs:label)

# Annotation Property: obo:CTO_0000121 (hasOfficialTitle)

AnnotationAssertion(obo:CTO_0000121 obo:CTO_0000121 "Corresponding to CT.gov XML tag \"official_title\"

<xs:element name=\"clinical_study\">
<xs:complexType>
<xs:sequence>
...
<xs:element name=\"official_title\" type=\"xs:string\" minOccurs=\"0\"/>
...")
AnnotationAssertion(dc:creator obo:CTO_0000121 "Asiyah Yu Lin, Qingliang \"Leon\" Li")
AnnotationAssertion(dc:date obo:CTO_0000121 "2021-06-10T13:26:41Z"^^xsd:dateTime)
AnnotationAssertion(dc:source obo:CTO_0000121 "https://clinicaltrials.gov/ct2/html/images/info/public.xsd")
AnnotationAssertion(rdfs:label obo:CTO_0000121 "hasOfficialTitle"@en)

# Annotation Property: obo:CTO_0000122 (hasBriefTitle)

AnnotationAssertion(obo:IAO_0000116 obo:CTO_0000122 "Corresponding to CT.gov XML tag \"brief_title\"

<xs:element name=\"clinical_study\">
<xs:complexType>
<xs:sequence>
...
<xs:element name=\"brief_title\" type=\"xs:string\"/>
...")
AnnotationAssertion(dc:creator obo:CTO_0000122 "Asiyah Yu Lin, Qingliang \"Leon\" Li")
AnnotationAssertion(dc:date obo:CTO_0000122 "2021-06-10T13:32:02Z"^^xsd:dateTime)
AnnotationAssertion(dc:source obo:CTO_0000122 "https://clinicaltrials.gov/ct2/html/images/info/public.xsd")
AnnotationAssertion(rdfs:label obo:CTO_0000122 "hasBriefTitle"@en)

# Annotation Property: obo:CTO_0000123 (hasCompletionDate)

AnnotationAssertion(obo:IAO_0000116 obo:CTO_0000123 "Corresponding to CT.gov XML tag \"primary completion date\" with flag \"Actual\"


<xs:element name=\"clinical_study\">
<xs:complexType>
<xs:sequence>
...
<xs:element name=\"primary_completion_date\" type=\"variable_date_struct\" minOccurs=\"0\"/>
...")
AnnotationAssertion(dc:creator obo:CTO_0000123 "Asiyah Yu Lin,")
AnnotationAssertion(dc:date obo:CTO_0000123 "2021-06-10T13:33:12Z"^^xsd:dateTime)
AnnotationAssertion(dc:source obo:CTO_0000123 "https://clinicaltrials.gov/ct2/html/images/info/public.xsd")
AnnotationAssertion(rdfs:label obo:CTO_0000123 "hasCompletionDate"@en)

# Annotation Property: obo:CTO_0000124 (hasStartDate)

AnnotationAssertion(obo:IAO_0000116 obo:CTO_0000124 "Corresponding to CT.gov XML tag \"start_date\" with flag \"Actual\".

<xs:element name=\"clinical_study\">
<xs:complexType>
<xs:sequence>
...
<xs:element name=\"start_date\" type=\"variable_date_struct\" minOccurs=\"0\"/>")
AnnotationAssertion(dc:creator obo:CTO_0000124 "Asiyah Yu Lin, Qingliang \"Leon\" Li")
AnnotationAssertion(dc:date obo:CTO_0000124 "2021-06-10T13:35:06Z"^^xsd:dateTime)
AnnotationAssertion(dc:source obo:CTO_0000124 "https://clinicaltrials.gov/ct2/html/images/info/public.xsd")
AnnotationAssertion(rdfs:label obo:CTO_0000124 "hasStartDate"@en)

# Annotation Property: obo:CTO_0000125 (hasPhase)

AnnotationAssertion(obo:IAO_0000116 obo:CTO_0000125 "Corresponding to CT.gov XML tag \"phase\":

<xs:simpleType name=\"phase_enum\">
<xs:restriction base=\"xs:string\">
<xs:enumeration value=\"N/A\"/>
<xs:enumeration value=\"Early Phase 1\"/>
<xs:enumeration value=\"Phase 1\"/>
<xs:enumeration value=\"Phase 1/Phase 2\"/>
<xs:enumeration value=\"Phase 2\"/>
<xs:enumeration value=\"Phase 2/Phase 3\"/>
<xs:enumeration value=\"Phase 3\"/>
<xs:enumeration value=\"Phase 4\"/>
</xs:restriction>
</xs:simpleType>")
AnnotationAssertion(dc:creator obo:CTO_0000125 "Asiyah Yu Lin, Qingliang \"Leon\" Li")
AnnotationAssertion(dc:date obo:CTO_0000125 "2021-06-10T13:36:18Z"^^xsd:dateTime)
AnnotationAssertion(dc:source obo:CTO_0000125 "https://clinicaltrials.gov/ct2/html/images/info/public.xsd")
AnnotationAssertion(rdfs:label obo:CTO_0000125 "hasPhase"@en)

# Annotation Property: obo:IAO_0000111 (editor preferred label)

AnnotationAssertion(obo:IAO_0000111 obo:IAO_0000111 "editor preferred label")
AnnotationAssertion(obo:IAO_0000111 obo:IAO_0000111 "editor preferred label"@en)
AnnotationAssertion(obo:IAO_0000111 obo:IAO_0000111 "editor preferred term")
AnnotationAssertion(obo:IAO_0000111 obo:IAO_0000111 "editor preferred term"@en)
AnnotationAssertion(obo:IAO_0000111 obo:IAO_0000111 "editor preferred term~editor preferred label")
AnnotationAssertion(obo:IAO_0000114 obo:IAO_0000111 obo:IAO_0000122)
AnnotationAssertion(obo:IAO_0000115 obo:IAO_0000111 "The concise, meaningful, and human-friendly name for a class or property preferred by the ontology developers. (US-English)"@en)
AnnotationAssertion(obo:IAO_0000117 obo:IAO_0000111 "PERSON:Daniel Schober"@en)
AnnotationAssertion(obo:IAO_0000119 obo:IAO_0000111 "GROUP:OBI:<http://purl.obolibrary.org/obo/obi>"@en)
AnnotationAssertion(rdfs:isDefinedBy obo:IAO_0000111 obo:iao.owl)
AnnotationAssertion(rdfs:label obo:IAO_0000111 "editor preferred label")
AnnotationAssertion(rdfs:label obo:IAO_0000111 "editor preferred label"@en)
AnnotationAssertion(rdfs:label obo:IAO_0000111 "editor preferred term")
AnnotationAssertion(rdfs:label obo:IAO_0000111 "editor preferred term"@en)
AnnotationAssertion(rdfs:label obo:IAO_0000111 "editor preferred term~editor preferred label")

# Annotation Property: obo:IAO_0000112 (example of usage)

AnnotationAssertion(obo:IAO_0000111 obo:IAO_0000112 "example"@en)
AnnotationAssertion(obo:IAO_0000111 obo:IAO_0000112 "example of usage"@en)
AnnotationAssertion(obo:IAO_0000114 obo:IAO_0000112 obo:IAO_0000122)
AnnotationAssertion(obo:IAO_0000115 obo:IAO_0000112 "A phrase describing how a class name should be used. May also include other kinds of examples that facilitate immediate understanding of a class semantics, such as widely known prototypical subclasses or instances of the class. Although essential for high level terms, examples for low level terms (e.g., Affymetrix HU133 array) are not"@en)
AnnotationAssertion(obo:IAO_0000115 obo:IAO_0000112 "A phrase describing how a term should be used and/or a citation to a work which uses it. May also include other kinds of examples that facilitate immediate understanding, such as widely know prototypes or instances of a class, or cases where a relation is said to hold."@en)
AnnotationAssertion(obo:IAO_0000117 obo:IAO_0000112 "PERSON:Daniel Schober"@en)
AnnotationAssertion(obo:IAO_0000119 obo:IAO_0000112 "GROUP:OBI:<http://purl.obolibrary.org/obo/obi>"@en)
AnnotationAssertion(rdfs:isDefinedBy obo:IAO_0000112 obo:iao.owl)
AnnotationAssertion(rdfs:label obo:IAO_0000112 "example of usage")
AnnotationAssertion(rdfs:label obo:IAO_0000112 "example of usage"@en)

# Annotation Property: obo:IAO_0000114 (has curation status)

AnnotationAssertion(obo:IAO_0000111 obo:IAO_0000114 "has curation status"@en)
AnnotationAssertion(obo:IAO_0000117 obo:IAO_0000114 "PERSON:Alan Ruttenberg"@en)
AnnotationAssertion(obo:IAO_0000117 obo:IAO_0000114 "PERSON:Bill Bug"@en)
AnnotationAssertion(obo:IAO_0000117 obo:IAO_0000114 "PERSON:Melanie Courtot"@en)
AnnotationAssertion(obo:IAO_0000119 obo:IAO_0000114 "OBI_0000281"@en)
AnnotationAssertion(rdfs:label obo:IAO_0000114 "has curation status")
AnnotationAssertion(rdfs:label obo:IAO_0000114 "has curation status"@en)

# Annotation Property: obo:IAO_0000115 (textual definition)

AnnotationAssertion(obo:IAO_0000111 obo:IAO_0000115 "definition")
AnnotationAssertion(obo:IAO_0000111 obo:IAO_0000115 "definition"@en)
AnnotationAssertion(obo:IAO_0000111 obo:IAO_0000115 "textual definition")
AnnotationAssertion(obo:IAO_0000114 obo:IAO_0000115 obo:IAO_0000122)
AnnotationAssertion(obo:IAO_0000115 obo:IAO_0000115 "A property representing the English language definitions of what NCI means by the concept. They may also include information about the definition's source and attribution in a form that can easily be interpreted by software.")
AnnotationAssertion(obo:IAO_0000115 obo:IAO_0000115 "English language definitions of what NCI means by the concept. These are limited to 1024 characters. They may also include information about the definition's source and attribution in a form that can easily be interpreted by software.")
AnnotationAssertion(obo:IAO_0000115 obo:IAO_0000115 "The official OBI definition, explaining the meaning of a class or property. Shall be Aristotelian, formalized and normalized. Can be augmented with colloquial definitions."@en)
AnnotationAssertion(obo:IAO_0000115 obo:IAO_0000115 "The official definition, explaining the meaning of a class or property. Shall be Aristotelian, formalized and normalized. Can be augmented with colloquial definitions."@en)
AnnotationAssertion(obo:IAO_0000116 obo:IAO_0000115 "2012-04-05:
Barry Smith

The official OBI definition, explaining the meaning of a class or property: 'Shall be Aristotelian, formalized and normalized. Can be augmented with colloquial definitions'  is terrible.

Can you fix to something like:

A statement of necessary and sufficient conditions explaining the meaning of an expression referring to a class or property.

Alan Ruttenberg

Your proposed definition is a reasonable candidate, except that it is very common that necessary and sufficient conditions are not given. Mostly they are necessary, occasionally they are necessary and sufficient or just sufficient. Often they use terms that are not themselves defined and so they effectively can't be evaluated by those criteria.

On the specifics of the proposed definition:

We don't have definitions of 'meaning' or 'expression' or 'property'. For 'reference' in the intended sense I think we use the term 'denotation'. For 'expression', I think we you mean symbol, or identifier. For 'meaning' it differs for class and property. For class we want documentation that let's the intended reader determine whether an entity is instance of the class, or not. For property we want documentation that let's the intended reader determine, given a pair of potential relata, whether the assertion that the relation holds is true. The 'intended reader' part suggests that we also specify who, we expect, would be able to understand the definition, and also generalizes over human and computer reader to include textual and logical definition.

Personally, I am more comfortable weakening definition to documentation, with instructions as to what is desirable.

We also have the outstanding issue of how to aim different definitions to different audiences. A clinical audience reading chebi wants a different sort of definition documentation/definition from a chemistry trained audience, and similarly there is a need for a definition that is adequate for an ontologist to work with.  "@en)
AnnotationAssertion(obo:IAO_0000116 obo:IAO_0000115 "2012-04-05: 
Barry Smith

The official OBI definition, explaining the meaning of a class or property: 'Shall be Aristotelian, formalized and normalized. Can be augmented with colloquial definitions'  is terrible.

Can you fix to something like:

A statement of necessary and sufficient conditions explaining the meaning of an expression referring to a class or property.

Alan Ruttenberg

Your proposed definition is a reasonable candidate, except that it is very common that necessary and sufficient conditions are not given. Mostly they are necessary, occasionally they are necessary and sufficient or just sufficient. Often they use terms that are not themselves defined and so they effectively can't be evaluated by those criteria. 

On the specifics of the proposed definition:

We don't have definitions of 'meaning' or 'expression' or 'property'. For 'reference' in the intended sense I think we use the term 'denotation'. For 'expression', I think we you mean symbol, or identifier. For 'meaning' it differs for class and property. For class we want documentation that let's the intended reader determine whether an entity is instance of the class, or not. For property we want documentation that let's the intended reader determine, given a pair of potential relata, whether the assertion that the relation holds is true. The 'intended reader' part suggests that we also specify who, we expect, would be able to understand the definition, and also generalizes over human and computer reader to include textual and logical definition. 

Personally, I am more comfortable weakening definition to documentation, with instructions as to what is desirable. 

We also have the outstanding issue of how to aim different definitions to different audiences. A clinical audience reading chebi wants a different sort of definition documentation/definition from a chemistry trained audience, and similarly there is a need for a definition that is adequate for an ontologist to work with.  "@en)
AnnotationAssertion(obo:IAO_0000117 obo:IAO_0000115 "PERSON:Daniel Schober"@en)
AnnotationAssertion(obo:IAO_0000119 obo:IAO_0000115 "GROUP:OBI:<http://purl.obolibrary.org/obo/obi>"@en)
AnnotationAssertion(oboInOwl:hasExactSynonym obo:IAO_0000115 "DEFINITION")
AnnotationAssertion(rdfs:isDefinedBy obo:IAO_0000115 obo:iao.owl)
AnnotationAssertion(rdfs:label obo:IAO_0000115 "definition")
AnnotationAssertion(rdfs:label obo:IAO_0000115 "definition"@en)
AnnotationAssertion(rdfs:label obo:IAO_0000115 "textual definition")

# Annotation Property: obo:IAO_0000116 (editor note)

AnnotationAssertion(obo:IAO_0000111 obo:IAO_0000116 "editor note"@en)
AnnotationAssertion(obo:IAO_0000114 obo:IAO_0000116 obo:IAO_0000122)
AnnotationAssertion(obo:IAO_0000115 obo:IAO_0000116 "An administrative note intended for its editor. It may not be included in the publication version of the ontology, so it should contain nothing necessary for end users to understand the ontology."@en)
AnnotationAssertion(obo:IAO_0000117 obo:IAO_0000116 "PERSON:Daniel Schober"@en)
AnnotationAssertion(obo:IAO_0000119 obo:IAO_0000116 "GROUP:OBI:<http://purl.obfoundry.org/obo/obi>"@en)
AnnotationAssertion(obo:IAO_0000119 obo:IAO_0000116 "GROUP:OBI:<http://purl.obofoundry.org/obo/obi>"@en)
AnnotationAssertion(oboInOwl:hasDbXref obo:IAO_0000116 "IAO:0000116")
AnnotationAssertion(oboInOwl:hasOBONamespace obo:IAO_0000116 "uberon")
AnnotationAssertion(oboInOwl:id obo:IAO_0000116 "editor_note")
AnnotationAssertion(oboInOwl:is_metadata_tag obo:IAO_0000116 "1"^^xsd:integer)
AnnotationAssertion(oboInOwl:shorthand obo:IAO_0000116 "editor_note")
AnnotationAssertion(rdfs:isDefinedBy obo:IAO_0000116 obo:iao.owl)
AnnotationAssertion(rdfs:label obo:IAO_0000116 "editor note")
AnnotationAssertion(rdfs:label obo:IAO_0000116 "editor note"@en)

# Annotation Property: obo:IAO_0000117 (term editor)

AnnotationAssertion(obo:IAO_0000111 obo:IAO_0000117 "definition editor"@en)
AnnotationAssertion(obo:IAO_0000111 obo:IAO_0000117 "term editor"@en)
AnnotationAssertion(obo:IAO_0000114 obo:IAO_0000117 obo:IAO_0000122)
AnnotationAssertion(obo:IAO_0000115 obo:IAO_0000117 "Name of editor entering the definition in the file. The definition editor is a point of contact for information regarding the term. The definition editor may be, but is not always, the author of the definition, which may have been worked upon by several people"@en)
AnnotationAssertion(obo:IAO_0000115 obo:IAO_0000117 "Name of editor entering the term in the file. The term editor is a point of contact for information regarding the term. The term editor may be, but is not always, the author of the definition, which may have been worked upon by several people"@en)
AnnotationAssertion(obo:IAO_0000116 obo:IAO_0000117 "20110707, MC: label update to term editor and definition modified accordingly. See http://code.google.com/p/information-artifact-ontology/issues/detail?id=115."@en)
AnnotationAssertion(obo:IAO_0000116 obo:IAO_0000117 "20110707, MC: label update to term editor and definition modified accordingly. See https://github.com/information-artifact-ontology/IAO/issues/115."@en)
AnnotationAssertion(obo:IAO_0000117 obo:IAO_0000117 "PERSON:Daniel Schober"@en)
AnnotationAssertion(obo:IAO_0000119 obo:IAO_0000117 "GROUP:OBI:<http://purl.obolibrary.org/obo/obi>"@en)
AnnotationAssertion(rdfs:isDefinedBy obo:IAO_0000117 obo:iao.owl)
AnnotationAssertion(rdfs:label obo:IAO_0000117 "definition editor")
AnnotationAssertion(rdfs:label obo:IAO_0000117 "definition editor"@en)
AnnotationAssertion(rdfs:label obo:IAO_0000117 "term editor")
AnnotationAssertion(rdfs:label obo:IAO_0000117 "term editor"@en)

# Annotation Property: obo:IAO_0000118 (alternative term)

AnnotationAssertion(obo:IAO_0000111 obo:IAO_0000118 "alternative term"@en)
AnnotationAssertion(obo:IAO_0000114 obo:IAO_0000118 obo:IAO_0000125)
AnnotationAssertion(obo:IAO_0000115 obo:IAO_0000118 "An alternative name for a class or property which means the same thing as the preferred name (semantically equivalent)"@en)
AnnotationAssertion(obo:IAO_0000117 obo:IAO_0000118 "PERSON:Daniel Schober"@en)
AnnotationAssertion(obo:IAO_0000119 obo:IAO_0000118 "GROUP:OBI:<http://purl.obolibrary.org/obo/obi>"@en)
AnnotationAssertion(rdfs:isDefinedBy obo:IAO_0000118 obo:iao.owl)
AnnotationAssertion(rdfs:label obo:IAO_0000118 "alternative term")
AnnotationAssertion(rdfs:label obo:IAO_0000118 "alternative term"@en)

# Annotation Property: obo:IAO_0000119 (definition source)

AnnotationAssertion(obo:IAO_0000111 obo:IAO_0000119 "definition source"@en)
AnnotationAssertion(obo:IAO_0000114 obo:IAO_0000119 obo:IAO_0000122)
AnnotationAssertion(obo:IAO_0000115 obo:IAO_0000119 "Formal citation, e.g. identifier in external database to indicate / attribute source(s) for the definition. Free text indicate / attribute source(s) for the definition. EXAMPLE: Author Name, URI, MeSH Term C04, PUBMED ID, Wiki uri on 31.01.2007"@en)
AnnotationAssertion(obo:IAO_0000115 obo:IAO_0000119 "formal citation, e.g. identifier in external database to indicate / attribute source(s) for the definition. Free text indicate / attribute source(s) for the definition. EXAMPLE: Author Name, URI, MeSH Term C04, PUBMED ID, Wiki uri on 31.01.2007"@en)
AnnotationAssertion(obo:IAO_0000117 obo:IAO_0000119 "PERSON:Daniel Schober"@en)
AnnotationAssertion(obo:IAO_0000119 obo:IAO_0000119 "Discussion on obo-discuss mailing-list, see http://bit.ly/hgm99w")
AnnotationAssertion(obo:IAO_0000119 obo:IAO_0000119 "Discussion on obo-discuss mailing-list, see http://bit.ly/hgm99w"@en)
AnnotationAssertion(obo:IAO_0000119 obo:IAO_0000119 "GROUP:OBI:<http://purl.obolibrary.org/obo/obi>"@en)
AnnotationAssertion(rdfs:isDefinedBy obo:IAO_0000119 obo:iao.owl)
AnnotationAssertion(rdfs:label obo:IAO_0000119 "definition source")
AnnotationAssertion(rdfs:label obo:IAO_0000119 "definition source"@en)

# Annotation Property: obo:IAO_0000232 (curator note)

AnnotationAssertion(obo:IAO_0000111 obo:IAO_0000232 "curator note"@en)
AnnotationAssertion(obo:IAO_0000114 obo:IAO_0000232 obo:IAO_0000122)
AnnotationAssertion(obo:IAO_0000115 obo:IAO_0000232 "An administrative note of use for a curator but of no use for a user"@en)
AnnotationAssertion(obo:IAO_0000117 obo:IAO_0000232 "PERSON:Alan Ruttenberg"@en)
AnnotationAssertion(oboInOwl:hasDbXref obo:IAO_0000232 "IAO:0000232")
AnnotationAssertion(oboInOwl:hasOBONamespace obo:IAO_0000232 "uberon")
AnnotationAssertion(oboInOwl:id obo:IAO_0000232 "curator_notes")
AnnotationAssertion(oboInOwl:is_metadata_tag obo:IAO_0000232 "1"^^xsd:integer)
AnnotationAssertion(oboInOwl:shorthand obo:IAO_0000232 "curator_notes")
AnnotationAssertion(rdfs:isDefinedBy obo:IAO_0000232 obo:iao.owl)
AnnotationAssertion(rdfs:label obo:IAO_0000232 "curator note")
AnnotationAssertion(rdfs:label obo:IAO_0000232 "curator note"@en)
AnnotationAssertion(rdfs:label obo:IAO_0000232 "curator notes")

# Annotation Property: obo:IAO_0000233 (term tracker item)

AnnotationAssertion(obo:IAO_0000111 obo:IAO_0000233 "term tracker item")
AnnotationAssertion(obo:IAO_0000112 obo:IAO_0000233 "the URI for an OBI Terms ticket at sourceforge, such as https://sourceforge.net/p/obi/obi-terms/772/")
AnnotationAssertion(obo:IAO_0000114 obo:IAO_0000233 obo:IAO_0000125)
AnnotationAssertion(obo:IAO_0000115 obo:IAO_0000233 "An IRI or similar locator for a request or discussion of an ontology term.")
AnnotationAssertion(obo:IAO_0000117 obo:IAO_0000233 "Person: Jie Zheng, Chris Stoeckert, Alan Ruttenberg")
AnnotationAssertion(obo:IAO_0000119 obo:IAO_0000233 "Person: Jie Zheng, Chris Stoeckert, Alan Ruttenberg")
AnnotationAssertion(rdfs:comment obo:IAO_0000233 "The 'tracker item' can associate a tracker with a specific ontology term.")
AnnotationAssertion(rdfs:label obo:IAO_0000233 "term tracker item"@en)

# Annotation Property: obo:IAO_0000412 (imported from)

AnnotationAssertion(obo:IAO_0000111 obo:IAO_0000412 "imported from"@en)
AnnotationAssertion(obo:IAO_0000114 obo:IAO_0000412 obo:IAO_0000125)
AnnotationAssertion(obo:IAO_0000115 obo:IAO_0000412 "For external terms/classes, the ontology from which the term was imported"@en)
AnnotationAssertion(obo:IAO_0000117 obo:IAO_0000412 "PERSON:Alan Ruttenberg"@en)
AnnotationAssertion(obo:IAO_0000117 obo:IAO_0000412 "PERSON:Melanie Courtot"@en)
AnnotationAssertion(obo:IAO_0000119 obo:IAO_0000412 "GROUP:OBI:<http://purl.obolibrary.org/obo/obi>"@en)
AnnotationAssertion(rdfs:isDefinedBy obo:IAO_0000412 obo:iao.owl)
AnnotationAssertion(rdfs:label obo:IAO_0000412 "imported from")
AnnotationAssertion(rdfs:label obo:IAO_0000412 "imported from"@en)

# Annotation Property: obo:IAO_0000600 (elucidation)

AnnotationAssertion(obo:IAO_0000111 obo:IAO_0000600 "elucidation"@en)
AnnotationAssertion(obo:IAO_0000117 obo:IAO_0000600 "person:Alan Ruttenberg"@en)
AnnotationAssertion(obo:IAO_0000119 obo:IAO_0000600 "Person:Barry Smith"@en)
AnnotationAssertion(obo:IAO_0000600 obo:IAO_0000600 "Primitive terms in a highest-level ontology such as BFO are terms which are so basic to our understanding of reality that there is no way of defining them in a non-circular fashion. For these, therefore, we can provide only elucidations, supplemented by examples and by axioms"@en)
AnnotationAssertion(rdfs:isDefinedBy obo:IAO_0000600 obo:iao.owl)
AnnotationAssertion(rdfs:label obo:IAO_0000600 "elucidation")
AnnotationAssertion(rdfs:label obo:IAO_0000600 "elucidation"@en)

# Annotation Property: obo:IAO_0000601 (has associated axiom(nl))

AnnotationAssertion(obo:IAO_0000111 obo:IAO_0000601 "has associated axiom(nl)"@en)
AnnotationAssertion(obo:IAO_0000117 obo:IAO_0000601 "Person:Alan Ruttenberg"@en)
AnnotationAssertion(obo:IAO_0000119 obo:IAO_0000601 "Person:Alan Ruttenberg"@en)
AnnotationAssertion(obo:IAO_0000600 obo:IAO_0000601 "An axiom associated with a term expressed using natural language"@en)
AnnotationAssertion(rdfs:isDefinedBy obo:IAO_0000601 obo:iao.owl)
AnnotationAssertion(rdfs:label obo:IAO_0000601 "has associated axiom(nl)")
AnnotationAssertion(rdfs:label obo:IAO_0000601 "has associated axiom(nl)"@en)

# Annotation Property: obo:IAO_0000602 (has associated axiom(fol))

AnnotationAssertion(obo:IAO_0000111 obo:IAO_0000602 "has associated axiom(fol)"@en)
AnnotationAssertion(obo:IAO_0000117 obo:IAO_0000602 "Person:Alan Ruttenberg"@en)
AnnotationAssertion(obo:IAO_0000119 obo:IAO_0000602 "Person:Alan Ruttenberg"@en)
AnnotationAssertion(obo:IAO_0000600 obo:IAO_0000602 "An axiom expressed in first order logic using CLIF syntax"@en)
AnnotationAssertion(rdfs:isDefinedBy obo:IAO_0000602 obo:iao.owl)
AnnotationAssertion(rdfs:label obo:IAO_0000602 "has associated axiom(fol)")
AnnotationAssertion(rdfs:label obo:IAO_0000602 "has associated axiom(fol)"@en)

# Annotation Property: obo:IAO_0010000 (has axiom label)

AnnotationAssertion(rdfs:isDefinedBy obo:IAO_0010000 obo:iao.owl)
AnnotationAssertion(rdfs:label obo:IAO_0010000 "has axiom label"@en)

# Annotation Property: obo:NCIT_A11 (Has_NICHD_Parent)

AnnotationAssertion(obo:IAO_0000115 obo:NCIT_A11 "A property created to allow the source NICHD to assign a parent to each concept with the intent of creating a hierarchy that includes only terms in which they are the contributing source.")
AnnotationAssertion(obo:IAO_0000115 obo:NCIT_A11 "An association created to allow the source NICHD to assign a parent to each concept with the intent of creating a hierarchy that includes only terms in which they are a contributing source.")
AnnotationAssertion(obo:NCIT_NHC0 obo:NCIT_A11 "A11")
AnnotationAssertion(obo:NCIT_P106 obo:NCIT_A11 "Conceptual Entity")
AnnotationAssertion(obo:NCIT_P108 obo:NCIT_A11 "Has_NICHD_Parent")
AnnotationAssertion(oboInOwl:hasExactSynonym obo:NCIT_A11 "Has_NICHD_Parent")
AnnotationAssertion(rdfs:label obo:NCIT_A11 "Has_NICHD_Parent")
AnnotationPropertyRange(obo:NCIT_A11 xsd:anyURI)

# Annotation Property: obo:NCIT_NHC0 (code)

AnnotationAssertion(protege:readOnly obo:NCIT_NHC0 "true")
AnnotationAssertion(obo:IAO_0000115 obo:NCIT_NHC0 "A property representing a concept unique identifier within the NCI Enterprise Vocabulary Service's NCI Thesaurus.")
AnnotationAssertion(obo:NCIT_NHC0 obo:NCIT_NHC0 "NHC0")
AnnotationAssertion(obo:NCIT_P108 obo:NCIT_NHC0 "code")
AnnotationAssertion(oboInOwl:hasExactSynonym obo:NCIT_NHC0 "code")
AnnotationAssertion(rdfs:label obo:NCIT_NHC0 "code")
AnnotationPropertyRange(obo:NCIT_NHC0 xsd:string)

# Annotation Property: obo:NCIT_P106 (Semantic_Type)

AnnotationAssertion(obo:IAO_0000115 obo:NCIT_P106 "A property that represents a description of the sort of thing or category to which a concept belongs in the context of the UMLS semantic network.")
AnnotationAssertion(obo:IAO_0000115 obo:NCIT_P106 "The semantic type describes the sort of thing or category to which a concept belongs in the context of the UMLS semantic network.")
AnnotationAssertion(obo:NCIT_NHC0 obo:NCIT_P106 "P106")
AnnotationAssertion(obo:NCIT_P106 obo:NCIT_P106 "Conceptual Entity")
AnnotationAssertion(obo:NCIT_P107 obo:NCIT_P106 "Semantic Type")
AnnotationAssertion(obo:NCIT_P108 obo:NCIT_P106 "Semantic_Type")
AnnotationAssertion(obo:NCIT_P98 obo:NCIT_P106 "In general, applying semantic types aids in allowing users (or computer programs) to draw conclusions about concepts by virtue of the categories to which they have been assigned.  We use a set of semantic types developed for the UMLS Metathesaurus. There are currently 134 semantic types in the UMLS.")
AnnotationAssertion(oboInOwl:hasExactSynonym obo:NCIT_P106 "Semantic_Type")
AnnotationAssertion(rdfs:label obo:NCIT_P106 "Semantic_Type")
AnnotationPropertyRange(obo:NCIT_P106 obo:NCIT_Semantic_Type-enum)

# Annotation Property: obo:NCIT_P107 (Display_Name)

AnnotationAssertion(obo:IAO_0000115 obo:NCIT_P107 "A property representing an alternative Preferred Name for use in some NCI systems.")
AnnotationAssertion(obo:IAO_0000115 obo:NCIT_P107 "Provides an alternative Preferred Name for use in some NCI systems.")
AnnotationAssertion(obo:NCIT_NHC0 obo:NCIT_P107 "P107")
AnnotationAssertion(obo:NCIT_P106 obo:NCIT_P107 "Conceptual Entity")
AnnotationAssertion(obo:NCIT_P107 obo:NCIT_P107 "Display Name")
AnnotationAssertion(obo:NCIT_P108 obo:NCIT_P107 "Display_Name")
AnnotationAssertion(oboInOwl:hasExactSynonym obo:NCIT_P107 "Display Name")
AnnotationAssertion(oboInOwl:hasExactSynonym obo:NCIT_P107 "Display_Name")
AnnotationAssertion(rdfs:label obo:NCIT_P107 "Display_Name")
AnnotationPropertyRange(obo:NCIT_P107 xsd:string)

# Annotation Property: obo:NCIT_P108 (Preferred_Name)

AnnotationAssertion(obo:IAO_0000115 obo:NCIT_P108 "A property representing the word or phrase that NCI uses by preference to refer to the concept.")
AnnotationAssertion(obo:IAO_0000115 obo:NCIT_P108 "The word or phrase that NCI uses by preference to refer to the concept.")
AnnotationAssertion(obo:NCIT_NHC0 obo:NCIT_P108 "P108")
AnnotationAssertion(obo:NCIT_P106 obo:NCIT_P108 "Conceptual Entity")
AnnotationAssertion(obo:NCIT_P107 obo:NCIT_P108 "Preferred Name")
AnnotationAssertion(obo:NCIT_P108 obo:NCIT_P108 "Preferred_Name")
AnnotationAssertion(oboInOwl:hasExactSynonym obo:NCIT_P108 "Preferred Name")
AnnotationAssertion(oboInOwl:hasExactSynonym obo:NCIT_P108 "Preferred Term")
AnnotationAssertion(oboInOwl:hasExactSynonym obo:NCIT_P108 "Preferred_Name")
AnnotationAssertion(rdfs:label obo:NCIT_P108 "Preferred_Name")
AnnotationPropertyRange(obo:NCIT_P108 xsd:string)

# Annotation Property: obo:NCIT_P207 (UMLS_CUI)

AnnotationAssertion(obo:IAO_0000115 obo:NCIT_P207 "A property representing the concept unique identifier (CUI) assigned by the National Library of Medicine (NLM). If a concept in any NCI-maintained knowledgebase exists in the NLM Unified Medical Language System (UMLS), NCI includes the NLM CUI among the information we provide about the concept.")
AnnotationAssertion(obo:IAO_0000115 obo:NCIT_P207 "Concept Unique Identifiers, or CUIs, are concept numbers assigned by the National Library of Medicine (NLM). If a concept in any NCI-maintained knowledgebase exists in the NLM Unified Medical Language System (UMLS), NCI includes the NLM CUI among the information we provide about the concept.")
AnnotationAssertion(obo:NCIT_NHC0 obo:NCIT_P207 "P207")
AnnotationAssertion(obo:NCIT_P106 obo:NCIT_P207 "Conceptual Entity")
AnnotationAssertion(obo:NCIT_P107 obo:NCIT_P207 "UMLS CUI")
AnnotationAssertion(obo:NCIT_P108 obo:NCIT_P207 "UMLS_CUI")
AnnotationAssertion(oboInOwl:hasExactSynonym obo:NCIT_P207 "UMLS_CUI")
AnnotationAssertion(rdfs:label obo:NCIT_P207 "UMLS_CUI")
AnnotationPropertyRange(obo:NCIT_P207 xsd:string)

# Annotation Property: obo:NCIT_P208 (NCI_META_CUI)

AnnotationAssertion(obo:IAO_0000115 obo:NCIT_P208 "A property representing the concept unique identifier (CUI) for those concepts that appear in NCI Metathesaurus but not in the National Library of Medicine Unified Medical Language System (NLM UMLS).")
AnnotationAssertion(obo:NCIT_NHC0 obo:NCIT_P208 "P208")
AnnotationAssertion(obo:NCIT_P106 obo:NCIT_P208 "Conceptual Entity")
AnnotationAssertion(obo:NCIT_P107 obo:NCIT_P208 "NCI Metathesaurus CUI")
AnnotationAssertion(obo:NCIT_P108 obo:NCIT_P208 "NCI_META_CUI")
AnnotationAssertion(oboInOwl:hasExactSynonym obo:NCIT_P208 "NCI_META_CUI")
AnnotationAssertion(rdfs:label obo:NCIT_P208 "NCI_META_CUI")
AnnotationPropertyRange(obo:NCIT_P208 xsd:string)

# Annotation Property: obo:NCIT_P322 (Contributing_Source)

AnnotationAssertion(obo:IAO_0000115 obo:NCIT_P322 "A property is used to indicate when a non-EVS entity has contributed to, and has a stake in, a concept. This is used where such entities, within or outside NCI, have indicated the need to be able to track their own concepts. A single concept can have multiple instances of this property if multiple entities have such a defined stake.")
AnnotationAssertion(obo:IAO_0000115 obo:NCIT_P322 "This property is used to indicate when a non-EVS entity has contributed to, and has a stake in, a concept.  This is used where such entities, within or outside NCI, have indicated the need to be able to track their own concepts. A single concept can have multiple instances of this property if multiple entities have such a defined stake.")
AnnotationAssertion(obo:NCIT_NHC0 obo:NCIT_P322 "P322")
AnnotationAssertion(obo:NCIT_P106 obo:NCIT_P322 "Conceptual Entity")
AnnotationAssertion(obo:NCIT_P107 obo:NCIT_P322 "Contributing Source")
AnnotationAssertion(obo:NCIT_P108 obo:NCIT_P322 "Contributing_Source")
AnnotationAssertion(oboInOwl:hasExactSynonym obo:NCIT_P322 "Contributing_Source")
AnnotationAssertion(rdfs:label obo:NCIT_P322 "Contributing_Source")
AnnotationPropertyRange(obo:NCIT_P322 obo:NCIT_Contributing_Source-enum)

# Annotation Property: obo:NCIT_P325 (ALT_DEFINITION)

AnnotationAssertion(obo:IAO_0000115 obo:NCIT_P325 "A property representing the English language definition of a concept from a source other than NCI.")
AnnotationAssertion(obo:IAO_0000115 obo:NCIT_P325 "English language definitions of what a source other than NCI means by the concept. These are limited to 1024 characters. They include information about the definition's source in a form that can easily be interpreted by software.")
AnnotationAssertion(obo:NCIT_NHC0 obo:NCIT_P325 "P325")
AnnotationAssertion(obo:NCIT_P106 obo:NCIT_P325 "Conceptual Entity")
AnnotationAssertion(obo:NCIT_P107 obo:NCIT_P325 "[source] Definition")
AnnotationAssertion(obo:NCIT_P108 obo:NCIT_P325 "ALT_DEFINITION")
AnnotationAssertion(oboInOwl:hasExactSynonym obo:NCIT_P325 "ALT_DEFINITION")
AnnotationAssertion(rdfs:label obo:NCIT_P325 "ALT_DEFINITION")
AnnotationPropertyRange(obo:NCIT_P325 obo:NCIT_textArea)

# Annotation Property: obo:NCIT_P366 (Legacy_Concept_Name)

AnnotationAssertion(protege:readOnly obo:NCIT_P366 "true")
AnnotationAssertion(obo:IAO_0000115 obo:NCIT_P366 "A property representing a retired unique concept identifier created and stored as Concept Name by legacy EVS software. Use of these values was long discouraged, but continued as late as 2009 when creation of new values ceased and Concept Name was retired. Legacy values are intended solely to help resolve and update earlier coding.")
AnnotationAssertion(obo:IAO_0000115 obo:NCIT_P366 "A retired unique concept identifier created and stored as Concept Name by legacy EVS software.  Use of these values was long discouraged, but continued as late as 2009 when creation of new values ceased and Concept Name was retired.  Legacy values are intended solely to help resolve and update earlier coding.")
AnnotationAssertion(obo:NCIT_NHC0 obo:NCIT_P366 "P366")
AnnotationAssertion(obo:NCIT_P106 obo:NCIT_P366 "Conceptual Entity")
AnnotationAssertion(obo:NCIT_P108 obo:NCIT_P366 "Legacy Concept Name")
AnnotationAssertion(oboInOwl:hasExactSynonym obo:NCIT_P366 "Legacy Concept Name")
AnnotationAssertion(rdfs:label obo:NCIT_P366 "Legacy_Concept_Name")
AnnotationPropertyRange(obo:NCIT_P366 xsd:string)

# Annotation Property: obo:NCIT_P371 (NICHD_Hierarchy_Term)

AnnotationAssertion(obo:IAO_0000115 obo:NCIT_P371 "A property representing a term chosen by NICHD to be used in the representation of the NICHD hierarchy.")
AnnotationAssertion(obo:NCIT_NHC0 obo:NCIT_P371 "P371")
AnnotationAssertion(obo:NCIT_P106 obo:NCIT_P371 "Conceptual Entity")
AnnotationAssertion(obo:NCIT_P108 obo:NCIT_P371 "NICHD_Hierarchy_Term")
AnnotationAssertion(obo:NCIT_P322 obo:NCIT_P371 "NICHD")
AnnotationAssertion(oboInOwl:hasExactSynonym obo:NCIT_P371 "NICHD_Hierarchy_Term")
AnnotationAssertion(rdfs:label obo:NCIT_P371 "NICHD_Hierarchy_Term")
AnnotationPropertyRange(obo:NCIT_P371 xsd:string)

# Annotation Property: obo:NCIT_P375 (Maps_To)

AnnotationAssertion(obo:IAO_0000115 obo:NCIT_P375 "A property representing that a term in another terminology has been mapped to a term in NCIt and describes the relationship between the mapped terms.")
AnnotationAssertion(obo:NCIT_NHC0 obo:NCIT_P375 "P375")
AnnotationAssertion(obo:NCIT_P106 obo:NCIT_P375 "Conceptual Entity")
AnnotationAssertion(obo:NCIT_P108 obo:NCIT_P375 "Maps_To")
AnnotationAssertion(oboInOwl:hasExactSynonym obo:NCIT_P375 "Maps_To")
AnnotationAssertion(rdfs:label obo:NCIT_P375 "Maps_To")
AnnotationPropertyRange(obo:NCIT_P375 obo:NCIT_textArea)

# Annotation Property: obo:NCIT_P98 (DesignNote)

AnnotationAssertion(obo:IAO_0000115 obo:NCIT_P98 "A property representing notations made by NCI vocabulary curators. They are intended to provide supplemental, unstructured information to the user or additional insight about the concept.")
AnnotationAssertion(obo:IAO_0000115 obo:NCIT_P98 "Design notes are notations made by NCI vocabulary curators. They are intended to provide supplemental, unstructured information to the user or additional insight about the concept.")
AnnotationAssertion(obo:NCIT_NHC0 obo:NCIT_P98 "P98")
AnnotationAssertion(obo:NCIT_P106 obo:NCIT_P98 "Conceptual Entity")
AnnotationAssertion(obo:NCIT_P107 obo:NCIT_P98 "DesignNote")
AnnotationAssertion(obo:NCIT_P108 obo:NCIT_P98 "DesignNote")
AnnotationAssertion(oboInOwl:hasExactSynonym obo:NCIT_P98 "DesignNote")
AnnotationAssertion(rdfs:label obo:NCIT_P98 "DesignNote")
AnnotationPropertyRange(obo:NCIT_P98 xsd:string)

# Annotation Property: obo:OBI_0001847 (ISA alternative term)

AnnotationAssertion(obo:IAO_0000111 obo:OBI_0001847 "ISA alternative term"@en)
AnnotationAssertion(obo:IAO_0000114 obo:OBI_0001847 obo:IAO_0000122)
AnnotationAssertion(obo:IAO_0000115 obo:OBI_0001847 "An alternative term used by the ISA tools project (http://isa-tools.org).")
AnnotationAssertion(obo:IAO_0000116 obo:OBI_0001847 "Requested by Alejandra Gonzalez-Beltran
https://sourceforge.net/tracker/?func=detail&aid=3603413&group_id=177891&atid=886178")
AnnotationAssertion(obo:IAO_0000117 obo:OBI_0001847 "Person: Alejandra Gonzalez-Beltran")
AnnotationAssertion(obo:IAO_0000117 obo:OBI_0001847 "Person: Philippe Rocca-Serra")
AnnotationAssertion(obo:IAO_0000119 obo:OBI_0001847 "ISA tools project (http://isa-tools.org)")
AnnotationAssertion(rdfs:label obo:OBI_0001847 "ISA alternative term"@en)
SubAnnotationPropertyOf(obo:OBI_0001847 obo:IAO_0000118)

# Annotation Property: obo:OBI_0001886 (NIAID GSCID-BRC alternative term)

AnnotationAssertion(obo:IAO_0000111 obo:OBI_0001886 "NIAID GSCID-BRC alternative term"@en)
AnnotationAssertion(obo:IAO_0000114 obo:OBI_0001886 obo:IAO_0000122)
AnnotationAssertion(obo:IAO_0000115 obo:OBI_0001886 "An alternative term used by the National Institute of Allergy and Infectious Diseases (NIAID) Genomic Sequencing Centers for Infectious Diseases (GSCID) and Bioinformatics Resource Centers (BRC).")
AnnotationAssertion(obo:IAO_0000117 obo:OBI_0001886 "PERSON: Chris Stoeckert, Jie Zheng")
AnnotationAssertion(obo:IAO_0000119 obo:OBI_0001886 "NIAID GSCID-BRC metadata working group")
AnnotationAssertion(rdfs:label obo:OBI_0001886 "NIAID GSCID-BRC alternative term"@en)
SubAnnotationPropertyOf(obo:OBI_0001886 obo:IAO_0000118)

# Annotation Property: obo:OBI_9991118 (IEDB alternative term)

AnnotationAssertion(obo:IAO_0000111 obo:OBI_9991118 "IEDB alternative term")
AnnotationAssertion(obo:IAO_0000114 obo:OBI_9991118 obo:IAO_0000122)
AnnotationAssertion(obo:IAO_0000115 obo:OBI_9991118 "An alternative term used by the IEDB.")
AnnotationAssertion(obo:IAO_0000117 obo:OBI_9991118 "PERSON:Randi Vita, Jason Greenbaum, Bjoern Peters")
AnnotationAssertion(obo:IAO_0000119 obo:OBI_9991118 "IEDB")
AnnotationAssertion(rdfs:label obo:OBI_9991118 "IEDB alternative term")
SubAnnotationPropertyOf(obo:OBI_9991118 obo:IAO_0000118)

# Annotation Property: obo:OPMI_0000364 (NCIT code)

AnnotationAssertion(obo:IAO_0000115 obo:OPMI_0000364 "An annotation property that refers to a code defined by NCIT")
AnnotationAssertion(rdfs:label obo:OPMI_0000364 "NCIT code"@en)

# Annotation Property: <http://purl.obolibrary.org/obo/ncbitaxon#has_rank> (has_rank)

AnnotationAssertion(obo:IAO_0000115 <http://purl.obolibrary.org/obo/ncbitaxon#has_rank> "A metadata relation between a class and its taxonomic rank (eg species, family)")
AnnotationAssertion(oboInOwl:hasOBONamespace <http://purl.obolibrary.org/obo/ncbitaxon#has_rank> "ncbi_taxonomy")
AnnotationAssertion(rdfs:label <http://purl.obolibrary.org/obo/ncbitaxon#has_rank> "has_rank")

# Annotation Property: dc:description (Description)

AnnotationAssertion(dc:description dc:description "Description may include but is not limited to: an abstract,
         table of contents, reference to a graphical representation
         of content or a free-text account of the content."@en-us)
AnnotationAssertion(rdfs:comment dc:description "An account of the content of the resource."@en-us)
AnnotationAssertion(rdfs:isDefinedBy dc:description <http://purl.org/dc/elements/1.1/>)
AnnotationAssertion(rdfs:label dc:description "Description")
AnnotationAssertion(rdfs:label dc:description "Description"@en-us)

# Annotation Property: dc:source (Source)

AnnotationAssertion(dc:description dc:source "The present resource may be derived from the Source resource
         in whole or in part.  Recommended best practice is to reference
         the resource by means of a string or number conforming to a
         formal identification system."@en-us)
AnnotationAssertion(rdfs:comment dc:source "A reference to a resource from which the present resource
         is derived."@en-us)
AnnotationAssertion(rdfs:isDefinedBy dc:source <http://purl.org/dc/elements/1.1/>)
AnnotationAssertion(rdfs:label dc:source "Source")
AnnotationAssertion(rdfs:label dc:source "Source"@en-us)

# Annotation Property: oboInOwl:hasAlternativeId (has_alternative_id)

AnnotationAssertion(rdfs:label oboInOwl:hasAlternativeId "has_alternative_id")

# Annotation Property: oboInOwl:hasDbXref (database_cross_reference)

AnnotationAssertion(rdfs:label oboInOwl:hasDbXref "database_cross_reference")

# Annotation Property: oboInOwl:hasExactSynonym (has exact synonym)

AnnotationAssertion(obo:IAO_0000115 oboInOwl:hasExactSynonym "A property representing a fully qualified synonym, contains the string, term type, source, and an optional source code if appropriate. Each subfield is deliniated to facilitate interpretation by software.")
AnnotationAssertion(obo:IAO_0000115 oboInOwl:hasExactSynonym "Fully qualified synonym, contains the string, term type, source, and an optional source code if appropriate. Each subfield is deliniated to facilitate interpretation by software.")
AnnotationAssertion(oboInOwl:hasExactSynonym oboInOwl:hasExactSynonym "FULL_SYN")
AnnotationAssertion(oboInOwl:hasExactSynonym oboInOwl:hasExactSynonym "Synonym with Source Data")
AnnotationAssertion(rdfs:label oboInOwl:hasExactSynonym "has exact synonym")
AnnotationAssertion(rdfs:label oboInOwl:hasExactSynonym "has_exact_synonym")

# Annotation Property: oboInOwl:hasNarrowSynonym (has_narrow_synonym)

AnnotationAssertion(rdfs:label oboInOwl:hasNarrowSynonym "has_narrow_synonym")

# Annotation Property: oboInOwl:hasOBONamespace (has_obo_namespace)

AnnotationAssertion(rdfs:label oboInOwl:hasOBONamespace "has_obo_namespace")

# Annotation Property: oboInOwl:hasRelatedSynonym (has_related_synonym)

AnnotationAssertion(rdfs:label oboInOwl:hasRelatedSynonym "has_related_synonym")

# Annotation Property: oboInOwl:inSubset (in_subset)

AnnotationAssertion(obo:IAO_0000115 oboInOwl:inSubset "An association that connects the concept defining a particular terminology subset with concepts that belong to this subset.")
AnnotationAssertion(obo:IAO_0000115 oboInOwl:inSubset "Used to associate the concept defining a particular terminology subset with concepts that belong to this subset.")
AnnotationAssertion(oboInOwl:hasExactSynonym oboInOwl:inSubset "Concept_In_Subset")
AnnotationAssertion(rdfs:label oboInOwl:inSubset "in subset")
AnnotationAssertion(rdfs:label oboInOwl:inSubset "in_subset")

# Annotation Property: oboInOwl:shorthand (shorthand)

AnnotationAssertion(rdfs:label oboInOwl:shorthand "shorthand")

# Annotation Property: rdfs:label (label)

AnnotationAssertion(obo:IAO_0000111 rdfs:label "label")
AnnotationAssertion(rdfs:label rdfs:label "label")
AnnotationAssertion(rdfs:label rdfs:label "label"@en)


############################
#   Object Properties
############################

# Object Property: obo:BFO_0000051 (has part)

AnnotationAssertion(rdfs:label obo:BFO_0000051 "has part"@en)
TransitiveObjectProperty(obo:BFO_0000051)

# Object Property: obo:BFO_0000055 (realizes)

AnnotationAssertion(rdfs:label obo:BFO_0000055 "realizes"@en)

# Object Property: obo:BFO_0000062 (preceded_by)

AnnotationAssertion(rdfs:label obo:BFO_0000062 "preceded by"@en)
AnnotationAssertion(rdfs:label obo:BFO_0000062 "preceded_by")
TransitiveObjectProperty(obo:BFO_0000062)

# Object Property: obo:CTO_0000126 (has investigator)

AnnotationAssertion(obo:IAO_0000116 obo:CTO_0000126 "Corresponding to CT.gov XML tag \"Principal Investigator\", a type of \"responsible party\"

<xs:simpleType name=\"role_enum\">
<xs:restriction base=\"xs:string\">
<xs:enumeration value=\"Principal Investigator\"/>
<xs:enumeration value=\"Sub-Investigator\"/>
<xs:enumeration value=\"Study Chair\"/>
<xs:enumeration value=\"Study Director\"/>
</xs:restriction>
</xs:simpleType>")
AnnotationAssertion(dc:creator obo:CTO_0000126 "Asiyah Yu Lin, Qingliang \"Leon\" Li")
AnnotationAssertion(dc:date obo:CTO_0000126 "2021-06-10T13:42:36Z"^^xsd:dateTime)
AnnotationAssertion(dc:source obo:CTO_0000126 "https://clinicaltrials.gov/ct2/html/images/info/public.xsd")
AnnotationAssertion(rdfs:label obo:CTO_0000126 "has investigator"@en)

# Object Property: obo:CTO_0000127 (has collaborator)

AnnotationAssertion(obo:IAO_0000116 obo:CTO_0000127 "Corresponding to CT.gov XML tag \"collaborator\", a type of \"sponsors\"

<!--  === Sponsors ====================================================  -->
<xs:complexType name=\"sponsors_struct\">
<xs:sequence>
<xs:element name=\"lead_sponsor\" type=\"sponsor_struct\"/>
<xs:element name=\"collaborator\" type=\"sponsor_struct\" minOccurs=\"0\" maxOccurs=\"unbounded\"/>
</xs:sequence>
</xs:complexType>")
AnnotationAssertion(dc:creator obo:CTO_0000127 "Asiyah Yu Lin, Qingliang \"Leon\" Li")
AnnotationAssertion(dc:date obo:CTO_0000127 "2021-06-10T13:45:21Z"^^xsd:dateTime)
AnnotationAssertion(dc:source obo:CTO_0000127 "https://clinicaltrials.gov/ct2/html/images/info/public.xsd")
AnnotationAssertion(rdfs:label obo:CTO_0000127 "has collaborator"@en)

# Object Property: obo:CTO_0000128 (has contact)

AnnotationAssertion(obo:IAO_0000116 obo:CTO_0000128 "Corresponding to CT.gov XML tag: \"overall_contact\"


<xs:element name=\"clinical_study\">
<xs:complexType>
<xs:sequence>
...
<xs:element name=\"overall_contact\" type=\"contact_struct\" minOccurs=\"0\"/>
...")
AnnotationAssertion(dc:creator obo:CTO_0000128 "Asiyah Yu Lin, Qingliang \"Leon\" Li")
AnnotationAssertion(dc:date obo:CTO_0000128 "2021-06-10T13:46:58Z"^^xsd:dateTime)
AnnotationAssertion(dc:source obo:CTO_0000128 "https://clinicaltrials.gov/ct2/html/images/info/public.xsd")
AnnotationAssertion(rdfs:label obo:CTO_0000128 "has contact"@en)

# Object Property: obo:CTO_0000129 (has clinical trial site)

AnnotationAssertion(obo:IAO_0000116 obo:CTO_0000129 "Corresponding to CT.gov XML tag : \"location_countries\"


<xs:element name=\"clinical_study\">
<xs:complexType>
<xs:sequence>
...
<xs:element name=\"location_countries\" type=\"countries_struct\" minOccurs=\"0\"/>
...")
AnnotationAssertion(dc:creator obo:CTO_0000129 "Asiyah Yu Lin, Qingliang \"Leon\" Li")
AnnotationAssertion(dc:date obo:CTO_0000129 "2021-06-10T13:47:26Z"^^xsd:dateTime)
AnnotationAssertion(dc:source obo:CTO_0000129 "https://clinicaltrials.gov/ct2/html/images/info/public.xsd")
AnnotationAssertion(rdfs:label obo:CTO_0000129 "has clinical trial site"@en)

# Object Property: obo:CTO_0000130 (has primary sponsor)

AnnotationAssertion(obo:IAO_0000116 obo:CTO_0000130 "Corresponding to CT.gov XML tag \"lead_sponsor\", a type of \"sponsors\"

<!--  === Sponsors ====================================================  -->
<xs:complexType name=\"sponsors_struct\">
<xs:sequence>
<xs:element name=\"lead_sponsor\" type=\"sponsor_struct\"/>
<xs:element name=\"collaborator\" type=\"sponsor_struct\" minOccurs=\"0\" maxOccurs=\"unbounded\"/>
</xs:sequence>
</xs:complexType>")
AnnotationAssertion(dc:creator obo:CTO_0000130 "Asiyah Yu Lin, Qingliang \"Leon\" Li")
AnnotationAssertion(dc:date obo:CTO_0000130 "2021-06-10T13:47:47Z"^^xsd:dateTime)
AnnotationAssertion(dc:source obo:CTO_0000130 "https://clinicaltrials.gov/ct2/html/images/info/public.xsd")
AnnotationAssertion(rdfs:label obo:CTO_0000130 "has primary sponsor"@en)

# Object Property: obo:CTO_0000131 (has funding agency)

AnnotationAssertion(obo:IAO_0000116 obo:CTO_0000131 "Corresponding to CT.gov XML tag \"agency\"

<!--  === Sponsor =====================================================  -->
<xs:simpleType name=\"agency_class_enum\">
<xs:restriction base=\"xs:string\">
<xs:enumeration value=\"NIH\"/>
<xs:enumeration value=\"U.S. Fed\"/>
<xs:enumeration value=\"Industry\"/>
<xs:enumeration value=\"Other\"/>
</xs:restriction>
</xs:simpleType>
<xs:complexType name=\"sponsor_struct\">
<xs:sequence>
<xs:element name=\"agency\" type=\"xs:string\"/>
<xs:element name=\"agency_class\" type=\"agency_class_enum\" minOccurs=\"0\"/>
</xs:sequence>
</xs:complexType>")
AnnotationAssertion(dc:creator obo:CTO_0000131 "Asiyah Yu Lin, Qingliang \"Leon\" Li")
AnnotationAssertion(dc:date obo:CTO_0000131 "2021-06-10T13:48:23Z"^^xsd:dateTime)
AnnotationAssertion(dc:source obo:CTO_0000131 "https://clinicaltrials.gov/ct2/html/images/info/public.xsd")
AnnotationAssertion(rdfs:label obo:CTO_0000131 "has funding agency"@en)

# Object Property: obo:IAO_0000136 (is about)

AnnotationAssertion(rdfs:label obo:IAO_0000136 "is about"@en)

# Object Property: obo:OBI_0000293 (has_specified_input)

AnnotationAssertion(rdfs:label obo:OBI_0000293 "has_specified_input"@en)

# Object Property: obo:OPMI_0000366 (has process quality)

AnnotationAssertion(rdfs:label obo:OPMI_0000366 "has process quality"@en)

# Object Property: obo:RO_0000057 (has participant)

AnnotationAssertion(rdfs:label obo:RO_0000057 "has participant"@en)

# Object Property: obo:RO_0000059 (concretizes)

AnnotationAssertion(rdfs:label obo:RO_0000059 "concretizes"@en)

# Object Property: obo:RO_0000087 (has role)

AnnotationAssertion(rdfs:label obo:RO_0000087 "has role"@en)

# Object Property: obo:RO_0002248 (has active ingredient)

AnnotationAssertion(obo:IAO_0000112 obo:RO_0002248 "Any portion of roundup 'has active ingredient' some glyphosate")
AnnotationAssertion(obo:IAO_0000115 obo:RO_0002248 "A relationship that holds between a substance and a chemical entity, if the chemical entity is part of the substance, and the chemical entity forms the biologically active component of the substance.")
AnnotationAssertion(obo:IAO_0000412 obo:RO_0002248 obo:ro.owl)
AnnotationAssertion(oboInOwl:hasExactSynonym obo:RO_0002248 "has active substance")
AnnotationAssertion(oboInOwl:hasRelatedSynonym obo:RO_0002248 "has active pharmaceutical ingredient")
AnnotationAssertion(rdfs:label obo:RO_0002248 "has active ingredient")
InverseObjectProperties(obo:RO_0002248 obo:RO_0002249)

# Object Property: obo:RO_0002249 (active ingredient in)

AnnotationAssertion(rdfs:label obo:RO_0002249 "active ingredient in")

# Object Property: rdfs:subClassOf (rdfs:subClassOf)

AnnotationAssertion(obo:IAO_0000412 rdfs:subClassOf obo:gaz.owl)
AnnotationAssertion(obo:IAO_0000412 rdfs:subClassOf obo:opmi.owl)
TransitiveObjectProperty(rdfs:subClassOf)



############################
#   Classes
############################

# Class: obo:BFO_0000001 (entity)

AnnotationAssertion(obo:BFO_0000179 obo:BFO_0000001 "entity")
AnnotationAssertion(obo:BFO_0000180 obo:BFO_0000001 "Entity")
AnnotationAssertion(obo:IAO_0000112 obo:BFO_0000001 "Julius Caesar"@en)
AnnotationAssertion(obo:IAO_0000112 obo:BFO_0000001 "Verdi’s Requiem"@en)
AnnotationAssertion(obo:IAO_0000112 obo:BFO_0000001 "the Second World War"@en)
AnnotationAssertion(obo:IAO_0000112 obo:BFO_0000001 "your body mass index"@en)
AnnotationAssertion(obo:IAO_0000116 obo:BFO_0000001 "BFO 2 Reference: In all areas of empirical inquiry we encounter general terms of two sorts. First are general terms which refer to universals or types:animaltuberculosissurgical procedurediseaseSecond, are general terms used to refer to groups of entities which instantiate a given universal but do not correspond to the extension of any subuniversal of that universal because there is nothing intrinsic to the entities in question by virtue of which they – and only they – are counted as belonging to the given group. Examples are: animal purchased by the Emperortuberculosis diagnosed on a Wednesdaysurgical procedure performed on a patient from Stockholmperson identified as candidate for clinical trial #2056-555person who is signatory of Form 656-PPVpainting by Leonardo da VinciSuch terms, which represent what are called ‘specializations’ in [81"@en)
AnnotationAssertion(Annotation(obo:IAO_0010000 <http://purl.obolibrary.org/obo/bfo/axiom/0000004>) Annotation(rdfs:comment "per discussion with Barry Smith") Annotation(rdfs:seeAlso <http://www.referent-tracking.com/_RTU/papers/CeustersICbookRevised.pdf>) obo:IAO_0000116 obo:BFO_0000001 "Entity doesn't have a closure axiom because the subclasses don't necessarily exhaust all possibilites. For example Werner Ceusters 'portions of reality' include 4 sorts, entities (as BFO construes them), universals, configurations, and relations. It is an open question as to whether entities as construed in BFO will at some point also include these other portions of reality. See, for example, 'How to track absolutely everything' at http://www.referent-tracking.com/_RTU/papers/CeustersICbookRevised.pdf"@en)
AnnotationAssertion(Annotation(obo:IAO_0010000 <http://purl.obolibrary.org/obo/bfo/axiom/001-001>) obo:IAO_0000600 obo:BFO_0000001 "An entity is anything that exists or has existed or will exist. (axiom label in BFO2 Reference: [001-001])"@en)
AnnotationAssertion(rdfs:isDefinedBy obo:BFO_0000001 obo:bfo.owl)
AnnotationAssertion(rdfs:label obo:BFO_0000001 "entity"@en)
SubClassOf(obo:BFO_0000001 owl:Thing)

# Class: obo:BFO_0000002 (continuant)

AnnotationAssertion(obo:BFO_0000179 obo:BFO_0000002 "continuant")
AnnotationAssertion(obo:BFO_0000180 obo:BFO_0000002 "Continuant")
AnnotationAssertion(obo:IAO_0000115 obo:BFO_0000002 "An entity that exists in full at any time in which it exists at all, persists through time while maintaining its identity and has no temporal parts."@en)
AnnotationAssertion(obo:IAO_0000116 obo:BFO_0000002 "BFO 2 Reference: Continuant entities are entities which can be sliced to yield parts only along the spatial dimension, yielding for example the parts of your table which we call its legs, its top, its nails. ‘My desk stretches from the window to the door. It has spatial parts, and can be sliced (in space) in two. With respect to time, however, a thing is a continuant.’ [60, p. 240"@en)
AnnotationAssertion(obo:IAO_0000116 obo:BFO_0000002 "Continuant doesn't have a closure axiom because the subclasses don't necessarily exhaust all possibilites. For example, in an expansion involving bringing in some of Ceuster's other portions of reality, questions are raised as to whether universals are continuants"@en)
AnnotationAssertion(Annotation(obo:IAO_0010000 <http://purl.obolibrary.org/obo/bfo/axiom/0000007>) obo:IAO_0000116 obo:BFO_0000002 "Continuant doesn't have a closure axiom because the subclasses don't necessarily exhaust all possibilites. For example, in an expansion involving bringing in some of Ceuster's other portions of reality, questions are raised as to whether universals are continuants"@en)
AnnotationAssertion(obo:IAO_0000412 obo:BFO_0000002 obo:iao.owl)
AnnotationAssertion(obo:IAO_0000600 obo:BFO_0000002 "A continuant is an entity that persists, endures, or continues to exist through time while maintaining its identity. (axiom label in BFO2 Reference: [008-002])"@en)
AnnotationAssertion(Annotation(obo:IAO_0010000 <http://purl.obolibrary.org/obo/bfo/axiom/008-002>) obo:IAO_0000600 obo:BFO_0000002 "A continuant is an entity that persists, endures, or continues to exist through time while maintaining its identity. (axiom label in BFO2 Reference: [008-002])"@en)
AnnotationAssertion(obo:IAO_0000601 obo:BFO_0000002 "if b is a continuant and if, for some t, c has_continuant_part b at t, then c is a continuant. (axiom label in BFO2 Reference: [126-001])"@en)
AnnotationAssertion(Annotation(obo:IAO_0010000 <http://purl.obolibrary.org/obo/bfo/axiom/126-001>) obo:IAO_0000601 obo:BFO_0000002 "if b is a continuant and if, for some t, c has_continuant_part b at t, then c is a continuant. (axiom label in BFO2 Reference: [126-001])"@en)
AnnotationAssertion(obo:IAO_0000601 obo:BFO_0000002 "if b is a continuant and if, for some t, cis continuant_part of b at t, then c is a continuant. (axiom label in BFO2 Reference: [009-002])"@en)
AnnotationAssertion(Annotation(obo:IAO_0010000 <http://purl.obolibrary.org/obo/bfo/axiom/009-002>) obo:IAO_0000601 obo:BFO_0000002 "if b is a continuant and if, for some t, cis continuant_part of b at t, then c is a continuant. (axiom label in BFO2 Reference: [009-002])"@en)
AnnotationAssertion(obo:IAO_0000601 obo:BFO_0000002 "if b is a material entity, then there is some temporal interval (referred to below as a one-dimensional temporal region) during which b exists. (axiom label in BFO2 Reference: [011-002])"@en)
AnnotationAssertion(Annotation(obo:IAO_0010000 <http://purl.obolibrary.org/obo/bfo/axiom/011-002>) obo:IAO_0000601 obo:BFO_0000002 "if b is a material entity, then there is some temporal interval (referred to below as a one-dimensional temporal region) during which b exists. (axiom label in BFO2 Reference: [011-002])"@en)
AnnotationAssertion(obo:IAO_0000602 obo:BFO_0000002 "(forall (x y) (if (and (Continuant x) (exists (t) (continuantPartOfAt y x t))) (Continuant y))) // axiom label in BFO2 CLIF: [009-002] ")
AnnotationAssertion(Annotation(obo:IAO_0010000 <http://purl.obolibrary.org/obo/bfo/axiom/009-002>) obo:IAO_0000602 obo:BFO_0000002 "(forall (x y) (if (and (Continuant x) (exists (t) (continuantPartOfAt y x t))) (Continuant y))) // axiom label in BFO2 CLIF: [009-002] ")
AnnotationAssertion(obo:IAO_0000602 obo:BFO_0000002 "(forall (x y) (if (and (Continuant x) (exists (t) (hasContinuantPartOfAt y x t))) (Continuant y))) // axiom label in BFO2 CLIF: [126-001] ")
AnnotationAssertion(Annotation(obo:IAO_0010000 <http://purl.obolibrary.org/obo/bfo/axiom/126-001>) obo:IAO_0000602 obo:BFO_0000002 "(forall (x y) (if (and (Continuant x) (exists (t) (hasContinuantPartOfAt y x t))) (Continuant y))) // axiom label in BFO2 CLIF: [126-001] ")
AnnotationAssertion(obo:IAO_0000602 obo:BFO_0000002 "(forall (x) (if (Continuant x) (Entity x))) // axiom label in BFO2 CLIF: [008-002] ")
AnnotationAssertion(Annotation(obo:IAO_0010000 <http://purl.obolibrary.org/obo/bfo/axiom/008-002>) obo:IAO_0000602 obo:BFO_0000002 "(forall (x) (if (Continuant x) (Entity x))) // axiom label in BFO2 CLIF: [008-002] ")
AnnotationAssertion(obo:IAO_0000602 obo:BFO_0000002 "(forall (x) (if (Material Entity x) (exists (t) (and (TemporalRegion t) (existsAt x t))))) // axiom label in BFO2 CLIF: [011-002] ")
AnnotationAssertion(Annotation(obo:IAO_0010000 <http://purl.obolibrary.org/obo/bfo/axiom/011-002>) obo:IAO_0000602 obo:BFO_0000002 "(forall (x) (if (Material Entity x) (exists (t) (and (TemporalRegion t) (existsAt x t))))) // axiom label in BFO2 CLIF: [011-002] ")
AnnotationAssertion(rdfs:isDefinedBy obo:BFO_0000002 obo:bfo.owl)
AnnotationAssertion(rdfs:label obo:BFO_0000002 "continuant"@en)
SubClassOf(obo:BFO_0000002 obo:BFO_0000001)
DisjointClasses(obo:BFO_0000002 obo:BFO_0000003)

# Class: obo:BFO_0000003 (occurrent)

AnnotationAssertion(obo:BFO_0000179 obo:BFO_0000003 "occurrent")
AnnotationAssertion(obo:BFO_0000180 obo:BFO_0000003 "Occurrent")
AnnotationAssertion(obo:IAO_0000116 obo:BFO_0000003 "BFO 2 Reference: every occurrent that is not a temporal or spatiotemporal region is s-dependent on some independent continuant that is not a spatial region"@en)
AnnotationAssertion(obo:IAO_0000116 obo:BFO_0000003 "BFO 2 Reference: s-dependence obtains between every process and its participants in the sense that, as a matter of necessity, this process could not have existed unless these or those participants existed also. A process may have a succession of participants at different phases of its unfolding. Thus there may be different players on the field at different times during the course of a football game; but the process which is the entire game s-depends_on all of these players nonetheless. Some temporal parts of this process will s-depend_on on only some of the players."@en)
AnnotationAssertion(Annotation(obo:IAO_0010000 <http://purl.obolibrary.org/obo/bfo/axiom/0000006>) Annotation(rdfs:comment "per discussion with Barry Smith") obo:IAO_0000116 obo:BFO_0000003 "Occurrent doesn't have a closure axiom because the subclasses don't necessarily exhaust all possibilites. An example would be the sum of a process and the process boundary of another process."@en)
AnnotationAssertion(Annotation(obo:IAO_0010000 <http://purl.obolibrary.org/obo/bfo/axiom/0000012>) obo:IAO_0000116 obo:BFO_0000003 "Simons uses different terminology for relations of occurrents to regions: Denote the spatio-temporal location of a given occurrent e by 'spn[e]' and call this region its span. We may say an occurrent is at its span, in any larger region, and covers any smaller region. Now suppose we have fixed a frame of reference so that we can speak not merely of spatio-temporal but also of spatial regions (places) and temporal regions (times). The spread of an occurrent, (relative to a frame of reference) is the space it exactly occupies, and its spell is likewise the time it exactly occupies. We write 'spr[e]' and `spl[e]' respectively for the spread and spell of e, omitting mention of the frame.")
AnnotationAssertion(Annotation(obo:IAO_0010000 <http://purl.obolibrary.org/obo/bfo/axiom/077-002>) obo:IAO_0000600 obo:BFO_0000003 "An occurrent is an entity that unfolds itself in time or it is the instantaneous boundary of such an entity (for example a beginning or an ending) or it is a temporal or spatiotemporal region which such an entity occupies_temporal_region or occupies_spatiotemporal_region. (axiom label in BFO2 Reference: [077-002])"@en)
AnnotationAssertion(Annotation(obo:IAO_0010000 <http://purl.obolibrary.org/obo/bfo/axiom/108-001>) obo:IAO_0000601 obo:BFO_0000003 "Every occurrent occupies_spatiotemporal_region some spatiotemporal region. (axiom label in BFO2 Reference: [108-001])"@en)
AnnotationAssertion(Annotation(obo:IAO_0010000 <http://purl.obolibrary.org/obo/bfo/axiom/079-001>) obo:IAO_0000601 obo:BFO_0000003 "b is an occurrent entity iff b is an entity that has temporal parts. (axiom label in BFO2 Reference: [079-001])"@en)
AnnotationAssertion(Annotation(obo:IAO_0010000 <http://purl.obolibrary.org/obo/bfo/axiom/108-001>) obo:IAO_0000602 obo:BFO_0000003 "(forall (x) (if (Occurrent x) (exists (r) (and (SpatioTemporalRegion r) (occupiesSpatioTemporalRegion x r))))) // axiom label in BFO2 CLIF: [108-001] ")
AnnotationAssertion(Annotation(obo:IAO_0010000 <http://purl.obolibrary.org/obo/bfo/axiom/079-001>) obo:IAO_0000602 obo:BFO_0000003 "(forall (x) (iff (Occurrent x) (and (Entity x) (exists (y) (temporalPartOf y x))))) // axiom label in BFO2 CLIF: [079-001] ")
AnnotationAssertion(rdfs:isDefinedBy obo:BFO_0000003 obo:bfo.owl)
AnnotationAssertion(rdfs:label obo:BFO_0000003 "occurrent"@en)
SubClassOf(obo:BFO_0000003 obo:BFO_0000001)

# Class: obo:BFO_0000004 (independent continuant)

AnnotationAssertion(obo:BFO_0000179 obo:BFO_0000004 "ic")
AnnotationAssertion(obo:BFO_0000180 obo:BFO_0000004 "IndependentContinuant")
AnnotationAssertion(obo:IAO_0000112 obo:BFO_0000004 "a chair"@en)
AnnotationAssertion(obo:IAO_0000112 obo:BFO_0000004 "a heart"@en)
AnnotationAssertion(obo:IAO_0000112 obo:BFO_0000004 "a leg"@en)
AnnotationAssertion(obo:IAO_0000112 obo:BFO_0000004 "a molecule"@en)
AnnotationAssertion(obo:IAO_0000112 obo:BFO_0000004 "a spatial region"@en)
AnnotationAssertion(obo:IAO_0000112 obo:BFO_0000004 "an atom"@en)
AnnotationAssertion(obo:IAO_0000112 obo:BFO_0000004 "an orchestra."@en)
AnnotationAssertion(obo:IAO_0000112 obo:BFO_0000004 "an organism"@en)
AnnotationAssertion(obo:IAO_0000112 obo:BFO_0000004 "the bottom right portion of a human torso"@en)
AnnotationAssertion(obo:IAO_0000112 obo:BFO_0000004 "the interior of your mouth"@en)
AnnotationAssertion(Annotation(obo:IAO_0010000 <http://purl.obolibrary.org/obo/bfo/axiom/017-002>) obo:IAO_0000115 obo:BFO_0000004 "b is an independent continuant = Def. b is a continuant which is such that there is no c and no t such that b s-depends_on c at t. (axiom label in BFO2 Reference: [017-002])"@en)
AnnotationAssertion(Annotation(obo:IAO_0010000 <http://purl.obolibrary.org/obo/bfo/axiom/134-001>) obo:IAO_0000601 obo:BFO_0000004 "For any independent continuant b and any time t there is some spatial region r such that b is located_in r at t. (axiom label in BFO2 Reference: [134-001])"@en)
AnnotationAssertion(Annotation(obo:IAO_0010000 <http://purl.obolibrary.org/obo/bfo/axiom/018-002>) obo:IAO_0000601 obo:BFO_0000004 "For every independent continuant b and time t during the region of time spanned by its life, there are entities which s-depends_on b during t. (axiom label in BFO2 Reference: [018-002])"@en)
AnnotationAssertion(Annotation(obo:IAO_0010000 <http://purl.obolibrary.org/obo/bfo/axiom/134-001>) obo:IAO_0000602 obo:BFO_0000004 "(forall (x t) (if (IndependentContinuant x) (exists (r) (and (SpatialRegion r) (locatedInAt x r t))))) // axiom label in BFO2 CLIF: [134-001] ")
AnnotationAssertion(Annotation(obo:IAO_0010000 <http://purl.obolibrary.org/obo/bfo/axiom/018-002>) obo:IAO_0000602 obo:BFO_0000004 "(forall (x t) (if (and (IndependentContinuant x) (existsAt x t)) (exists (y) (and (Entity y) (specificallyDependsOnAt y x t))))) // axiom label in BFO2 CLIF: [018-002] ")
AnnotationAssertion(Annotation(obo:IAO_0010000 <http://purl.obolibrary.org/obo/bfo/axiom/017-002>) obo:IAO_0000602 obo:BFO_0000004 "(iff (IndependentContinuant a) (and (Continuant a) (not (exists (b t) (specificallyDependsOnAt a b t))))) // axiom label in BFO2 CLIF: [017-002] ")
AnnotationAssertion(rdfs:isDefinedBy obo:BFO_0000004 obo:bfo.owl)
AnnotationAssertion(rdfs:label obo:BFO_0000004 "independent continuant"@en)
SubClassOf(obo:BFO_0000004 obo:BFO_0000002)
DisjointClasses(obo:BFO_0000004 obo:BFO_0000020)
DisjointClasses(obo:BFO_0000004 obo:BFO_0000031)

# Class: obo:BFO_0000006 (spatial region)

AnnotationAssertion(obo:BFO_0000179 obo:BFO_0000006 "s-region")
AnnotationAssertion(obo:BFO_0000180 obo:BFO_0000006 "SpatialRegion")
AnnotationAssertion(obo:IAO_0000116 obo:BFO_0000006 "BFO 2 Reference: Spatial regions do not participate in processes."@en)
AnnotationAssertion(Annotation(obo:IAO_0010000 <http://purl.obolibrary.org/obo/bfo/axiom/0000002>) Annotation(rdfs:comment "per discussion with Barry Smith") obo:IAO_0000116 obo:BFO_0000006 "Spatial region doesn't have a closure axiom because the subclasses don't exhaust all possibilites. An example would be the union of a spatial point and a spatial line that doesn't overlap the point, or two spatial lines that intersect at a single point. In both cases the resultant spatial region is neither 0-dimensional, 1-dimensional, 2-dimensional, or 3-dimensional."@en)
AnnotationAssertion(Annotation(obo:IAO_0010000 <http://purl.obolibrary.org/obo/bfo/axiom/035-001>) obo:IAO_0000600 obo:BFO_0000006 "A spatial region is a continuant entity that is a continuant_part_of spaceR as defined relative to some frame R. (axiom label in BFO2 Reference: [035-001])"@en)
AnnotationAssertion(Annotation(obo:IAO_0010000 <http://purl.obolibrary.org/obo/bfo/axiom/036-001>) obo:IAO_0000601 obo:BFO_0000006 "All continuant parts of spatial regions are spatial regions. (axiom label in BFO2 Reference: [036-001])"@en)
AnnotationAssertion(Annotation(obo:IAO_0010000 <http://purl.obolibrary.org/obo/bfo/axiom/036-001>) obo:IAO_0000602 obo:BFO_0000006 "(forall (x y t) (if (and (SpatialRegion x) (continuantPartOfAt y x t)) (SpatialRegion y))) // axiom label in BFO2 CLIF: [036-001] ")
AnnotationAssertion(Annotation(obo:IAO_0010000 <http://purl.obolibrary.org/obo/bfo/axiom/035-001>) obo:IAO_0000602 obo:BFO_0000006 "(forall (x) (if (SpatialRegion x) (Continuant x))) // axiom label in BFO2 CLIF: [035-001] ")
AnnotationAssertion(rdfs:isDefinedBy obo:BFO_0000006 obo:bfo.owl)
AnnotationAssertion(rdfs:label obo:BFO_0000006 "spatial region"@en)
SubClassOf(obo:BFO_0000006 obo:BFO_0000141)
DisjointClasses(obo:BFO_0000006 obo:BFO_0000029)
DisjointClasses(obo:BFO_0000006 obo:BFO_0000140)

# Class: obo:BFO_0000008 (temporal region)

AnnotationAssertion(obo:BFO_0000179 obo:BFO_0000008 "t-region")
AnnotationAssertion(obo:BFO_0000180 obo:BFO_0000008 "TemporalRegion")
AnnotationAssertion(Annotation(obo:IAO_0010000 <http://purl.obolibrary.org/obo/bfo/axiom/0000003>) Annotation(rdfs:comment "per discussion with Barry Smith") obo:IAO_0000116 obo:BFO_0000008 "Temporal region doesn't have a closure axiom because the subclasses don't exhaust all possibilites. An example would be the mereological sum of a temporal instant and a temporal interval that doesn't overlap the instant. In this case the resultant temporal region is neither 0-dimensional nor 1-dimensional"@en)
AnnotationAssertion(Annotation(obo:IAO_0010000 <http://purl.obolibrary.org/obo/bfo/axiom/100-001>) obo:IAO_0000600 obo:BFO_0000008 "A temporal region is an occurrent entity that is part of time as defined relative to some reference frame. (axiom label in BFO2 Reference: [100-001])"@en)
AnnotationAssertion(Annotation(obo:IAO_0010000 <http://purl.obolibrary.org/obo/bfo/axiom/101-001>) obo:IAO_0000601 obo:BFO_0000008 "All parts of temporal regions are temporal regions. (axiom label in BFO2 Reference: [101-001])"@en)
AnnotationAssertion(Annotation(obo:IAO_0010000 <http://purl.obolibrary.org/obo/bfo/axiom/119-002>) obo:IAO_0000601 obo:BFO_0000008 "Every temporal region t is such that t occupies_temporal_region t. (axiom label in BFO2 Reference: [119-002])"@en)
AnnotationAssertion(Annotation(obo:IAO_0010000 <http://purl.obolibrary.org/obo/bfo/axiom/119-002>) obo:IAO_0000602 obo:BFO_0000008 "(forall (r) (if (TemporalRegion r) (occupiesTemporalRegion r r))) // axiom label in BFO2 CLIF: [119-002] ")
AnnotationAssertion(Annotation(obo:IAO_0010000 <http://purl.obolibrary.org/obo/bfo/axiom/101-001>) obo:IAO_0000602 obo:BFO_0000008 "(forall (x y) (if (and (TemporalRegion x) (occurrentPartOf y x)) (TemporalRegion y))) // axiom label in BFO2 CLIF: [101-001] ")
AnnotationAssertion(Annotation(obo:IAO_0010000 <http://purl.obolibrary.org/obo/bfo/axiom/100-001>) obo:IAO_0000602 obo:BFO_0000008 "(forall (x) (if (TemporalRegion x) (Occurrent x))) // axiom label in BFO2 CLIF: [100-001] ")
AnnotationAssertion(rdfs:isDefinedBy obo:BFO_0000008 obo:bfo.owl)
AnnotationAssertion(rdfs:label obo:BFO_0000008 "temporal region"@en)
SubClassOf(obo:BFO_0000008 obo:BFO_0000003)
DisjointClasses(obo:BFO_0000008 obo:BFO_0000011)
DisjointClasses(obo:BFO_0000008 obo:BFO_0000015)
DisjointClasses(obo:BFO_0000008 obo:BFO_0000035)

# Class: obo:BFO_0000009 (two-dimensional spatial region)

AnnotationAssertion(obo:BFO_0000179 obo:BFO_0000009 "2d-s-region")
AnnotationAssertion(obo:BFO_0000180 obo:BFO_0000009 "TwoDimensionalSpatialRegion")
AnnotationAssertion(obo:IAO_0000112 obo:BFO_0000009 "an infinitely thin plane in space."@en)
AnnotationAssertion(obo:IAO_0000112 obo:BFO_0000009 "the surface of a sphere-shaped part of space"@en)
AnnotationAssertion(Annotation(obo:IAO_0010000 <http://purl.obolibrary.org/obo/bfo/axiom/039-001>) obo:IAO_0000600 obo:BFO_0000009 "A two-dimensional spatial region is a spatial region that is of two dimensions. (axiom label in BFO2 Reference: [039-001])"@en)
AnnotationAssertion(Annotation(obo:IAO_0010000 <http://purl.obolibrary.org/obo/bfo/axiom/039-001>) obo:IAO_0000602 obo:BFO_0000009 "(forall (x) (if (TwoDimensionalSpatialRegion x) (SpatialRegion x))) // axiom label in BFO2 CLIF: [039-001] ")
AnnotationAssertion(rdfs:isDefinedBy obo:BFO_0000009 obo:bfo.owl)
AnnotationAssertion(rdfs:label obo:BFO_0000009 "two-dimensional spatial region"@en)
SubClassOf(obo:BFO_0000009 obo:BFO_0000006)
DisjointClasses(obo:BFO_0000009 obo:BFO_0000028)

# Class: obo:BFO_0000011 (spatiotemporal region)

AnnotationAssertion(obo:BFO_0000179 obo:BFO_0000011 "st-region")
AnnotationAssertion(obo:BFO_0000180 obo:BFO_0000011 "SpatiotemporalRegion")
AnnotationAssertion(obo:IAO_0000112 obo:BFO_0000011 "the spatiotemporal region occupied by a human life"@en)
AnnotationAssertion(obo:IAO_0000112 obo:BFO_0000011 "the spatiotemporal region occupied by a process of cellular meiosis."@en)
AnnotationAssertion(obo:IAO_0000112 obo:BFO_0000011 "the spatiotemporal region occupied by the development of a cancer tumor"@en)
AnnotationAssertion(Annotation(obo:IAO_0010000 <http://purl.obolibrary.org/obo/bfo/axiom/095-001>) obo:IAO_0000600 obo:BFO_0000011 "A spatiotemporal region is an occurrent entity that is part of spacetime. (axiom label in BFO2 Reference: [095-001])"@en)
AnnotationAssertion(Annotation(obo:IAO_0010000 <http://purl.obolibrary.org/obo/bfo/axiom/096-001>) obo:IAO_0000601 obo:BFO_0000011 "All parts of spatiotemporal regions are spatiotemporal regions. (axiom label in BFO2 Reference: [096-001])"@en)
AnnotationAssertion(Annotation(obo:IAO_0010000 <http://purl.obolibrary.org/obo/bfo/axiom/099-001>) obo:IAO_0000601 obo:BFO_0000011 "Each spatiotemporal region at any time t projects_onto some spatial region at t. (axiom label in BFO2 Reference: [099-001])"@en)
AnnotationAssertion(Annotation(obo:IAO_0010000 <http://purl.obolibrary.org/obo/bfo/axiom/098-001>) obo:IAO_0000601 obo:BFO_0000011 "Each spatiotemporal region projects_onto some temporal region. (axiom label in BFO2 Reference: [098-001])"@en)
AnnotationAssertion(obo:IAO_0000601 obo:BFO_0000011 "Every spatiotemporal region occupies_spatiotemporal_region itself."@en)
AnnotationAssertion(Annotation(obo:IAO_0010000 <http://purl.obolibrary.org/obo/bfo/axiom/107-002>) obo:IAO_0000601 obo:BFO_0000011 "Every spatiotemporal region s is such that s occupies_spatiotemporal_region s. (axiom label in BFO2 Reference: [107-002])"@en)
AnnotationAssertion(Annotation(obo:IAO_0010000 <http://purl.obolibrary.org/obo/bfo/axiom/107-002>) obo:IAO_0000602 obo:BFO_0000011 "(forall (r) (if (SpatioTemporalRegion r) (occupiesSpatioTemporalRegion r r))) // axiom label in BFO2 CLIF: [107-002] ")
AnnotationAssertion(Annotation(obo:IAO_0010000 <http://purl.obolibrary.org/obo/bfo/axiom/099-001>) obo:IAO_0000602 obo:BFO_0000011 "(forall (x t) (if (SpatioTemporalRegion x) (exists (y) (and (SpatialRegion y) (spatiallyProjectsOntoAt x y t))))) // axiom label in BFO2 CLIF: [099-001] ")
AnnotationAssertion(Annotation(obo:IAO_0010000 <http://purl.obolibrary.org/obo/bfo/axiom/096-001>) obo:IAO_0000602 obo:BFO_0000011 "(forall (x y) (if (and (SpatioTemporalRegion x) (occurrentPartOf y x)) (SpatioTemporalRegion y))) // axiom label in BFO2 CLIF: [096-001] ")
AnnotationAssertion(Annotation(obo:IAO_0010000 <http://purl.obolibrary.org/obo/bfo/axiom/095-001>) obo:IAO_0000602 obo:BFO_0000011 "(forall (x) (if (SpatioTemporalRegion x) (Occurrent x))) // axiom label in BFO2 CLIF: [095-001] ")
AnnotationAssertion(Annotation(obo:IAO_0010000 <http://purl.obolibrary.org/obo/bfo/axiom/098-001>) obo:IAO_0000602 obo:BFO_0000011 "(forall (x) (if (SpatioTemporalRegion x) (exists (y) (and (TemporalRegion y) (temporallyProjectsOnto x y))))) // axiom label in BFO2 CLIF: [098-001] ")
AnnotationAssertion(rdfs:isDefinedBy obo:BFO_0000011 obo:bfo.owl)
AnnotationAssertion(rdfs:label obo:BFO_0000011 "spatiotemporal region"@en)
SubClassOf(obo:BFO_0000011 obo:BFO_0000003)

# Class: obo:BFO_0000015 (process)

AnnotationAssertion(obo:BFO_0000179 obo:BFO_0000015 "process")
AnnotationAssertion(obo:BFO_0000180 obo:BFO_0000015 "Process")
AnnotationAssertion(obo:IAO_0000112 obo:BFO_0000015 "a process of cell-division, \\ a beating of the heart"@en)
AnnotationAssertion(obo:IAO_0000112 obo:BFO_0000015 "a process of meiosis"@en)
AnnotationAssertion(obo:IAO_0000112 obo:BFO_0000015 "a process of sleeping"@en)
AnnotationAssertion(obo:IAO_0000112 obo:BFO_0000015 "the course of a disease"@en)
AnnotationAssertion(obo:IAO_0000112 obo:BFO_0000015 "the flight of a bird"@en)
AnnotationAssertion(obo:IAO_0000112 obo:BFO_0000015 "the life of an organism"@en)
AnnotationAssertion(obo:IAO_0000112 obo:BFO_0000015 "your process of aging."@en)
AnnotationAssertion(obo:IAO_0000115 obo:BFO_0000015 "An occurrent that has temporal proper parts and for some time t, p s-depends_on some material entity at t."@en)
AnnotationAssertion(obo:IAO_0000115 obo:BFO_0000015 "p is a process = Def. p is an occurrent that has temporal proper parts and for some time t, p s-depends_on some material entity at t. (axiom label in BFO2 Reference: [083-003])"@en)
AnnotationAssertion(Annotation(obo:IAO_0010000 <http://purl.obolibrary.org/obo/bfo/axiom/083-003>) obo:IAO_0000115 obo:BFO_0000015 "p is a process = Def. p is an occurrent that has temporal proper parts and for some time t, p s-depends_on some material entity at t. (axiom label in BFO2 Reference: [083-003])"@en)
AnnotationAssertion(obo:IAO_0000116 obo:BFO_0000015 "BFO 2 Reference: The realm of occurrents is less pervasively marked by the presence of natural units than is the case in the realm of independent continuants. Thus there is here no counterpart of ‘object’. In BFO 1.0 ‘process’ served as such a counterpart. In BFO 2.0 ‘process’ is, rather, the occurrent counterpart of ‘material entity’. Those natural – as contrasted with engineered, which here means: deliberately executed – units which do exist in the realm of occurrents are typically either parasitic on the existence of natural units on the continuant side, or they are fiat in nature. Thus we can count lives; we can count football games; we can count chemical reactions performed in experiments or in chemical manufacturing. We cannot count the processes taking place, for instance, in an episode of insect mating behavior.Even where natural units are identifiable, for example cycles in a cyclical process such as the beating of a heart or an organism’s sleep/wake cycle, the processes in question form a sequence with no discontinuities (temporal gaps) of the sort that we find for instance where billiard balls or zebrafish or planets are separated by clear spatial gaps. Lives of organisms are process units, but they too unfold in a continuous series from other, prior processes such as fertilization, and they unfold in turn in continuous series of post-life processes such as post-mortem decay. Clear examples of boundaries of processes are almost always of the fiat sort (midnight, a time of death as declared in an operating theater or on a death certificate, the initiation of a state of war)"@en)
AnnotationAssertion(obo:IAO_0000412 obo:BFO_0000015 obo:bfo.owl)
AnnotationAssertion(obo:IAO_0000412 obo:BFO_0000015 obo:oae.owl)
AnnotationAssertion(obo:IAO_0000412 obo:BFO_0000015 obo:obi.owl)
AnnotationAssertion(obo:IAO_0000412 obo:BFO_0000015 obo:ro.owl)
AnnotationAssertion(obo:IAO_0000602 obo:BFO_0000015 "(iff (Process a) (and (Occurrent a) (exists (b) (properTemporalPartOf b a)) (exists (c t) (and (MaterialEntity c) (specificallyDependsOnAt a c t))))) // axiom label in BFO2 CLIF: [083-003] ")
AnnotationAssertion(Annotation(obo:IAO_0010000 <http://purl.obolibrary.org/obo/bfo/axiom/083-003>) obo:IAO_0000602 obo:BFO_0000015 "(iff (Process a) (and (Occurrent a) (exists (b) (properTemporalPartOf b a)) (exists (c t) (and (MaterialEntity c) (specificallyDependsOnAt a c t))))) // axiom label in BFO2 CLIF: [083-003] ")
AnnotationAssertion(rdfs:isDefinedBy obo:BFO_0000015 obo:bfo.owl)
AnnotationAssertion(rdfs:label obo:BFO_0000015 "process"@en)
SubClassOf(obo:BFO_0000015 obo:BFO_0000003)

# Class: obo:BFO_0000016 (disposition)

AnnotationAssertion(obo:BFO_0000179 obo:BFO_0000016 "disposition")
AnnotationAssertion(obo:BFO_0000180 obo:BFO_0000016 "Disposition")
AnnotationAssertion(obo:IAO_0000112 obo:BFO_0000016 "an atom of element X has the disposition to decay to an atom of element Y"@en)
AnnotationAssertion(obo:IAO_0000112 obo:BFO_0000016 "certain people have a predisposition to colon cancer"@en)
AnnotationAssertion(obo:IAO_0000112 obo:BFO_0000016 "children are innately disposed to categorize objects in certain ways."@en)
AnnotationAssertion(obo:IAO_0000112 obo:BFO_0000016 "the cell wall is disposed to filter chemicals in endocytosis and exocytosis"@en)
AnnotationAssertion(obo:IAO_0000116 obo:BFO_0000016 "BFO 2 Reference: Dispositions exist along a strength continuum. Weaker forms of disposition are realized in only a fraction of triggering cases. These forms occur in a significant number of cases of a similar type."@en)
AnnotationAssertion(obo:IAO_0000412 obo:BFO_0000016 obo:ogms.owl)
AnnotationAssertion(Annotation(obo:IAO_0010000 <http://purl.obolibrary.org/obo/bfo/axiom/062-002>) obo:IAO_0000600 obo:BFO_0000016 "b is a disposition means: b is a realizable entity & b’s bearer is some material entity & b is such that if it ceases to exist, then its bearer is physically changed, & b’s realization occurs when and because this bearer is in some special physical circumstances, & this realization occurs in virtue of the bearer’s physical make-up. (axiom label in BFO2 Reference: [062-002])"@en)
AnnotationAssertion(Annotation(obo:IAO_0010000 <http://purl.obolibrary.org/obo/bfo/axiom/063-002>) obo:IAO_0000601 obo:BFO_0000016 "If b is a realizable entity then for all t at which b exists, b s-depends_on some material entity at t. (axiom label in BFO2 Reference: [063-002])"@en)
AnnotationAssertion(Annotation(obo:IAO_0010000 <http://purl.obolibrary.org/obo/bfo/axiom/063-002>) obo:IAO_0000602 obo:BFO_0000016 "(forall (x t) (if (and (RealizableEntity x) (existsAt x t)) (exists (y) (and (MaterialEntity y) (specificallyDepends x y t))))) // axiom label in BFO2 CLIF: [063-002] ")
AnnotationAssertion(Annotation(obo:IAO_0010000 <http://purl.obolibrary.org/obo/bfo/axiom/062-002>) obo:IAO_0000602 obo:BFO_0000016 "(forall (x) (if (Disposition x) (and (RealizableEntity x) (exists (y) (and (MaterialEntity y) (bearerOfAt x y t)))))) // axiom label in BFO2 CLIF: [062-002] ")
AnnotationAssertion(rdfs:isDefinedBy obo:BFO_0000016 obo:bfo.owl)
AnnotationAssertion(rdfs:label obo:BFO_0000016 "disposition"@en)
SubClassOf(obo:BFO_0000016 obo:BFO_0000017)
DisjointClasses(obo:BFO_0000016 obo:BFO_0000023)

# Class: obo:BFO_0000017 (realizable entity)

AnnotationAssertion(obo:BFO_0000179 obo:BFO_0000017 "realizable")
AnnotationAssertion(obo:BFO_0000180 obo:BFO_0000017 "RealizableEntity")
AnnotationAssertion(obo:IAO_0000112 obo:BFO_0000017 "the disposition of this piece of metal to conduct electricity."@en)
AnnotationAssertion(obo:IAO_0000112 obo:BFO_0000017 "the disposition of your blood to coagulate"@en)
AnnotationAssertion(obo:IAO_0000112 obo:BFO_0000017 "the function of your reproductive organs"@en)
AnnotationAssertion(obo:IAO_0000112 obo:BFO_0000017 "the role of being a doctor"@en)
AnnotationAssertion(obo:IAO_0000112 obo:BFO_0000017 "the role of this boundary to delineate where Utah and Colorado meet"@en)
AnnotationAssertion(obo:IAO_0000115 obo:BFO_0000017 "A specifically dependent continuant  that inheres in continuant  entities and are not exhibited in full at every time in which it inheres in an entity or group of entities. The exhibition or actualization of a realizable entity is a particular manifestation, functioning or process that occurs under certain circumstances."@en)
AnnotationAssertion(obo:IAO_0000412 obo:BFO_0000017 obo:dron.owl)
AnnotationAssertion(obo:IAO_0000412 obo:BFO_0000017 obo:envo.owl)
AnnotationAssertion(obo:IAO_0000412 obo:BFO_0000017 obo:obi.owl)
AnnotationAssertion(obo:IAO_0000412 obo:BFO_0000017 obo:ogms.owl)
AnnotationAssertion(obo:IAO_0000412 obo:BFO_0000017 obo:omrse.owl)
AnnotationAssertion(obo:IAO_0000412 obo:BFO_0000017 obo:opmi.owl)
AnnotationAssertion(obo:IAO_0000600 obo:BFO_0000017 "To say that b is a realizable entity is to say that b is a specifically dependent continuant that inheres in some independent continuant which is not a spatial region and is of a type instances of which are realized in processes of a correlated type. (axiom label in BFO2 Reference: [058-002])"@en)
AnnotationAssertion(Annotation(obo:IAO_0010000 <http://purl.obolibrary.org/obo/bfo/axiom/058-002>) obo:IAO_0000600 obo:BFO_0000017 "To say that b is a realizable entity is to say that b is a specifically dependent continuant that inheres in some independent continuant which is not a spatial region and is of a type instances of which are realized in processes of a correlated type. (axiom label in BFO2 Reference: [058-002])"@en)
AnnotationAssertion(obo:IAO_0000601 obo:BFO_0000017 "All realizable dependent continuants have independent continuants that are not spatial regions as their bearers. (axiom label in BFO2 Reference: [060-002])"@en)
AnnotationAssertion(Annotation(obo:IAO_0010000 <http://purl.obolibrary.org/obo/bfo/axiom/060-002>) obo:IAO_0000601 obo:BFO_0000017 "All realizable dependent continuants have independent continuants that are not spatial regions as their bearers. (axiom label in BFO2 Reference: [060-002])"@en)
AnnotationAssertion(obo:IAO_0000602 obo:BFO_0000017 "(forall (x t) (if (RealizableEntity x) (exists (y) (and (IndependentContinuant y) (not (SpatialRegion y)) (bearerOfAt y x t))))) // axiom label in BFO2 CLIF: [060-002] ")
AnnotationAssertion(Annotation(obo:IAO_0010000 <http://purl.obolibrary.org/obo/bfo/axiom/060-002>) obo:IAO_0000602 obo:BFO_0000017 "(forall (x t) (if (RealizableEntity x) (exists (y) (and (IndependentContinuant y) (not (SpatialRegion y)) (bearerOfAt y x t))))) // axiom label in BFO2 CLIF: [060-002] ")
AnnotationAssertion(obo:IAO_0000602 obo:BFO_0000017 "(forall (x) (if (RealizableEntity x) (and (SpecificallyDependentContinuant x) (exists (y) (and (IndependentContinuant y) (not (SpatialRegion y)) (inheresIn x y)))))) // axiom label in BFO2 CLIF: [058-002] ")
AnnotationAssertion(Annotation(obo:IAO_0010000 <http://purl.obolibrary.org/obo/bfo/axiom/058-002>) obo:IAO_0000602 obo:BFO_0000017 "(forall (x) (if (RealizableEntity x) (and (SpecificallyDependentContinuant x) (exists (y) (and (IndependentContinuant y) (not (SpatialRegion y)) (inheresIn x y)))))) // axiom label in BFO2 CLIF: [058-002] ")
AnnotationAssertion(rdfs:isDefinedBy obo:BFO_0000017 obo:bfo.owl)
AnnotationAssertion(rdfs:label obo:BFO_0000017 "realizable entity"@en)
SubClassOf(obo:BFO_0000017 obo:BFO_0000020)
DisjointClasses(obo:BFO_0000017 obo:BFO_0000019)

# Class: obo:BFO_0000018 (zero-dimensional spatial region)

AnnotationAssertion(obo:BFO_0000179 obo:BFO_0000018 "0d-s-region")
AnnotationAssertion(obo:BFO_0000180 obo:BFO_0000018 "ZeroDimensionalSpatialRegion")
AnnotationAssertion(Annotation(obo:IAO_0010000 <http://purl.obolibrary.org/obo/bfo/axiom/037-001>) obo:IAO_0000600 obo:BFO_0000018 "A zero-dimensional spatial region is a point in space. (axiom label in BFO2 Reference: [037-001])"@en)
AnnotationAssertion(Annotation(obo:IAO_0010000 <http://purl.obolibrary.org/obo/bfo/axiom/037-001>) obo:IAO_0000602 obo:BFO_0000018 "(forall (x) (if (ZeroDimensionalSpatialRegion x) (SpatialRegion x))) // axiom label in BFO2 CLIF: [037-001] ")
AnnotationAssertion(rdfs:isDefinedBy obo:BFO_0000018 obo:bfo.owl)
AnnotationAssertion(rdfs:label obo:BFO_0000018 "zero-dimensional spatial region"@en)
SubClassOf(obo:BFO_0000018 obo:BFO_0000006)
DisjointClasses(obo:BFO_0000018 obo:BFO_0000028)

# Class: obo:BFO_0000019 (quality)

AnnotationAssertion(obo:BFO_0000179 obo:BFO_0000019 "quality")
AnnotationAssertion(obo:BFO_0000180 obo:BFO_0000019 "Quality")
AnnotationAssertion(obo:IAO_0000112 obo:BFO_0000019 "the ambient temperature of this portion of air"@en)
AnnotationAssertion(obo:IAO_0000112 obo:BFO_0000019 "the color of a tomato"@en)
AnnotationAssertion(obo:IAO_0000112 obo:BFO_0000019 "the length of the circumference of your waist"@en)
AnnotationAssertion(obo:IAO_0000112 obo:BFO_0000019 "the mass of this piece of gold."@en)
AnnotationAssertion(obo:IAO_0000112 obo:BFO_0000019 "the shape of your nose"@en)
AnnotationAssertion(obo:IAO_0000112 obo:BFO_0000019 "the shape of your nostril"@en)
AnnotationAssertion(Annotation(obo:IAO_0010000 <http://purl.obolibrary.org/obo/bfo/axiom/055-001>) obo:IAO_0000600 obo:BFO_0000019 "a quality is a specifically dependent continuant that, in contrast to roles and dispositions, does not require any further process in order to be realized. (axiom label in BFO2 Reference: [055-001])"@en)
AnnotationAssertion(Annotation(obo:IAO_0010000 <http://purl.obolibrary.org/obo/bfo/axiom/105-001>) obo:IAO_0000601 obo:BFO_0000019 "If an entity is a quality at any time that it exists, then it is a quality at every time that it exists. (axiom label in BFO2 Reference: [105-001])"@en)
AnnotationAssertion(Annotation(obo:IAO_0010000 <http://purl.obolibrary.org/obo/bfo/axiom/055-001>) obo:IAO_0000602 obo:BFO_0000019 "(forall (x) (if (Quality x) (SpecificallyDependentContinuant x))) // axiom label in BFO2 CLIF: [055-001] ")
AnnotationAssertion(Annotation(obo:IAO_0010000 <http://purl.obolibrary.org/obo/bfo/axiom/105-001>) obo:IAO_0000602 obo:BFO_0000019 "(forall (x) (if (exists (t) (and (existsAt x t) (Quality x))) (forall (t_1) (if (existsAt x t_1) (Quality x))))) // axiom label in BFO2 CLIF: [105-001] ")
AnnotationAssertion(rdfs:isDefinedBy obo:BFO_0000019 obo:bfo.owl)
AnnotationAssertion(rdfs:label obo:BFO_0000019 "quality"@en)
SubClassOf(obo:BFO_0000019 obo:BFO_0000020)

# Class: obo:BFO_0000020 (specifically dependent continuant)

AnnotationAssertion(obo:BFO_0000179 obo:BFO_0000020 "sdc")
AnnotationAssertion(obo:BFO_0000180 obo:BFO_0000020 "SpecificallyDependentContinuant")
AnnotationAssertion(obo:IAO_0000112 obo:BFO_0000020 "Reciprocal specifically dependent continuants: the function of this key to open this lock and the mutually dependent disposition of this lock: to be opened by this key"@en)
AnnotationAssertion(obo:IAO_0000112 obo:BFO_0000020 "of one-sided specifically dependent continuants: the mass of this tomato"@en)
AnnotationAssertion(obo:IAO_0000112 obo:BFO_0000020 "of relational dependent continuants (multiple bearers): John’s love for Mary, the ownership relation between John and this statue, the relation of authority between John and his subordinates."@en)
AnnotationAssertion(obo:IAO_0000112 obo:BFO_0000020 "the disposition of this fish to decay"@en)
AnnotationAssertion(obo:IAO_0000112 obo:BFO_0000020 "the function of this heart: to pump blood"@en)
AnnotationAssertion(obo:IAO_0000112 obo:BFO_0000020 "the mutual dependence of proton donors and acceptors in chemical reactions [79"@en)
AnnotationAssertion(obo:IAO_0000112 obo:BFO_0000020 "the mutual dependence of the role predator and the role prey as played by two organisms in a given interaction"@en)
AnnotationAssertion(obo:IAO_0000112 obo:BFO_0000020 "the pink color of a medium rare piece of grilled filet mignon at its center"@en)
AnnotationAssertion(obo:IAO_0000112 obo:BFO_0000020 "the role of being a doctor"@en)
AnnotationAssertion(obo:IAO_0000112 obo:BFO_0000020 "the shape of this hole."@en)
AnnotationAssertion(obo:IAO_0000112 obo:BFO_0000020 "the smell of this portion of mozzarella"@en)
AnnotationAssertion(Annotation(obo:IAO_0010000 <http://purl.obolibrary.org/obo/bfo/axiom/050-003>) obo:IAO_0000115 obo:BFO_0000020 "b is a specifically dependent continuant = Def. b is a continuant & there is some independent continuant c which is not a spatial region and which is such that b s-depends_on c at every time t during the course of b’s existence. (axiom label in BFO2 Reference: [050-003])"@en)
AnnotationAssertion(Annotation(obo:IAO_0010000 <http://purl.obolibrary.org/obo/bfo/axiom/0000005>) Annotation(rdfs:comment "per discussion with Barry Smith") obo:IAO_0000116 obo:BFO_0000020 "Specifically dependent continuant doesn't have a closure axiom because the subclasses don't necessarily exhaust all possibilites. We're not sure what else will develop here, but for example there are questions such as what are promises, obligation, etc."@en)
AnnotationAssertion(Annotation(obo:IAO_0010000 <http://purl.obolibrary.org/obo/bfo/axiom/050-003>) obo:IAO_0000602 obo:BFO_0000020 "(iff (SpecificallyDependentContinuant a) (and (Continuant a) (forall (t) (if (existsAt a t) (exists (b) (and (IndependentContinuant b) (not (SpatialRegion b)) (specificallyDependsOnAt a b t))))))) // axiom label in BFO2 CLIF: [050-003] ")
AnnotationAssertion(rdfs:isDefinedBy obo:BFO_0000020 obo:bfo.owl)
AnnotationAssertion(rdfs:label obo:BFO_0000020 "specifically dependent continuant"@en)
SubClassOf(obo:BFO_0000020 obo:BFO_0000002)
DisjointClasses(obo:BFO_0000020 obo:BFO_0000031)

# Class: obo:BFO_0000023 (role)

AnnotationAssertion(obo:BFO_0000179 obo:BFO_0000023 "role")
AnnotationAssertion(obo:BFO_0000180 obo:BFO_0000023 "Role")
AnnotationAssertion(obo:IAO_0000112 obo:BFO_0000023 "John’s role of husband to Mary is dependent on Mary’s role of wife to John, and both are dependent on the object aggregate comprising John and Mary as member parts joined together through the relational quality of being married."@en)
AnnotationAssertion(obo:IAO_0000112 obo:BFO_0000023 "the priest role"@en)
AnnotationAssertion(obo:IAO_0000112 obo:BFO_0000023 "the role of a boundary to demarcate two neighboring administrative territories"@en)
AnnotationAssertion(obo:IAO_0000112 obo:BFO_0000023 "the role of a building in serving as a military target"@en)
AnnotationAssertion(obo:IAO_0000112 obo:BFO_0000023 "the role of a stone in marking a property boundary"@en)
AnnotationAssertion(obo:IAO_0000112 obo:BFO_0000023 "the role of subject in a clinical trial"@en)
AnnotationAssertion(obo:IAO_0000112 obo:BFO_0000023 "the student role"@en)
AnnotationAssertion(obo:IAO_0000115 obo:BFO_0000023 "A realizable entity  the manifestation of which brings about some result or end that is not essential to a continuant  in virtue of the kind of thing that it is but that can be served or participated in by that kind of continuant  in some kinds of natural, social or institutional contexts."@en)
AnnotationAssertion(obo:IAO_0000116 obo:BFO_0000023 "BFO 2 Reference: One major family of examples of non-rigid universals involves roles, and ontologies developed for corresponding administrative purposes may consist entirely of representatives of entities of this sort. Thus ‘professor’, defined as follows,b instance_of professor at t =Def. there is some c, c instance_of professor role & c inheres_in b at t.denotes a non-rigid universal and so also do ‘nurse’, ‘student’, ‘colonel’, ‘taxpayer’, and so forth. (These terms are all, in the jargon of philosophy, phase sortals.) By using role terms in definitions, we can create a BFO conformant treatment of such entities drawing on the fact that, while an instance of professor may be simultaneously an instance of trade union member, no instance of the type professor role is also (at any time) an instance of the type trade union member role (any more than any instance of the type color is at any time an instance of the type length).If an ontology of employment positions should be defined in terms of roles following the above pattern, this enables the ontology to do justice to the fact that individuals instantiate the corresponding universals –  professor, sergeant, nurse – only during certain phases in their lives."@en)
AnnotationAssertion(obo:IAO_0000412 obo:BFO_0000023 obo:dron.owl)
AnnotationAssertion(obo:IAO_0000412 obo:BFO_0000023 obo:obi.owl)
AnnotationAssertion(obo:IAO_0000412 obo:BFO_0000023 obo:omrse.owl)
AnnotationAssertion(obo:IAO_0000412 obo:BFO_0000023 obo:opmi.owl)
AnnotationAssertion(obo:IAO_0000600 obo:BFO_0000023 "b is a role means: b is a realizable entity & b exists because there is some single bearer that is in some special physical, social, or institutional set of circumstances in which this bearer does not have to be& b is not such that, if it ceases to exist, then the physical make-up of the bearer is thereby changed. (axiom label in BFO2 Reference: [061-001])"@en)
AnnotationAssertion(Annotation(obo:IAO_0010000 <http://purl.obolibrary.org/obo/bfo/axiom/061-001>) obo:IAO_0000600 obo:BFO_0000023 "b is a role means: b is a realizable entity & b exists because there is some single bearer that is in some special physical, social, or institutional set of circumstances in which this bearer does not have to be& b is not such that, if it ceases to exist, then the physical make-up of the bearer is thereby changed. (axiom label in BFO2 Reference: [061-001])"@en)
AnnotationAssertion(obo:IAO_0000602 obo:BFO_0000023 "(forall (x) (if (Role x) (RealizableEntity x))) // axiom label in BFO2 CLIF: [061-001] ")
AnnotationAssertion(Annotation(obo:IAO_0010000 <http://purl.obolibrary.org/obo/bfo/axiom/061-001>) obo:IAO_0000602 obo:BFO_0000023 "(forall (x) (if (Role x) (RealizableEntity x))) // axiom label in BFO2 CLIF: [061-001] ")
AnnotationAssertion(rdfs:isDefinedBy obo:BFO_0000023 obo:bfo.owl)
AnnotationAssertion(rdfs:label obo:BFO_0000023 "role"@en)
SubClassOf(obo:BFO_0000023 obo:BFO_0000017)

# Class: obo:BFO_0000024 (fiat object part)

AnnotationAssertion(obo:BFO_0000179 obo:BFO_0000024 "fiat-object-part")
AnnotationAssertion(obo:BFO_0000180 obo:BFO_0000024 "FiatObjectPart")
AnnotationAssertion(obo:IAO_0000112 obo:BFO_0000024 "or with divisions drawn by cognitive subjects for practical reasons, such as the division of a cake (before slicing) into (what will become) slices (and thus member parts of an object aggregate). However, this does not mean that fiat object parts are dependent for their existence on divisions or delineations effected by cognitive subjects. If, for example, it is correct to conceive geological layers of the Earth as fiat object parts of the Earth, then even though these layers were first delineated in recent times, still existed long before such delineation and what holds of these layers (for example that the oldest layers are also the lowest layers) did not begin to hold because of our acts of delineation.Treatment of material entity in BFOExamples viewed by some as problematic cases for the trichotomy of fiat object part, object, and object aggregate include: a mussel on (and attached to) a rock, a slime mold, a pizza, a cloud, a galaxy, a railway train with engine and multiple carriages, a clonal stand of quaking aspen, a bacterial community (biofilm), a broken femur. Note that, as Aristotle already clearly recognized, such problematic cases – which lie at or near the penumbra of instances defined by the categories in question – need not invalidate these categories. The existence of grey objects does not prove that there are not objects which are black and objects which are white; the existence of mules does not prove that there are not objects which are donkeys and objects which are horses. It does, however, show that the examples in question need to be addressed carefully in order to show how they can be fitted into the proposed scheme, for example by recognizing additional subdivisions [29"@en)
AnnotationAssertion(obo:IAO_0000112 obo:BFO_0000024 "the FMA:regional parts of an intact human body."@en)
AnnotationAssertion(obo:IAO_0000112 obo:BFO_0000024 "the Western hemisphere of the Earth"@en)
AnnotationAssertion(obo:IAO_0000112 obo:BFO_0000024 "the division of the brain into regions"@en)
AnnotationAssertion(obo:IAO_0000112 obo:BFO_0000024 "the division of the planet into hemispheres"@en)
AnnotationAssertion(obo:IAO_0000112 obo:BFO_0000024 "the dorsal and ventral surfaces of the body"@en)
AnnotationAssertion(obo:IAO_0000112 obo:BFO_0000024 "the upper and lower lobes of the left lung"@en)
AnnotationAssertion(obo:IAO_0000116 obo:BFO_0000024 "BFO 2 Reference: Most examples of fiat object parts are associated with theoretically drawn divisions"@en)
AnnotationAssertion(Annotation(obo:IAO_0010000 <http://purl.obolibrary.org/obo/bfo/axiom/027-004>) obo:IAO_0000600 obo:BFO_0000024 "b is a fiat object part = Def. b is a material entity which is such that for all times t, if b exists at t then there is some object c such that b proper continuant_part of  c at t and c is demarcated from the remainder of c by a two-dimensional continuant fiat boundary. (axiom label in BFO2 Reference: [027-004])"@en)
AnnotationAssertion(Annotation(obo:IAO_0010000 <http://purl.obolibrary.org/obo/bfo/axiom/027-004>) obo:IAO_0000602 obo:BFO_0000024 "(forall (x) (if (FiatObjectPart x) (and (MaterialEntity x) (forall (t) (if (existsAt x t) (exists (y) (and (Object y) (properContinuantPartOfAt x y t)))))))) // axiom label in BFO2 CLIF: [027-004] ")
AnnotationAssertion(rdfs:isDefinedBy obo:BFO_0000024 obo:bfo.owl)
AnnotationAssertion(rdfs:label obo:BFO_0000024 "fiat object part"@en)
SubClassOf(obo:BFO_0000024 obo:BFO_0000040)

# Class: obo:BFO_0000026 (one-dimensional spatial region)

AnnotationAssertion(obo:BFO_0000179 obo:BFO_0000026 "1d-s-region")
AnnotationAssertion(obo:BFO_0000180 obo:BFO_0000026 "OneDimensionalSpatialRegion")
AnnotationAssertion(obo:IAO_0000112 obo:BFO_0000026 "an edge of a cube-shaped portion of space."@en)
AnnotationAssertion(Annotation(obo:IAO_0010000 <http://purl.obolibrary.org/obo/bfo/axiom/038-001>) obo:IAO_0000600 obo:BFO_0000026 "A one-dimensional spatial region is a line or aggregate of lines stretching from one point in space to another. (axiom label in BFO2 Reference: [038-001])"@en)
AnnotationAssertion(Annotation(obo:IAO_0010000 <http://purl.obolibrary.org/obo/bfo/axiom/038-001>) obo:IAO_0000602 obo:BFO_0000026 "(forall (x) (if (OneDimensionalSpatialRegion x) (SpatialRegion x))) // axiom label in BFO2 CLIF: [038-001] ")
AnnotationAssertion(rdfs:isDefinedBy obo:BFO_0000026 obo:bfo.owl)
AnnotationAssertion(rdfs:label obo:BFO_0000026 "one-dimensional spatial region"@en)
SubClassOf(obo:BFO_0000026 obo:BFO_0000006)
DisjointClasses(obo:BFO_0000026 obo:BFO_0000028)

# Class: obo:BFO_0000027 (object aggregate)

AnnotationAssertion(obo:BFO_0000179 obo:BFO_0000027 "object-aggregate")
AnnotationAssertion(obo:BFO_0000180 obo:BFO_0000027 "ObjectAggregate")
AnnotationAssertion(obo:IAO_0000112 obo:BFO_0000027 "a collection of cells in a blood biobank."@en)
AnnotationAssertion(obo:IAO_0000112 obo:BFO_0000027 "a swarm of bees is an aggregate of members who are linked together through natural bonds"@en)
AnnotationAssertion(obo:IAO_0000112 obo:BFO_0000027 "a symphony orchestra"@en)
AnnotationAssertion(obo:IAO_0000112 obo:BFO_0000027 "an organization is an aggregate whose member parts have roles of specific types (for example in a jazz band, a chess club, a football team)"@en)
AnnotationAssertion(obo:IAO_0000112 obo:BFO_0000027 "defined by fiat: the aggregate of members of an organization"@en)
AnnotationAssertion(obo:IAO_0000112 obo:BFO_0000027 "defined through physical attachment: the aggregate of atoms in a lump of granite"@en)
AnnotationAssertion(obo:IAO_0000112 obo:BFO_0000027 "defined through physical containment: the aggregate of molecules of carbon dioxide in a sealed container"@en)
AnnotationAssertion(obo:IAO_0000112 obo:BFO_0000027 "defined via attributive delimitations such as: the patients in this hospital"@en)
AnnotationAssertion(obo:IAO_0000112 obo:BFO_0000027 "the aggregate of bearings in a constant velocity axle joint"@en)
AnnotationAssertion(obo:IAO_0000112 obo:BFO_0000027 "the aggregate of blood cells in your body"@en)
AnnotationAssertion(obo:IAO_0000112 obo:BFO_0000027 "the nitrogen atoms in the atmosphere"@en)
AnnotationAssertion(obo:IAO_0000112 obo:BFO_0000027 "the restaurants in Palo Alto"@en)
AnnotationAssertion(obo:IAO_0000112 obo:BFO_0000027 "your collection of Meissen ceramic plates."@en)
AnnotationAssertion(Annotation(obo:IAO_0010000 <http://purl.obolibrary.org/obo/bfo/axiom/0000011>) obo:IAO_0000116 obo:BFO_0000027 "An entity a is an object aggregate if and only if there is a mutually exhaustive and pairwise disjoint partition of a into objects ")
AnnotationAssertion(Annotation(obo:IAO_0010000 <http://purl.obolibrary.org/obo/bfo/axiom/0000301>) obo:IAO_0000116 obo:BFO_0000027 "An entity a is an object aggregate if and only if there is a mutually exhaustive and pairwise disjoint partition of a into objects ")
AnnotationAssertion(obo:IAO_0000116 obo:BFO_0000027 "BFO 2 Reference: object aggregates may gain and lose parts while remaining numerically identical (one and the same individual) over time. This holds both for aggregates whose membership is determined naturally (the aggregate of cells in your body) and aggregates determined by fiat (a baseball team, a congressional committee)."@en)
AnnotationAssertion(Annotation(obo:IAO_0010000 <http://purl.obolibrary.org/obo/bfo/axiom/0000300>) obo:IAO_0000119 obo:BFO_0000027 "ISBN:978-3-938793-98-5pp124-158#Thomas Bittner and Barry Smith, 'A Theory of Granular Partitions', in K. Munn and B. Smith (eds.), Applied Ontology: An Introduction, Frankfurt/Lancaster: ontos, 2008, 125-158.")
AnnotationAssertion(Annotation(obo:IAO_0010000 <http://purl.obolibrary.org/obo/bfo/axiom/025-004>) obo:IAO_0000600 obo:BFO_0000027 "b is an object aggregate means: b is a material entity consisting exactly of a plurality of objects as member_parts at all times at which b exists. (axiom label in BFO2 Reference: [025-004])"@en)
AnnotationAssertion(Annotation(obo:IAO_0010000 <http://purl.obolibrary.org/obo/bfo/axiom/025-004>) obo:IAO_0000602 obo:BFO_0000027 "(forall (x) (if (ObjectAggregate x) (and (MaterialEntity x) (forall (t) (if (existsAt x t) (exists (y z) (and (Object y) (Object z) (memberPartOfAt y x t) (memberPartOfAt z x t) (not (= y z)))))) (not (exists (w t_1) (and (memberPartOfAt w x t_1) (not (Object w)))))))) // axiom label in BFO2 CLIF: [025-004] ")
AnnotationAssertion(rdfs:isDefinedBy obo:BFO_0000027 obo:bfo.owl)
AnnotationAssertion(rdfs:label obo:BFO_0000027 "object aggregate"@en)
SubClassOf(obo:BFO_0000027 obo:BFO_0000040)

# Class: obo:BFO_0000028 (three-dimensional spatial region)

AnnotationAssertion(obo:BFO_0000179 obo:BFO_0000028 "3d-s-region")
AnnotationAssertion(obo:BFO_0000180 obo:BFO_0000028 "ThreeDimensionalSpatialRegion")
AnnotationAssertion(obo:IAO_0000112 obo:BFO_0000028 "a cube-shaped region of space"@en)
AnnotationAssertion(obo:IAO_0000112 obo:BFO_0000028 "a sphere-shaped region of space,"@en)
AnnotationAssertion(Annotation(obo:IAO_0010000 <http://purl.obolibrary.org/obo/bfo/axiom/040-001>) obo:IAO_0000600 obo:BFO_0000028 "A three-dimensional spatial region is a spatial region that is of three dimensions. (axiom label in BFO2 Reference: [040-001])"@en)
AnnotationAssertion(Annotation(obo:IAO_0010000 <http://purl.obolibrary.org/obo/bfo/axiom/040-001>) obo:IAO_0000602 obo:BFO_0000028 "(forall (x) (if (ThreeDimensionalSpatialRegion x) (SpatialRegion x))) // axiom label in BFO2 CLIF: [040-001] ")
AnnotationAssertion(rdfs:isDefinedBy obo:BFO_0000028 obo:bfo.owl)
AnnotationAssertion(rdfs:label obo:BFO_0000028 "three-dimensional spatial region"@en)
SubClassOf(obo:BFO_0000028 obo:BFO_0000006)

# Class: obo:BFO_0000029 (site)

AnnotationAssertion(obo:BFO_0000179 obo:BFO_0000029 "site")
AnnotationAssertion(obo:BFO_0000180 obo:BFO_0000029 "Site")
AnnotationAssertion(obo:IAO_0000112 obo:BFO_0000029 "Manhattan Canyon)"@en)
AnnotationAssertion(obo:IAO_0000112 obo:BFO_0000029 "a hole in the interior of a portion of cheese"@en)
AnnotationAssertion(obo:IAO_0000112 obo:BFO_0000029 "a rabbit hole"@en)
AnnotationAssertion(obo:IAO_0000112 obo:BFO_0000029 "an air traffic control region defined in the airspace above an airport"@en)
AnnotationAssertion(obo:IAO_0000112 obo:BFO_0000029 "the Grand Canyon"@en)
AnnotationAssertion(obo:IAO_0000112 obo:BFO_0000029 "the Piazza San Marco"@en)
AnnotationAssertion(obo:IAO_0000112 obo:BFO_0000029 "the cockpit of an aircraft"@en)
AnnotationAssertion(obo:IAO_0000112 obo:BFO_0000029 "the hold of a ship"@en)
AnnotationAssertion(obo:IAO_0000112 obo:BFO_0000029 "the interior of a kangaroo pouch"@en)
AnnotationAssertion(obo:IAO_0000112 obo:BFO_0000029 "the interior of the trunk of your car"@en)
AnnotationAssertion(obo:IAO_0000112 obo:BFO_0000029 "the interior of your bedroom"@en)
AnnotationAssertion(obo:IAO_0000112 obo:BFO_0000029 "the interior of your office"@en)
AnnotationAssertion(obo:IAO_0000112 obo:BFO_0000029 "the interior of your refrigerator"@en)
AnnotationAssertion(obo:IAO_0000112 obo:BFO_0000029 "the lumen of your gut"@en)
AnnotationAssertion(obo:IAO_0000112 obo:BFO_0000029 "your left nostril (a fiat part – the opening – of your left nasal cavity)"@en)
AnnotationAssertion(Annotation(obo:IAO_0010000 <http://purl.obolibrary.org/obo/bfo/axiom/034-002>) obo:IAO_0000600 obo:BFO_0000029 "b is a site means: b is a three-dimensional immaterial entity that is (partially or wholly) bounded by a material entity or it is a three-dimensional immaterial part thereof. (axiom label in BFO2 Reference: [034-002])"@en)
AnnotationAssertion(Annotation(obo:IAO_0010000 <http://purl.obolibrary.org/obo/bfo/axiom/034-002>) obo:IAO_0000602 obo:BFO_0000029 "(forall (x) (if (Site x) (ImmaterialEntity x))) // axiom label in BFO2 CLIF: [034-002] ")
AnnotationAssertion(rdfs:isDefinedBy obo:BFO_0000029 obo:bfo.owl)
AnnotationAssertion(rdfs:label obo:BFO_0000029 "site"@en)
SubClassOf(obo:BFO_0000029 obo:BFO_0000141)

# Class: obo:BFO_0000030 (object)

AnnotationAssertion(obo:BFO_0000179 obo:BFO_0000030 "object")
AnnotationAssertion(obo:BFO_0000180 obo:BFO_0000030 "Object")
AnnotationAssertion(obo:IAO_0000112 obo:BFO_0000030 "atom"@en)
AnnotationAssertion(obo:IAO_0000112 obo:BFO_0000030 "cell"@en)
AnnotationAssertion(obo:IAO_0000112 obo:BFO_0000030 "cells and organisms"@en)
AnnotationAssertion(obo:IAO_0000112 obo:BFO_0000030 "engineered artifacts"@en)
AnnotationAssertion(obo:IAO_0000112 obo:BFO_0000030 "grain of sand"@en)
AnnotationAssertion(obo:IAO_0000112 obo:BFO_0000030 "molecule"@en)
AnnotationAssertion(obo:IAO_0000112 obo:BFO_0000030 "organelle"@en)
AnnotationAssertion(obo:IAO_0000112 obo:BFO_0000030 "organism"@en)
AnnotationAssertion(obo:IAO_0000112 obo:BFO_0000030 "planet"@en)
AnnotationAssertion(obo:IAO_0000112 obo:BFO_0000030 "solid portions of matter"@en)
AnnotationAssertion(obo:IAO_0000112 obo:BFO_0000030 "star"@en)
AnnotationAssertion(obo:IAO_0000116 obo:BFO_0000030 "BFO 2 Reference: BFO rests on the presupposition that at multiple micro-, meso- and macroscopic scales reality exhibits certain stable, spatially separated or separable material units, combined or combinable into aggregates of various sorts (for example organisms into what are called ‘populations’). Such units play a central role in almost all domains of natural science from particle physics to cosmology. Many scientific laws govern the units in question, employing general terms (such as ‘molecule’ or ‘planet’) referring to the types and subtypes of units, and also to the types and subtypes of the processes through which such units develop and interact. The division of reality into such natural units is at the heart of biological science, as also is the fact that these units may form higher-level units (as cells form multicellular organisms) and that they may also form aggregates of units, for example as cells form portions of tissue and organs form families, herds, breeds, species, and so on. At the same time, the division of certain portions of reality into engineered units (manufactured artifacts) is the basis of modern industrial technology, which rests on the distributed mass production of engineered parts through division of labor and on their assembly into larger, compound units such as cars and laptops. The division of portions of reality into units is one starting point for the phenomenon of counting."@en)
AnnotationAssertion(obo:IAO_0000116 obo:BFO_0000030 "BFO 2 Reference: Each object is such that there are entities of which we can assert unproblematically that they lie in its interior, and other entities of which we can assert unproblematically that they lie in its exterior. This may not be so for entities lying at or near the boundary between the interior and exterior. This means that two objects – for example the two cells depicted in Figure 3 – may be such that there are material entities crossing their boundaries which belong determinately to neither cell. Something similar obtains in certain cases of conjoined twins (see below)."@en)
AnnotationAssertion(obo:IAO_0000116 obo:BFO_0000030 "BFO 2 Reference: To say that b is causally unified means: b is a material entity which is such that its material parts are tied together in such a way that, in environments typical for entities of the type in question,if c, a continuant part of b that is in the interior of b at t, is larger than a certain threshold size (which will be determined differently from case to case, depending on factors such as porosity of external cover) and is moved in space to be at t at a location on the exterior of the spatial region that had been occupied by b at t, then either b’s other parts will be moved in coordinated fashion or b will be damaged (be affected, for example, by breakage or tearing) in the interval between t and t.causal changes in one part of b can have consequences for other parts of b without the mediation of any entity that lies on the exterior of b. Material entities with no proper material parts would satisfy these conditions trivially. Candidate examples of types of causal unity for material entities of more complex sorts are as follows (this is not intended to be an exhaustive list):CU1: Causal unity via physical coveringHere the parts in the interior of the unified entity are combined together causally through a common membrane or other physical covering\\. The latter points outwards toward and may serve a protective function in relation to what lies on the exterior of the entity [13, 47"@en)
AnnotationAssertion(obo:IAO_0000116 obo:BFO_0000030 "BFO 2 Reference: an object is a maximal causally unified material entity"@en)
AnnotationAssertion(obo:IAO_0000116 obo:BFO_0000030 "BFO 2 Reference: ‘objects’ are sometimes referred to as ‘grains’ [74"@en)
AnnotationAssertion(obo:IAO_0000412 obo:BFO_0000030 obo:dron.owl)
AnnotationAssertion(obo:IAO_0000412 obo:BFO_0000030 obo:envo.owl)
AnnotationAssertion(obo:IAO_0000412 obo:BFO_0000030 obo:opmi.owl)
AnnotationAssertion(obo:IAO_0000600 obo:BFO_0000030 "b is an object means: b is a material entity which manifests causal unity of one or other of the types CUn listed above & is of a type (a material universal) instances of which are maximal relative to this criterion of causal unity. (axiom label in BFO2 Reference: [024-001])"@en)
AnnotationAssertion(Annotation(obo:IAO_0010000 <http://purl.obolibrary.org/obo/bfo/axiom/024-001>) obo:IAO_0000600 obo:BFO_0000030 "b is an object means: b is a material entity which manifests causal unity of one or other of the types CUn listed above & is of a type (a material universal) instances of which are maximal relative to this criterion of causal unity. (axiom label in BFO2 Reference: [024-001])"@en)
AnnotationAssertion(rdfs:isDefinedBy obo:BFO_0000030 obo:bfo.owl)
AnnotationAssertion(rdfs:label obo:BFO_0000030 "object"@en)
SubClassOf(obo:BFO_0000030 obo:BFO_0000040)

# Class: obo:BFO_0000031 (generically dependent continuant)

AnnotationAssertion(obo:BFO_0000179 obo:BFO_0000031 "gdc")
AnnotationAssertion(obo:BFO_0000180 obo:BFO_0000031 "GenericallyDependentContinuant")
AnnotationAssertion(obo:IAO_0000112 obo:BFO_0000031 "The entries in your database are patterns instantiated as quality instances in your hard drive. The database itself is an aggregate of such patterns. When you create the database you create a particular instance of the generically dependent continuant type database. Each entry in the database is an instance of the generically dependent continuant type IAO: information content entity."@en)
AnnotationAssertion(obo:IAO_0000112 obo:BFO_0000031 "the pdf file on your laptop, the pdf file that is a copy thereof on my laptop"@en)
AnnotationAssertion(obo:IAO_0000112 obo:BFO_0000031 "the sequence of this protein molecule; the sequence that is a copy thereof in that protein molecule."@en)
AnnotationAssertion(obo:IAO_0000115 obo:BFO_0000031 "A continuant that is dependent on one or other independent continuant bearers. For every instance of A requires some instance of (an independent continuant type) B but which instance of B serves can change from time to time."@en)
AnnotationAssertion(obo:IAO_0000115 obo:BFO_0000031 "b is a generically dependent continuant = Def. b is a continuant that g-depends_on one or more other entities. (axiom label in BFO2 Reference: [074-001])"@en)
AnnotationAssertion(Annotation(obo:IAO_0010000 <http://purl.obolibrary.org/obo/bfo/axiom/074-001>) obo:IAO_0000115 obo:BFO_0000031 "b is a generically dependent continuant = Def. b is a continuant that g-depends_on one or more other entities. (axiom label in BFO2 Reference: [074-001])"@en)
AnnotationAssertion(obo:IAO_0000412 obo:BFO_0000031 obo:iao.owl)
AnnotationAssertion(obo:IAO_0000602 obo:BFO_0000031 "(iff (GenericallyDependentContinuant a) (and (Continuant a) (exists (b t) (genericallyDependsOnAt a b t)))) // axiom label in BFO2 CLIF: [074-001] ")
AnnotationAssertion(Annotation(obo:IAO_0010000 <http://purl.obolibrary.org/obo/bfo/axiom/074-001>) obo:IAO_0000602 obo:BFO_0000031 "(iff (GenericallyDependentContinuant a) (and (Continuant a) (exists (b t) (genericallyDependsOnAt a b t)))) // axiom label in BFO2 CLIF: [074-001] ")
AnnotationAssertion(rdfs:isDefinedBy obo:BFO_0000031 obo:bfo.owl)
AnnotationAssertion(rdfs:label obo:BFO_0000031 "generically dependent continuant"@en)
SubClassOf(obo:BFO_0000031 obo:BFO_0000002)

# Class: obo:BFO_0000034 (function)

AnnotationAssertion(obo:BFO_0000179 obo:BFO_0000034 "function")
AnnotationAssertion(obo:BFO_0000180 obo:BFO_0000034 "Function")
AnnotationAssertion(obo:IAO_0000112 obo:BFO_0000034 "the function of a hammer to drive in nails"@en)
AnnotationAssertion(obo:IAO_0000112 obo:BFO_0000034 "the function of a heart pacemaker to regulate the beating of a heart through electricity"@en)
AnnotationAssertion(obo:IAO_0000112 obo:BFO_0000034 "the function of amylase in saliva to break down starch into sugar"@en)
AnnotationAssertion(obo:IAO_0000116 obo:BFO_0000034 "BFO 2 Reference: In the past, we have distinguished two varieties of function, artifactual function and biological function. These are not asserted subtypes of BFO:function however, since the same function – for example: to pump, to transport – can exist both in artifacts and in biological entities. The asserted subtypes of function that would be needed in order to yield a separate monoheirarchy are not artifactual function, biological function, etc., but rather transporting function, pumping function, etc."@en)
AnnotationAssertion(Annotation(obo:IAO_0010000 <http://purl.obolibrary.org/obo/bfo/axiom/064-001>) obo:IAO_0000600 obo:BFO_0000034 "A function is a disposition that exists in virtue of the bearer’s physical make-up and this physical make-up is something the bearer possesses because it came into being, either through evolution (in the case of natural biological entities) or through intentional design (in the case of artifacts), in order to realize processes of a certain sort. (axiom label in BFO2 Reference: [064-001])"@en)
AnnotationAssertion(Annotation(obo:IAO_0010000 <http://purl.obolibrary.org/obo/bfo/axiom/064-001>) obo:IAO_0000602 obo:BFO_0000034 "(forall (x) (if (Function x) (Disposition x))) // axiom label in BFO2 CLIF: [064-001] ")
AnnotationAssertion(rdfs:isDefinedBy obo:BFO_0000034 obo:bfo.owl)
AnnotationAssertion(rdfs:label obo:BFO_0000034 "function"@en)
SubClassOf(obo:BFO_0000034 obo:BFO_0000016)

# Class: obo:BFO_0000035 (process boundary)

AnnotationAssertion(obo:BFO_0000179 obo:BFO_0000035 "p-boundary")
AnnotationAssertion(obo:BFO_0000180 obo:BFO_0000035 "ProcessBoundary")
AnnotationAssertion(obo:IAO_0000112 obo:BFO_0000035 "the boundary between the 2nd and 3rd year of your life."@en)
AnnotationAssertion(Annotation(obo:IAO_0010000 <http://purl.obolibrary.org/obo/bfo/axiom/084-001>) obo:IAO_0000115 obo:BFO_0000035 "p is a process boundary =Def. p is a temporal part of a process & p has no proper temporal parts. (axiom label in BFO2 Reference: [084-001])"@en)
AnnotationAssertion(Annotation(obo:IAO_0010000 <http://purl.obolibrary.org/obo/bfo/axiom/085-002>) obo:IAO_0000601 obo:BFO_0000035 "Every process boundary occupies_temporal_region a zero-dimensional temporal region. (axiom label in BFO2 Reference: [085-002])"@en)
AnnotationAssertion(Annotation(obo:IAO_0010000 <http://purl.obolibrary.org/obo/bfo/axiom/085-002>) obo:IAO_0000602 obo:BFO_0000035 "(forall (x) (if (ProcessBoundary x) (exists (y) (and (ZeroDimensionalTemporalRegion y) (occupiesTemporalRegion x y))))) // axiom label in BFO2 CLIF: [085-002] ")
AnnotationAssertion(Annotation(obo:IAO_0010000 <http://purl.obolibrary.org/obo/bfo/axiom/084-001>) obo:IAO_0000602 obo:BFO_0000035 "(iff (ProcessBoundary a) (exists (p) (and (Process p) (temporalPartOf a p) (not (exists (b) (properTemporalPartOf b a)))))) // axiom label in BFO2 CLIF: [084-001] ")
AnnotationAssertion(rdfs:isDefinedBy obo:BFO_0000035 obo:bfo.owl)
AnnotationAssertion(rdfs:label obo:BFO_0000035 "process boundary"@en)
SubClassOf(obo:BFO_0000035 obo:BFO_0000003)

# Class: obo:BFO_0000038 (one-dimensional temporal region)

AnnotationAssertion(obo:BFO_0000179 obo:BFO_0000038 "1d-t-region")
AnnotationAssertion(obo:BFO_0000180 obo:BFO_0000038 "OneDimensionalTemporalRegion")
AnnotationAssertion(obo:IAO_0000112 obo:BFO_0000038 "the temporal region during which a process occurs."@en)
AnnotationAssertion(obo:IAO_0000116 obo:BFO_0000038 "BFO 2 Reference: A temporal interval is a special kind of one-dimensional temporal region, namely one that is self-connected (is without gaps or breaks)."@en)
AnnotationAssertion(Annotation(obo:IAO_0010000 <http://purl.obolibrary.org/obo/bfo/axiom/103-001>) obo:IAO_0000600 obo:BFO_0000038 "A one-dimensional temporal region is a temporal region that is extended. (axiom label in BFO2 Reference: [103-001])"@en)
AnnotationAssertion(Annotation(obo:IAO_0010000 <http://purl.obolibrary.org/obo/bfo/axiom/103-001>) obo:IAO_0000602 obo:BFO_0000038 "(forall (x) (if (OneDimensionalTemporalRegion x) (TemporalRegion x))) // axiom label in BFO2 CLIF: [103-001] ")
AnnotationAssertion(rdfs:isDefinedBy obo:BFO_0000038 obo:bfo.owl)
AnnotationAssertion(rdfs:label obo:BFO_0000038 "one-dimensional temporal region"@en)
SubClassOf(obo:BFO_0000038 obo:BFO_0000008)
DisjointClasses(obo:BFO_0000038 obo:BFO_0000148)

# Class: obo:BFO_0000040 (material_entity)

AnnotationAssertion(obo:BFO_0000179 obo:BFO_0000040 "material")
AnnotationAssertion(obo:BFO_0000180 obo:BFO_0000040 "MaterialEntity")
AnnotationAssertion(obo:IAO_0000112 obo:BFO_0000040 "a flame"@en)
AnnotationAssertion(obo:IAO_0000112 obo:BFO_0000040 "a forest fire"@en)
AnnotationAssertion(obo:IAO_0000112 obo:BFO_0000040 "a human being"@en)
AnnotationAssertion(obo:IAO_0000112 obo:BFO_0000040 "a hurricane"@en)
AnnotationAssertion(obo:IAO_0000112 obo:BFO_0000040 "a photon"@en)
AnnotationAssertion(obo:IAO_0000112 obo:BFO_0000040 "a puff of smoke"@en)
AnnotationAssertion(obo:IAO_0000112 obo:BFO_0000040 "a sea wave"@en)
AnnotationAssertion(obo:IAO_0000112 obo:BFO_0000040 "a tornado"@en)
AnnotationAssertion(obo:IAO_0000112 obo:BFO_0000040 "an aggregate of human beings."@en)
AnnotationAssertion(obo:IAO_0000112 obo:BFO_0000040 "an energy wave"@en)
AnnotationAssertion(obo:IAO_0000112 obo:BFO_0000040 "an epidemic"@en)
AnnotationAssertion(obo:IAO_0000112 obo:BFO_0000040 "the undetached arm of a human being"@en)
AnnotationAssertion(obo:IAO_0000115 obo:BFO_0000040 "An independent continuant that is spatially extended whose identity is independent of that of other entities and can be maintained through time."@en)
AnnotationAssertion(obo:IAO_0000116 obo:BFO_0000040 "BFO 2 Reference: Material entities (continuants) can preserve their identity even while gaining and losing material parts. Continuants are contrasted with occurrents, which unfold themselves in successive temporal parts or phases [60"@en)
AnnotationAssertion(obo:IAO_0000116 obo:BFO_0000040 "BFO 2 Reference: Object, Fiat Object Part and Object Aggregate are not intended to be exhaustive of Material Entity. Users are invited to propose new subcategories of Material Entity."@en)
AnnotationAssertion(obo:IAO_0000116 obo:BFO_0000040 "BFO 2 Reference: ‘Matter’ is intended to encompass both mass and energy (we will address the ontological treatment of portions of energy in a later version of BFO). A portion of matter is anything that includes elementary particles among its proper or improper parts: quarks and leptons, including electrons, as the smallest particles thus far discovered; baryons (including protons and neutrons) at a higher level of granularity; atoms and molecules at still higher levels, forming the cells, organs, organisms and other material entities studied by biologists, the portions of rock studied by geologists, the fossils studied by paleontologists, and so on.Material entities are three-dimensional entities (entities extended in three spatial dimensions), as contrasted with the processes in which they participate, which are four-dimensional entities (entities extended also along the dimension of time).According to the FMA, material entities may have immaterial entities as parts – including the entities identified below as sites; for example the interior (or ‘lumen’) of your small intestine is a part of your body. BFO 2.0 embodies a decision to follow the FMA here."@en)
AnnotationAssertion(obo:IAO_0000412 obo:BFO_0000040 obo:bfo.owl)
AnnotationAssertion(obo:IAO_0000412 obo:BFO_0000040 obo:dron.owl)
AnnotationAssertion(obo:IAO_0000412 obo:BFO_0000040 obo:envo.owl)
AnnotationAssertion(obo:IAO_0000412 obo:BFO_0000040 obo:ero.owl)
AnnotationAssertion(obo:IAO_0000412 obo:BFO_0000040 obo:oae.owl)
AnnotationAssertion(obo:IAO_0000412 obo:BFO_0000040 obo:obi.owl)
AnnotationAssertion(obo:IAO_0000412 obo:BFO_0000040 obo:omrse.owl)
AnnotationAssertion(obo:IAO_0000412 obo:BFO_0000040 obo:opmi.owl)
AnnotationAssertion(obo:IAO_0000600 obo:BFO_0000040 "A material entity is an independent continuant that has some portion of matter as proper or improper continuant part. (axiom label in BFO2 Reference: [019-002])"@en)
AnnotationAssertion(Annotation(obo:IAO_0010000 <http://purl.obolibrary.org/obo/bfo/axiom/019-002>) obo:IAO_0000600 obo:BFO_0000040 "A material entity is an independent continuant that has some portion of matter as proper or improper continuant part. (axiom label in BFO2 Reference: [019-002])"@en)
AnnotationAssertion(obo:IAO_0000601 obo:BFO_0000040 "Every entity which has a material entity as continuant part is a material entity. (axiom label in BFO2 Reference: [020-002])"@en)
AnnotationAssertion(Annotation(obo:IAO_0010000 <http://purl.obolibrary.org/obo/bfo/axiom/020-002>) obo:IAO_0000601 obo:BFO_0000040 "Every entity which has a material entity as continuant part is a material entity. (axiom label in BFO2 Reference: [020-002])"@en)
AnnotationAssertion(obo:IAO_0000601 obo:BFO_0000040 "every entity of which a material entity is continuant part is also a material entity. (axiom label in BFO2 Reference: [021-002])"@en)
AnnotationAssertion(Annotation(obo:IAO_0010000 <http://purl.obolibrary.org/obo/bfo/axiom/021-002>) obo:IAO_0000601 obo:BFO_0000040 "every entity of which a material entity is continuant part is also a material entity. (axiom label in BFO2 Reference: [021-002])"@en)
AnnotationAssertion(obo:IAO_0000602 obo:BFO_0000040 "(forall (x) (if (MaterialEntity x) (IndependentContinuant x))) // axiom label in BFO2 CLIF: [019-002] ")
AnnotationAssertion(Annotation(obo:IAO_0010000 <http://purl.obolibrary.org/obo/bfo/axiom/019-002>) obo:IAO_0000602 obo:BFO_0000040 "(forall (x) (if (MaterialEntity x) (IndependentContinuant x))) // axiom label in BFO2 CLIF: [019-002] ")
AnnotationAssertion(obo:IAO_0000602 obo:BFO_0000040 "(forall (x) (if (and (Entity x) (exists (y t) (and (MaterialEntity y) (continuantPartOfAt x y t)))) (MaterialEntity x))) // axiom label in BFO2 CLIF: [021-002] ")
AnnotationAssertion(Annotation(obo:IAO_0010000 <http://purl.obolibrary.org/obo/bfo/axiom/021-002>) obo:IAO_0000602 obo:BFO_0000040 "(forall (x) (if (and (Entity x) (exists (y t) (and (MaterialEntity y) (continuantPartOfAt x y t)))) (MaterialEntity x))) // axiom label in BFO2 CLIF: [021-002] ")
AnnotationAssertion(obo:IAO_0000602 obo:BFO_0000040 "(forall (x) (if (and (Entity x) (exists (y t) (and (MaterialEntity y) (continuantPartOfAt y x t)))) (MaterialEntity x))) // axiom label in BFO2 CLIF: [020-002] ")
AnnotationAssertion(Annotation(obo:IAO_0010000 <http://purl.obolibrary.org/obo/bfo/axiom/020-002>) obo:IAO_0000602 obo:BFO_0000040 "(forall (x) (if (and (Entity x) (exists (y t) (and (MaterialEntity y) (continuantPartOfAt y x t)))) (MaterialEntity x))) // axiom label in BFO2 CLIF: [020-002] ")
AnnotationAssertion(rdfs:isDefinedBy obo:BFO_0000040 obo:bfo.owl)
AnnotationAssertion(rdfs:label obo:BFO_0000040 "material entity"@en)
AnnotationAssertion(rdfs:label obo:BFO_0000040 "material_entity"@en)
SubClassOf(obo:BFO_0000040 obo:BFO_0000004)
DisjointClasses(obo:BFO_0000040 obo:BFO_0000141)

# Class: obo:BFO_0000140 (continuant fiat boundary)

AnnotationAssertion(obo:BFO_0000179 obo:BFO_0000140 "cf-boundary")
AnnotationAssertion(obo:BFO_0000180 obo:BFO_0000140 "ContinuantFiatBoundary")
AnnotationAssertion(Annotation(obo:IAO_0010000 <http://purl.obolibrary.org/obo/bfo/axiom/029-001>) obo:IAO_0000115 obo:BFO_0000140 "b is a continuant fiat boundary = Def. b is an immaterial entity that is of zero, one or two dimensions and does not include a spatial region as part. (axiom label in BFO2 Reference: [029-001])"@en)
AnnotationAssertion(obo:IAO_0000116 obo:BFO_0000140 "BFO 2 Reference: In BFO 1.1 the assumption was made that the external surface of a material entity such as a cell could be treated as if it were a boundary in the mathematical sense. The new document propounds the view that when we talk about external surfaces of material objects in this way then we are talking about something fiat. To be dealt with in a future version: fiat boundaries at different levels of granularity.More generally, the focus in discussion of boundaries in BFO 2.0 is now on fiat boundaries, which means: boundaries for which there is no assumption that they coincide with physical discontinuities. The ontology of boundaries becomes more closely allied with the ontology of regions."@en)
AnnotationAssertion(obo:IAO_0000116 obo:BFO_0000140 "BFO 2 Reference: a continuant fiat boundary is a boundary of some material entity (for example: the plane separating the Northern and Southern hemispheres; the North Pole), or it is a boundary of some immaterial entity (for example of some portion of airspace). Three basic kinds of continuant fiat boundary can be distinguished (together with various combination kinds [29"@en)
AnnotationAssertion(Annotation(obo:IAO_0010000 <http://purl.obolibrary.org/obo/bfo/axiom/0000008>) obo:IAO_0000116 obo:BFO_0000140 "Continuant fiat boundary doesn't have a closure axiom because the subclasses don't necessarily exhaust all possibilites. An example would be the mereological sum of two-dimensional continuant fiat boundary and a one dimensional continuant fiat boundary that doesn't overlap it. The situation is analogous to temporal and spatial regions."@en)
AnnotationAssertion(obo:IAO_0000601 obo:BFO_0000140 "Every continuant fiat boundary is located at some spatial region at every time at which it exists"@en)
AnnotationAssertion(Annotation(obo:IAO_0010000 <http://purl.obolibrary.org/obo/bfo/axiom/029-001>) obo:IAO_0000602 obo:BFO_0000140 "(iff (ContinuantFiatBoundary a) (and (ImmaterialEntity a) (exists (b) (and (or (ZeroDimensionalSpatialRegion b) (OneDimensionalSpatialRegion b) (TwoDimensionalSpatialRegion b)) (forall (t) (locatedInAt a b t)))) (not (exists (c t) (and (SpatialRegion c) (continuantPartOfAt c a t)))))) // axiom label in BFO2 CLIF: [029-001] ")
AnnotationAssertion(rdfs:isDefinedBy obo:BFO_0000140 obo:bfo.owl)
AnnotationAssertion(rdfs:label obo:BFO_0000140 "continuant fiat boundary"@en)
SubClassOf(obo:BFO_0000140 obo:BFO_0000141)

# Class: obo:BFO_0000141 (immaterial entity)

AnnotationAssertion(obo:BFO_0000179 obo:BFO_0000141 "immaterial")
AnnotationAssertion(obo:BFO_0000180 obo:BFO_0000141 "ImmaterialEntity")
AnnotationAssertion(obo:IAO_0000116 obo:BFO_0000141 "BFO 2 Reference: Immaterial entities are divided into two subgroups:boundaries and sites, which bound, or are demarcated in relation, to material entities, and which can thus change location, shape and size and as their material hosts move or change shape or size (for example: your nasal passage; the hold of a ship; the boundary of Wales (which moves with the rotation of the Earth) [38, 7, 10"@en)
AnnotationAssertion(rdfs:isDefinedBy obo:BFO_0000141 obo:bfo.owl)
AnnotationAssertion(rdfs:label obo:BFO_0000141 "immaterial entity"@en)
SubClassOf(obo:BFO_0000141 obo:BFO_0000004)

# Class: obo:BFO_0000142 (one-dimensional continuant fiat boundary)

AnnotationAssertion(obo:BFO_0000179 obo:BFO_0000142 "1d-cf-boundary")
AnnotationAssertion(obo:BFO_0000180 obo:BFO_0000142 "OneDimensionalContinuantFiatBoundary")
AnnotationAssertion(obo:IAO_0000112 obo:BFO_0000142 "The Equator"@en)
AnnotationAssertion(obo:IAO_0000112 obo:BFO_0000142 "all geopolitical boundaries"@en)
AnnotationAssertion(obo:IAO_0000112 obo:BFO_0000142 "all lines of latitude and longitude"@en)
AnnotationAssertion(obo:IAO_0000112 obo:BFO_0000142 "the line separating the outer surface of the mucosa of the lower lip from the outer surface of the skin of the chin."@en)
AnnotationAssertion(obo:IAO_0000112 obo:BFO_0000142 "the median sulcus of your tongue"@en)
AnnotationAssertion(Annotation(obo:IAO_0010000 <http://purl.obolibrary.org/obo/bfo/axiom/032-001>) obo:IAO_0000600 obo:BFO_0000142 "a one-dimensional continuant fiat boundary is a continuous fiat line whose location is defined in relation to some material entity. (axiom label in BFO2 Reference: [032-001])"@en)
AnnotationAssertion(Annotation(obo:IAO_0010000 <http://purl.obolibrary.org/obo/bfo/axiom/032-001>) obo:IAO_0000602 obo:BFO_0000142 "(iff (OneDimensionalContinuantFiatBoundary a) (and (ContinuantFiatBoundary a) (exists (b) (and (OneDimensionalSpatialRegion b) (forall (t) (locatedInAt a b t)))))) // axiom label in BFO2 CLIF: [032-001] ")
AnnotationAssertion(rdfs:isDefinedBy obo:BFO_0000142 obo:bfo.owl)
AnnotationAssertion(rdfs:label obo:BFO_0000142 "one-dimensional continuant fiat boundary"@en)
SubClassOf(obo:BFO_0000142 obo:BFO_0000140)
DisjointClasses(obo:BFO_0000142 obo:BFO_0000146)
DisjointClasses(obo:BFO_0000142 obo:BFO_0000147)

# Class: obo:BFO_0000144 (process profile)

AnnotationAssertion(obo:BFO_0000179 obo:BFO_0000144 "process-profile")
AnnotationAssertion(obo:BFO_0000180 obo:BFO_0000144 "ProcessProfile")
AnnotationAssertion(obo:IAO_0000112 obo:BFO_0000144 "On a somewhat higher level of complexity are what we shall call rate process profiles, which are the targets of selective abstraction focused not on determinate quality magnitudes plotted over time, but rather on certain ratios between these magnitudes and elapsed times. A speed process profile, for example, is represented by a graph plotting against time the ratio of distance covered per unit of time. Since rates may change, and since such changes, too, may have rates of change, we have to deal here with a hierarchy of process profile universals at successive levels"@en)
AnnotationAssertion(obo:IAO_0000112 obo:BFO_0000144 "One important sub-family of rate process profiles is illustrated by the beat or frequency profiles of cyclical processes, illustrated by the 60 beats per minute beating process of John’s heart, or the 120 beats per minute drumming process involved in one of John’s performances in a rock band, and so on. Each such process includes what we shall call a beat process profile instance as part, a subtype of rate process profile in which the salient ratio is not distance covered but rather number of beat cycles per unit of time. Each beat process profile instance instantiates the determinable universal beat process profile. But it also instantiates multiple more specialized universals at lower levels of generality, selected from   rate process profilebeat process profileregular beat process profile3 bpm beat process profile4 bpm beat process profileirregular beat process profileincreasing beat process profileand so on.In the case of a regular beat process profile, a rate can be assigned in the simplest possible fashion by dividing the number of cycles by the length of the temporal region occupied by the beating process profile as a whole. Irregular process profiles of this sort, for example as identified in the clinic, or in the readings on an aircraft instrument panel, are often of diagnostic significance."@en)
AnnotationAssertion(obo:IAO_0000112 obo:BFO_0000144 "The simplest type of process profiles are what we shall call ‘quality process profiles’, which are the process profiles which serve as the foci of the sort of selective abstraction that is involved when measurements are made of changes in single qualities, as illustrated, for example, by process profiles of mass, temperature, aortic pressure, and so on."@en)
AnnotationAssertion(Annotation(obo:IAO_0010000 <http://purl.obolibrary.org/obo/bfo/axiom/093-002>) obo:IAO_0000115 obo:BFO_0000144 "b is a process_profile =Def. there is some process c such that b process_profile_of c (axiom label in BFO2 Reference: [093-002])"@en)
AnnotationAssertion(Annotation(obo:IAO_0010000 <http://purl.obolibrary.org/obo/bfo/axiom/094-005>) obo:IAO_0000600 obo:BFO_0000144 "b process_profile_of c holds when b proper_occurrent_part_of c& there is some proper_occurrent_part d of c which has no parts in common with b & is mutually dependent on b& is such that b, c and d occupy the same temporal region (axiom label in BFO2 Reference: [094-005])"@en)
AnnotationAssertion(Annotation(obo:IAO_0010000 <http://purl.obolibrary.org/obo/bfo/axiom/094-005>) obo:IAO_0000602 obo:BFO_0000144 "(forall (x y) (if (processProfileOf x y) (and (properContinuantPartOf x y) (exists (z t) (and (properOccurrentPartOf z y) (TemporalRegion t) (occupiesSpatioTemporalRegion x t) (occupiesSpatioTemporalRegion y t) (occupiesSpatioTemporalRegion z t) (not (exists (w) (and (occurrentPartOf w x) (occurrentPartOf w z))))))))) // axiom label in BFO2 CLIF: [094-005] ")
AnnotationAssertion(Annotation(obo:IAO_0010000 <http://purl.obolibrary.org/obo/bfo/axiom/093-002>) obo:IAO_0000602 obo:BFO_0000144 "(iff (ProcessProfile a) (exists (b) (and (Process b) (processProfileOf a b)))) // axiom label in BFO2 CLIF: [093-002] ")
AnnotationAssertion(rdfs:isDefinedBy obo:BFO_0000144 obo:bfo.owl)
AnnotationAssertion(rdfs:label obo:BFO_0000144 "process profile"@en)
SubClassOf(obo:BFO_0000144 obo:BFO_0000015)
DisjointClasses(obo:BFO_0000144 obo:BFO_0000182)

# Class: obo:BFO_0000145 (relational quality)

AnnotationAssertion(obo:BFO_0000179 obo:BFO_0000145 "r-quality")
AnnotationAssertion(obo:BFO_0000180 obo:BFO_0000145 "RelationalQuality")
AnnotationAssertion(obo:IAO_0000112 obo:BFO_0000145 "John’s role of husband to Mary is dependent on Mary’s role of wife to John, and both are dependent on the object aggregate comprising John and Mary as member parts joined together through the relational quality of being married."@en)
AnnotationAssertion(obo:IAO_0000112 obo:BFO_0000145 "a marriage bond, an instance of requited love, an obligation between one person and another."@en)
AnnotationAssertion(Annotation(obo:IAO_0010000 <http://purl.obolibrary.org/obo/bfo/axiom/057-001>) obo:IAO_0000115 obo:BFO_0000145 "b is a relational quality = Def. for some independent continuants c, d and for some time t: b quality_of c at t & b quality_of d at t. (axiom label in BFO2 Reference: [057-001])"@en)
AnnotationAssertion(Annotation(obo:IAO_0010000 <http://purl.obolibrary.org/obo/bfo/axiom/057-001>) obo:IAO_0000602 obo:BFO_0000145 "(iff (RelationalQuality a) (exists (b c t) (and (IndependentContinuant b) (IndependentContinuant c) (qualityOfAt a b t) (qualityOfAt a c t)))) // axiom label in BFO2 CLIF: [057-001] ")
AnnotationAssertion(rdfs:isDefinedBy obo:BFO_0000145 obo:bfo.owl)
AnnotationAssertion(rdfs:label obo:BFO_0000145 "relational quality"@en)
SubClassOf(obo:BFO_0000145 obo:BFO_0000019)

# Class: obo:BFO_0000146 (two-dimensional continuant fiat boundary)

AnnotationAssertion(obo:BFO_0000179 obo:BFO_0000146 "2d-cf-boundary")
AnnotationAssertion(obo:BFO_0000180 obo:BFO_0000146 "TwoDimensionalContinuantFiatBoundary")
AnnotationAssertion(Annotation(obo:IAO_0010000 <http://purl.obolibrary.org/obo/bfo/axiom/033-001>) obo:IAO_0000600 obo:BFO_0000146 "a two-dimensional continuant fiat boundary (surface) is a self-connected fiat surface whose location is defined in relation to some material entity. (axiom label in BFO2 Reference: [033-001])"@en)
AnnotationAssertion(Annotation(obo:IAO_0010000 <http://purl.obolibrary.org/obo/bfo/axiom/033-001>) obo:IAO_0000602 obo:BFO_0000146 "(iff (TwoDimensionalContinuantFiatBoundary a) (and (ContinuantFiatBoundary a) (exists (b) (and (TwoDimensionalSpatialRegion b) (forall (t) (locatedInAt a b t)))))) // axiom label in BFO2 CLIF: [033-001] ")
AnnotationAssertion(rdfs:isDefinedBy obo:BFO_0000146 obo:bfo.owl)
AnnotationAssertion(rdfs:label obo:BFO_0000146 "two-dimensional continuant fiat boundary"@en)
SubClassOf(obo:BFO_0000146 obo:BFO_0000140)

# Class: obo:BFO_0000147 (zero-dimensional continuant fiat boundary)

AnnotationAssertion(obo:BFO_0000179 obo:BFO_0000147 "0d-cf-boundary")
AnnotationAssertion(obo:BFO_0000180 obo:BFO_0000147 "ZeroDimensionalContinuantFiatBoundary")
AnnotationAssertion(obo:IAO_0000112 obo:BFO_0000147 "the geographic North Pole"@en)
AnnotationAssertion(obo:IAO_0000112 obo:BFO_0000147 "the point of origin of some spatial coordinate system."@en)
AnnotationAssertion(obo:IAO_0000112 obo:BFO_0000147 "the quadripoint where the boundaries of Colorado, Utah, New Mexico, and Arizona meet"@en)
AnnotationAssertion(Annotation(obo:IAO_0010000 <http://purl.obolibrary.org/obo/bfo/axiom/0000001>) Annotation(rdfs:comment "requested by Melanie Courtot") Annotation(rdfs:seeAlso <https://groups.google.com/d/msg/bfo-owl-devel/s9Uug5QmAws/ZDRnpiIi_TUJ>) obo:IAO_0000116 obo:BFO_0000147 "zero dimension continuant fiat boundaries are not spatial points. Considering the example 'the quadripoint where the boundaries of Colorado, Utah, New Mexico, and Arizona meet' : There are many frames in which that point is zooming through many points in space. Whereas, no matter what the frame, the quadripoint is always in the same relation to the boundaries of Colorado, Utah, New Mexico, and Arizona."@en)
AnnotationAssertion(Annotation(obo:IAO_0010000 <http://purl.obolibrary.org/obo/bfo/axiom/031-001>) obo:IAO_0000600 obo:BFO_0000147 "a zero-dimensional continuant fiat boundary is a fiat point whose location is defined in relation to some material entity. (axiom label in BFO2 Reference: [031-001])"@en)
AnnotationAssertion(Annotation(obo:IAO_0010000 <http://purl.obolibrary.org/obo/bfo/axiom/031-001>) obo:IAO_0000602 obo:BFO_0000147 "(iff (ZeroDimensionalContinuantFiatBoundary a) (and (ContinuantFiatBoundary a) (exists (b) (and (ZeroDimensionalSpatialRegion b) (forall (t) (locatedInAt a b t)))))) // axiom label in BFO2 CLIF: [031-001] ")
AnnotationAssertion(rdfs:isDefinedBy obo:BFO_0000147 obo:bfo.owl)
AnnotationAssertion(rdfs:label obo:BFO_0000147 "zero-dimensional continuant fiat boundary"@en)
SubClassOf(obo:BFO_0000147 obo:BFO_0000140)

# Class: obo:BFO_0000148 (zero-dimensional temporal region)

AnnotationAssertion(obo:BFO_0000179 obo:BFO_0000148 "0d-t-region")
AnnotationAssertion(obo:BFO_0000180 obo:BFO_0000148 "ZeroDimensionalTemporalRegion")
AnnotationAssertion(obo:IAO_0000112 obo:BFO_0000148 "a temporal region that is occupied by a process boundary"@en)
AnnotationAssertion(obo:IAO_0000112 obo:BFO_0000148 "right now"@en)
AnnotationAssertion(obo:IAO_0000112 obo:BFO_0000148 "the moment at which a child is born"@en)
AnnotationAssertion(obo:IAO_0000112 obo:BFO_0000148 "the moment at which a finger is detached in an industrial accident"@en)
AnnotationAssertion(obo:IAO_0000112 obo:BFO_0000148 "the moment of death."@en)
AnnotationAssertion(obo:IAO_0000118 obo:BFO_0000148 "temporal instant."@en)
AnnotationAssertion(obo:IAO_0000412 obo:BFO_0000148 obo:obi.owl)
AnnotationAssertion(obo:IAO_0000412 obo:BFO_0000148 obo:opmi.owl)
AnnotationAssertion(obo:IAO_0000600 obo:BFO_0000148 "A zero-dimensional temporal region is a temporal region that is without extent. (axiom label in BFO2 Reference: [102-001])"@en)
AnnotationAssertion(Annotation(obo:IAO_0010000 <http://purl.obolibrary.org/obo/bfo/axiom/102-001>) obo:IAO_0000600 obo:BFO_0000148 "A zero-dimensional temporal region is a temporal region that is without extent. (axiom label in BFO2 Reference: [102-001])"@en)
AnnotationAssertion(obo:IAO_0000602 obo:BFO_0000148 "(forall (x) (if (ZeroDimensionalTemporalRegion x) (TemporalRegion x))) // axiom label in BFO2 CLIF: [102-001] ")
AnnotationAssertion(Annotation(obo:IAO_0010000 <http://purl.obolibrary.org/obo/bfo/axiom/102-001>) obo:IAO_0000602 obo:BFO_0000148 "(forall (x) (if (ZeroDimensionalTemporalRegion x) (TemporalRegion x))) // axiom label in BFO2 CLIF: [102-001] ")
AnnotationAssertion(rdfs:isDefinedBy obo:BFO_0000148 obo:bfo.owl)
AnnotationAssertion(rdfs:label obo:BFO_0000148 "zero-dimensional temporal region"@en)
SubClassOf(obo:BFO_0000148 obo:BFO_0000008)

# Class: obo:BFO_0000182 (history)

AnnotationAssertion(obo:BFO_0000179 obo:BFO_0000182 "history")
AnnotationAssertion(obo:BFO_0000180 obo:BFO_0000182 "History")
AnnotationAssertion(Annotation(obo:IAO_0010000 <http://purl.obolibrary.org/obo/bfo/axiom/138-001>) obo:IAO_0000600 obo:BFO_0000182 "A history is a process that is the sum of the totality of processes taking place in the spatiotemporal region occupied by a material entity or site, including processes on the surface of the entity or within the cavities to which it serves as host. (axiom label in BFO2 Reference: [138-001])"@en)
AnnotationAssertion(rdfs:isDefinedBy obo:BFO_0000182 obo:bfo.owl)
AnnotationAssertion(rdfs:label obo:BFO_0000182 "history"@en)
SubClassOf(obo:BFO_0000182 obo:BFO_0000015)

# Class: obo:CHEBI_23367 (molecular entity)

AnnotationAssertion(obo:IAO_0000111 obo:CHEBI_23367 "molecular entity")
AnnotationAssertion(obo:IAO_0000115 obo:CHEBI_23367 "Any constitutionally or isotopically distinct atom, molecule, ion, ion pair, radical, radical ion, complex, conformer etc., identifiable as a separately distinguishable entity.")
AnnotationAssertion(obo:IAO_0000116 obo:CHEBI_23367 "We are assuming that every molecular entity has to be completely connected by chemical bonds. This excludes protein complexes, which are comprised of minimally two separate molecular entities. We will follow up with Chebi to ensure this is their understanding as well"@en)
AnnotationAssertion(obo:IAO_0000412 obo:CHEBI_23367 obo:chebi.owl)
AnnotationAssertion(obo:IAO_0000412 obo:CHEBI_23367 obo:dron.owl)
AnnotationAssertion(obo:IAO_0000412 obo:CHEBI_23367 obo:obi.owl)
AnnotationAssertion(obo:IAO_0000412 obo:CHEBI_23367 obo:opmi.owl)
AnnotationAssertion(oboInOwl:hasExactSynonym obo:CHEBI_23367 "molecular entity")
AnnotationAssertion(oboInOwl:hasOBONamespace obo:CHEBI_23367 "chebi_ontology")
AnnotationAssertion(oboInOwl:hasRelatedSynonym obo:CHEBI_23367 "entidad molecular")
AnnotationAssertion(oboInOwl:hasRelatedSynonym obo:CHEBI_23367 "entidades moleculares")
AnnotationAssertion(oboInOwl:hasRelatedSynonym obo:CHEBI_23367 "entite moleculaire")
AnnotationAssertion(oboInOwl:hasRelatedSynonym obo:CHEBI_23367 "molecular entities")
AnnotationAssertion(oboInOwl:hasRelatedSynonym obo:CHEBI_23367 "molekulare Entitaet")
AnnotationAssertion(oboInOwl:id obo:CHEBI_23367 "CHEBI:23367")
AnnotationAssertion(oboInOwl:inSubset obo:CHEBI_23367 <http://purl.oboInOwlInOwllibrary.org/oboInOwlInOwl/chebi#3_STAR>)
AnnotationAssertion(rdfs:label obo:CHEBI_23367 "molecular entity")
SubClassOf(obo:CHEBI_23367 obo:BFO_0000030)
SubClassOf(obo:CHEBI_23367 obo:BFO_0000040)
SubClassOf(obo:CHEBI_23367 obo:CHEBI_24431)

# Class: obo:CHEBI_24431 (chemical entity)

AnnotationAssertion(obo:IAO_0000115 obo:CHEBI_24431 "A chemical entity is a physical entity of interest in chemistry including molecular entities, parts thereof, and chemical substances.")
AnnotationAssertion(obo:IAO_0000412 obo:CHEBI_24431 obo:chebi.owl)
AnnotationAssertion(obo:IAO_0000412 obo:CHEBI_24431 obo:dron.owl)
AnnotationAssertion(obo:IAO_0000412 obo:CHEBI_24431 obo:opmi.owl)
AnnotationAssertion(oboInOwl:hasExactSynonym obo:CHEBI_24431 "chemical entity")
AnnotationAssertion(oboInOwl:hasOBONamespace obo:CHEBI_24431 "chebi_ontology")
AnnotationAssertion(oboInOwl:id obo:CHEBI_24431 "CHEBI:24431")
AnnotationAssertion(oboInOwl:inSubset obo:CHEBI_24431 <http://purl.oboInOwlInOwllibrary.org/oboInOwlInOwl/chebi#3_STAR>)
AnnotationAssertion(rdfs:label obo:CHEBI_24431 "chemical entity")
SubClassOf(obo:CHEBI_24431 obo:BFO_0000040)

# Class: obo:CTO_0000001 (secondary identifier)

AnnotationAssertion(Annotation(obo:IAO_0000119 "https://prsinfo.clinicaltrials.gov/definitions.html") obo:IAO_0000115 obo:CTO_0000001 "An identifier(s) (ID), if any, other than the organization's Unique Protocol Identification Number or the NCT number that is assigned to the clinical study. This includes any unique clinical study identifiers assigned by other publicly available clinical trial registries. If the clinical study is funded in whole or in part by a U.S. Federal Government agency, the complete grant or contract number must be submitted as a Secondary ID.")
AnnotationAssertion(Annotation(obo:IAO_0000119 "https://www.who.int/ictrp/network/trds/en/") obo:IAO_0000115 obo:CTO_0000001 "Other identifiers besides the Trial Identifying Number allocated by the Primary Registry, if any.")
AnnotationAssertion(rdfs:label obo:CTO_0000001 "secondary identifier")
SubClassOf(obo:CTO_0000001 obo:IAO_0000030)

# Class: obo:CTO_0000002 (Australian New Zealand clinical trials registry identifier)

AnnotationAssertion(obo:IAO_0000115 obo:CTO_0000002 "A centrally registered identifier that is assigned for a specific clinical trial registered in the Australian New Zealand clinical trials registry (ANZCTR). The format for the registry number is “ACTRN” followed by a 14-digit number, e.g., ACTRN12620000457943.")
AnnotationAssertion(oboInOwl:hasExactSynonym obo:CTO_0000002 "ANZCTR identifier")
AnnotationAssertion(rdfs:label obo:CTO_0000002 "Australian New Zealand clinical trials registry identifier")
AnnotationAssertion(rdfs:seeAlso obo:CTO_0000002 "http://www.anzctr.org.au/")
AnnotationAssertion(rdfs:seeAlso obo:CTO_0000002 "https://www.who.int/ictrp/network/primary/en/")
SubClassOf(obo:CTO_0000002 obo:NCIT_C98714)

# Class: obo:CTO_0000003 (Australian New Zealand clinical trials registry)

AnnotationAssertion(obo:IAO_0000115 obo:CTO_0000003 "Australian New Zealand Clinical Trials Registry  is a primary clinical trial registry recognised by WHO and ICMJE that enables the registration of clinical trials.")
AnnotationAssertion(oboInOwl:hasExactSynonym obo:CTO_0000003 "ANZCTR")
AnnotationAssertion(rdfs:label obo:CTO_0000003 "Australian New Zealand clinical trials registry")
AnnotationAssertion(rdfs:seeAlso obo:CTO_0000003 "http://www.anzctr.org.au/")
AnnotationAssertion(rdfs:seeAlso obo:CTO_0000003 "https://www.who.int/ictrp/network/primary/en/")
SubClassOf(obo:CTO_0000003 obo:CTO_0000073)

# Class: obo:CTO_0000004 (Peruvian clinical trial registry identifier)

AnnotationAssertion(obo:IAO_0000115 obo:CTO_0000004 "A centrally registered identifier that is assigned for a specific clinical trial registered in the Peruvian clinical trial registry  (REPEC). The format for the registry number is “PER-” followed by a 3-digit number, followed by a hyphen, followed by a 2-digit number e.g., PER-010-20.")
AnnotationAssertion(oboInOwl:hasExactSynonym obo:CTO_0000004 "REPEC identifier")
AnnotationAssertion(rdfs:label obo:CTO_0000004 "Peruvian clinical trial registry identifier")
AnnotationAssertion(rdfs:seeAlso obo:CTO_0000004 "https://ensayosclinicos-repec.ins.gob.pe/en/")
AnnotationAssertion(rdfs:seeAlso obo:CTO_0000004 "https://www.who.int/ictrp/network/primary/en/")
SubClassOf(obo:CTO_0000004 obo:NCIT_C98714)

# Class: obo:CTO_0000005 (masking design)

AnnotationAssertion(Annotation(obo:IAO_0000119 "https://prsinfo.clinicaltrials.gov/definitions.html") obo:IAO_0000115 obo:CTO_0000005 "The party or parties involved in the clinical trial who are prevented from having knowledge of the interventions assigned to individual participants.")
AnnotationAssertion(oboInOwl:hasRelatedSynonym obo:CTO_0000005 "blinding")
AnnotationAssertion(oboInOwl:hasRelatedSynonym obo:CTO_0000005 "masking")
AnnotationAssertion(rdfs:label obo:CTO_0000005 "masking design")
AnnotationAssertion(rdfs:seeAlso obo:CTO_0000005 "http://www.icmje.org/recommendations/")
AnnotationAssertion(rdfs:seeAlso obo:CTO_0000005 "http://www.who.int/ictrp/network/trds/en/index.html")
SubClassOf(obo:CTO_0000005 obo:OBI_0500000)

# Class: obo:CTO_0000006 (non-random allocation)

AnnotationAssertion(Annotation(obo:IAO_0000119 "https://prsinfo.clinicaltrials.gov/definitions.html") obo:IAO_0000115 obo:CTO_0000006 "Participants are expressly assigned to intervention groups through a non-random method, such as physician choice")
AnnotationAssertion(oboInOwl:hasExactSynonym obo:CTO_0000006 "non-randomized")
AnnotationAssertion(oboInOwl:hasExactSynonym obo:CTO_0000006 "nonrandomized")
AnnotationAssertion(rdfs:label obo:CTO_0000006 "non-random allocation")
SubClassOf(obo:CTO_0000006 obo:NCIT_C52580)

# Class: obo:CTO_0000007 (study summary result)

AnnotationAssertion(Annotation(obo:IAO_0000119 "https://clinicaltrials.gov/ct2/about-studies/glossary") obo:IAO_0000115 obo:CTO_0000007 "A study record that includes the summary results posted in the ClinicalTrials.gov results database. Summary results information includes participant flow, baseline characteristics, outcome measures, and adverse events (including serious adverse events).")
AnnotationAssertion(oboInOwl:hasExactSynonym obo:CTO_0000007 "summary results")
AnnotationAssertion(rdfs:label obo:CTO_0000007 "study summary result")
AnnotationAssertion(rdfs:seeAlso obo:CTO_0000007 "https://www.who.int/ictrp/network/trds/en/")
SubClassOf(obo:CTO_0000007 obo:IAO_0000088)

# Class: obo:CTO_0000008 (secondary outcome measure information)

AnnotationAssertion(obo:IAO_0000115 obo:CTO_0000008 "A description of each secondary outcome measure (or for observational studies, specific secondary measurement[s] or observation[s] used to describe patterns of diseases or traits or associations with exposures, risk factors or treatment).
Each secondary outcome measure information includes title, description and time frame.")
AnnotationAssertion(obo:IAO_0000119 obo:CTO_0000008 "https://prsinfo.clinicaltrials.gov/definitions.html")
AnnotationAssertion(Annotation(rdfs:isDefinedBy "https://www.who.int/ictrp/network/trds/en/") oboInOwl:hasRelatedSynonym obo:CTO_0000008 "key secondary outcome")
AnnotationAssertion(rdfs:label obo:CTO_0000008 "secondary outcome measure information")
AnnotationAssertion(rdfs:seeAlso obo:CTO_0000008 "https://clinicaltrials.gov/ct2/about-studies/glossary")
SubClassOf(obo:CTO_0000008 obo:CTO_0000051)

# Class: obo:CTO_0000009 (Iranian registry of clinical trials)

AnnotationAssertion(obo:IAO_0000115 obo:CTO_0000009 "The Iranian registry of clinical trials is a primary clinical trial registry recognised by WHO and ICMJE that enables the registration of clinical trials.")
AnnotationAssertion(oboInOwl:hasExactSynonym obo:CTO_0000009 "IRCT")
AnnotationAssertion(rdfs:label obo:CTO_0000009 "Iranian registry of clinical trials")
AnnotationAssertion(rdfs:seeAlso obo:CTO_0000009 "http://www.irct.ir/")
AnnotationAssertion(rdfs:seeAlso obo:CTO_0000009 "https://www.who.int/ictrp/network/primary/en/")
SubClassOf(obo:CTO_0000009 obo:CTO_0000073)

# Class: obo:CTO_0000010 (other outcome measure information)

AnnotationAssertion(obo:IAO_0000115 obo:CTO_0000010 "Any other measurements, excluding post-hoc measures, that will be used to evaluate the intervention(s) or, for observational studies, that are a focus of the study.
Each primary outcome measure information includes title, description and time frame.")
AnnotationAssertion(obo:IAO_0000119 obo:CTO_0000010 "https://prsinfo.clinicaltrials.gov/definitions.html")
AnnotationAssertion(oboInOwl:hasExactSynonym obo:CTO_0000010 "other pre-specified outcome measures")
AnnotationAssertion(rdfs:label obo:CTO_0000010 "other outcome measure information")
SubClassOf(obo:CTO_0000010 obo:CTO_0000051)

# Class: obo:CTO_0000011 (Indian clinical trials registry)

AnnotationAssertion(obo:IAO_0000115 obo:CTO_0000011 "The Indian clinical trials registry is a primary clinical trial registry recognised by WHO and ICMJE that enables the registration of clinical trials.")
AnnotationAssertion(oboInOwl:hasExactSynonym obo:CTO_0000011 "CTRI")
AnnotationAssertion(oboInOwl:hasExactSynonym obo:CTO_0000011 "clinical trials registry - India")
AnnotationAssertion(rdfs:label obo:CTO_0000011 "Indian clinical trials registry")
AnnotationAssertion(rdfs:seeAlso obo:CTO_0000011 "http://ctri.nic.in/")
AnnotationAssertion(rdfs:seeAlso obo:CTO_0000011 "https://www.who.int/ictrp/network/primary/en/")
SubClassOf(obo:CTO_0000011 obo:CTO_0000073)

# Class: obo:CTO_0000012 (The Netherlands national trial register)

AnnotationAssertion(obo:IAO_0000115 obo:CTO_0000012 "The Netherlands national trial register is a primary clinical trial registry recognised by WHO and ICMJE that enables the registration of clinical trials.")
AnnotationAssertion(oboInOwl:hasExactSynonym obo:CTO_0000012 "NTR")
AnnotationAssertion(rdfs:label obo:CTO_0000012 "The Netherlands national trial register")
AnnotationAssertion(rdfs:seeAlso obo:CTO_0000012 "http://www.trialregister.nl/")
AnnotationAssertion(rdfs:seeAlso obo:CTO_0000012 "https://www.who.int/ictrp/network/primary/en/")
SubClassOf(obo:CTO_0000012 obo:CTO_0000073)

# Class: obo:CTO_0000013 (Iranian registry of clinical trials identifier)

AnnotationAssertion(obo:IAO_0000115 obo:CTO_0000013 "A centrally registered identifier that is assigned for a specific clinical trial registered in the Iranian registry of clinical trials (IRCT). The format for the registry number is “IRCT” followed by a 14-digit number, one letter and again one or  two numbers, e.g., IRCT20100228003449N29.")
AnnotationAssertion(oboInOwl:hasExactSynonym obo:CTO_0000013 "IRCT identifier")
AnnotationAssertion(rdfs:label obo:CTO_0000013 "Iranian registry of clinical trials identifier")
AnnotationAssertion(rdfs:seeAlso obo:CTO_0000013 "http://www.irct.ir/")
AnnotationAssertion(rdfs:seeAlso obo:CTO_0000013 "https://www.who.int/ictrp/network/primary/en/")
SubClassOf(obo:CTO_0000013 obo:NCIT_C98714)

# Class: obo:CTO_0000014 (German clinical trials register identifier)

AnnotationAssertion(obo:IAO_0000115 obo:CTO_0000014 "A centrally registered identifier that is assigned for a specific clinical trial registered in the German clinical trials register (DRKS). The format for the registry number is “DRKS” followed by a 8-digit number, e.g., DRKS00000494.")
AnnotationAssertion(oboInOwl:hasExactSynonym obo:CTO_0000014 "DRKS identifier")
AnnotationAssertion(rdfs:label obo:CTO_0000014 "German clinical trials register identifier")
AnnotationAssertion(rdfs:seeAlso obo:CTO_0000014 "https://www.drks.de/drks_web/")
AnnotationAssertion(rdfs:seeAlso obo:CTO_0000014 "https://www.who.int/ictrp/network/primary/en/")
SubClassOf(obo:CTO_0000014 obo:NCIT_C98714)

# Class: obo:CTO_0000015 (Cuban public registry of clinical trials)

AnnotationAssertion(obo:IAO_0000115 obo:CTO_0000015 "The Cuban public registry of clinical trials is a primary clinical trial registry recognised by WHO and ICMJE that enables the registration of clinical trials.")
AnnotationAssertion(oboInOwl:hasExactSynonym obo:CTO_0000015 "RPCEC")
AnnotationAssertion(rdfs:label obo:CTO_0000015 "Cuban public registry of clinical trials")
AnnotationAssertion(rdfs:seeAlso obo:CTO_0000015 "http://registroclinico.sld.cu/en/home")
AnnotationAssertion(rdfs:seeAlso obo:CTO_0000015 "https://www.who.int/ictrp/network/primary/en/")
SubClassOf(obo:CTO_0000015 obo:CTO_0000073)

# Class: obo:CTO_0000016 (clinical trial outcome measurement)

AnnotationAssertion(Annotation(obo:IAO_0000119 "https://clinicaltrials.gov/ct2/about-studies/glossary") obo:IAO_0000115 obo:CTO_0000016 "For clinical trials, a planned measurement described in the protocol that is used to determine the effect of an intervention/treatment on participants. For observational studies, a measurement or observation that is used to describe patterns of diseases or traits, or associations with exposures, risk factors, or treatment. Types of outcome measures include primary outcome measure and secondary outcome measure.")
AnnotationAssertion(oboInOwl:hasExactSynonym obo:CTO_0000016 "outcome measure")
AnnotationAssertion(oboInOwl:hasExactSynonym obo:CTO_0000016 "outcome measurement")
AnnotationAssertion(rdfs:label obo:CTO_0000016 "clinical trial outcome measurement")
SubClassOf(obo:CTO_0000016 obo:OBI_0000070)

# Class: obo:CTO_0000017 (Pan African clinical trial registry)

AnnotationAssertion(obo:IAO_0000115 obo:CTO_0000017 "The Pan African clinical trial registry is a primary clinical trial registry recognised by WHO and ICMJE that enables the registration of clinical trials.")
AnnotationAssertion(oboInOwl:hasExactSynonym obo:CTO_0000017 "PACTR")
AnnotationAssertion(rdfs:label obo:CTO_0000017 "Pan African clinical trial registry")
AnnotationAssertion(rdfs:seeAlso obo:CTO_0000017 "http://www.pactr.org/")
AnnotationAssertion(rdfs:seeAlso obo:CTO_0000017 "https://www.who.int/ictrp/network/primary/en/")
SubClassOf(obo:CTO_0000017 obo:CTO_0000073)

# Class: obo:CTO_0000018 (The Netherlands national trial register identifier)

AnnotationAssertion(obo:IAO_0000115 obo:CTO_0000018 "A centrally registered identifier that is assigned for a specific clinical trial registered in the The Netherlands national trial register (NTR). The format for the registry number is “NTR” followed by a 1 to 4-digit number, e.g., NL8498.")
AnnotationAssertion(oboInOwl:hasExactSynonym obo:CTO_0000018 "NTR identifier")
AnnotationAssertion(rdfs:label obo:CTO_0000018 "The Netherlands national trial register identifier")
AnnotationAssertion(rdfs:seeAlso obo:CTO_0000018 "https://www.trialregister.nl/")
AnnotationAssertion(rdfs:seeAlso obo:CTO_0000018 "https://www.who.int/ictrp/network/primary/en/")
SubClassOf(obo:CTO_0000018 obo:NCIT_C98714)

# Class: obo:CTO_0000019 (JAPIC clinical trials registry)

AnnotationAssertion(obo:IAO_0000115 obo:CTO_0000019 "The JAPIC (Japan Pharmaceutical Information Center) clinical trials registry is a primary clinical trial registry recognised by WHO and ICMJE that enables the registration of clinical trials.")
AnnotationAssertion(oboInOwl:hasExactSynonym obo:CTO_0000019 "JapicCTI")
AnnotationAssertion(rdfs:label obo:CTO_0000019 "JAPIC clinical trials registry")
AnnotationAssertion(rdfs:seeAlso obo:CTO_0000019 "https://rctportal.niph.go.jp/en/")
AnnotationAssertion(rdfs:seeAlso obo:CTO_0000019 "https://www.japic.or.jp/")
AnnotationAssertion(rdfs:seeAlso obo:CTO_0000019 "https://www.who.int/ictrp/network/primary/en/")
SubClassOf(obo:CTO_0000019 obo:CTO_0000073)

# Class: obo:CTO_0000020 (Pan African clinical trial registry identifier)

AnnotationAssertion(obo:IAO_0000115 obo:CTO_0000020 "A centrally registered identifier that is assigned for a specific clinical trial registered in the Pan African clinical trial register. The format for the registry number is “KCT” followed by a 15-digit number, e.g., PACTR202004893013257.")
AnnotationAssertion(oboInOwl:hasExactSynonym obo:CTO_0000020 "PACTR identifier")
AnnotationAssertion(rdfs:label obo:CTO_0000020 "Pan African clinical trial registry identifier")
AnnotationAssertion(rdfs:seeAlso obo:CTO_0000020 "https://pactr.samrc.ac.za/")
AnnotationAssertion(rdfs:seeAlso obo:CTO_0000020 "https://www.who.int/ictrp/network/primary/en/")
SubClassOf(obo:CTO_0000020 obo:NCIT_C98714)

# Class: obo:CTO_0000022 (Chinese clinical trail registry identifier)

AnnotationAssertion(obo:IAO_0000115 obo:CTO_0000022 "A centrally registered identifier that is assigned for a specific clinical trial registered in the Chinese clinical trials register (ChiCTR). The format for the registry number is “ChiCTR” followed by a 10-digit number, e.g., ChiCTR2000031589.")
AnnotationAssertion(obo:IAO_0000118 obo:CTO_0000022 "ChiCTR identifier")
AnnotationAssertion(oboInOwl:hasExactSynonym obo:CTO_0000022 "Chinese Clinical Trial Register number")
AnnotationAssertion(rdfs:label obo:CTO_0000022 "Chinese clinical trail registry identifier")
AnnotationAssertion(rdfs:seeAlso obo:CTO_0000022 "http://www.chictr.org.cn/enIndex.aspx")
SubClassOf(obo:CTO_0000022 obo:NCIT_C98714)

# Class: obo:CTO_0000023 (Lebanese clinical trials registry)

AnnotationAssertion(obo:IAO_0000115 obo:CTO_0000023 "The Lebanese clinical trials registry  is a primary clinical trial registry recognised by WHO and ICMJE that enables the registration of clinical trials.")
AnnotationAssertion(oboInOwl:hasExactSynonym obo:CTO_0000023 "LBCTR")
AnnotationAssertion(rdfs:label obo:CTO_0000023 "Lebanese clinical trials registry")
AnnotationAssertion(rdfs:seeAlso obo:CTO_0000023 "http://lbctr.emro.who.int/")
AnnotationAssertion(rdfs:seeAlso obo:CTO_0000023 "https://www.who.int/ictrp/network/primary/en/")
SubClassOf(obo:CTO_0000023 obo:CTO_0000073)

# Class: obo:CTO_0000024 (German clinical trials register)

AnnotationAssertion(obo:IAO_0000115 obo:CTO_0000024 "German clinical trials register is a primary clinical trial registry recognised by WHO and ICMJE that enables the registration of clinical trials.")
AnnotationAssertion(oboInOwl:hasExactSynonym obo:CTO_0000024 "DRKS")
AnnotationAssertion(rdfs:label obo:CTO_0000024 "German clinical trials register")
AnnotationAssertion(rdfs:seeAlso obo:CTO_0000024 "http://www.germanctr.de/")
AnnotationAssertion(rdfs:seeAlso obo:CTO_0000024 "https://www.who.int/ictrp/network/primary/en/")
SubClassOf(obo:CTO_0000024 obo:CTO_0000073)

# Class: obo:CTO_0000025 (JMACCT clinical trials registry)

AnnotationAssertion(obo:IAO_0000115 obo:CTO_0000025 "The JMACCT (Japan Medical Association, Center for Clinical Trials) clinical trials registry is a primary clinical trial registry recognised by WHO and ICMJE that enables the registration of clinical trials.")
AnnotationAssertion(oboInOwl:hasExactSynonym obo:CTO_0000025 "JMACCT")
AnnotationAssertion(rdfs:label obo:CTO_0000025 "JMACCT clinical trials registry")
AnnotationAssertion(rdfs:seeAlso obo:CTO_0000025 "https://dbcentre3.jmacct.med.or.jp/jmactr/Default_Eng.aspx")
AnnotationAssertion(rdfs:seeAlso obo:CTO_0000025 "https://rctportal.niph.go.jp/en/")
SubClassOf(obo:CTO_0000025 obo:CTO_0000073)

# Class: obo:CTO_0000026 (age_between_18_and_64)

AnnotationAssertion(oboInOwl:hasExactSynonym obo:CTO_0000026 "adult (18-64)")
AnnotationAssertion(rdfs:label obo:CTO_0000026 "age_between_18_and_64")
AnnotationAssertion(rdfs:seeAlso obo:CTO_0000026 "https://clinicaltrials.gov/ct2/about-studies/glossary")
SubClassOf(obo:CTO_0000026 obo:NCIT_C25150)

# Class: obo:CTO_0000028 (number of participants)

AnnotationAssertion(obo:IAO_0000115 obo:CTO_0000028 "The actual total number of participants that are enrolled in a clinical study")
AnnotationAssertion(obo:IAO_0000119 obo:CTO_0000028 "https://prsinfo.clinicaltrials.gov/definitions.html")
AnnotationAssertion(Annotation(rdfs:isDefinedBy "https://prsinfo.clinicaltrials.gov/definitions.html") oboInOwl:hasRelatedSynonym obo:CTO_0000028 "enrollment")
AnnotationAssertion(Annotation(rdfs:isDefinedBy "http://www.who.int/ictrp/network/trds/en/index.html") oboInOwl:hasRelatedSynonym obo:CTO_0000028 "sample size")
AnnotationAssertion(rdfs:label obo:CTO_0000028 "number of participants")
AnnotationAssertion(rdfs:seeAlso obo:CTO_0000028 "http://www.icmje.org/recommendations/")
SubClassOf(obo:CTO_0000028 obo:IAO_0000027)

# Class: obo:CTO_0000030 (Brazilian clinical trial registry identifier)

AnnotationAssertion(obo:IAO_0000115 obo:CTO_0000030 "A centrally registered identifier that is assigned for a specific clinical trial registered in  Brazilian Registry of Clinical Trials (ReBEC). The format for the ReBEC registry number is “RBR-” followed by  6 characters, e.g., RBR-4hb9qs.")
AnnotationAssertion(oboInOwl:hasExactSynonym obo:CTO_0000030 "Brazilian Registry of Clinical Trials identifier")
AnnotationAssertion(oboInOwl:hasExactSynonym obo:CTO_0000030 "ReBEC identifier")
AnnotationAssertion(rdfs:label obo:CTO_0000030 "Brazilian clinical trial registry identifier")
AnnotationAssertion(rdfs:seeAlso obo:CTO_0000030 "http://www.ensaiosclinicos.gov.br/")
SubClassOf(obo:CTO_0000030 obo:NCIT_C98714)

# Class: obo:CTO_0000031 (clinical trial phase 2/3)

AnnotationAssertion(obo:IAO_0000115 obo:CTO_0000031 "Clinical trial phase that is a combination of phases 2 and 3.")
AnnotationAssertion(oboInOwl:hasExactSynonym obo:CTO_0000031 "Phase 2/3")
AnnotationAssertion(oboInOwl:hasExactSynonym obo:CTO_0000031 "Phase 2/Phase 3")
AnnotationAssertion(oboInOwl:hasExactSynonym obo:CTO_0000031 "Phase I/II")
AnnotationAssertion(rdfs:label obo:CTO_0000031 "clinical trial phase 2/3")
AnnotationAssertion(rdfs:seeAlso obo:CTO_0000031 "https://prsinfo.clinicaltrials.gov/definitions.html")
SubClassOf(obo:CTO_0000031 obo:CTO_0000201)

# Class: obo:CTO_0000032 (study result)

AnnotationAssertion(obo:IAO_0000115 obo:CTO_0000032 "data item ....")
AnnotationAssertion(rdfs:label obo:CTO_0000032 "study result")
SubClassOf(obo:CTO_0000032 obo:IAO_0000027)

# Class: obo:CTO_0000033 (healthy volunteer criterion)

AnnotationAssertion(Annotation(obo:IAO_0000119 "https://clinicaltrials.gov/ct2/about-studies/glossary") obo:IAO_0000115 obo:CTO_0000033 "A type of eligibility criteria that indicates whether people who do not have the condition/disease being studied can participate in that clinical study.")
AnnotationAssertion(Annotation(obo:IAO_0000119 "https://prsinfo.clinicaltrials.gov/definitions.html") obo:IAO_0000115 obo:CTO_0000033 "Indication that participants who do not have a disease or condition, or related conditions or symptoms, under study in the clinical study are permitted to participate in the clinical study.")
AnnotationAssertion(oboInOwl:hasExactSynonym obo:CTO_0000033 "accepts healthy volunteers")
AnnotationAssertion(rdfs:label obo:CTO_0000033 "healthy volunteer criterion")
AnnotationAssertion(rdfs:seeAlso obo:CTO_0000033 "https://www.who.int/ictrp/network/trds/en/")
SubClassOf(obo:CTO_0000033 obo:OBI_0500027)

# Class: obo:CTO_0000034 (age_between_birth_and_17_years)

AnnotationAssertion(oboInOwl:hasExactSynonym obo:CTO_0000034 "child (birth-17)")
AnnotationAssertion(rdfs:label obo:CTO_0000034 "age_between_birth_and_17_years")
SubClassOf(obo:CTO_0000034 obo:NCIT_C25150)

# Class: obo:CTO_0000035 (primary outcome measure information)

AnnotationAssertion(obo:IAO_0000115 obo:CTO_0000035 "A description of each primary outcome measure (or for observational studies, specific key measurement[s] or observation[s] used to describe patterns of diseases or traits or associations with exposures, risk factors or treatment).
Each primary outcome measure information includes title, description and time frame.")
AnnotationAssertion(obo:IAO_0000119 obo:CTO_0000035 "https://prsinfo.clinicaltrials.gov/definitions.html")
AnnotationAssertion(Annotation(rdfs:seeAlso "https://www.clinicaltrialsregister.eu/doc/EU_Clinical_Trials_Register_Glossary.pdf") oboInOwl:hasRelatedSynonym obo:CTO_0000035 "primary end point")
AnnotationAssertion(Annotation(rdfs:isDefinedBy "https://www.who.int/ictrp/network/trds/en/") oboInOwl:hasRelatedSynonym obo:CTO_0000035 "primary outcome(s)")
AnnotationAssertion(rdfs:label obo:CTO_0000035 "primary outcome measure information")
AnnotationAssertion(rdfs:seeAlso obo:CTO_0000035 "https://clinicaltrials.gov/ct2/about-studies/glossary")
SubClassOf(obo:CTO_0000035 obo:CTO_0000051)

# Class: obo:CTO_0000036 (EU clinical trials register)

AnnotationAssertion(obo:IAO_0000115 obo:CTO_0000036 "The EU clinical trials register is a primary clinical trial registry recognised by WHO and ICMJE that enables the registration of clinical trials.")
AnnotationAssertion(oboInOwl:hasExactSynonym obo:CTO_0000036 "EU-CTR")
AnnotationAssertion(rdfs:label obo:CTO_0000036 "EU clinical trials register")
AnnotationAssertion(rdfs:seeAlso obo:CTO_0000036 "https://eudract.ema.europa.eu/")
AnnotationAssertion(rdfs:seeAlso obo:CTO_0000036 "https://www.clinicaltrialsregister.eu")
AnnotationAssertion(rdfs:seeAlso obo:CTO_0000036 "https://www.who.int/ictrp/network/primary/en/")
SubClassOf(obo:CTO_0000036 obo:CTO_0000073)

# Class: obo:CTO_0000037 (UMIN clinical trials registry)

AnnotationAssertion(obo:IAO_0000115 obo:CTO_0000037 "The UMIN (University Hospital Medical Information Network Center) clinical trials registry is a Japanese primary clinical trial registry recognised by WHO and ICMJE that enables the registration of clinical trials.")
AnnotationAssertion(oboInOwl:hasExactSynonym obo:CTO_0000037 "UMIN CTR")
AnnotationAssertion(rdfs:label obo:CTO_0000037 "UMIN clinical trials registry")
AnnotationAssertion(rdfs:seeAlso obo:CTO_0000037 "https://rctportal.niph.go.jp/en/")
AnnotationAssertion(rdfs:seeAlso obo:CTO_0000037 "https://www.umin.ac.jp/ctr/")
AnnotationAssertion(rdfs:seeAlso obo:CTO_0000037 "https://www.who.int/ictrp/network/primary/en/")
SubClassOf(obo:CTO_0000037 obo:CTO_0000073)

# Class: obo:CTO_0000038 (age_older_than_64)

AnnotationAssertion(oboInOwl:hasExactSynonym obo:CTO_0000038 "older adult (65+)")
AnnotationAssertion(rdfs:label obo:CTO_0000038 "age_older_than_64")
AnnotationAssertion(rdfs:seeAlso obo:CTO_0000038 "https://clinicaltrials.gov/ct2/about-studies/glossary")
SubClassOf(obo:CTO_0000038 obo:NCIT_C25150)

# Class: obo:CTO_0000039 (outcome measure result)

AnnotationAssertion(obo:IAO_0000115 obo:CTO_0000039 "Data generated from measurement of experimental variables in a study, or for observational studies, from descriptions of patterns of diseases or traits or associations with exposures, risk factors or treatment.")
AnnotationAssertion(rdfs:label obo:CTO_0000039 "outcome measure result")
SubClassOf(obo:CTO_0000039 obo:IAO_0000088)

# Class: obo:CTO_0000040 (human subjects protection review board status)

AnnotationAssertion(Annotation(obo:IAO_0000119 "https://prsinfo.clinicaltrials.gov/definitions.html") obo:IAO_0000115 obo:CTO_0000040 "Indicate whether a clinical study has been reviewed and approved by at least one human subjects protection review board or such review is not required per applicable law (for example, 21 CFR Part 56, 45 CFR Part 46, or other applicable regulation).")
AnnotationAssertion(rdfs:label obo:CTO_0000040 "human subjects protection review board status")
SubClassOf(obo:CTO_0000040 obo:OPMI_0000326)

# Class: obo:CTO_0000041 (Korean clinical trials registry)

AnnotationAssertion(obo:IAO_0000115 obo:CTO_0000041 "ClinicalTrials.gov is a registry of clinical trials.")
AnnotationAssertion(obo:IAO_0000115 obo:CTO_0000041 "The Korean clinical trials registry (Clinical Research Information Service (CRiS), Republic of Korea) is a primary clinical trial registry recognised by WHO and ICMJE that enables the registration of clinical trials.")
AnnotationAssertion(oboInOwl:hasExactSynonym obo:CTO_0000041 "CRiS")
AnnotationAssertion(oboInOwl:hasExactSynonym obo:CTO_0000041 "Clinical Research Information Service, Republic of Korea")
AnnotationAssertion(rdfs:label obo:CTO_0000041 "Korean clinical trials registry")
AnnotationAssertion(rdfs:seeAlso obo:CTO_0000041 "http://cris.nih.go.kr/cris/en/use_guide/cris_introduce.jsp")
AnnotationAssertion(rdfs:seeAlso obo:CTO_0000041 "https://www.who.int/ictrp/network/primary/en/")
SubClassOf(obo:CTO_0000041 obo:CTO_0000073)

# Class: obo:CTO_0000043 (phase not applicable)

AnnotationAssertion(Annotation(obo:IAO_0000119 "https://prsinfo.clinicaltrials.gov/definitions.html") obo:IAO_0000115 obo:CTO_0000043 "Trials without phases (for example, studies of devices or behavioral interventions).")
AnnotationAssertion(oboInOwl:hasExactSynonym obo:CTO_0000043 "N/A")
AnnotationAssertion(rdfs:label obo:CTO_0000043 "phase not applicable")
SubClassOf(obo:CTO_0000043 obo:CTO_0000201)

# Class: obo:CTO_0000044 (retrospective study design)

AnnotationAssertion(Annotation(obo:IAO_0000119 "https://prsinfo.clinicaltrials.gov/definitions.html") obo:IAO_0000115 obo:CTO_0000044 "Look back using observations collected predominantly prior to subject selection and enrollment")
AnnotationAssertion(rdfs:label obo:CTO_0000044 "retrospective study design")
SubClassOf(obo:CTO_0000044 obo:OBI_0500000)

# Class: obo:CTO_0000045 (International standard randomised controlled trial register identifier)

AnnotationAssertion(obo:IAO_0000115 obo:CTO_0000045 "A centrally registered identifier that is assigned for a specific clinical trial registered in the international standard randomised controlled trial register  (ISRCT). The format for the registry number is “ISRCTN” followed by a 8-digit number, e.g., ISRCTN14966673.")
AnnotationAssertion(oboInOwl:hasExactSynonym obo:CTO_0000045 "ISRCTN")
AnnotationAssertion(oboInOwl:hasExactSynonym obo:CTO_0000045 "International Standard Randomised Controlled Trial Number")
AnnotationAssertion(rdfs:label obo:CTO_0000045 "International standard randomised controlled trial register identifier")
AnnotationAssertion(rdfs:seeAlso obo:CTO_0000045 "http://www.isrctn.com/")
AnnotationAssertion(rdfs:seeAlso obo:CTO_0000045 "https://www.who.int/ictrp/network/primary/en/")
SubClassOf(obo:CTO_0000045 obo:NCIT_C98714)

# Class: obo:CTO_0000046 (clinical trial phase 1/2)

AnnotationAssertion(obo:IAO_0000115 obo:CTO_0000046 "Clinical trial phase that is a combination of phases 1 and 2.")
AnnotationAssertion(oboInOwl:hasExactSynonym obo:CTO_0000046 "Phase 1/2")
AnnotationAssertion(oboInOwl:hasExactSynonym obo:CTO_0000046 "Phase 1/Phase 2")
AnnotationAssertion(oboInOwl:hasExactSynonym obo:CTO_0000046 "Phase I/II")
AnnotationAssertion(rdfs:label obo:CTO_0000046 "clinical trial phase 1/2")
AnnotationAssertion(rdfs:seeAlso obo:CTO_0000046 "https://prsinfo.clinicaltrials.gov/definitions.html")
SubClassOf(obo:CTO_0000046 obo:CTO_0000201)

# Class: obo:CTO_0000047 (prospective study design)

AnnotationAssertion(Annotation(obo:IAO_0000119 "https://prsinfo.clinicaltrials.gov/definitions.html") obo:IAO_0000115 obo:CTO_0000047 "Look forward using periodic observations collected predominantly following subject enrollment")
AnnotationAssertion(rdfs:label obo:CTO_0000047 "prospective study design")
SubClassOf(obo:CTO_0000047 obo:OBI_0500000)

# Class: obo:CTO_0000048 (Thai clinical trials registry identifier)

AnnotationAssertion(obo:IAO_0000115 obo:CTO_0000048 "A centrally registered identifier that is assigned for a specific clinical trial registered in the Thai clinical trials registry  (TCTR). The format for the registry number is “TCTR” followed by a 11-digit number, e.g., TCTR20200405001")
AnnotationAssertion(oboInOwl:hasExactSynonym obo:CTO_0000048 "TCTR identifier")
AnnotationAssertion(rdfs:label obo:CTO_0000048 "Thai clinical trials registry identifier")
AnnotationAssertion(rdfs:seeAlso obo:CTO_0000048 "http://www.clinicaltrials.in.th/")
AnnotationAssertion(rdfs:seeAlso obo:CTO_0000048 "https://www.who.int/ictrp/network/primary/en/")
SubClassOf(obo:CTO_0000048 obo:NCIT_C98714)

# Class: obo:CTO_0000049 (Chinese clinical trial registry)

AnnotationAssertion(obo:IAO_0000115 obo:CTO_0000049 "The Chinese clinical trial registry is a primary clinical trial registry recognised by WHO and ICMJE that enables the registration of clinical trials.")
AnnotationAssertion(oboInOwl:hasExactSynonym obo:CTO_0000049 "ChiCTR")
AnnotationAssertion(rdfs:label obo:CTO_0000049 "Chinese clinical trial registry")
AnnotationAssertion(rdfs:seeAlso obo:CTO_0000049 "http://www.chictr.org.cn/")
AnnotationAssertion(rdfs:seeAlso obo:CTO_0000049 "https://www.who.int/ictrp/network/primary/en/")
SubClassOf(obo:CTO_0000049 obo:CTO_0000073)

# Class: obo:CTO_0000050 (Thai clinical trials registry)

AnnotationAssertion(obo:IAO_0000115 obo:CTO_0000050 "The Thai clinical trials registry  is a primary clinical trial registry recognised by WHO and ICMJE that enables the registration of clinical trials.")
AnnotationAssertion(oboInOwl:hasExactSynonym obo:CTO_0000050 "TCTR")
AnnotationAssertion(rdfs:label obo:CTO_0000050 "Thai clinical trials registry")
AnnotationAssertion(rdfs:seeAlso obo:CTO_0000050 "http://www.clinicaltrials.in.th/")
AnnotationAssertion(rdfs:seeAlso obo:CTO_0000050 "https://www.who.int/ictrp/network/primary/en/")
SubClassOf(obo:CTO_0000050 obo:CTO_0000073)

# Class: obo:CTO_0000051 (outcome specification)

AnnotationAssertion(obo:IAO_0000115 obo:CTO_0000051 "A description of the outcome measure in an interventional study or for observational studies, specific key measurement[s] or observation[s] used to describe patterns of diseases or traits or associations with exposures, risk factors or treatment.")
AnnotationAssertion(rdfs:label obo:CTO_0000051 "outcome specification")
AnnotationAssertion(rdfs:seeAlso obo:CTO_0000051 "https://clinicaltrials.gov/ct2/about-studies/glossary")
SubClassOf(obo:CTO_0000051 obo:IAO_0000033)

# Class: obo:CTO_0000052 (Indian clinical trial registry identifier)

AnnotationAssertion(obo:IAO_0000115 obo:CTO_0000052 "A centrally registered identifier that is assigned for a specific clinical trial registered in the Indian clinical trial register. The format for the registry number is “CRTI/” followed  by a 4-digit number, followed by a slash, followed a 2-digit number, followed by a slash, followed a 6-digit number, e.g., CTRI/2020/03/024402.")
AnnotationAssertion(oboInOwl:hasExactSynonym obo:CTO_0000052 "CRTI identifier")
AnnotationAssertion(oboInOwl:hasExactSynonym obo:CTO_0000052 "Clinical Trials Registry - India identifier")
AnnotationAssertion(rdfs:label obo:CTO_0000052 "Indian clinical trial registry identifier")
AnnotationAssertion(rdfs:seeAlso obo:CTO_0000052 "http://ctri.nic.in/Clinicaltrials/login.php")
AnnotationAssertion(rdfs:seeAlso obo:CTO_0000052 "https://www.who.int/ictrp/network/primary/en/")
SubClassOf(obo:CTO_0000052 obo:NCIT_C98714)

# Class: obo:CTO_0000053 (Brazilian clinical trials registry)

AnnotationAssertion(obo:IAO_0000115 obo:CTO_0000053 "The Brazilian clinical trials registry is a primary clinical trial registry recognised by WHO and ICMJE that enables the registration of clinical trials.")
AnnotationAssertion(oboInOwl:hasExactSynonym obo:CTO_0000053 "ReBec")
AnnotationAssertion(rdfs:label obo:CTO_0000053 "Brazilian clinical trials registry")
AnnotationAssertion(rdfs:seeAlso obo:CTO_0000053 "http://www.ensaiosclinicos.gov.br/")
AnnotationAssertion(rdfs:seeAlso obo:CTO_0000053 "https://www.who.int/ictrp/network/primary/en/")
SubClassOf(obo:CTO_0000053 obo:CTO_0000073)

# Class: obo:CTO_0000054 (jRCT clinical trial identifier)

AnnotationAssertion(obo:IAO_0000115 obo:CTO_0000054 "A centrally registered identifier that is assigned for a specific clinical trial registered in the Japan Registry of Clinical Trials (jRCT). The format for the registry number is “jRCTs” followed by a 9-digit number, e.g., JPRN-jRCTs031190227")
AnnotationAssertion(oboInOwl:hasExactSynonym obo:CTO_0000054 "Japan registry of clinical trials identifier")
AnnotationAssertion(rdfs:label obo:CTO_0000054 "jRCT clinical trial identifier")
AnnotationAssertion(rdfs:seeAlso obo:CTO_0000054 "https://jrct.niph.go.jp/")
AnnotationAssertion(rdfs:seeAlso obo:CTO_0000054 "https://rctportal.niph.go.jp/en/")
AnnotationAssertion(rdfs:seeAlso obo:CTO_0000054 "https://www.who.int/ictrp/network/primary/en/")
SubClassOf(obo:CTO_0000054 obo:CTO_0000209)

# Class: obo:CTO_0000055 (Cuban public registry of clinical trials identifier)

AnnotationAssertion(obo:IAO_0000115 obo:CTO_0000055 "A centrally registered identifier that is assigned for a specific clinical trial registered in the Cuban public registry of clinical trials (RPCEC). The format for the registry number is “RPCEC” followed by a 8-digit number, e.g., RPCEC00000306.")
AnnotationAssertion(oboInOwl:hasExactSynonym obo:CTO_0000055 "RPCEC identifier")
AnnotationAssertion(rdfs:label obo:CTO_0000055 "Cuban public registry of clinical trials identifier")
AnnotationAssertion(rdfs:seeAlso obo:CTO_0000055 "http://registroclinico.sld.cu/en/home")
AnnotationAssertion(rdfs:seeAlso obo:CTO_0000055 "https://www.who.int/ictrp/network/primary/en/")
SubClassOf(obo:CTO_0000055 obo:NCIT_C98714)

# Class: obo:CTO_0000056 (Lebanese clinical trials registry identifier)

AnnotationAssertion(obo:IAO_0000115 obo:CTO_0000056 "A centrally registered identifier that is assigned for a specific clinical trial registered in the Lebanese clinical trials registry  (LBCTR). The format for the registry number is “LBCTR” followed by a 10-digit number, e.g., LBCTR2020043459.")
AnnotationAssertion(rdfs:label obo:CTO_0000056 "Lebanese clinical trials registry identifier")
AnnotationAssertion(rdfs:seeAlso obo:CTO_0000056 "LBCTR identifier")
AnnotationAssertion(rdfs:seeAlso obo:CTO_0000056 "http://lbctr.emro.who.int/")
AnnotationAssertion(rdfs:seeAlso obo:CTO_0000056 "https://www.who.int/ictrp/network/primary/en/")
SubClassOf(obo:CTO_0000056 obo:NCIT_C98714)

# Class: obo:CTO_0000073 (primary registry)

AnnotationAssertion(obo:IAO_0000115 obo:CTO_0000073 "A primary registry is clinical trial registry in the WHO registry network that meet specific criteria for content, quality and validity, accessibility, unique identification, technical capacity and administration. Primary registries also meet the requirements of the International Clinical Trials Registry Platform (ICMJE).")
AnnotationAssertion(rdfs:label obo:CTO_0000073 "primary registry"^^rdf:langString)
AnnotationAssertion(rdfs:seeAlso obo:CTO_0000073 "https://www.who.int/ictrp/network/primary/en/")
SubClassOf(obo:CTO_0000073 obo:CTO_0000077)

# Class: obo:CTO_0000074 (Peruvian clinical trial registry)

AnnotationAssertion(obo:IAO_0000115 obo:CTO_0000074 "The Peruvian clinical trial registry is a primary clinical trial registry recognised by WHO and ICMJE that enables the registration of clinical trials.")
AnnotationAssertion(oboInOwl:hasExactSynonym obo:CTO_0000074 "REPEC")
AnnotationAssertion(rdfs:label obo:CTO_0000074 "Peruvian clinical trial registry"^^rdf:langString)
AnnotationAssertion(rdfs:seeAlso obo:CTO_0000074 "https://ensayosclinicos-repec.ins.gob.pe/en/")
AnnotationAssertion(rdfs:seeAlso obo:CTO_0000074 "https://www.who.int/ictrp/network/primary/en/")
SubClassOf(obo:CTO_0000074 obo:CTO_0000073)

# Class: obo:CTO_0000075 (Sri Lanka clinical trials registry)

AnnotationAssertion(obo:IAO_0000115 obo:CTO_0000075 "The Sri Lanka clinical trials registry is a primary clinical trial registry recognised by WHO and ICMJE that enables the registration of clinical trials.")
AnnotationAssertion(oboInOwl:hasExactSynonym obo:CTO_0000075 "SLCTR")
AnnotationAssertion(rdfs:label obo:CTO_0000075 "Sri Lanka clinical trials registry"^^rdf:langString)
AnnotationAssertion(rdfs:seeAlso obo:CTO_0000075 "http://www.slctr.lk/")
AnnotationAssertion(rdfs:seeAlso obo:CTO_0000075 "https://www.who.int/ictrp/network/primary/en/")
SubClassOf(obo:CTO_0000075 obo:CTO_0000073)

# Class: obo:CTO_0000076 (US ClinicalTrial.gov registry)

AnnotationAssertion(obo:IAO_0000115 obo:CTO_0000076 "ClinicalTrials.gov is a registry for clinical trials funded and maintained by NIH/NLM in US."@en)
AnnotationAssertion(oboInOwl:hasExactSynonym obo:CTO_0000076 "ClinicalTrials.gov")
AnnotationAssertion(rdfs:label obo:CTO_0000076 "US ClinicalTrial.gov registry"^^rdf:langString)
AnnotationAssertion(rdfs:seeAlso obo:CTO_0000076 "https://clinicaltrials.gov/")
SubClassOf(obo:CTO_0000076 obo:CTO_0000073)

# Class: obo:CTO_0000077 (clinical trials registry organization)

AnnotationAssertion(obo:IAO_0000115 obo:CTO_0000077 "A clinical trials registry organization is an organization that enables the registration and documentation of clinical trials.")
AnnotationAssertion(oboInOwl:hasExactSynonym obo:CTO_0000077 "clinical trials registry")
AnnotationAssertion(rdfs:label obo:CTO_0000077 "clinical trials registry organization"^^rdf:langString)
SubClassOf(obo:CTO_0000077 obo:ERO_0001843)

# Class: obo:CTO_0000099 (clinical trial enrollment)

AnnotationAssertion(rdfs:label obo:CTO_0000099 "clinical trial enrollment"^^rdf:langString)
SubClassOf(obo:CTO_0000099 obo:OBI_0600004)

# Class: obo:CTO_0000100 (clinical trial participant)

AnnotationAssertion(rdfs:label obo:CTO_0000100 "clinical trial participant"^^rdf:langString)
SubClassOf(obo:CTO_0000100 obo:OPMI_0000381)

# Class: obo:CTO_0000101 (healthy enrollee)

AnnotationAssertion(rdfs:label obo:CTO_0000101 "healthy enrollee"^^rdf:langString)
SubClassOf(obo:CTO_0000101 obo:OPMI_0000381)

# Class: obo:CTO_0000102 (enrolled patient)

AnnotationAssertion(rdfs:label obo:CTO_0000102 "enrolled patient"^^rdf:langString)
SubClassOf(obo:CTO_0000102 obo:OPMI_0000381)

# Class: obo:CTO_0000103 (placebo medical intervention)

AnnotationAssertion(rdfs:label obo:CTO_0000103 "placebo medical intervention"^^rdf:langString)
SubClassOf(obo:CTO_0000103 obo:OAE_0000002)

# Class: obo:CTO_0000104 (outcome measurement datum)

AnnotationAssertion(rdfs:label obo:CTO_0000104 "outcome measurement datum"^^rdf:langString)
SubClassOf(obo:CTO_0000104 obo:IAO_0000027)

# Class: obo:CTO_0000105 (primary outcome measurement datum)

AnnotationAssertion(rdfs:label obo:CTO_0000105 "primary outcome measurement datum"^^rdf:langString)
EquivalentClasses(obo:CTO_0000105 obo:NCIT_C98772)
SubClassOf(obo:CTO_0000105 obo:CTO_0000104)

# Class: obo:CTO_0000106 (secondary outcome measurement datum)

AnnotationAssertion(rdfs:label obo:CTO_0000106 "secondary outcome measurement datum"^^rdf:langString)
EquivalentClasses(obo:CTO_0000106 obo:NCIT_C98781)
SubClassOf(obo:CTO_0000106 obo:CTO_0000104)

# Class: obo:CTO_0000107 (investigational molecular entity administration)

AnnotationAssertion(dc:creator obo:CTO_0000107 "Asiyah Yu Lin, Qingliang \"Leon\" Li")
AnnotationAssertion(dc:date obo:CTO_0000107 "2021-06-10T13:15:41Z"^^xsd:dateTime)
AnnotationAssertion(rdfs:label obo:CTO_0000107 "investigational molecular entity administration"@en)
SubClassOf(obo:CTO_0000107 obo:OAE_0000002)

# Class: obo:CTO_0000108 (investigational molecular entity)

AnnotationAssertion(rdfs:label obo:CTO_0000108 "investigational molecular entity"^^rdf:langString)
SubClassOf(obo:CTO_0000108 obo:CHEBI_23367)

# Class: obo:CTO_0000109 (drug clinical trial)

AnnotationAssertion(obo:IAO_0000115 obo:CTO_0000109 "A clinical trial investigate some molecular entity which either will be a new drug or is already an approved drug but looking for new indications or new populations that are not stated in the drug label."@en)
AnnotationAssertion(dc:creator obo:CTO_0000109 "Asiyah Yu Lin"@en)
AnnotationAssertion(rdfs:label obo:CTO_0000109 "drug clinical trial"^^rdf:langString)
SubClassOf(obo:CTO_0000109 obo:CTO_0000220)

# Class: obo:CTO_0000110 (clinical trial sponsor role)

AnnotationAssertion(obo:IAO_0000115 obo:CTO_0000110 "a sponsor role that ties to a clinical trial."@en)
AnnotationAssertion(dc:creator obo:CTO_0000110 "Asiyah Yu Lin"@en)
AnnotationAssertion(rdfs:label obo:CTO_0000110 "clinical trial sponsor role"^^rdf:langString)
SubClassOf(obo:CTO_0000110 obo:OBI_0000243)

# Class: obo:CTO_0000111 (procedure clinical trIal)

AnnotationAssertion(rdfs:label obo:CTO_0000111 "procedure clinical trIal"^^rdf:langString)
SubClassOf(obo:CTO_0000111 obo:ERO_0001402)

# Class: obo:CTO_0000112 (double blinded design)

AnnotationAssertion(obo:IAO_0000115 obo:CTO_0000112 "a study design in which neither the subjects nor the investigators are permitted to know which subject is receiving which treatment")
AnnotationAssertion(oboInOwl:hasExactSynonym obo:CTO_0000112 "double-blind")
AnnotationAssertion(oboInOwl:hasExactSynonym obo:CTO_0000112 "double-blinded")
AnnotationAssertion(rdfs:label obo:CTO_0000112 "double blinded design"^^rdf:langString)
SubClassOf(obo:CTO_0000112 obo:CTO_0000005)

# Class: obo:CTO_0000113 (single blinded design)

AnnotationAssertion(obo:IAO_0000115 obo:CTO_0000113 "a study design in which only the  investigators are permitted to know which subject is receiving which treatment")
AnnotationAssertion(oboInOwl:hasExactSynonym obo:CTO_0000113 "double blind")
AnnotationAssertion(oboInOwl:hasExactSynonym obo:CTO_0000113 "double blinded")
AnnotationAssertion(rdfs:label obo:CTO_0000113 "single blinded design"^^rdf:langString)
SubClassOf(obo:CTO_0000113 obo:CTO_0000005)

# Class: obo:CTO_0000114 (open blinded design)

AnnotationAssertion(obo:IAO_0000115 obo:CTO_0000114 "a study design in which  the subjects and  the investigators are permitted to know which subject is receiving which treatment")
AnnotationAssertion(oboInOwl:hasExactSynonym obo:CTO_0000114 "open blind")
AnnotationAssertion(oboInOwl:hasExactSynonym obo:CTO_0000114 "open label")
AnnotationAssertion(rdfs:label obo:CTO_0000114 "open blinded design"^^rdf:langString)
SubClassOf(obo:CTO_0000114 obo:CTO_0000005)

# Class: obo:CTO_0000115 (sequential design)

AnnotationAssertion(Annotation(obo:IAO_0000119 "https://prsinfo.clinicaltrials.gov/definitions.html") obo:IAO_0000115 obo:CTO_0000115 "Groups of participants are assigned to receive interventions based on prior milestones being reached in the study, such as in some dose escalation and adaptive design studies")
AnnotationAssertion(rdfs:label obo:CTO_0000115 "sequential design"^^rdf:langString)
SubClassOf(obo:CTO_0000115 obo:OBI_0000115)

# Class: obo:CTO_0000116 (single arm design)

AnnotationAssertion(obo:IAO_0000115 obo:CTO_0000116 "study design with a single group (arm)")
AnnotationAssertion(oboInOwl:hasExactSynonym obo:CTO_0000116 "sinlge arm")
AnnotationAssertion(rdfs:label obo:CTO_0000116 "single arm design"^^rdf:langString)
SubClassOf(obo:CTO_0000116 obo:OBI_0000115)

# Class: obo:CTO_0000117 (primary outcome measurement)

AnnotationAssertion(rdfs:label obo:CTO_0000117 "primary outcome measurement"^^rdf:langString)
SubClassOf(obo:CTO_0000117 obo:CTO_0000016)

# Class: obo:CTO_0000118 (secondary outcome measurement)

AnnotationAssertion(rdfs:label obo:CTO_0000118 "secondary outcome measurement"^^rdf:langString)
SubClassOf(obo:CTO_0000118 obo:CTO_0000016)

# Class: obo:CTO_0000119 (investigational drug administration)

AnnotationAssertion(dc:creator obo:CTO_0000119 "Asiyah Yu Lin, Qingliang \"Leon\" Li")
AnnotationAssertion(dc:date obo:CTO_0000119 "2021-06-10T13:15:58Z"^^xsd:dateTime)
AnnotationAssertion(rdfs:label obo:CTO_0000119 "investigational drug administration"@en)
SubClassOf(obo:CTO_0000119 obo:CTO_0000107)

# Class: obo:CTO_0000120 (investigational supplement administration)

AnnotationAssertion(dc:creator obo:CTO_0000120 "Asiyah Yu Lin, Qingliang \"Leon\" Li")
AnnotationAssertion(dc:date obo:CTO_0000120 "2021-06-10T13:16:26Z"^^xsd:dateTime)
AnnotationAssertion(rdfs:label obo:CTO_0000120 "investigational supplement administration"@en)
SubClassOf(obo:CTO_0000120 obo:CTO_0000107)

# Class: obo:CTO_0000132 (pivotal clinical trial)

AnnotationAssertion(obo:IAO_0000115 obo:CTO_0000132 "A clinical trial is conducted for the purpose of demonstrating the efficacy of a new drug in order to obtain its marketing approval by regulatory authorities (e.g. FDA in the United States and EMA in Europe). The pivotal clinical trial usually is a Phase III clinical trial, but exceptionally phase 2 studies could also be utilized as pivotal trials."@en)
AnnotationAssertion(obo:IAO_0000116 obo:CTO_0000132 "This is the same terms as the pre-version of this ontology: Clinical Trials Ontology - Neurodegenerative Diseases:  http://www.co-ode.org/ontologies/ont.owl#Pivotal_trial"@en)
AnnotationAssertion(obo:IAO_0000118 obo:CTO_0000132 "pivotal trial"@en)
AnnotationAssertion(obo:IAO_0000119 obo:CTO_0000132 "https://en.wikipedia.org/wiki/Pivotal_trial"@en)
AnnotationAssertion(obo:IAO_0000119 obo:CTO_0000132 "https://www.sofpromed.com/pivotal-clinical-trials-frequently-asked-questions/"@en)
AnnotationAssertion(dc:creator obo:CTO_0000132 "Asiyah Yu Lin")
AnnotationAssertion(dc:date obo:CTO_0000132 "2021-06-10T16:49:17Z"^^xsd:dateTime)
AnnotationAssertion(rdfs:label obo:CTO_0000132 "pivotal clinical trial"@en)
SubClassOf(obo:CTO_0000132 obo:CTO_0000220)

# Class: obo:CTO_0000200 (clinical trial primary purpose specification)

AnnotationAssertion(obo:IAO_0000115 obo:CTO_0000200 "The main objective of the intervention(s) being evaluated by the clinical trial.")
AnnotationAssertion(obo:IAO_0000118 obo:CTO_0000200 "primary purpose of clinical trial")
AnnotationAssertion(obo:IAO_0000119 obo:CTO_0000200 "https://prsinfo.clinicaltrials.gov/definitions.html")
AnnotationAssertion(rdfs:label obo:CTO_0000200 "clinical trial primary purpose specification"@en)
SubClassOf(obo:CTO_0000200 obo:IAO_0000005)

# Class: obo:CTO_0000201 (clinical trial phase)

AnnotationAssertion(obo:IAO_0000115 obo:CTO_0000201 "The quality of a clinical trial that studies a drug or biological product. The phase is based on the study's objective, the number of participants, and other characteristics. According to USA FDA, there are five phases: Early Phase 1 (formerly listed as Phase 0), Phase 1, Phase 2, Phase 3, and Phase 4.")
AnnotationAssertion(obo:IAO_0000117 obo:CTO_0000201 "Leon Li, Asiyah Lin, Oliver He")
AnnotationAssertion(obo:IAO_0000118 obo:CTO_0000201 "clinical trial stage")
AnnotationAssertion(obo:IAO_0000119 obo:CTO_0000201 "https://www.clinicaltrials.gov/ct2/help/glossary/phase")
AnnotationAssertion(oboInOwl:hasNarrowSynonym obo:CTO_0000201 "phase")
AnnotationAssertion(rdfs:label obo:CTO_0000201 "clinical trial phase"@en)
AnnotationAssertion(rdfs:seeAlso obo:CTO_0000201 "https://www.who.int/ictrp/network/trds/en/")
SubClassOf(obo:CTO_0000201 obo:PATO_0001236)

# Class: obo:CTO_0000202 (clinical trial early phase 1)

AnnotationAssertion(obo:IAO_0000115 obo:CTO_0000202 "A clinical trial phase that is designed to use an investigational agent that is available only in very limited quantities and which has never previously given to humans or for which there is extremely limited human experience. Phase 0 clinical trials are intended to enable researchers to understand the path of the drug in the body and its efficacy. Adverse event reporting in Phase 0 trials is expedited. [def-source: NCI]")
AnnotationAssertion(obo:IAO_0000117 obo:CTO_0000202 "Leon Li, Asiyah Lin, Oliver He")
AnnotationAssertion(obo:IAO_0000118 obo:CTO_0000202 "")
AnnotationAssertion(obo:IAO_0000118 obo:CTO_0000202 "Early Phase 1")
AnnotationAssertion(obo:IAO_0000118 obo:CTO_0000202 "Pre-Clinical Phase")
AnnotationAssertion(obo:IAO_0000118 obo:CTO_0000202 "clinical trial phase 0"@en)
AnnotationAssertion(obo:IAO_0000119 obo:CTO_0000202 "http://purl.obolibrary.org/obo/NCIT_C54721")
AnnotationAssertion(obo:IAO_0000119 obo:CTO_0000202 "https://en.wikipedia.org/wiki/Clinical_trial")
AnnotationAssertion(obo:NCIT_P207 obo:CTO_0000202 "C1882358")
AnnotationAssertion(obo:OPMI_0000364 obo:CTO_0000202 "C54721")
AnnotationAssertion(rdfs:label obo:CTO_0000202 "clinical trial early phase 1")
SubClassOf(obo:CTO_0000202 obo:CTO_0000201)

# Class: obo:CTO_0000203 (clinical trial phase 1)

AnnotationAssertion(obo:IAO_0000115 obo:CTO_0000203 "A clinical trial phase that represents the first-in-man trial, which tests within a small group of people (typically 20-80) to evaluate safety, determine safe dosage ranges, and begin to identify side effects. A drug's side effects could be subtle or long term, or may only happen with a few people, so phase 1 trials are not expected to identify all side effects.")
AnnotationAssertion(obo:IAO_0000117 obo:CTO_0000203 "Leon Li, Asiyah Lin, Oliver He")
AnnotationAssertion(obo:IAO_0000118 obo:CTO_0000203 "Phase 1")
AnnotationAssertion(obo:IAO_0000118 obo:CTO_0000203 "Phase I")
AnnotationAssertion(obo:IAO_0000119 obo:CTO_0000203 "http://purl.obolibrary.org/obo/NCIT_C15600")
AnnotationAssertion(obo:IAO_0000119 obo:CTO_0000203 "https://en.wikipedia.org/wiki/Clinical_trial")
AnnotationAssertion(obo:NCIT_P207 obo:CTO_0000203 "C0920321")
AnnotationAssertion(obo:OPMI_0000364 obo:CTO_0000203 "C15600")
AnnotationAssertion(rdfs:label obo:CTO_0000203 "clinical trial phase 1"@en)
SubClassOf(obo:CTO_0000203 obo:CTO_0000201)

# Class: obo:CTO_0000204 (clinical trial phase 2)

AnnotationAssertion(obo:IAO_0000115 obo:CTO_0000204 "A clinical trial phase that is designed to study a biomedical or behavioral intervention in a larger group of people (several hundred), to evaluate the drug's effectiveness for a particular indication in patients with the disease or condition under study, and to determine the common short-term side effects and risks associated with the intervention. [def-source: NCI]")
AnnotationAssertion(obo:IAO_0000117 obo:CTO_0000204 "Leon Li, Asiyah Lin, Oliver He")
AnnotationAssertion(obo:IAO_0000118 obo:CTO_0000204 "Phase II")
AnnotationAssertion(obo:IAO_0000119 obo:CTO_0000204 "http://purl.obolibrary.org/obo/NCIT_C15601")
AnnotationAssertion(obo:IAO_0000119 obo:CTO_0000204 "https://en.wikipedia.org/wiki/Clinical_trial")
AnnotationAssertion(obo:NCIT_P207 obo:CTO_0000204 "C0282460")
AnnotationAssertion(obo:OPMI_0000364 obo:CTO_0000204 "C15601")
AnnotationAssertion(rdfs:label obo:CTO_0000204 "clinical trial phase 2"@en)
SubClassOf(obo:CTO_0000204 obo:CTO_0000201)

# Class: obo:CTO_0000205 (clinical trial phase 3)

AnnotationAssertion(obo:IAO_0000115 obo:CTO_0000205 "A clinical trial phase that is designed to investigate the efficacy of the biomedical or behavioral intervention in large groups of human subjects (from several hundred to several thousand), to confirm efficacy, to monitor adverse reactions to the new medication or treatment regimen with respect to long-term use and by comparing the intervention to other standard or experimental interventions as well as to a placebo. [def-source: NCI]")
AnnotationAssertion(obo:IAO_0000117 obo:CTO_0000205 "Leon Li, Asiyah Lin, Oliver He")
AnnotationAssertion(obo:IAO_0000118 obo:CTO_0000205 "Phase III")
AnnotationAssertion(obo:IAO_0000119 obo:CTO_0000205 "http://purl.obolibrary.org/obo/NCIT_C15602")
AnnotationAssertion(obo:IAO_0000119 obo:CTO_0000205 "https://en.wikipedia.org/wiki/Clinical_trial")
AnnotationAssertion(obo:NCIT_P207 obo:CTO_0000205 "C0282461")
AnnotationAssertion(obo:OPMI_0000364 obo:CTO_0000205 "C15602")
AnnotationAssertion(rdfs:label obo:CTO_0000205 "clinical trial phase 3"@en)
SubClassOf(obo:CTO_0000205 obo:CTO_0000201)

# Class: obo:CTO_0000206 (clinical trial phase 4)

AnnotationAssertion(obo:IAO_0000115 obo:CTO_0000206 "A clinical trial phase that is designed for a randomized, controlled trial to evaluate the long-term safety and efficacy of a drug for a given indication. Often they are designed to study side effects that may have become apparent after the phase III study was completed. [def-source: NCI]")
AnnotationAssertion(obo:IAO_0000117 obo:CTO_0000206 "Leon Li, Asiyah Lin, Oliver He")
AnnotationAssertion(obo:IAO_0000118 obo:CTO_0000206 "Phase IV")
AnnotationAssertion(obo:IAO_0000119 obo:CTO_0000206 "https://en.wikipedia.org/wiki/Clinical_trial")
AnnotationAssertion(obo:NCIT_P207 obo:CTO_0000206 "C0282462")
AnnotationAssertion(obo:OPMI_0000364 obo:CTO_0000206 "C15603")
AnnotationAssertion(rdfs:label obo:CTO_0000206 "clinical trial phase 4"@en)
SubClassOf(obo:CTO_0000206 obo:CTO_0000201)

# Class: obo:CTO_0000207 (Early Phase 1 clinical trial)

AnnotationAssertion(obo:IAO_0000115 obo:CTO_0000207 "A clinical trial that is at Early Phase 1 or Phase 0")
AnnotationAssertion(obo:IAO_0000115 obo:CTO_0000207 "A clinical trial that is at an Early Phase i or Phase 0, which is designed to use an investigational agent that is available only in very limited quantities and which has never previously given to humans or for which there is extremely limited human experience. Phase 0 clinical trials are intended to enable researchers to understand the path of the drug in the body and its efficacy. Adverse event reporting in Phase 0 trials is expedited. [def-source: NCI]")
AnnotationAssertion(Annotation(obo:IAO_0000119 "https://prsinfo.clinicaltrials.gov/definitions.html") obo:IAO_0000115 obo:CTO_0000207 "Exploratory trials, involving very limited human exposure, with no therapeutic or diagnostic intent (e.g., screening studies, microdose studies). (Formerly listed as \"Phase 0\")")
AnnotationAssertion(obo:IAO_0000117 obo:CTO_0000207 "Leon Li, Asiyah Lin, Oliver He")
AnnotationAssertion(obo:IAO_0000118 obo:CTO_0000207 "Phase 0 clinical trial")
AnnotationAssertion(obo:IAO_0000118 obo:CTO_0000207 "Phase 0 trial")
AnnotationAssertion(obo:IAO_0000118 obo:CTO_0000207 "Pre-Clinical Trial")
AnnotationAssertion(obo:IAO_0000119 obo:CTO_0000207 "http://purl.obolibrary.org/obo/NCIT_C54721")
AnnotationAssertion(obo:IAO_0000119 obo:CTO_0000207 "https://en.wikipedia.org/wiki/Clinical_trial")
AnnotationAssertion(rdfs:label obo:CTO_0000207 "Early Phase 1 clinical trial"@en)
EquivalentClasses(obo:CTO_0000207 ObjectSomeValuesFrom(obo:OPMI_0000366 obo:CTO_0000202))
SubClassOf(obo:CTO_0000207 obo:CTO_0000220)

# Class: obo:CTO_0000208 (European clinical trial registry identifier)

AnnotationAssertion(obo:IAO_0000112 obo:CTO_0000208 "EudraCT Number: 2007-002422-29")
AnnotationAssertion(obo:IAO_0000117 obo:CTO_0000208 "Qingliang Leon Li, Asiyah Yu Lin, Oliver He")
AnnotationAssertion(obo:IAO_0000118 obo:CTO_0000208 "EudraCT identifier")
AnnotationAssertion(obo:IAO_0000119 obo:CTO_0000208 "https://en.wikipedia.org/wiki/EudraCT")
AnnotationAssertion(obo:IAO_0000119 obo:CTO_0000208 "https://www.clinicaltrialsregister.eu/ctr-search/search")
AnnotationAssertion(obo:IAO_0000119 obo:CTO_0000208 "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract")
AnnotationAssertion(rdfs:label obo:CTO_0000208 "European clinical trial registry identifier"@en)
AnnotationAssertion(rdfs:seeAlso obo:CTO_0000208 "https://www.who.int/ictrp/network/primary/en/")
SubClassOf(obo:CTO_0000208 obo:NCIT_C98714)

# Class: obo:CTO_0000209 (Japan clinical trial identifier)

AnnotationAssertion(obo:IAO_0000117 obo:CTO_0000209 "Qingliang Leon Li, Asiyah Yu Lin, Oliver He")
AnnotationAssertion(obo:IAO_0000119 obo:CTO_0000209 "https://pubchem.ncbi.nlm.nih.gov/source/NIPH%20Clinical%20Trials%20Search%20of%20Japan")
AnnotationAssertion(obo:IAO_0000119 obo:CTO_0000209 "https://rctportal.niph.go.jp/en/")
AnnotationAssertion(rdfs:label obo:CTO_0000209 "Japan clinical trial identifier"@en)
AnnotationAssertion(rdfs:seeAlso obo:CTO_0000209 "https://www.who.int/ictrp/network/jprn2/en/")
SubClassOf(obo:CTO_0000209 obo:NCIT_C98714)

# Class: obo:CTO_0000210 (JAPIC clinical trial identifier)

AnnotationAssertion(obo:IAO_0000117 obo:CTO_0000210 "Qingliang Leon Li, Asiyah Yu Lin, Oliver He")
AnnotationAssertion(obo:IAO_0000118 obo:CTO_0000210 "JapicCTI")
AnnotationAssertion(obo:IAO_0000119 obo:CTO_0000210 "https://rctportal.niph.go.jp/en/")
AnnotationAssertion(rdfs:label obo:CTO_0000210 "JAPIC clinical trial identifier"@en)
SubClassOf(obo:CTO_0000210 obo:NCIT_C98714)

# Class: obo:CTO_0000211 (JMACCT clinical trial identifier)

AnnotationAssertion(obo:IAO_0000115 obo:CTO_0000211 "A centrally registered identifier that is assigned for a specific clinical trial registered in JMACCT. The format for the JMACCT registry number is “JMA-IIA” followed by a 5-digit number, e.g., JMA-IIA00391.")
AnnotationAssertion(obo:IAO_0000117 obo:CTO_0000211 "Qingliang Leon Li, Asiyah Yu Lin, Oliver He")
AnnotationAssertion(obo:IAO_0000118 obo:CTO_0000211 "JMACCT")
AnnotationAssertion(obo:IAO_0000119 obo:CTO_0000211 "https://rctportal.niph.go.jp/en/")
AnnotationAssertion(rdfs:label obo:CTO_0000211 "JMACCT clinical trial identifier"@en)
SubClassOf(obo:CTO_0000211 obo:CTO_0000209)

# Class: obo:CTO_0000212 (UMIN-CTR clinical trial identifier)

AnnotationAssertion(obo:IAO_0000115 obo:CTO_0000212 "A Japan clinical trial identifier provided by the University Hospital Medical Information Network Center (UMIN-CTR)")
AnnotationAssertion(obo:IAO_0000117 obo:CTO_0000212 "Qingliang Leon Li, Asiyah Yu Lin, Oliver He")
AnnotationAssertion(obo:IAO_0000118 obo:CTO_0000212 "UMIN")
AnnotationAssertion(obo:IAO_0000119 obo:CTO_0000212 "https://rctportal.niph.go.jp/en/")
AnnotationAssertion(rdfs:label obo:CTO_0000212 "UMIN-CTR clinical trial identifier"@en)
SubClassOf(obo:CTO_0000212 obo:CTO_0000209)

# Class: obo:CTO_0000213 (USA National Clinical Trial identifier)

AnnotationAssertion(obo:IAO_0000115 obo:CTO_0000213 "A centrally registered identifier that is assigned for a specific clinical trial registered in  the ClinicalTrials.gov. The format for the ClinicalTrials.gov registry number is “NCT” followed by an 8-digit number, e.g.: NCT00000419.")
AnnotationAssertion(obo:IAO_0000117 obo:CTO_0000213 "Qingliang Leon Li, Asiyah Yu Lin, Oliver He")
AnnotationAssertion(obo:IAO_0000118 obo:CTO_0000213 "NCT identifier")
AnnotationAssertion(obo:IAO_0000118 obo:CTO_0000213 "NCT number")
AnnotationAssertion(obo:IAO_0000118 obo:CTO_0000213 "National Clinical Trial identifier")
AnnotationAssertion(obo:IAO_0000119 obo:CTO_0000213 "https://clinicaltrials.gov/ct2/about-site/link-to")
AnnotationAssertion(obo:IAO_0000119 obo:CTO_0000213 "https://www.nlm.nih.gov/bsd/policy/clin_trials.html")
AnnotationAssertion(rdfs:label obo:CTO_0000213 "USA National Clinical Trial identifier"@en)
SubClassOf(obo:CTO_0000213 obo:NCIT_C98714)

# Class: obo:CTO_0000214 (study start date)

AnnotationAssertion(obo:IAO_0000115 obo:CTO_0000214 "The date on which a study starts")
AnnotationAssertion(rdfs:label obo:CTO_0000214 "study start date"@en)
SubClassOf(obo:CTO_0000214 obo:BFO_0000148)

# Class: obo:CTO_0000215 (clinical trial primary completion date)

AnnotationAssertion(obo:IAO_0000115 obo:CTO_0000215 "The date that the final participant was examined or received an intervention for the purposes of final collection of data for the primary outcome, whether the clinical study concluded according to the pre-specified protocol or was terminated. In the case of clinical studies with more than one primary outcome measure with different completion dates, this term refers to the date on which data collection is completed for all of the primary outcomes.")
AnnotationAssertion(obo:IAO_0000119 obo:CTO_0000215 "https://prsinfo.clinicaltrials.gov/definitions.html")
AnnotationAssertion(oboInOwl:hasExactSynonym obo:CTO_0000215 "primary completion")
AnnotationAssertion(rdfs:label obo:CTO_0000215 "clinical trial primary completion date"@en)
SubClassOf(obo:CTO_0000215 obo:OPMI_0000297)

# Class: obo:CTO_0000216 (clinical trial study completion date)

AnnotationAssertion(obo:IAO_0000115 obo:CTO_0000216 "The date the final participant was examined or received an intervention for purposes of final collection of data for the primary and secondary outcome measures and adverse events (for example, last participant’s last visit), whether the clinical study concluded according to the pre-specified protocol or was terminated.")
AnnotationAssertion(obo:IAO_0000119 obo:CTO_0000216 "https://prsinfo.clinicaltrials.gov/definitions.html")
AnnotationAssertion(Annotation(rdfs:seeAlso "http://www.icmje.org/recommendations/ 
http://www.who.int/ictrp/network/trds/en/index.html") oboInOwl:hasExactSynonym obo:CTO_0000216 "completion date")
AnnotationAssertion(rdfs:label obo:CTO_0000216 "clinical trial study completion date"@en)
SubClassOf(obo:CTO_0000216 obo:OPMI_0000297)

# Class: obo:CTO_0000217 (title of clinical trial)

AnnotationAssertion(obo:IAO_0000115 obo:CTO_0000217 "A textual entity that is the title of a clinical trial")
AnnotationAssertion(obo:IAO_0000119 obo:CTO_0000217 "https://prsinfo.clinicaltrials.gov/definitions.html")
AnnotationAssertion(rdfs:label obo:CTO_0000217 "title of clinical trial"@en)
SubClassOf(obo:CTO_0000217 obo:IAO_0000300)

# Class: obo:CTO_0000218 (lay title of clinical trial)

AnnotationAssertion(obo:IAO_0000115 obo:CTO_0000218 "A title of clinical trial that is meant for lay people understanding")
AnnotationAssertion(obo:IAO_0000119 obo:CTO_0000218 "https://prsinfo.clinicaltrials.gov/definitions.html")
AnnotationAssertion(oboInOwl:hasExactSynonym obo:CTO_0000218 "brief title")
AnnotationAssertion(oboInOwl:hasExactSynonym obo:CTO_0000218 "lay title")
AnnotationAssertion(oboInOwl:hasExactSynonym obo:CTO_0000218 "public title")
AnnotationAssertion(rdfs:label obo:CTO_0000218 "lay title of clinical trial"@en)
AnnotationAssertion(rdfs:seeAlso obo:CTO_0000218 "https://www.who.int/ictrp/network/trds/en/")
SubClassOf(obo:CTO_0000218 obo:CTO_0000217)

# Class: obo:CTO_0000219 (official title of clinical trial)

AnnotationAssertion(obo:IAO_0000115 obo:CTO_0000219 "A title of clinical trial that is recorded as official")
AnnotationAssertion(obo:IAO_0000119 obo:CTO_0000219 "https://prsinfo.clinicaltrials.gov/definitions.html")
AnnotationAssertion(oboInOwl:hasExactSynonym obo:CTO_0000219 "full title")
AnnotationAssertion(oboInOwl:hasExactSynonym obo:CTO_0000219 "scientific title")
AnnotationAssertion(rdfs:label obo:CTO_0000219 "official title of clinical trial"@en)
AnnotationAssertion(rdfs:seeAlso obo:CTO_0000219 "https://www.who.int/ictrp/network/trds/en/")
SubClassOf(obo:CTO_0000219 obo:CTO_0000217)

# Class: obo:CTO_0000220 (clinical trial)

AnnotationAssertion(obo:IAO_0000115 obo:CTO_0000220 "a clinical trial is a medical interventional study where participants are assigned prospectively to an intervention or interventions according to a protocol to evaluate the safety and efficacy of the intervention(s) on biomedical or other health related outcomes. The Interventions include but are not restricted to drugs, cells and other biological products, surgical procedures, radiologic procedures, devices, behavioral treatments, process-of-care changes, preventive care, etc.")
AnnotationAssertion(obo:IAO_0000117 obo:CTO_0000220 "Oliver He, Asiyah Yu Lin, Qingliang Li")
AnnotationAssertion(obo:IAO_0000118 obo:CTO_0000220 "interventional trial")
AnnotationAssertion(obo:IAO_0000119 obo:CTO_0000220 "https://clinicaltrials.gov/ct2/search/map")
AnnotationAssertion(obo:IAO_0000119 obo:CTO_0000220 "https://en.wikipedia.org/wiki/Clinical_trial")
AnnotationAssertion(obo:IAO_0000119 obo:CTO_0000220 "https://prsinfo.clinicaltrials.gov/definitions.html")
AnnotationAssertion(obo:IAO_0000119 obo:CTO_0000220 "https://www.who.int/ictrp/en/")
AnnotationAssertion(rdfs:label obo:CTO_0000220 "clinical trial"@en)
SubClassOf(obo:CTO_0000220 obo:NCIT_C98388)

# Class: obo:DRON_00000005 (drug product)

AnnotationAssertion(obo:IAO_0000115 obo:DRON_00000005 "a material entity (1) containing at least one scattered molecular aggregate as part that is the bearer of an active ingredient role and (2) that is itself the bearer of a clinical drug role"@en)
AnnotationAssertion(obo:IAO_0000117 obo:DRON_00000005 "William Hogan"@en)
AnnotationAssertion(obo:IAO_0000412 obo:DRON_00000005 obo:dron.owl)
AnnotationAssertion(dc:creator obo:DRON_00000005 "William Hogan"@en)
AnnotationAssertion(rdfs:label obo:DRON_00000005 "drug product"@en)
SubClassOf(obo:DRON_00000005 obo:BFO_0000040)

# Class: obo:ERO_0000017 (epidemiological study)

AnnotationAssertion(obo:IAO_0000111 obo:ERO_0000017 "epidemiological study")
AnnotationAssertion(obo:IAO_0000112 obo:ERO_0000017 "A study of the populations and demographic of the avian flu.")
AnnotationAssertion(obo:IAO_0000114 obo:ERO_0000017 obo:IAO_0000120)
AnnotationAssertion(obo:IAO_0000115 obo:ERO_0000017 "A human study of diseases in populations of humans or other animals, specifically how, when and where they occur. Epidemiological studies can never prove causation, epidemiological evidence can only show that this risk factor is correlated with a higher incidence of disease in the population exposed to that risk factor. The higher the correlation the more certain the association, but it cannot prove the causation.")
AnnotationAssertion(obo:IAO_0000117 obo:ERO_0000017 "PERSON: Karen Corday")
AnnotationAssertion(obo:IAO_0000119 obo:ERO_0000017 "http://pmep.cce.cornell.edu/profiles/extoxnet/TIB/epidemiology.html")
AnnotationAssertion(obo:IAO_0000412 obo:ERO_0000017 obo:ero.owl)
AnnotationAssertion(rdfs:label obo:ERO_0000017 "epidemiological study")
SubClassOf(obo:ERO_0000017 obo:OPMI_0000418)

# Class: obo:ERO_0001092 (medical device )

AnnotationAssertion(obo:IAO_0000112 obo:ERO_0001092 "A blood pressure monitor is a medical device.")
AnnotationAssertion(obo:IAO_0000114 obo:ERO_0001092 obo:IAO_0000120)
AnnotationAssertion(obo:IAO_0000115 obo:ERO_0001092 "An instrument used in the diagnosis of disease or other conditions or for use in the care, treatment, or prevention of disease that does not achieve any of its primary intended purposes by chemical action or by being metabolized.")
AnnotationAssertion(obo:IAO_0000117 obo:ERO_0001092 "PERSON: Nicole Vasilevsky")
AnnotationAssertion(obo:IAO_0000119 obo:ERO_0001092 "http://medical-dictionary.thefreedictionary.com/medical+device ")
AnnotationAssertion(obo:IAO_0000412 obo:ERO_0001092 obo:ero.owl)
AnnotationAssertion(rdfs:label obo:ERO_0001092 "medical device ")
SubClassOf(obo:ERO_0001092 obo:BFO_0000040)

# Class: obo:ERO_0001402 (feasibility study)

AnnotationAssertion(obo:IAO_0000114 obo:ERO_0001402 obo:IAO_0000123)
AnnotationAssertion(obo:IAO_0000115 obo:ERO_0001402 "A preliminary study to determine the practicability of a proposed health program or procedure or of a larger study and to appraise the factors that may influence its practicability. A feasibility study aims to discover those things which may affect successful study conduct on a larger scale.")
AnnotationAssertion(obo:IAO_0000117 obo:ERO_0001402 "PERSON: Melanie Wilson")
AnnotationAssertion(obo:IAO_0000119 obo:ERO_0001402 " Dictionary of Epidemiology, 5th edition.")
AnnotationAssertion(obo:IAO_0000412 obo:ERO_0001402 obo:ero.owl)
AnnotationAssertion(rdfs:label obo:ERO_0001402 "feasibility study"@en)
SubClassOf(obo:ERO_0001402 obo:OPMI_0000418)

# Class: obo:ERO_0001843 (registry)

AnnotationAssertion(obo:IAO_0000114 obo:ERO_0001843 obo:IAO_0000123)
AnnotationAssertion(obo:IAO_0000115 obo:ERO_0001843 "An organization dedicated to the collection, storage and dissemination of a set of scientific or clinical data.")
AnnotationAssertion(obo:IAO_0000117 obo:ERO_0001843 "PERSON: Nicole Vasilevsky")
AnnotationAssertion(obo:IAO_0000119 obo:ERO_0001843 "PERSON: Scott Hoffmann")
AnnotationAssertion(obo:IAO_0000412 obo:ERO_0001843 obo:ero.owl)
AnnotationAssertion(rdfs:label obo:ERO_0001843 "registry")
AnnotationAssertion(rdfs:seeAlso obo:ERO_0001843 "https://www.who.int/ictrp/network/trds/en/")
SubClassOf(obo:ERO_0001843 obo:OBI_0000245)

# Class: obo:IAO_0000005 (objective specification)

AnnotationAssertion(obo:IAO_0000111 obo:IAO_0000005 "objective specification"@en)
AnnotationAssertion(obo:IAO_0000112 obo:IAO_0000005 "In the protocol of a ChIP assay the objective specification says to identify protein and DNA interaction."@en)
AnnotationAssertion(obo:IAO_0000114 obo:IAO_0000005 obo:IAO_0000122)
AnnotationAssertion(obo:IAO_0000115 obo:IAO_0000005 "A directive information entity that describes an intended process endpoint. When part of a plan specification the concretization is realized in a planned process in which the bearer tries to effect the world so that the process endpoint is achieved."@en)
AnnotationAssertion(obo:IAO_0000116 obo:IAO_0000005 "2009-03-16: original definition when imported from OBI read: \"objective is an non realizable information entity which can serve as that  proper part of a plan towards which the realization of the plan is directed.\""@en)
AnnotationAssertion(obo:IAO_0000116 obo:IAO_0000005 "2014-03-31: In the example of usage (\"In the protocol of a ChIP assay the objective specification says to identify protein and DNA interaction\") there is a protocol which is the ChIP assay protocol. In addition to being concretized on paper, the protocol can be concretized as a realizable entity, such as a plan that inheres in a person. The objective specification is the part that says that some protein and DNA interactions are identified. This is a specification of a process endpoint: the boundary in the process before which they are not identified and after which they are. During the realization of the plan, the goal is to get to the point of having the interactions, and participants in the realization of the plan try to do that."@en)
AnnotationAssertion(obo:IAO_0000116 obo:IAO_0000005 "Answers the question, why did you do this experiment?"@en)
AnnotationAssertion(obo:IAO_0000117 obo:IAO_0000005 "PERSON: Alan Ruttenberg"@en)
AnnotationAssertion(obo:IAO_0000117 obo:IAO_0000005 "PERSON: Barry Smith"@en)
AnnotationAssertion(obo:IAO_0000117 obo:IAO_0000005 "PERSON: Bjoern Peters"@en)
AnnotationAssertion(obo:IAO_0000117 obo:IAO_0000005 "PERSON: Jennifer Fostel"@en)
AnnotationAssertion(obo:IAO_0000118 obo:IAO_0000005 "goal specification"@en)
AnnotationAssertion(obo:IAO_0000119 obo:IAO_0000005 "OBI Plan and Planned Process/Roles Branch"@en)
AnnotationAssertion(obo:IAO_0000119 obo:IAO_0000005 "OBI_0000217"@en)
AnnotationAssertion(obo:IAO_0000412 obo:IAO_0000005 obo:iao.owl)
AnnotationAssertion(rdfs:label obo:IAO_0000005 "objective specification"@en)
SubClassOf(obo:IAO_0000005 obo:IAO_0000033)

# Class: obo:IAO_0000007 (action specification)

AnnotationAssertion(obo:IAO_0000112 obo:IAO_0000007 "Pour the contents of flask 1 into flask 2"@en)
AnnotationAssertion(obo:IAO_0000114 obo:IAO_0000007 obo:IAO_0000122)
AnnotationAssertion(obo:IAO_0000115 obo:IAO_0000007 "A directive information entity that describes an action the bearer will take."@en)
AnnotationAssertion(obo:IAO_0000117 obo:IAO_0000007 "Alan Ruttenberg"@en)
AnnotationAssertion(obo:IAO_0000119 obo:IAO_0000007 "OBI Plan and Planned Process branch"@en)
AnnotationAssertion(obo:IAO_0000412 obo:IAO_0000007 obo:iao.owl)
AnnotationAssertion(rdfs:label obo:IAO_0000007 "action specification"@en)
SubClassOf(obo:IAO_0000007 obo:IAO_0000033)

# Class: obo:IAO_0000027 (data item)

AnnotationAssertion(obo:IAO_0000111 obo:IAO_0000027 "data item"@en)
AnnotationAssertion(obo:IAO_0000112 obo:IAO_0000027 "Data items include counts of things, analyte concentrations, and statistical summaries."@en)
AnnotationAssertion(obo:IAO_0000114 obo:IAO_0000027 obo:IAO_0000125)
AnnotationAssertion(obo:IAO_0000115 obo:IAO_0000027 "a data item is an information content entity that is intended to be a truthful statement about something (modulo, e.g., measurement precision or other systematic errors) and is constructed/acquired by a method which reliably tends to produce (approximately) truthful statements."@en)
AnnotationAssertion(obo:IAO_0000115 obo:IAO_0000027 "a data item that is about the outcome measured by a clinical trial."@en)
AnnotationAssertion(obo:IAO_0000116 obo:IAO_0000027 "2/2/2009 Alan and Bjoern discussing FACS run output data. This is a data item because it is about the cell population. Each element records an event and is typically further composed a set of measurment data items that record the fluorescent intensity stimulated by one of the lasers."@en)
AnnotationAssertion(obo:IAO_0000116 obo:IAO_0000027 "2009-03-16: data item deliberatly ambiguous: we merged data set and datum to be one entity, not knowing how to define singular versus plural. So data item is more general than datum."@en)
AnnotationAssertion(obo:IAO_0000116 obo:IAO_0000027 "2009-03-16: removed datum as alternative term as datum specifically refers to singular form, and is thus not an exact synonym."@en)
AnnotationAssertion(obo:IAO_0000116 obo:IAO_0000027 "2014-03-31: See discussion at http://odontomachus.wordpress.com/2014/03/30/aboutness-objects-propositions/")
AnnotationAssertion(obo:IAO_0000116 obo:IAO_0000027 "JAR: datum     -- well, this will be very tricky to define, but maybe some 
information-like stuff that might be put into a computer and that is 
meant, by someone, to denote and/or to be interpreted by some 
process... I would include lists, tables, sentences... I think I might 
defer to Barry, or to Brian Cantwell Smith

JAR: A data item is an approximately justified approximately true approximate belief"@en)
AnnotationAssertion(obo:IAO_0000117 obo:IAO_0000027 "PERSON: Alan Ruttenberg"@en)
AnnotationAssertion(obo:IAO_0000117 obo:IAO_0000027 "PERSON: Chris Stoeckert"@en)
AnnotationAssertion(obo:IAO_0000117 obo:IAO_0000027 "PERSON: Jonathan Rees"@en)
AnnotationAssertion(obo:IAO_0000118 obo:IAO_0000027 "data"@en)
AnnotationAssertion(obo:IAO_0000412 obo:IAO_0000027 obo:iao.owl)
AnnotationAssertion(obo:IAO_0000412 obo:IAO_0000027 obo:ogms.owl)
AnnotationAssertion(rdfs:label obo:IAO_0000027 "data item"@en)
SubClassOf(obo:IAO_0000027 obo:IAO_0000030)

# Class: obo:IAO_0000030 (information content entity)

AnnotationAssertion(obo:IAO_0000111 obo:IAO_0000030 "information content entity"@en)
AnnotationAssertion(obo:IAO_0000112 obo:IAO_0000030 "Examples of information content entites include journal articles, data, graphical layouts, and graphs."@en)
AnnotationAssertion(obo:IAO_0000114 obo:IAO_0000030 obo:IAO_0000122)
AnnotationAssertion(obo:IAO_0000115 obo:IAO_0000030 "A generically dependent continuant that is about some thing."@en)
AnnotationAssertion(obo:IAO_0000115 obo:IAO_0000030 "An information content entity is an entity that is generically dependent on some artifact and stands in relation of aboutness to some entity"@en)
AnnotationAssertion(obo:IAO_0000116 obo:IAO_0000030 "2014-03-10: The use of \"thing\" is intended to be general enough to include universals and configurations (see https://groups.google.com/d/msg/information-ontology/GBxvYZCk1oc/-L6B5fSBBTQJ)."@en)
AnnotationAssertion(obo:IAO_0000116 obo:IAO_0000030 "information_content_entity 'is_encoded_in' some digital_entity in obi before split (040907). information_content_entity 'is_encoded_in' some physical_document in obi before split (040907).

Previous. An information content entity is a non-realizable information entity that 'is encoded in' some digital or physical entity."@en)
AnnotationAssertion(obo:IAO_0000117 obo:IAO_0000030 "PERSON: Chris Stoeckert"@en)
AnnotationAssertion(obo:IAO_0000119 obo:IAO_0000030 "OBI_0000142"@en)
AnnotationAssertion(obo:IAO_0000412 obo:IAO_0000030 obo:dron.owl)
AnnotationAssertion(obo:IAO_0000412 obo:IAO_0000030 obo:envo.owl)
AnnotationAssertion(obo:IAO_0000412 obo:IAO_0000030 obo:iao.owl)
AnnotationAssertion(obo:IAO_0000412 obo:IAO_0000030 obo:ico.owl)
AnnotationAssertion(obo:IAO_0000412 obo:IAO_0000030 obo:obi.owl)
AnnotationAssertion(obo:IAO_0000412 obo:IAO_0000030 obo:ogms.owl)
AnnotationAssertion(obo:IAO_0000412 obo:IAO_0000030 obo:omrse.owl)
AnnotationAssertion(obo:IAO_0000412 obo:IAO_0000030 obo:ontoneo.owl)
AnnotationAssertion(obo:IAO_0000412 obo:IAO_0000030 obo:opmi.owl)
AnnotationAssertion(obo:IAO_0000412 obo:IAO_0000030 obo:pdro.owl)
AnnotationAssertion(rdfs:label obo:IAO_0000030 "information content entity")
AnnotationAssertion(rdfs:label obo:IAO_0000030 "information content entity"@en)
SubClassOf(obo:IAO_0000030 obo:BFO_0000031)

# Class: obo:IAO_0000033 (directive information entity)

AnnotationAssertion(obo:IAO_0000114 obo:IAO_0000033 obo:IAO_0000122)
AnnotationAssertion(obo:IAO_0000115 obo:IAO_0000033 "An information content entity whose concretizations indicate to their bearer how to realize them in a process."@en)
AnnotationAssertion(obo:IAO_0000116 obo:IAO_0000033 "2009-03-16: provenance: a term realizable information entity was proposed for OBI (OBI_0000337) , edited by the PlanAndPlannedProcess branch. Original definition was  \"is the specification of a process that can be concretized and realized by an actor\" with alternative term  \"instruction\".It has been subsequently moved to IAO where the objective for which the original term was defined was satisfied with the definitionof this, different, term."@en)
AnnotationAssertion(obo:IAO_0000116 obo:IAO_0000033 "2013-05-30 Alan Ruttenberg: What differentiates a directive information entity from an information concretization is that it can have concretizations that are either qualities or realizable entities. The concretizations that are realizable entities are created when an individual chooses to take up the direction, i.e. has the intention to (try to) realize it."@en)
AnnotationAssertion(obo:IAO_0000116 obo:IAO_0000033 "8/6/2009 Alan Ruttenberg: Changed label from \"information entity about a realizable\" after discussions at ICBO"@en)
AnnotationAssertion(obo:IAO_0000116 obo:IAO_0000033 "Werner pushed back on calling it realizable information entity as it isn't realizable. However this name isn't right either. An example would be a recipe. The realizable entity would be a plan, but the information entity isn't about the plan, it, once concretized, *is* the plan. -Alan"@en)
AnnotationAssertion(obo:IAO_0000117 obo:IAO_0000033 "PERSON: Alan Ruttenberg"@en)
AnnotationAssertion(obo:IAO_0000117 obo:IAO_0000033 "PERSON: Bjoern Peters"@en)
AnnotationAssertion(obo:IAO_0000412 obo:IAO_0000033 obo:iao.owl)
AnnotationAssertion(obo:IAO_0000412 obo:IAO_0000033 obo:obi.owl)
AnnotationAssertion(rdfs:label obo:IAO_0000033 "directive information entity"@en)
SubClassOf(obo:IAO_0000033 obo:IAO_0000030)

# Class: obo:IAO_0000078 (curation status specification)

AnnotationAssertion(obo:IAO_0000111 obo:IAO_0000078 "curation status specification"@en)
AnnotationAssertion(obo:IAO_0000114 obo:IAO_0000078 obo:IAO_0000125)
AnnotationAssertion(obo:IAO_0000115 obo:IAO_0000078 "The curation status of the term. The allowed values come from an enumerated list of predefined terms. See the specification of these instances for more detailed definitions of each enumerated value."@en)
AnnotationAssertion(obo:IAO_0000116 obo:IAO_0000078 "Better to represent curation as a process with parts and then relate labels to that process (in IAO meeting)"@en)
AnnotationAssertion(obo:IAO_0000117 obo:IAO_0000078 "PERSON:Bill Bug"@en)
AnnotationAssertion(obo:IAO_0000119 obo:IAO_0000078 "GROUP:OBI:<http://purl.obolibrary.org/obo/obi>"@en)
AnnotationAssertion(obo:IAO_0000119 obo:IAO_0000078 "OBI_0000266"@en)
AnnotationAssertion(obo:IAO_0000412 obo:IAO_0000078 obo:iao.owl)
AnnotationAssertion(rdfs:label obo:IAO_0000078 "curation status specification"@en)
SubClassOf(obo:IAO_0000078 obo:IAO_0000102)

# Class: obo:IAO_0000088 (report)

AnnotationAssertion(obo:IAO_0000111 obo:IAO_0000088 "report"@en)
AnnotationAssertion(obo:IAO_0000112 obo:IAO_0000088 "Examples of reports are gene lists and investigation reports. These are not published (journal) articles but may be included in a journal article."@en)
AnnotationAssertion(obo:IAO_0000114 obo:IAO_0000088 obo:IAO_0000125)
AnnotationAssertion(obo:IAO_0000115 obo:IAO_0000088 "a document assembled by an author for the purpose of providing information for the audience. A report is the output of a documenting process and has the objective to be consumed by a specific audience. Topic of the report is on something that has completed. A report is not a single figure. Examples of reports are journal article, patent application, grant progress report, case report (not patient record)"@en)
AnnotationAssertion(obo:IAO_0000116 obo:IAO_0000088 "2009-03-16: comment from Darren Natale: I am slightly uneasy with the sentence \"Topic of the report is on
something that has completed.\"  Should it be restricted to those things
that are completed?  For example, a progress report is (usually) about
something that definitely has *not* been completed, or may include
(only) projections.  I think the definition would not suffer if the
whole sentence is deleted."@en)
AnnotationAssertion(obo:IAO_0000116 obo:IAO_0000088 "2009-03-16: this was report of results with definition: A report is a narrative object that is a formal statement of the results of an investigation, or of any matter on which definite information is required, made by some person or body instructed or required to do so."@en)
AnnotationAssertion(obo:IAO_0000116 obo:IAO_0000088 "2009-03-16: work has been done on this term during during the OBI workshop winter 2009 and the current definition was considered acceptable for use in OBI. If there is a need to modify this definition please notify OBI."@en)
AnnotationAssertion(obo:IAO_0000116 obo:IAO_0000088 "2009-08-10 Alan Ruttenberg: Larry Hunter suggests that this be obsoleted and replaced by 'document'. Alan restored as there are OBI dependencies and this merits further discussion"@en)
AnnotationAssertion(obo:IAO_0000116 obo:IAO_0000088 "disagreement about where reports go. alan: only some gene lists are reports. Is a report all the content of some document? The example of usage suggests that a report may be part of  some article. Term needs clarification"@en)
AnnotationAssertion(obo:IAO_0000117 obo:IAO_0000088 "PERSON: Alan Ruttenberg"@en)
AnnotationAssertion(obo:IAO_0000117 obo:IAO_0000088 "PERSON: Melanie Courtot"@en)
AnnotationAssertion(obo:IAO_0000117 obo:IAO_0000088 "PERSON:Chris Stoeckert"@en)
AnnotationAssertion(obo:IAO_0000119 obo:IAO_0000088 "GROUP: OBI"@en)
AnnotationAssertion(obo:IAO_0000119 obo:IAO_0000088 "OBI_0000099"@en)
AnnotationAssertion(obo:IAO_0000412 obo:IAO_0000088 obo:iao.owl)
AnnotationAssertion(rdfs:label obo:IAO_0000088 "report"@en)
SubClassOf(obo:IAO_0000088 obo:IAO_0000310)

# Class: obo:IAO_0000102 (data about an ontology part)

AnnotationAssertion(obo:IAO_0000115 obo:IAO_0000102 "data about an ontology part is a data item about a part of an ontology, for example a term"@en)
AnnotationAssertion(obo:IAO_0000117 obo:IAO_0000102 "Person:Alan Ruttenberg")
AnnotationAssertion(obo:IAO_0000412 obo:IAO_0000102 obo:iao.owl)
AnnotationAssertion(rdfs:label obo:IAO_0000102 "data about an ontology part"@en)
SubClassOf(obo:IAO_0000102 obo:IAO_0000027)

# Class: obo:IAO_0000104 (plan specification)

AnnotationAssertion(obo:IAO_0000111 obo:IAO_0000104 "plan specification"@en)
AnnotationAssertion(obo:IAO_0000112 obo:IAO_0000104 "PMID: 18323827.Nat Med. 2008 Mar;14(3):226.New plan proposed to help resolve conflicting medical advice."@en)
AnnotationAssertion(obo:IAO_0000114 obo:IAO_0000104 obo:IAO_0000122)
AnnotationAssertion(obo:IAO_0000115 obo:IAO_0000104 "A directive information entity with action specifications and objective specifications as parts that, when concretized, is realized in a process in which the bearer tries to achieve the objectives by taking the actions specified."@en)
AnnotationAssertion(obo:IAO_0000116 obo:IAO_0000104 "2009-03-16: provenance: a term a plan was proposed for OBI (OBI_0000344) , edited by the PlanAndPlannedProcess branch. Original definition was \" a plan is a specification of a process that is realized by an actor to achieve the objective specified as part of the plan\". It has been subsequently moved to IAO where the objective for which the original term was defined was satisfied with the definitionof this, different, term."@en)
AnnotationAssertion(obo:IAO_0000116 obo:IAO_0000104 "2014-03-31: A plan specification can have other parts, such as conditional specifications."@en)
AnnotationAssertion(obo:IAO_0000116 obo:IAO_0000104 "Alternative previous definition: a plan is a set of instructions that specify how an objective should be achieved"@en)
AnnotationAssertion(obo:IAO_0000117 obo:IAO_0000104 "Alan Ruttenberg"@en)
AnnotationAssertion(obo:IAO_0000119 obo:IAO_0000104 "OBI Plan and Planned Process branch"@en)
AnnotationAssertion(obo:IAO_0000119 obo:IAO_0000104 "OBI_0000344"@en)
AnnotationAssertion(obo:IAO_0000412 obo:IAO_0000104 obo:obi.owl)
AnnotationAssertion(rdfs:comment obo:IAO_0000104 "2/3/2009 Comment from OBI review.

Action specification not well enough specified.
Conditional specification not well enough specified.
Question whether all plan specifications have objective specifications.

Request that IAO either clarify these or change definitions not to use them"@en)
AnnotationAssertion(rdfs:label obo:IAO_0000104 "plan specification"@en)
SubClassOf(obo:IAO_0000104 obo:IAO_0000033)

# Class: obo:IAO_0000300 (textual entity)

AnnotationAssertion(obo:IAO_0000111 obo:IAO_0000300 "textual entity"@en)
AnnotationAssertion(obo:IAO_0000112 obo:IAO_0000300 "Words, sentences, paragraphs, and the written (non-figure) parts of publications are all textual entities"@en)
AnnotationAssertion(obo:IAO_0000114 obo:IAO_0000300 obo:IAO_0000123)
AnnotationAssertion(obo:IAO_0000115 obo:IAO_0000300 "A textual entity is a part of a manifestation (FRBR sense), a generically dependent continuant whose concretizations are patterns of glyphs intended to be interpreted as words, formulas, etc."@en)
AnnotationAssertion(obo:IAO_0000116 obo:IAO_0000300 "AR, (IAO call 2009-09-01): a document as a whole is not typically a textual entity, because it has pictures in it - rather there are parts of it that are textual entities. Examples: The title, paragraph 2 sentence 7, etc."@en)
AnnotationAssertion(obo:IAO_0000116 obo:IAO_0000300 "MC, 2009-09-14 (following IAO call 2009-09-01): textual entities live at the FRBR (http://en.wikipedia.org/wiki/Functional_Requirements_for_Bibliographic_Records) manifestation level. Everything is significant: line break, pdf and html versions of same document are different textual entities."@en)
AnnotationAssertion(obo:IAO_0000117 obo:IAO_0000300 "PERSON: Lawrence Hunter"@en)
AnnotationAssertion(obo:IAO_0000118 obo:IAO_0000300 "text"@en)
AnnotationAssertion(obo:IAO_0000412 obo:IAO_0000300 obo:obi.owl)
AnnotationAssertion(rdfs:label obo:IAO_0000300 "textual entity"@en)
SubClassOf(obo:IAO_0000300 obo:IAO_0000030)

# Class: obo:IAO_0000310 (document)

AnnotationAssertion(obo:IAO_0000111 obo:IAO_0000310 "document"@en)
AnnotationAssertion(obo:IAO_0000112 obo:IAO_0000310 "A journal article, patent application, laboratory notebook, or a book"@en)
AnnotationAssertion(obo:IAO_0000114 obo:IAO_0000310 obo:IAO_0000120)
AnnotationAssertion(obo:IAO_0000115 obo:IAO_0000310 "A collection of information content entities intended to be understood together as a whole"@en)
AnnotationAssertion(obo:IAO_0000117 obo:IAO_0000310 "PERSON: Lawrence Hunter"@en)
AnnotationAssertion(obo:IAO_0000412 obo:IAO_0000310 obo:iao.owl)
AnnotationAssertion(rdfs:label obo:IAO_0000310 "document"@en)
SubClassOf(obo:IAO_0000310 obo:IAO_0000030)

# Class: obo:IAO_0000422 (postal address)

AnnotationAssertion(obo:IAO_0000114 obo:IAO_0000422 obo:IAO_0000123)
AnnotationAssertion(obo:IAO_0000115 obo:IAO_0000422 "A textual entity that is used as directive to deliver something to a person, or organization")
AnnotationAssertion(obo:IAO_0000116 obo:IAO_0000422 "2010-05-24 Alan Ruttenberg. Use label for the string representation. See issue https://github.com/information-artifact-ontology/IAO/issues/59")
AnnotationAssertion(obo:IAO_0000412 obo:IAO_0000422 obo:obi.owl)
AnnotationAssertion(rdfs:label obo:IAO_0000422 "postal address"@en)
SubClassOf(obo:IAO_0000422 obo:IAO_0000300)

# Class: obo:IAO_0000429 (email address)

AnnotationAssertion(obo:IAO_0000111 obo:IAO_0000429 "email address"@en)
AnnotationAssertion(obo:IAO_0000114 obo:IAO_0000429 obo:IAO_0000123)
AnnotationAssertion(obo:IAO_0000116 obo:IAO_0000429 "Alan Ruttenberg 1/3/2012 - Provisional id, see issue at https://github.com/information-artifact-ontology/IAO/issues/130&thanks=130&ts=1325636583"@en)
AnnotationAssertion(obo:IAO_0000117 obo:IAO_0000429 "Person:Alan Ruttenberg"@en)
AnnotationAssertion(obo:IAO_0000117 obo:IAO_0000429 "Person:Chris Stoeckart"@en)
AnnotationAssertion(obo:IAO_0000412 obo:IAO_0000429 obo:obi.owl)
AnnotationAssertion(rdfs:label obo:IAO_0000429 "email address"@en)
SubClassOf(obo:IAO_0000429 obo:OPMI_0000397)

# Class: obo:IAO_0000578 (centrally registered identifier)

AnnotationAssertion(obo:IAO_0000112 obo:IAO_0000578 "The sentence \"The article has Pubmed ID 12345.\" contains a CRID that has two parts: one part is the CRID symbol, which is '12345'; the other part denotes the CRID registry, which is Pubmed."@en)
AnnotationAssertion(obo:IAO_0000114 obo:IAO_0000578 obo:IAO_0000120)
AnnotationAssertion(obo:IAO_0000115 obo:IAO_0000578 "An information content entity that consists of a CRID symbol and additional information about the CRID registry to which it belongs."@en)
AnnotationAssertion(obo:IAO_0000116 obo:IAO_0000578 "2014-05-05: In defining this term we take no position on what the CRID denotes. In particular do not assume it denotes a *record* in the CRID registry (since the registry might not have 'records')."@en)
AnnotationAssertion(obo:IAO_0000116 obo:IAO_0000578 "Alan, IAO call 20101124: potentially the CRID denotes the instance it was associated with during creation. 
"@en)
AnnotationAssertion(obo:IAO_0000116 obo:IAO_0000578 "Note, IAO call 20101124: URIs are not always CRID, as not centrally registered. We acknowledge that CRID is a subset of a larger identifier class, but this subset fulfills our current needs. OBI PURLs are CRID as they are registered with OCLC. UPCs (Universal Product Codes from AC Nielsen)are not CRID as they are not centrally registered."@en)
AnnotationAssertion(obo:IAO_0000117 obo:IAO_0000578 "PERSON: Alan Ruttenberg"@en)
AnnotationAssertion(obo:IAO_0000117 obo:IAO_0000578 "PERSON: Bill Hogan"@en)
AnnotationAssertion(obo:IAO_0000117 obo:IAO_0000578 "PERSON: Bjoern Peters"@en)
AnnotationAssertion(obo:IAO_0000117 obo:IAO_0000578 "PERSON: Melanie Courtot"@en)
AnnotationAssertion(obo:IAO_0000118 obo:IAO_0000578 "CRID")
AnnotationAssertion(obo:IAO_0000119 obo:IAO_0000578 "Original proposal from Bjoern, discussions at IAO calls"@en)
AnnotationAssertion(obo:IAO_0000412 obo:IAO_0000578 obo:iao.owl)
AnnotationAssertion(Annotation(rdfs:seeAlso "http://www.icmje.org/recommendations/ 
http://www.who.int/ictrp/network/trds/en/index.html") oboInOwl:hasNarrowSynonym obo:IAO_0000578 "Primary Registry and Trial Identifying Number")
AnnotationAssertion(rdfs:label obo:IAO_0000578 "centrally registered identifier"@en)
SubClassOf(obo:IAO_0000578 obo:IAO_0000030)

# Class: obo:MS_1000590 (contact affiliation)

AnnotationAssertion(obo:IAO_0000115 obo:MS_1000590 "Home institution of the contact person.")
AnnotationAssertion(obo:IAO_0000412 obo:MS_1000590 obo:ms.owl)
AnnotationAssertion(oboInOwl:hasDbXref obo:MS_1000590 "value-type:xsd:string")
AnnotationAssertion(oboInOwl:hasOBONamespace obo:MS_1000590 "MS")
AnnotationAssertion(oboInOwl:id obo:MS_1000590 "MS:1000590")
AnnotationAssertion(rdfs:label obo:MS_1000590 "contact affiliation")
SubClassOf(obo:MS_1000590 obo:IAO_0000300)

# Class: obo:NCBITaxon_1 (root)

AnnotationAssertion(obo:IAO_0000412 obo:NCBITaxon_1 obo:ncbitaxon.owl)
AnnotationAssertion(oboInOwl:hasDbXref obo:NCBITaxon_1 "GC_ID:1")
AnnotationAssertion(oboInOwl:hasOBONamespace obo:NCBITaxon_1 "ncbi_taxonomy")
AnnotationAssertion(oboInOwl:hasRelatedSynonym obo:NCBITaxon_1 "all")
AnnotationAssertion(rdfs:label obo:NCBITaxon_1 "root")
SubClassOf(obo:NCBITaxon_1 obo:BFO_0000040)

# Class: obo:NCBITaxon_131567 (cellular organisms)

AnnotationAssertion(obo:IAO_0000412 obo:NCBITaxon_131567 obo:ncbitaxon.owl)
AnnotationAssertion(oboInOwl:hasDbXref obo:NCBITaxon_131567 "GC_ID:1")
AnnotationAssertion(oboInOwl:hasOBONamespace obo:NCBITaxon_131567 "ncbi_taxonomy")
AnnotationAssertion(oboInOwl:hasRelatedSynonym obo:NCBITaxon_131567 "biota")
AnnotationAssertion(rdfs:label obo:NCBITaxon_131567 "cellular organisms")
SubClassOf(obo:NCBITaxon_131567 obo:NCBITaxon_1)

# Class: obo:NCBITaxon_2759 (Eukaryota)

AnnotationAssertion(obo:IAO_0000412 obo:NCBITaxon_2759 obo:ncbitaxon.owl)
AnnotationAssertion(<http://purl.obolibrary.org/obo/ncbitaxon#has_rank> obo:NCBITaxon_2759 obo:NCBITaxon_superkingdom)
AnnotationAssertion(oboInOwl:hasDbXref obo:NCBITaxon_2759 "GC_ID:1")
AnnotationAssertion(oboInOwl:hasDbXref obo:NCBITaxon_2759 "PMID:23020233")
AnnotationAssertion(oboInOwl:hasDbXref obo:NCBITaxon_2759 "PMID:30257078")
AnnotationAssertion(oboInOwl:hasExactSynonym obo:NCBITaxon_2759 "eucaryotes")
AnnotationAssertion(oboInOwl:hasExactSynonym obo:NCBITaxon_2759 "eukaryotes")
AnnotationAssertion(oboInOwl:hasOBONamespace obo:NCBITaxon_2759 "ncbi_taxonomy")
AnnotationAssertion(oboInOwl:hasRelatedSynonym obo:NCBITaxon_2759 "Eucarya")
AnnotationAssertion(oboInOwl:hasRelatedSynonym obo:NCBITaxon_2759 "Eucaryotae")
AnnotationAssertion(oboInOwl:hasRelatedSynonym obo:NCBITaxon_2759 "Eukarya")
AnnotationAssertion(oboInOwl:hasRelatedSynonym obo:NCBITaxon_2759 "Eukaryotae")
AnnotationAssertion(oboInOwl:hasRelatedSynonym obo:NCBITaxon_2759 "eukaryotes")
AnnotationAssertion(rdfs:label obo:NCBITaxon_2759 "Eukaryota")
SubClassOf(obo:NCBITaxon_2759 obo:NCBITaxon_131567)

# Class: obo:NCBITaxon_40674 (Mammalia)

AnnotationAssertion(obo:IAO_0000412 obo:NCBITaxon_40674 obo:ncbitaxon.owl)
AnnotationAssertion(<http://purl.obolibrary.org/obo/ncbitaxon#has_rank> obo:NCBITaxon_40674 obo:NCBITaxon_class)
AnnotationAssertion(oboInOwl:hasDbXref obo:NCBITaxon_40674 "GC_ID:1")
AnnotationAssertion(oboInOwl:hasExactSynonym obo:NCBITaxon_40674 "mammals")
AnnotationAssertion(oboInOwl:hasOBONamespace obo:NCBITaxon_40674 "ncbi_taxonomy")
AnnotationAssertion(oboInOwl:hasRelatedSynonym obo:NCBITaxon_40674 "mammals")
AnnotationAssertion(rdfs:label obo:NCBITaxon_40674 "Mammalia")
SubClassOf(obo:NCBITaxon_40674 obo:NCBITaxon_7742)

# Class: obo:NCBITaxon_7742 (Vertebrata <vertebrates>)

AnnotationAssertion(obo:IAO_0000412 obo:NCBITaxon_7742 obo:ncbitaxon.owl)
AnnotationAssertion(oboInOwl:hasDbXref obo:NCBITaxon_7742 "GC_ID:1")
AnnotationAssertion(oboInOwl:hasExactSynonym obo:NCBITaxon_7742 "Vertebrata")
AnnotationAssertion(oboInOwl:hasExactSynonym obo:NCBITaxon_7742 "vertebrates")
AnnotationAssertion(oboInOwl:hasOBONamespace obo:NCBITaxon_7742 "ncbi_taxonomy")
AnnotationAssertion(oboInOwl:hasRelatedSynonym obo:NCBITaxon_7742 "vertebrates")
AnnotationAssertion(rdfs:label obo:NCBITaxon_7742 "Vertebrata <vertebrates>")
SubClassOf(obo:NCBITaxon_7742 obo:NCBITaxon_2759)

# Class: obo:NCBITaxon_9606 (Homo sapiens)

AnnotationAssertion(obo:IAO_0000111 obo:NCBITaxon_9606 "Homo sapiens")
AnnotationAssertion(obo:IAO_0000111 obo:NCBITaxon_9606 "Homo sapiens"@en)
AnnotationAssertion(obo:IAO_0000118 obo:NCBITaxon_9606 "human")
AnnotationAssertion(obo:IAO_0000118 obo:NCBITaxon_9606 "human being")
AnnotationAssertion(obo:IAO_0000118 obo:NCBITaxon_9606 "man")
AnnotationAssertion(obo:IAO_0000118 obo:NCBITaxon_9606 "person")
AnnotationAssertion(obo:IAO_0000412 obo:NCBITaxon_9606 obo:envo.owl)
AnnotationAssertion(obo:IAO_0000412 obo:NCBITaxon_9606 obo:ncbitaxon.owl)
AnnotationAssertion(obo:IAO_0000412 obo:NCBITaxon_9606 obo:obi.owl)
AnnotationAssertion(obo:IAO_0000412 obo:NCBITaxon_9606 obo:omrse.owl)
AnnotationAssertion(obo:IAO_0000412 obo:NCBITaxon_9606 obo:opmi.owl)
AnnotationAssertion(<http://purl.obolibrary.org/obo/ncbitaxon#has_rank> obo:NCBITaxon_9606 obo:NCBITaxon_species)
AnnotationAssertion(oboInOwl:hasDbXref obo:NCBITaxon_9606 "GC_ID:1")
AnnotationAssertion(oboInOwl:hasExactSynonym obo:NCBITaxon_9606 "human")
AnnotationAssertion(oboInOwl:hasExactSynonym obo:NCBITaxon_9606 "man")
AnnotationAssertion(oboInOwl:hasOBONamespace obo:NCBITaxon_9606 "ncbi_taxonomy")
AnnotationAssertion(oboInOwl:hasRelatedSynonym obo:NCBITaxon_9606 "Home sapiens")
AnnotationAssertion(oboInOwl:hasRelatedSynonym obo:NCBITaxon_9606 "Homo sampiens")
AnnotationAssertion(oboInOwl:hasRelatedSynonym obo:NCBITaxon_9606 "Homo sapeins")
AnnotationAssertion(oboInOwl:hasRelatedSynonym obo:NCBITaxon_9606 "Homo sapian")
AnnotationAssertion(oboInOwl:hasRelatedSynonym obo:NCBITaxon_9606 "Homo sapians")
AnnotationAssertion(oboInOwl:hasRelatedSynonym obo:NCBITaxon_9606 "Homo sapien")
AnnotationAssertion(oboInOwl:hasRelatedSynonym obo:NCBITaxon_9606 "Homo sapience")
AnnotationAssertion(oboInOwl:hasRelatedSynonym obo:NCBITaxon_9606 "Homo sapiense")
AnnotationAssertion(oboInOwl:hasRelatedSynonym obo:NCBITaxon_9606 "Homo sapients")
AnnotationAssertion(oboInOwl:hasRelatedSynonym obo:NCBITaxon_9606 "Homo sapines")
AnnotationAssertion(oboInOwl:hasRelatedSynonym obo:NCBITaxon_9606 "Homo spaiens")
AnnotationAssertion(oboInOwl:hasRelatedSynonym obo:NCBITaxon_9606 "Homo spiens")
AnnotationAssertion(oboInOwl:hasRelatedSynonym obo:NCBITaxon_9606 "Humo sapiens")
AnnotationAssertion(oboInOwl:hasRelatedSynonym obo:NCBITaxon_9606 "humans")
AnnotationAssertion(rdfs:label obo:NCBITaxon_9606 "Homo sapiens")
AnnotationAssertion(rdfs:label obo:NCBITaxon_9606 "Homo sapiens"@en)
SubClassOf(obo:NCBITaxon_9606 obo:NCBITaxon_40674)

# Class: obo:NCIT_C115575 (Clinical Trial Final Report)

AnnotationAssertion(obo:IAO_0000115 obo:NCIT_C115575 "Records containing any interim or final results, as well as clinical and statistical descriptions, presentations, analyses and interpretations of any therapeutic, prophylactic, or diagnostic agent used in human subjects in a clinical trial.")
AnnotationAssertion(obo:IAO_0000412 obo:NCIT_C115575 obo:ncit.owl)
AnnotationAssertion(obo:NCIT_NHC0 obo:NCIT_C115575 "C115575")
AnnotationAssertion(obo:NCIT_P106 obo:NCIT_C115575 "Intellectual Product")
AnnotationAssertion(obo:NCIT_P108 obo:NCIT_C115575 "Clinical Trial Final Report")
AnnotationAssertion(obo:NCIT_P207 obo:NCIT_C115575 "C3889645")
AnnotationAssertion(obo:NCIT_P322 obo:NCIT_C115575 "CDISC-GLOSS")
AnnotationAssertion(obo:NCIT_P322 obo:NCIT_C115575 "CareLex")
AnnotationAssertion(obo:NCIT_P325 obo:NCIT_C115575 "A written description of a trial/study of any therapeutic, prophylactic, or diagnostic agent conducted in human subjects, in which the clinical and statistical description, presentations, and analyses are fully integrated into a single report. [ICH E3]")
AnnotationAssertion(obo:NCIT_P325 obo:NCIT_C115575 "Subcategory name for the eTMF domain used to classify clinical study report documents.")
AnnotationAssertion(oboInOwl:hasExactSynonym obo:NCIT_C115575 "CTrial Fin Rept Subcat")
AnnotationAssertion(oboInOwl:hasExactSynonym obo:NCIT_C115575 "Central Trial Final Reports Subcategory")
AnnotationAssertion(oboInOwl:hasExactSynonym obo:NCIT_C115575 "Clinical Trial Final Report")
AnnotationAssertion(oboInOwl:hasExactSynonym obo:NCIT_C115575 "Reports")
AnnotationAssertion(oboInOwl:hasExactSynonym obo:NCIT_C115575 "final report")
AnnotationAssertion(oboInOwl:inSubset obo:NCIT_C115575 <http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C114548>)
AnnotationAssertion(oboInOwl:inSubset obo:NCIT_C115575 <http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C61410>)
AnnotationAssertion(oboInOwl:inSubset obo:NCIT_C115575 <http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C67497>)
AnnotationAssertion(rdfs:label obo:NCIT_C115575 "Clinical Trial Final Report")
SubClassOf(obo:NCIT_C115575 obo:IAO_0000088)

# Class: obo:NCIT_C129000 (Patient Registry Study)

AnnotationAssertion(Annotation(obo:IAO_0000119 "https://prsinfo.clinicaltrials.gov/definitions.html") obo:IAO_0000115 obo:NCIT_C129000 "An observational study that is also considered to be a Patient Registry. This type of study should only be registered once in the Protocol Registration and Results System (PRS), by the sponsor responsible for the primary data collection and analysis.")
AnnotationAssertion(obo:IAO_0000115 obo:NCIT_C129000 "Observational studies which include an organized system that uses observational methods to collect uniform data (clinical and other) prospectively for a population defined by a particular disorder/disease, condition (including susceptibility to a disorder), or exposure (including products, health care services, and/or procedures) and that serves a predetermined scientific, clinical, or policy purpose. Patient registries may be single purpose or on-going data collection programs that address one or more questions. (AHRQ)")
AnnotationAssertion(obo:IAO_0000412 obo:NCIT_C129000 obo:ncit.owl)
AnnotationAssertion(obo:NCIT_NHC0 obo:NCIT_C129000 "C129000")
AnnotationAssertion(obo:NCIT_P106 obo:NCIT_C129000 "Research Activity")
AnnotationAssertion(obo:NCIT_P108 obo:NCIT_C129000 "Patient Registry Study")
AnnotationAssertion(obo:NCIT_P207 obo:NCIT_C129000 "C0920631")
AnnotationAssertion(obo:NCIT_P322 obo:NCIT_C129000 "CDISC")
AnnotationAssertion(obo:NCIT_P325 obo:NCIT_C129000 "Observational studies which include an organized system that uses observational methods to collect uniform data (clinical and other) prospectively for a population defined by a particular disorder/disease, condition (including susceptibility to a disorder), or exposure (including products, health care services, and/or procedures) and that serves a predetermined scientific, clinical, or policy purpose. Patient registries may be single purpose or on-going data collection programs that address one or more questions. (AHRQ)")
AnnotationAssertion(oboInOwl:hasExactSynonym obo:NCIT_C129000 "PATIENT REGISTRY")
AnnotationAssertion(oboInOwl:hasExactSynonym obo:NCIT_C129000 "Patient Registry Study")
AnnotationAssertion(oboInOwl:inSubset obo:NCIT_C129000 <http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C132298>)
AnnotationAssertion(oboInOwl:inSubset obo:NCIT_C129000 <http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C61410>)
AnnotationAssertion(oboInOwl:inSubset obo:NCIT_C129000 <http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C66830>)
AnnotationAssertion(oboInOwl:inSubset obo:NCIT_C129000 <http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C99077>)
AnnotationAssertion(rdfs:label obo:NCIT_C129000 "Patient Registry Study")
SubClassOf(obo:NCIT_C129000 obo:NCIT_C16084)

# Class: obo:NCIT_C139174 (Device Feasibility Study)

AnnotationAssertion(obo:IAO_0000115 obo:NCIT_C139174 "An intervention of a device product is being evaluated to determine the feasibility of the product or to test a prototype device and not health outcomes. Such studies are conducted to confirm the design and operating specifications of a device before beginning a full clinical trial. (ClinicalTrials.gov)")
AnnotationAssertion(obo:IAO_0000412 obo:NCIT_C139174 obo:ncit.owl)
AnnotationAssertion(obo:NCIT_NHC0 obo:NCIT_C139174 "C139174")
AnnotationAssertion(obo:NCIT_P106 obo:NCIT_C139174 "Research Activity")
AnnotationAssertion(obo:NCIT_P108 obo:NCIT_C139174 "Device Feasibility Study")
AnnotationAssertion(obo:NCIT_P208 obo:NCIT_C139174 "CL526612")
AnnotationAssertion(obo:NCIT_P322 obo:NCIT_C139174 "CDISC")
AnnotationAssertion(obo:NCIT_P325 obo:NCIT_C139174 "An intervention of a device product is being evaluated to determine the feasibility of the product or to test a prototype device and not health outcomes. Such studies are conducted to confirm the design and operating specifications of a device before beginning a full clinical trial. (ClinicalTrials.gov)")
AnnotationAssertion(oboInOwl:hasExactSynonym obo:NCIT_C139174 "DEVICE FEASIBILITY")
AnnotationAssertion(oboInOwl:hasExactSynonym obo:NCIT_C139174 "Device Feasibility")
AnnotationAssertion(oboInOwl:hasExactSynonym obo:NCIT_C139174 "Device Feasibility Study")
AnnotationAssertion(oboInOwl:inSubset obo:NCIT_C139174 <http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C132298>)
AnnotationAssertion(oboInOwl:inSubset obo:NCIT_C139174 <http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C147067>)
AnnotationAssertion(oboInOwl:inSubset obo:NCIT_C139174 <http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C61410>)
AnnotationAssertion(oboInOwl:inSubset obo:NCIT_C139174 <http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C66736>)
AnnotationAssertion(oboInOwl:inSubset obo:NCIT_C139174 <http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C66830>)
AnnotationAssertion(rdfs:label obo:NCIT_C139174 "Device Feasibility Study")
SubClassOf(obo:NCIT_C139174 obo:ERO_0001402)

# Class: obo:NCIT_C142175 (Study Type)

AnnotationAssertion(obo:IAO_0000115 obo:NCIT_C142175 "The nature of the investigation or the investigational use for which clinical study is being done.")
AnnotationAssertion(obo:IAO_0000412 obo:NCIT_C142175 obo:ncit.owl)
AnnotationAssertion(obo:NCIT_NHC0 obo:NCIT_C142175 "C142175")
AnnotationAssertion(obo:NCIT_P106 obo:NCIT_C142175 "Research Activity")
AnnotationAssertion(obo:NCIT_P108 obo:NCIT_C142175 "Study Type")
AnnotationAssertion(obo:NCIT_P208 obo:NCIT_C142175 "CL540168")
AnnotationAssertion(obo:NCIT_P322 obo:NCIT_C142175 "CDISC")
AnnotationAssertion(obo:NCIT_P325 obo:NCIT_C142175 "Describes the role the study plays in determining the interventions a subject receives.")
AnnotationAssertion(oboInOwl:hasExactSynonym obo:NCIT_C142175 "STYPE")
AnnotationAssertion(oboInOwl:hasExactSynonym obo:NCIT_C142175 "Study Type")
AnnotationAssertion(oboInOwl:inSubset obo:NCIT_C142175 <http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C132298>)
AnnotationAssertion(oboInOwl:inSubset obo:NCIT_C142175 <http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C142191>)
AnnotationAssertion(oboInOwl:inSubset obo:NCIT_C142175 <http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C61410>)
AnnotationAssertion(oboInOwl:inSubset obo:NCIT_C142175 <http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C66738>)
AnnotationAssertion(oboInOwl:inSubset obo:NCIT_C142175 <http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C66830>)
AnnotationAssertion(oboInOwl:inSubset obo:NCIT_C142175 <http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C67152>)
AnnotationAssertion(rdfs:label obo:NCIT_C142175 "Study Type")
AnnotationAssertion(rdfs:seeAlso obo:NCIT_C142175 "https://prsinfo.clinicaltrials.gov/definitions.html")
AnnotationAssertion(rdfs:seeAlso obo:NCIT_C142175 "https://www.who.int/ictrp/network/trds/en/")
SubClassOf(obo:NCIT_C142175 obo:OBI_0000011)

# Class: obo:NCIT_C142660 (Random Allocation)

AnnotationAssertion(Annotation(obo:IAO_0000119 "https://prsinfo.clinicaltrials.gov/definitions.html") obo:IAO_0000115 obo:NCIT_C142660 "Participants are assigned to intervention groups by chance")
AnnotationAssertion(obo:IAO_0000115 obo:NCIT_C142660 "The process of resource distribution that is done by chance.")
AnnotationAssertion(obo:IAO_0000412 obo:NCIT_C142660 obo:ncit.owl)
AnnotationAssertion(obo:NCIT_NHC0 obo:NCIT_C142660 "C142660")
AnnotationAssertion(obo:NCIT_P106 obo:NCIT_C142660 "Activity")
AnnotationAssertion(obo:NCIT_P108 obo:NCIT_C142660 "Random Allocation")
AnnotationAssertion(obo:NCIT_P208 obo:NCIT_C142660 "CL540611")
AnnotationAssertion(obo:NCIT_P322 obo:NCIT_C142660 "CDISC-GLOSS")
AnnotationAssertion(obo:NCIT_P325 obo:NCIT_C142660 "Assignment of subjects to treatment (or control) groups in an unpredictable way. NOTE: in a blinded study, assignment sequences are concealed, but available for disclosure in the event a subject has an adverse experience.")
AnnotationAssertion(oboInOwl:hasExactSynonym obo:NCIT_C142660 "Random Allocation")
AnnotationAssertion(oboInOwl:hasExactSynonym obo:NCIT_C142660 "random allocation")
AnnotationAssertion(oboInOwl:hasExactSynonym obo:NCIT_C142660 "randomized")
AnnotationAssertion(oboInOwl:inSubset obo:NCIT_C142660 <http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C61410>)
AnnotationAssertion(oboInOwl:inSubset obo:NCIT_C142660 <http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C67497>)
AnnotationAssertion(rdfs:label obo:NCIT_C142660 "Random Allocation")
SubClassOf(obo:NCIT_C142660 obo:NCIT_C52580)

# Class: obo:NCIT_C147141 (Study Primary Purpose)

AnnotationAssertion(Annotation(obo:IAO_0000119 "https://prsinfo.clinicaltrials.gov/definitions.html") obo:IAO_0000115 obo:NCIT_C147141 "The main objective of the intervention(s) being evaluated by the clinical trial.")
AnnotationAssertion(obo:IAO_0000115 obo:NCIT_C147141 "The principal reason or intention for the execution of an interventional or non-interventional clinical study.")
AnnotationAssertion(obo:IAO_0000412 obo:NCIT_C147141 obo:ncit.owl)
AnnotationAssertion(obo:NCIT_NHC0 obo:NCIT_C147141 "C147141")
AnnotationAssertion(obo:NCIT_P106 obo:NCIT_C147141 "Idea or Concept")
AnnotationAssertion(obo:NCIT_P108 obo:NCIT_C147141 "Study Primary Purpose")
AnnotationAssertion(obo:NCIT_P208 obo:NCIT_C147141 "CL545057")
AnnotationAssertion(obo:NCIT_P322 obo:NCIT_C147141 "CDISC")
AnnotationAssertion(obo:NCIT_P325 obo:NCIT_C147141 "The principal reason or intention for the execution of an interventional or non-interventional clinical study. (NCI)")
AnnotationAssertion(oboInOwl:hasExactSynonym obo:NCIT_C147141 "Study Primary Purpose")
AnnotationAssertion(oboInOwl:inSubset obo:NCIT_C147141 <http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C132298>)
AnnotationAssertion(oboInOwl:inSubset obo:NCIT_C147141 <http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C147066>)
AnnotationAssertion(oboInOwl:inSubset obo:NCIT_C147141 <http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C61410>)
AnnotationAssertion(rdfs:label obo:NCIT_C147141 "Study Primary Purpose")
AnnotationAssertion(rdfs:seeAlso obo:NCIT_C147141 "http://www.icmje.org/recommendations/ 
http://www.who.int/ictrp/network/trds/en/index.html")
SubClassOf(obo:NCIT_C147141 obo:IAO_0000104)

# Class: obo:NCIT_C15238 (Gene Therapy)

AnnotationAssertion(obo:IAO_0000115 obo:NCIT_C15238 "Application of genetic material (usually DNA) into cells in order to permanently correct an inherited disease or acquired disease.")
AnnotationAssertion(obo:IAO_0000412 obo:NCIT_C15238 obo:ncit.owl)
AnnotationAssertion(obo:NCIT_NHC0 obo:NCIT_C15238 "C15238")
AnnotationAssertion(obo:NCIT_P106 obo:NCIT_C15238 "Therapeutic or Preventive Procedure")
AnnotationAssertion(obo:NCIT_P107 obo:NCIT_C15238 "Gene Therapy")
AnnotationAssertion(obo:NCIT_P108 obo:NCIT_C15238 "Gene Therapy")
AnnotationAssertion(obo:NCIT_P207 obo:NCIT_C15238 "C0017296")
AnnotationAssertion(obo:NCIT_P322 obo:NCIT_C15238 "CDISC")
AnnotationAssertion(obo:NCIT_P322 obo:NCIT_C15238 "CTRP")
AnnotationAssertion(obo:NCIT_P325 obo:NCIT_C15238 "Application of genetic material into cells in order to correct an inherited or acquired disease.")
AnnotationAssertion(obo:NCIT_P325 obo:NCIT_C15238 "Treatment of human disease by gene transfer.")
AnnotationAssertion(obo:NCIT_P325 obo:NCIT_C15238 "Treatment that alters a gene. In studies of gene therapy for cancer, researchers are trying to improve the body's natural ability to fight the disease or to make the cancer cells more sensitive to other kinds of therapy.")
AnnotationAssertion(obo:NCIT_P366 obo:NCIT_C15238 "Gene_Therapy")
AnnotationAssertion(obo:NCIT_P98 obo:NCIT_C15238 "Gene therapy techniques attempt to replace a faulty or missing gene associated with a particular disease, mediate localized delivery of a protein producing specified therapeutic effects, or introduce new cellular functions.")
AnnotationAssertion(oboInOwl:hasExactSynonym obo:NCIT_C15238 "DNA Therapy")
AnnotationAssertion(oboInOwl:hasExactSynonym obo:NCIT_C15238 "GENETIC")
AnnotationAssertion(oboInOwl:hasExactSynonym obo:NCIT_C15238 "Gene Therapy")
AnnotationAssertion(oboInOwl:hasExactSynonym obo:NCIT_C15238 "Gene Transfer Procedure")
AnnotationAssertion(oboInOwl:hasExactSynonym obo:NCIT_C15238 "Gene transfer")
AnnotationAssertion(Annotation(rdfs:seeAlso "https://prsinfo.clinicaltrials.gov/definitions.html") oboInOwl:hasExactSynonym obo:NCIT_C15238 "Genetic")
AnnotationAssertion(oboInOwl:hasExactSynonym obo:NCIT_C15238 "Intervention, Genetic")
AnnotationAssertion(oboInOwl:hasExactSynonym obo:NCIT_C15238 "Molecular Biology, Gene Therapy")
AnnotationAssertion(oboInOwl:hasExactSynonym obo:NCIT_C15238 "gene therapy")
AnnotationAssertion(oboInOwl:inSubset obo:NCIT_C15238 <http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C116977>)
AnnotationAssertion(oboInOwl:inSubset obo:NCIT_C15238 <http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C118169>)
AnnotationAssertion(oboInOwl:inSubset obo:NCIT_C15238 <http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C61410>)
AnnotationAssertion(oboInOwl:inSubset obo:NCIT_C15238 <http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C66830>)
AnnotationAssertion(oboInOwl:inSubset obo:NCIT_C15238 <http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C99078>)
AnnotationAssertion(rdfs:label obo:NCIT_C15238 "Gene Therapy")
SubClassOf(obo:NCIT_C15238 obo:OAE_0000002)

# Class: obo:NCIT_C15245 (Health Services Research)

AnnotationAssertion(obo:IAO_0000115 obo:NCIT_C15245 "A multidisciplinary field of inquiry that examines the costs, quality, accessibility, delivery, organization, financing, and outcomes of health care services.")
AnnotationAssertion(Annotation(obo:IAO_0000119 "https://prsinfo.clinicaltrials.gov/definitions.html") obo:IAO_0000115 obo:NCIT_C15245 "One or more interventions for evaluating the delivery, processes, management, organization, or financing of healthcare.")
AnnotationAssertion(obo:IAO_0000412 obo:NCIT_C15245 obo:ncit.owl)
AnnotationAssertion(obo:NCIT_NHC0 obo:NCIT_C15245 "C15245")
AnnotationAssertion(obo:NCIT_P106 obo:NCIT_C15245 "Research Activity")
AnnotationAssertion(obo:NCIT_P108 obo:NCIT_C15245 "Health Services Research")
AnnotationAssertion(obo:NCIT_P207 obo:NCIT_C15245 "C0018757")
AnnotationAssertion(obo:NCIT_P322 obo:NCIT_C15245 "CDISC")
AnnotationAssertion(obo:NCIT_P325 obo:NCIT_C15245 "A type of study designed to evaluate the delivery, processes, management, organization or financing of health care. (ClinicalTrials.gov)")
AnnotationAssertion(obo:NCIT_P366 obo:NCIT_C15245 "Health_Services_Research")
AnnotationAssertion(oboInOwl:hasExactSynonym obo:NCIT_C15245 "HEALTH SERVICES RESEARCH")
AnnotationAssertion(oboInOwl:hasExactSynonym obo:NCIT_C15245 "Health Services Research")
AnnotationAssertion(oboInOwl:inSubset obo:NCIT_C15245 <http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C132298>)
AnnotationAssertion(oboInOwl:inSubset obo:NCIT_C15245 <http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C147067>)
AnnotationAssertion(oboInOwl:inSubset obo:NCIT_C15245 <http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C61410>)
AnnotationAssertion(oboInOwl:inSubset obo:NCIT_C15245 <http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C66736>)
AnnotationAssertion(oboInOwl:inSubset obo:NCIT_C15245 <http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C66830>)
AnnotationAssertion(rdfs:label obo:NCIT_C15245 "Health Services Research")
SubClassOf(obo:NCIT_C15245 obo:NCIT_C147141)

# Class: obo:NCIT_C15329 (Surgical Procedure)

AnnotationAssertion(obo:IAO_0000115 obo:NCIT_C15329 "A diagnostic or treatment procedure performed by manual and/or instrumental means, often involving an incision and the removal or replacement of a diseased organ or tissue; of or relating to or involving or used in surgery or requiring or amenable to treatment by surgery.")
AnnotationAssertion(obo:IAO_0000412 obo:NCIT_C15329 obo:ncit.owl)
AnnotationAssertion(obo:NCIT_A11 obo:NCIT_C15329 obo:NCIT_C25218)
AnnotationAssertion(obo:NCIT_NHC0 obo:NCIT_C15329 "C15329")
AnnotationAssertion(obo:NCIT_P106 obo:NCIT_C15329 "Health Care Activity")
AnnotationAssertion(obo:NCIT_P107 obo:NCIT_C15329 "Surgical Procedure")
AnnotationAssertion(obo:NCIT_P108 obo:NCIT_C15329 "Surgical Procedure")
AnnotationAssertion(obo:NCIT_P207 obo:NCIT_C15329 "C0543467")
AnnotationAssertion(obo:NCIT_P322 obo:NCIT_C15329 "CPTAC")
AnnotationAssertion(obo:NCIT_P322 obo:NCIT_C15329 "CTRP")
AnnotationAssertion(obo:NCIT_P322 obo:NCIT_C15329 "NICHD")
AnnotationAssertion(obo:NCIT_P325 obo:NCIT_C15329 "A procedure to remove or repair a part of the body or to find out whether disease is present. An operation.")
AnnotationAssertion(obo:NCIT_P366 obo:NCIT_C15329 "Surgical_Procedure")
AnnotationAssertion(obo:NCIT_P371 obo:NCIT_C15329 "Surgical Procedure")
AnnotationAssertion(obo:NCIT_P375 obo:NCIT_C15329 "Surgery")
AnnotationAssertion(obo:NCIT_P375 obo:NCIT_C15329 "Surgically Treated")
AnnotationAssertion(oboInOwl:hasExactSynonym obo:NCIT_C15329 "Operation")
AnnotationAssertion(oboInOwl:hasExactSynonym obo:NCIT_C15329 "Surgery")
AnnotationAssertion(oboInOwl:hasExactSynonym obo:NCIT_C15329 "Surgical")
AnnotationAssertion(oboInOwl:hasExactSynonym obo:NCIT_C15329 "Surgical Interventions")
AnnotationAssertion(oboInOwl:hasExactSynonym obo:NCIT_C15329 "Surgical Procedure")
AnnotationAssertion(oboInOwl:hasExactSynonym obo:NCIT_C15329 "Surgical Procedures")
AnnotationAssertion(oboInOwl:hasExactSynonym obo:NCIT_C15329 "Surgically")
AnnotationAssertion(oboInOwl:hasExactSynonym obo:NCIT_C15329 "Type of Surgery")
AnnotationAssertion(oboInOwl:hasExactSynonym obo:NCIT_C15329 "surgery")
AnnotationAssertion(oboInOwl:inSubset obo:NCIT_C15329 <http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C116977>)
AnnotationAssertion(oboInOwl:inSubset obo:NCIT_C15329 <http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C118169>)
AnnotationAssertion(oboInOwl:inSubset obo:NCIT_C15329 <http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C156952>)
AnnotationAssertion(oboInOwl:inSubset obo:NCIT_C15329 <http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C156953>)
AnnotationAssertion(oboInOwl:inSubset obo:NCIT_C15329 <http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C156954>)
AnnotationAssertion(oboInOwl:inSubset obo:NCIT_C15329 <http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C157524>)
AnnotationAssertion(oboInOwl:inSubset obo:NCIT_C15329 <http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C157526>)
AnnotationAssertion(oboInOwl:inSubset obo:NCIT_C15329 <http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C157527>)
AnnotationAssertion(oboInOwl:inSubset obo:NCIT_C15329 <http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C157528>)
AnnotationAssertion(oboInOwl:inSubset obo:NCIT_C15329 <http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C157529>)
AnnotationAssertion(oboInOwl:inSubset obo:NCIT_C15329 <http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C157530>)
AnnotationAssertion(oboInOwl:inSubset obo:NCIT_C15329 <http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C157532>)
AnnotationAssertion(oboInOwl:inSubset obo:NCIT_C15329 <http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C157533>)
AnnotationAssertion(oboInOwl:inSubset obo:NCIT_C15329 <http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C157534>)
AnnotationAssertion(oboInOwl:inSubset obo:NCIT_C15329 <http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C159412>)
AnnotationAssertion(oboInOwl:inSubset obo:NCIT_C15329 <http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C90259>)
AnnotationAssertion(rdfs:label obo:NCIT_C15329 "Surgical Procedure")
AnnotationAssertion(rdfs:seeAlso obo:NCIT_C15329 "https://prsinfo.clinicaltrials.gov/definitions.html")
SubClassOf(obo:NCIT_C15329 obo:OAE_0002807)

# Class: obo:NCIT_C15600 (Phase I Trial)

AnnotationAssertion(obo:IAO_0000115 obo:NCIT_C15600 "A clinical research protocol designed to test a new biomedical intervention in a small group of people for the first time. A Phase I trial can be to establish the toxicity of a new treatment with escalating intensity of the treatment administered and/or to determine the side effects of a new treatment for a particular indication in subjects.")
AnnotationAssertion(Annotation(obo:IAO_0000119 "https://prsinfo.clinicaltrials.gov/definitions.html") obo:IAO_0000115 obo:NCIT_C15600 "Includes initial studies to determine the metabolism and pharmacologic actions of drugs in humans, the side effects associated with increasing doses, and to gain early evidence of effectiveness; may include healthy participants and/or patients.")
AnnotationAssertion(obo:IAO_0000412 obo:NCIT_C15600 obo:ncit.owl)
AnnotationAssertion(obo:NCIT_NHC0 obo:NCIT_C15600 "C15600")
AnnotationAssertion(obo:NCIT_P106 obo:NCIT_C15600 "Research Activity")
AnnotationAssertion(obo:NCIT_P108 obo:NCIT_C15600 "Phase I Trial")
AnnotationAssertion(obo:NCIT_P207 obo:NCIT_C15600 "C0920321")
AnnotationAssertion(obo:NCIT_P322 obo:NCIT_C15600 "CDISC")
AnnotationAssertion(obo:NCIT_P322 obo:NCIT_C15600 "CDISC-GLOSS")
AnnotationAssertion(obo:NCIT_P325 obo:NCIT_C15600 "The first step in testing a new treatment in humans. These studies test the best way to give a new treatment (for example, by mouth, intravenous infusion, or injection) and the best dose. The dose is usually increased a little at a time in order to find the highest dose that does not cause harmful side effects. Because little is known about the possible risks and benefits of the treatments being tested, phase I trials usually include only a small number of patients who have not been helped by other treatments.")
AnnotationAssertion(obo:NCIT_P325 obo:NCIT_C15600 "The initial introduction of an investigational new drug into humans. Phase 1 studies are typically closely monitored and may be conducted in patients or normal volunteer subjects. NOTE: These studies are designed to determine the metabolism and pharmacologic actions of the drug in humans, the side effects associated with increasing doses, and, if possible, to gain early evidence on effectiveness. During Phase 1, sufficient information about the drug's pharmacokinetics and pharmacological effects should be obtained to permit the design of well-controlled, scientifically valid Phase 2 studies. The total number of subjects and patients included in Phase 1 studies varies with the drug, but is generally in the range of 20 to 80. Phase 1 studies also include studies of drug metabolism, structure-activity relationships, and mechanism of action in humans, as well as studies in which investigational drugs are used as research tools to explore biological phenomena or disease processes. [after FDA CDER handbook, ICH E8]")
AnnotationAssertion(obo:NCIT_P325 obo:NCIT_C15600 "The initial introduction of an investigational new drug into humans. Phase 1 studies are typically closely monitored and may be conducted in patients or normal volunteer subjects. NOTE: These studies are designed to determine the metabolism and pharmacologic actions of the drug in humans, the side effects associated with increasing doses, and, if possible, to gain early evidence on effectiveness. During Phase 1, sufficient information about the drug's pharmacokinetics and pharmacological effects should be obtained to permit the design of well-controlled, scientifically valid, Phase 2 studies. The total number of subjects and patients included in Phase I studies varies with the drug, but is generally in the range of 20 to 80. Phase 1 studies also include studies of drug metabolism, structure-activity relationships, and mechanism of action in humans, as well as studies in which investigational drugs are used as research tools to explore biological phenomena or disease processes. [After FDA CDER Handbook, ICH E8] (CDISC glossary)")
AnnotationAssertion(obo:NCIT_P366 obo:NCIT_C15600 "Phase_I_Trial")
AnnotationAssertion(oboInOwl:hasExactSynonym obo:NCIT_C15600 "1")
AnnotationAssertion(oboInOwl:hasExactSynonym obo:NCIT_C15600 "Clinical Trials, Phase I")
AnnotationAssertion(oboInOwl:hasExactSynonym obo:NCIT_C15600 "Early-Stage Clinical Trials")
AnnotationAssertion(oboInOwl:hasExactSynonym obo:NCIT_C15600 "PHASE I TRIAL")
AnnotationAssertion(oboInOwl:hasExactSynonym obo:NCIT_C15600 "Phase 1 Study")
AnnotationAssertion(oboInOwl:hasExactSynonym obo:NCIT_C15600 "Phase I Clinical Trials")
AnnotationAssertion(oboInOwl:hasExactSynonym obo:NCIT_C15600 "Phase I Protocol")
AnnotationAssertion(oboInOwl:hasExactSynonym obo:NCIT_C15600 "Phase I Study")
AnnotationAssertion(oboInOwl:hasExactSynonym obo:NCIT_C15600 "Phase I Trial")
AnnotationAssertion(oboInOwl:hasExactSynonym obo:NCIT_C15600 "Trial Phase 1")
AnnotationAssertion(oboInOwl:hasExactSynonym obo:NCIT_C15600 "phase 1")
AnnotationAssertion(oboInOwl:hasExactSynonym obo:NCIT_C15600 "phase I trial")
AnnotationAssertion(oboInOwl:inSubset obo:NCIT_C15600 <http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C132298>)
AnnotationAssertion(oboInOwl:inSubset obo:NCIT_C15600 <http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C61410>)
AnnotationAssertion(oboInOwl:inSubset obo:NCIT_C15600 <http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C66737>)
AnnotationAssertion(oboInOwl:inSubset obo:NCIT_C15600 <http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C66830>)
AnnotationAssertion(oboInOwl:inSubset obo:NCIT_C15600 <http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C67497>)
AnnotationAssertion(rdfs:label obo:NCIT_C15600 "Phase I Trial")
SubClassOf(obo:NCIT_C15600 obo:CTO_0000220)

# Class: obo:NCIT_C15601 (Phase II Trial)

AnnotationAssertion(obo:IAO_0000115 obo:NCIT_C15601 "A clinical research protocol designed to study a biomedical or behavioral intervention in a larger group of people (several hundred), to evaluate the drug's effectiveness for a particular indication in patients with the disease or condition under study, and to determine the common short-term side effects and risks associated with the intervention.")
AnnotationAssertion(Annotation(obo:IAO_0000119 "https://prsinfo.clinicaltrials.gov/definitions.html") obo:IAO_0000115 obo:NCIT_C15601 "Includes controlled clinical studies conducted to evaluate the effectiveness of the drug for a particular indication or indications in participants with the disease or condition under study and to determine the common short-term side effects and risks.")
AnnotationAssertion(obo:IAO_0000412 obo:NCIT_C15601 obo:ncit.owl)
AnnotationAssertion(obo:NCIT_NHC0 obo:NCIT_C15601 "C15601")
AnnotationAssertion(obo:NCIT_P106 obo:NCIT_C15601 "Research Activity")
AnnotationAssertion(obo:NCIT_P108 obo:NCIT_C15601 "Phase II Trial")
AnnotationAssertion(obo:NCIT_P207 obo:NCIT_C15601 "C0282460")
AnnotationAssertion(obo:NCIT_P322 obo:NCIT_C15601 "CDISC")
AnnotationAssertion(obo:NCIT_P322 obo:NCIT_C15601 "CDISC-GLOSS")
AnnotationAssertion(obo:NCIT_P325 obo:NCIT_C15601 "A study to test whether a new treatment has an anticancer effect (for example, whether it shrinks a tumor or improves blood test results) and whether it works against a certain type of cancer.")
AnnotationAssertion(obo:NCIT_P325 obo:NCIT_C15601 "Controlled clinical studies conducted to evaluate the effectiveness of the drug for a particular indication or indications in patients with the disease or condition under study and to determine the common short-term side effects and risks associated with the drug. NOTE: Phase 2 studies are typically well controlled, closely monitored, and conducted in a relatively small number of patients, usually involving no more than several hundred subjects. [after FDA CDER handbook, ICH E8]")
AnnotationAssertion(obo:NCIT_P325 obo:NCIT_C15601 "Phase 2. Controlled clinical studies conducted to evaluate the effectiveness of the drug for a particular indication or indications in patients with the disease or condition under study and to determine the common short-term side effects and risks associated with the drug. NOTE: Phase 2 studies are typically well controlled, closely monitored, and conducted in a relatively small number of patients, usually involving no more than several hundred subjects. [After FDA CDER Handbook, ICH E8] (CDISC glossary)")
AnnotationAssertion(obo:NCIT_P366 obo:NCIT_C15601 "Phase_II_Trial")
AnnotationAssertion(oboInOwl:hasExactSynonym obo:NCIT_C15601 "2")
AnnotationAssertion(oboInOwl:hasExactSynonym obo:NCIT_C15601 "Clinical Trials, Phase II")
AnnotationAssertion(oboInOwl:hasExactSynonym obo:NCIT_C15601 "PHASE II TRIAL")
AnnotationAssertion(oboInOwl:hasExactSynonym obo:NCIT_C15601 "Phase 2 Study")
AnnotationAssertion(oboInOwl:hasExactSynonym obo:NCIT_C15601 "Phase II Clinical Trial")
AnnotationAssertion(oboInOwl:hasExactSynonym obo:NCIT_C15601 "Phase II Protocol")
AnnotationAssertion(oboInOwl:hasExactSynonym obo:NCIT_C15601 "Phase II Study")
AnnotationAssertion(oboInOwl:hasExactSynonym obo:NCIT_C15601 "Phase II Trial")
AnnotationAssertion(oboInOwl:hasExactSynonym obo:NCIT_C15601 "Trial Phase 2")
AnnotationAssertion(oboInOwl:hasExactSynonym obo:NCIT_C15601 "phase 2")
AnnotationAssertion(oboInOwl:hasExactSynonym obo:NCIT_C15601 "phase II trial")
AnnotationAssertion(oboInOwl:inSubset obo:NCIT_C15601 <http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C132298>)
AnnotationAssertion(oboInOwl:inSubset obo:NCIT_C15601 <http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C61410>)
AnnotationAssertion(oboInOwl:inSubset obo:NCIT_C15601 <http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C66737>)
AnnotationAssertion(oboInOwl:inSubset obo:NCIT_C15601 <http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C66830>)
AnnotationAssertion(oboInOwl:inSubset obo:NCIT_C15601 <http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C67497>)
AnnotationAssertion(rdfs:label obo:NCIT_C15601 "Phase II Trial")
SubClassOf(obo:NCIT_C15601 obo:CTO_0000220)

# Class: obo:NCIT_C15602 (Phase III Trial)

AnnotationAssertion(obo:IAO_0000115 obo:NCIT_C15602 "A clinical research protocol designed to investigate the efficacy of the biomedical or behavioral intervention in large groups of human subjects (from several hundred to several thousand), to confirm efficacy, to monitor adverse reactions to the new medication or treatment regimen with respect to long-term use and by comparing the intervention to other standard or experimental interventions as well as to a placebo.")
AnnotationAssertion(Annotation(rdfs:comment "https://prsinfo.clinicaltrials.gov/definitions.html") obo:IAO_0000115 obo:NCIT_C15602 "Includes trials conducted after preliminary evidence suggesting effectiveness of the drug has been obtained, and are intended to gather additional information to evaluate the overall benefit-risk relationship of the drug.")
AnnotationAssertion(obo:IAO_0000412 obo:NCIT_C15602 obo:ncit.owl)
AnnotationAssertion(obo:NCIT_NHC0 obo:NCIT_C15602 "C15602")
AnnotationAssertion(obo:NCIT_P106 obo:NCIT_C15602 "Research Activity")
AnnotationAssertion(obo:NCIT_P108 obo:NCIT_C15602 "Phase III Trial")
AnnotationAssertion(obo:NCIT_P207 obo:NCIT_C15602 "C0282461")
AnnotationAssertion(obo:NCIT_P322 obo:NCIT_C15602 "CDISC")
AnnotationAssertion(obo:NCIT_P322 obo:NCIT_C15602 "CDISC-GLOSS")
AnnotationAssertion(obo:NCIT_P325 obo:NCIT_C15602 "A study to compare the results of people taking a new treatment with the results of people taking the standard treatment (for example, which group has better survival rates or fewer side effects). In most cases, studies move into phase III only after a treatment seems to work in phases I and II. Phase III trials may include hundreds of people.")
AnnotationAssertion(obo:NCIT_P325 obo:NCIT_C15602 "Phase 3. Studies are expanded controlled and uncontrolled trials. They are performed after preliminary evidence suggesting effectiveness of the drug has been obtained, and are intended to gather the additional information about effectiveness and safety that is needed to confirm efficacy and evaluate the overall benefit-risk relationship of the drug and to provide an adequate basis for physician labeling. NOTE: Phase 3 studies usually include from several hundred to several thousand subjects. [After FDA CDER Handbook, ICH E8] (CDISC glossary)")
AnnotationAssertion(obo:NCIT_P325 obo:NCIT_C15602 "Studies are expanded controlled and uncontrolled trials. They are performed after preliminary evidence suggesting effectiveness of the drug has been obtained and are intended to gather the additional information about effectiveness and safety that is needed to confirm efficacy and evaluate the overall benefit-risk relationship of the drug and to provide an adequate basis for physician labeling. NOTE: Phase 3 studies usually include from several hundred to several thousand subjects. [after FDA CDER handbook, ICH E8]")
AnnotationAssertion(obo:NCIT_P366 obo:NCIT_C15602 "Phase_III_Trial")
AnnotationAssertion(oboInOwl:hasExactSynonym obo:NCIT_C15602 "3")
AnnotationAssertion(oboInOwl:hasExactSynonym obo:NCIT_C15602 "Clinical Trials, Phase III")
AnnotationAssertion(oboInOwl:hasExactSynonym obo:NCIT_C15602 "PHASE III TRIAL")
AnnotationAssertion(oboInOwl:hasExactSynonym obo:NCIT_C15602 "Phase 3 Study")
AnnotationAssertion(oboInOwl:hasExactSynonym obo:NCIT_C15602 "Phase III Clinical Trial")
AnnotationAssertion(oboInOwl:hasExactSynonym obo:NCIT_C15602 "Phase III Protocol")
AnnotationAssertion(oboInOwl:hasExactSynonym obo:NCIT_C15602 "Phase III Study")
AnnotationAssertion(oboInOwl:hasExactSynonym obo:NCIT_C15602 "Phase III Trial")
AnnotationAssertion(oboInOwl:hasExactSynonym obo:NCIT_C15602 "Phase III Trials")
AnnotationAssertion(oboInOwl:hasExactSynonym obo:NCIT_C15602 "Trial Phase 3")
AnnotationAssertion(oboInOwl:hasExactSynonym obo:NCIT_C15602 "phase 3")
AnnotationAssertion(oboInOwl:hasExactSynonym obo:NCIT_C15602 "phase III trial")
AnnotationAssertion(oboInOwl:inSubset obo:NCIT_C15602 <http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C132298>)
AnnotationAssertion(oboInOwl:inSubset obo:NCIT_C15602 <http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C61410>)
AnnotationAssertion(oboInOwl:inSubset obo:NCIT_C15602 <http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C66737>)
AnnotationAssertion(oboInOwl:inSubset obo:NCIT_C15602 <http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C66830>)
AnnotationAssertion(oboInOwl:inSubset obo:NCIT_C15602 <http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C67497>)
AnnotationAssertion(rdfs:label obo:NCIT_C15602 "Phase III Trial")
SubClassOf(obo:NCIT_C15602 obo:CTO_0000220)

# Class: obo:NCIT_C15603 (Phase IV Trial)

AnnotationAssertion(obo:IAO_0000115 obo:NCIT_C15603 "A randomized, controlled trial that is designed to evaluate the long-term safety and efficacy of a drug for a given indication. Often they are designed to study side effects that may have become apparent after the phase III study was completed.")
AnnotationAssertion(Annotation(obo:IAO_0000119 "https://prsinfo.clinicaltrials.gov/definitions.html") obo:IAO_0000115 obo:NCIT_C15603 "Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.")
AnnotationAssertion(obo:IAO_0000412 obo:NCIT_C15603 obo:ncit.owl)
AnnotationAssertion(obo:NCIT_NHC0 obo:NCIT_C15603 "C15603")
AnnotationAssertion(obo:NCIT_P106 obo:NCIT_C15603 "Research Activity")
AnnotationAssertion(obo:NCIT_P108 obo:NCIT_C15603 "Phase IV Trial")
AnnotationAssertion(obo:NCIT_P207 obo:NCIT_C15603 "C0282462")
AnnotationAssertion(obo:NCIT_P322 obo:NCIT_C15603 "CDISC")
AnnotationAssertion(obo:NCIT_P322 obo:NCIT_C15603 "CDISC-GLOSS")
AnnotationAssertion(obo:NCIT_P325 obo:NCIT_C15603 "After a treatment has been approved and is being marketed, it is studied in a phase IV trial to evaluate side effects that were not apparent in the phase III trial. Thousands of people are involved in a phase IV trial.")
AnnotationAssertion(obo:NCIT_P325 obo:NCIT_C15603 "Phase 4. Postmarketing (Phase 4) studies to delineate additional information about the drug's risks, benefits, and optimal use that may be requested by regulatory authorities in conjunction with marketing approval. NOTE: These studies could include, but would not be limited to, studying different doses or schedules of administration than were used in Phase 2 studies, use of the drug in other patient populations or other stages of the disease, or use of the drug over a longer period of time. [After FDA CDER Handbook, ICH E8] (CDISC glossary)")
AnnotationAssertion(obo:NCIT_P325 obo:NCIT_C15603 "Post approval studies to delineate additional information about the drug's risks, benefits, and optimal use that may be requested by regulatory authorities in conjunction with marketing approval. NOTE: These studies could include, but would not be limited to, studying different doses or schedules of administration than were used in Phase 2 studies, use of the drug in other patient populations or other stages of the disease, or use of the drug over a longer period of time. [after FDA CDER handbook, ICH E8]")
AnnotationAssertion(obo:NCIT_P366 obo:NCIT_C15603 "Phase_IV_Trial")
AnnotationAssertion(oboInOwl:hasExactSynonym obo:NCIT_C15603 "4")
AnnotationAssertion(oboInOwl:hasExactSynonym obo:NCIT_C15603 "Clinical Trials, Phase IV")
AnnotationAssertion(oboInOwl:hasExactSynonym obo:NCIT_C15603 "PHASE IV TRIAL")
AnnotationAssertion(oboInOwl:hasExactSynonym obo:NCIT_C15603 "Phase 4 Study")
AnnotationAssertion(oboInOwl:hasExactSynonym obo:NCIT_C15603 "Phase IV Clinical Trials")
AnnotationAssertion(oboInOwl:hasExactSynonym obo:NCIT_C15603 "Phase IV Study")
AnnotationAssertion(oboInOwl:hasExactSynonym obo:NCIT_C15603 "Phase IV Trial")
AnnotationAssertion(oboInOwl:hasExactSynonym obo:NCIT_C15603 "Trial Phase 4")
AnnotationAssertion(oboInOwl:hasExactSynonym obo:NCIT_C15603 "phase 4")
AnnotationAssertion(oboInOwl:hasExactSynonym obo:NCIT_C15603 "phase IV trial")
AnnotationAssertion(oboInOwl:inSubset obo:NCIT_C15603 <http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C132298>)
AnnotationAssertion(oboInOwl:inSubset obo:NCIT_C15603 <http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C61410>)
AnnotationAssertion(oboInOwl:inSubset obo:NCIT_C15603 <http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C66737>)
AnnotationAssertion(oboInOwl:inSubset obo:NCIT_C15603 <http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C66830>)
AnnotationAssertion(oboInOwl:inSubset obo:NCIT_C15603 <http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C67497>)
AnnotationAssertion(rdfs:label obo:NCIT_C15603 "Phase IV Trial")
SubClassOf(obo:NCIT_C15603 obo:CTO_0000220)

# Class: obo:NCIT_C15693 (Phase I/II Trial)

AnnotationAssertion(obo:IAO_0000115 obo:NCIT_C15693 "A clinical research protocol designed to study the safety, dosage levels and response to new treatment. Phase I/II trials combine a Phase I and a Phase II trial of the same treatment into a single protocol.")
AnnotationAssertion(Annotation(obo:IAO_0000119 "https://prsinfo.clinicaltrials.gov/definitions.html") obo:IAO_0000115 obo:NCIT_C15693 "Trials that are a combination of phases 1 and 2.")
AnnotationAssertion(obo:IAO_0000412 obo:NCIT_C15693 obo:ncit.owl)
AnnotationAssertion(obo:NCIT_NHC0 obo:NCIT_C15693 "C15693")
AnnotationAssertion(obo:NCIT_P106 obo:NCIT_C15693 "Research Activity")
AnnotationAssertion(obo:NCIT_P108 obo:NCIT_C15693 "Phase I/II Trial")
AnnotationAssertion(obo:NCIT_P207 obo:NCIT_C15693 "C1519043")
AnnotationAssertion(obo:NCIT_P322 obo:NCIT_C15693 "CDISC")
AnnotationAssertion(obo:NCIT_P325 obo:NCIT_C15693 "A class of clinical study that combines elements characteristic of traditional Phase I and Phase II trials. See also Phase I, Phase II.")
AnnotationAssertion(obo:NCIT_P325 obo:NCIT_C15693 "A trial to study the safety, dosage levels, and response to a new treatment.")
AnnotationAssertion(obo:NCIT_P366 obo:NCIT_C15693 "Phase_I_II_Trial")
AnnotationAssertion(oboInOwl:hasExactSynonym obo:NCIT_C15693 "1-2")
AnnotationAssertion(oboInOwl:hasExactSynonym obo:NCIT_C15693 "PHASE I/II TRIAL")
AnnotationAssertion(oboInOwl:hasExactSynonym obo:NCIT_C15693 "Phase I/II Trial")
AnnotationAssertion(oboInOwl:hasExactSynonym obo:NCIT_C15693 "Phase I/II trial")
AnnotationAssertion(oboInOwl:hasExactSynonym obo:NCIT_C15693 "Trial Phase 1-2")
AnnotationAssertion(oboInOwl:hasExactSynonym obo:NCIT_C15693 "Trial Phase 1/2")
AnnotationAssertion(oboInOwl:inSubset obo:NCIT_C15693 <http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C132298>)
AnnotationAssertion(oboInOwl:inSubset obo:NCIT_C15693 <http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C61410>)
AnnotationAssertion(oboInOwl:inSubset obo:NCIT_C15693 <http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C66737>)
AnnotationAssertion(oboInOwl:inSubset obo:NCIT_C15693 <http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C66830>)
AnnotationAssertion(rdfs:label obo:NCIT_C15693 "Phase I/II Trial")
SubClassOf(obo:NCIT_C15693 obo:CTO_0000220)

# Class: obo:NCIT_C15694 (Phase II/III Trial)

AnnotationAssertion(obo:IAO_0000115 obo:NCIT_C15694 "A type of clinical study that combines elements characteristic of traditional Phase II and Phase III trials.")
AnnotationAssertion(Annotation(obo:IAO_0000119 "https://prsinfo.clinicaltrials.gov/definitions.html") obo:IAO_0000115 obo:NCIT_C15694 "Trials that are a combination of phases 2 and 3.")
AnnotationAssertion(obo:IAO_0000412 obo:NCIT_C15694 obo:ncit.owl)
AnnotationAssertion(obo:NCIT_NHC0 obo:NCIT_C15694 "C15694")
AnnotationAssertion(obo:NCIT_P106 obo:NCIT_C15694 "Research Activity")
AnnotationAssertion(obo:NCIT_P108 obo:NCIT_C15694 "Phase II/III Trial")
AnnotationAssertion(obo:NCIT_P207 obo:NCIT_C15694 "C1519042")
AnnotationAssertion(obo:NCIT_P322 obo:NCIT_C15694 "CDISC")
AnnotationAssertion(obo:NCIT_P325 obo:NCIT_C15694 "A class of clinical study that combines elements characteristic of traditional Phase II and Phase III trials.")
AnnotationAssertion(obo:NCIT_P325 obo:NCIT_C15694 "A trial to study response to a new treatment and the effectiveness of the treatment compared with the standard treatment regimen.")
AnnotationAssertion(obo:NCIT_P366 obo:NCIT_C15694 "Phase_II_III_Trial")
AnnotationAssertion(oboInOwl:hasExactSynonym obo:NCIT_C15694 "2-3")
AnnotationAssertion(oboInOwl:hasExactSynonym obo:NCIT_C15694 "PHASE II/III TRIAL")
AnnotationAssertion(oboInOwl:hasExactSynonym obo:NCIT_C15694 "Phase II/III Trial")
AnnotationAssertion(oboInOwl:hasExactSynonym obo:NCIT_C15694 "Trial Phase 2-3")
AnnotationAssertion(oboInOwl:hasExactSynonym obo:NCIT_C15694 "Trial Phase 2/3")
AnnotationAssertion(oboInOwl:hasExactSynonym obo:NCIT_C15694 "phase II/III trial")
AnnotationAssertion(oboInOwl:inSubset obo:NCIT_C15694 <http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C132298>)
AnnotationAssertion(oboInOwl:inSubset obo:NCIT_C15694 <http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C61410>)
AnnotationAssertion(oboInOwl:inSubset obo:NCIT_C15694 <http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C66737>)
AnnotationAssertion(oboInOwl:inSubset obo:NCIT_C15694 <http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C66830>)
AnnotationAssertion(rdfs:label obo:NCIT_C15694 "Phase II/III Trial")
SubClassOf(obo:NCIT_C15694 obo:CTO_0000220)

# Class: obo:NCIT_C15714 (Basic Research)

AnnotationAssertion(obo:IAO_0000115 obo:NCIT_C15714 "Fundamental research designed to obtain or increase general scientific knowledge.")
AnnotationAssertion(Annotation(obo:IAO_0000119 "https://prsinfo.clinicaltrials.gov/definitions.html") obo:IAO_0000115 obo:NCIT_C15714 "One or more interventions for examining the basic mechanism of action (for example, physiology or biomechanics of an intervention).")
AnnotationAssertion(obo:IAO_0000412 obo:NCIT_C15714 obo:ncit.owl)
AnnotationAssertion(obo:NCIT_NHC0 obo:NCIT_C15714 "C15714")
AnnotationAssertion(obo:NCIT_P106 obo:NCIT_C15714 "Research Activity")
AnnotationAssertion(obo:NCIT_P108 obo:NCIT_C15714 "Basic Research")
AnnotationAssertion(obo:NCIT_P207 obo:NCIT_C15714 "C0681833")
AnnotationAssertion(obo:NCIT_P322 obo:NCIT_C15714 "CDISC")
AnnotationAssertion(obo:NCIT_P325 obo:NCIT_C15714 "A type of study designed to examine the basic mechanism of action (e.g., physiology, biomechanics) of an intervention. (ClinicalTrials.gov)")
AnnotationAssertion(obo:NCIT_P366 obo:NCIT_C15714 "Basic_Science")
AnnotationAssertion(oboInOwl:hasExactSynonym obo:NCIT_C15714 "BASIC SCIENCE")
AnnotationAssertion(oboInOwl:hasExactSynonym obo:NCIT_C15714 "Basic Research")
AnnotationAssertion(oboInOwl:hasExactSynonym obo:NCIT_C15714 "Basic Science")
AnnotationAssertion(oboInOwl:hasExactSynonym obo:NCIT_C15714 "Basic Science Research")
AnnotationAssertion(oboInOwl:inSubset obo:NCIT_C15714 <http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C132298>)
AnnotationAssertion(oboInOwl:inSubset obo:NCIT_C15714 <http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C147067>)
AnnotationAssertion(oboInOwl:inSubset obo:NCIT_C15714 <http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C61410>)
AnnotationAssertion(oboInOwl:inSubset obo:NCIT_C15714 <http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C66736>)
AnnotationAssertion(oboInOwl:inSubset obo:NCIT_C15714 <http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C66830>)
AnnotationAssertion(rdfs:label obo:NCIT_C15714 "Basic Research")
SubClassOf(obo:NCIT_C15714 obo:NCIT_C147141)

# Class: obo:NCIT_C16084 (Observational Study)

AnnotationAssertion(obo:IAO_0000115 obo:NCIT_C16084 "Studies among cancer patients and healthy populations that involve no intervention or alteration in the status of the participants.")
AnnotationAssertion(obo:IAO_0000412 obo:NCIT_C16084 obo:ncit.owl)
AnnotationAssertion(obo:NCIT_NHC0 obo:NCIT_C16084 "C16084")
AnnotationAssertion(obo:NCIT_P106 obo:NCIT_C16084 "Research Activity")
AnnotationAssertion(obo:NCIT_P108 obo:NCIT_C16084 "Observational Study")
AnnotationAssertion(obo:NCIT_P207 obo:NCIT_C16084 "C1518527")
AnnotationAssertion(obo:NCIT_P322 obo:NCIT_C16084 "CDISC")
AnnotationAssertion(obo:NCIT_P325 obo:NCIT_C16084 "A type of study in which individuals are observed or certain outcomes are measured. No attempt is made to affect the outcome (for example, no treatment is given).")
AnnotationAssertion(obo:NCIT_P325 obo:NCIT_C16084 "Studies in which biomedical and/or health outcomes are assessed in pre-defined groups of individuals. Subjects in the study may receive diagnostic, therapeutic, or other interventions, but the investigator does not assign specific interventions to the subjects of the study.")
AnnotationAssertion(obo:NCIT_P366 obo:NCIT_C16084 "Observational_Study")
AnnotationAssertion(oboInOwl:hasExactSynonym obo:NCIT_C16084 "OBSERVATIONAL")
AnnotationAssertion(oboInOwl:hasExactSynonym obo:NCIT_C16084 "Observational Study")
AnnotationAssertion(oboInOwl:hasExactSynonym obo:NCIT_C16084 "Observational Trial")
AnnotationAssertion(oboInOwl:hasExactSynonym obo:NCIT_C16084 "observational study")
AnnotationAssertion(oboInOwl:inSubset obo:NCIT_C16084 <http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C132298>)
AnnotationAssertion(oboInOwl:inSubset obo:NCIT_C16084 <http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C61410>)
AnnotationAssertion(oboInOwl:inSubset obo:NCIT_C16084 <http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C66830>)
AnnotationAssertion(oboInOwl:inSubset obo:NCIT_C16084 <http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C99077>)
AnnotationAssertion(rdfs:label obo:NCIT_C16084 "Observational Study")
SubClassOf(obo:NCIT_C16084 obo:OPMI_0000418)

# Class: obo:NCIT_C161319 (Condition or Disease under Study)

AnnotationAssertion(obo:IAO_0000115 obo:NCIT_C161319 "Primary disease(s) or condition(s) being studied in the trial, or the focus of the study. (clinicaltrials.gov)")
AnnotationAssertion(Annotation(obo:IAO_0000119 "https://clinicaltrials.gov/ct2/about-studies/glossary") obo:IAO_0000115 obo:NCIT_C161319 "The disease, disorder, syndrome, illness, or injury that is being studied. On ClinicalTrials.gov, conditions may also include other health-related issues, such as lifespan, quality of life, and health risks.")
AnnotationAssertion(Annotation(obo:IAO_0000119 "https://prsinfo.clinicaltrials.gov/definitions.html") obo:IAO_0000115 obo:NCIT_C161319 "The name(s) of the disease(s) or condition(s) studied in the clinical study, or the focus of the clinical study. Use, if available, appropriate descriptors from NLM's Medical Subject Headings (MeSH)-controlled vocabulary thesaurus or terms from another vocabulary, such as the Systematized Nomenclature of Medicine—Clinical Terms (SNOMED CT), that has been mapped to MeSH within the Unified Medical Language System (UMLS) Metathesaurus.")
AnnotationAssertion(obo:IAO_0000412 obo:NCIT_C161319 obo:ncit.owl)
AnnotationAssertion(obo:NCIT_NHC0 obo:NCIT_C161319 "C161319")
AnnotationAssertion(obo:NCIT_P106 obo:NCIT_C161319 "Qualitative Concept")
AnnotationAssertion(obo:NCIT_P108 obo:NCIT_C161319 "Condition or Disease under Study")
AnnotationAssertion(obo:NCIT_P322 obo:NCIT_C161319 "CDISC")
AnnotationAssertion(obo:NCIT_P325 obo:NCIT_C161319 "Primary disease(s) or condition(s) being studied in the trial, or the focus of the study. (clinicaltrials.gov)")
AnnotationAssertion(oboInOwl:hasExactSynonym obo:NCIT_C161319 "Condition or Disease under Study")
AnnotationAssertion(oboInOwl:hasExactSynonym obo:NCIT_C161319 "Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study")
AnnotationAssertion(Annotation(rdfs:seeAlso "https://www.who.int/ictrp/network/trds/en/") oboInOwl:hasExactSynonym obo:NCIT_C161319 "health condition(s) or problem(s) studied")
AnnotationAssertion(oboInOwl:hasExactSynonym obo:NCIT_C161319 "target disease")
AnnotationAssertion(oboInOwl:hasNarrowSynonym obo:NCIT_C161319 "condition")
AnnotationAssertion(oboInOwl:inSubset obo:NCIT_C161319 <http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C132298>)
AnnotationAssertion(oboInOwl:inSubset obo:NCIT_C161319 <http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C160921>)
AnnotationAssertion(oboInOwl:inSubset obo:NCIT_C161319 <http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C61410>)
AnnotationAssertion(rdfs:label obo:NCIT_C161319 "Condition or Disease under Study")
SubClassOf(obo:NCIT_C161319 obo:OPMI_0000282)

# Class: obo:NCIT_C19332 (Personal Attribute)

AnnotationAssertion(obo:IAO_0000115 obo:NCIT_C19332 "The distinguishing qualities or prominent aspects of an individual person.")
AnnotationAssertion(obo:IAO_0000412 obo:NCIT_C19332 obo:ncit.owl)
AnnotationAssertion(obo:IAO_0000412 obo:NCIT_C19332 obo:opmi.owl)
AnnotationAssertion(obo:NCIT_NHC0 obo:NCIT_C19332 "C19332")
AnnotationAssertion(obo:NCIT_P106 obo:NCIT_C19332 "Organism Attribute")
AnnotationAssertion(obo:NCIT_P108 obo:NCIT_C19332 "Personal Attribute")
AnnotationAssertion(obo:NCIT_P207 obo:NCIT_C19332 "C0681884")
AnnotationAssertion(obo:NCIT_P366 obo:NCIT_C19332 "Personal_Attribute")
AnnotationAssertion(oboInOwl:hasExactSynonym obo:NCIT_C19332 "Personal")
AnnotationAssertion(oboInOwl:hasExactSynonym obo:NCIT_C19332 "Personal Attribute")
AnnotationAssertion(oboInOwl:hasExactSynonym obo:NCIT_C19332 "Subject Characteristics")
AnnotationAssertion(rdfs:label obo:NCIT_C19332 "Personal Attribute")
SubClassOf(obo:NCIT_C19332 obo:IAO_0000030)

# Class: obo:NCIT_C25150 (Age)

AnnotationAssertion(Annotation(obo:IAO_0000119 "https://clinicaltrials.gov/ct2/about-studies/glossary") obo:IAO_0000115 obo:NCIT_C25150 "A type of eligibility criteria that indicates the age a person must be to participate in a clinical study.")
AnnotationAssertion(obo:IAO_0000115 obo:NCIT_C25150 "How long something has existed; elapsed time since birth.")
AnnotationAssertion(obo:IAO_0000412 obo:NCIT_C25150 obo:ncit.owl)
AnnotationAssertion(obo:IAO_0000412 obo:NCIT_C25150 obo:opmi.owl)
AnnotationAssertion(obo:NCIT_A11 obo:NCIT_C25150 obo:NCIT_C89335)
AnnotationAssertion(obo:NCIT_NHC0 obo:NCIT_C25150 "C25150")
AnnotationAssertion(obo:NCIT_P106 obo:NCIT_C25150 "Organism Attribute")
AnnotationAssertion(obo:NCIT_P108 obo:NCIT_C25150 "Age")
AnnotationAssertion(obo:NCIT_P207 obo:NCIT_C25150 "C0001779")
AnnotationAssertion(obo:NCIT_P322 obo:NCIT_C25150 "CDISC")
AnnotationAssertion(obo:NCIT_P322 obo:NCIT_C25150 "FDA")
AnnotationAssertion(obo:NCIT_P322 obo:NCIT_C25150 "NICHD")
AnnotationAssertion(obo:NCIT_P325 obo:NCIT_C25150 "How long something has existed; elapsed time since birth. (NCI)")
AnnotationAssertion(obo:NCIT_P325 obo:NCIT_C25150 "The time elapsed since birth.")
AnnotationAssertion(obo:NCIT_P366 obo:NCIT_C25150 "Age")
AnnotationAssertion(obo:NCIT_P371 obo:NCIT_C25150 "Chronological Age")
AnnotationAssertion(oboInOwl:hasExactSynonym obo:NCIT_C25150 "AGE")
AnnotationAssertion(oboInOwl:hasExactSynonym obo:NCIT_C25150 "Age")
AnnotationAssertion(oboInOwl:hasExactSynonym obo:NCIT_C25150 "Aged")
AnnotationAssertion(oboInOwl:hasExactSynonym obo:NCIT_C25150 "Chronological Age")
AnnotationAssertion(oboInOwl:hasExactSynonym obo:NCIT_C25150 "Postnatal Age")
AnnotationAssertion(oboInOwl:hasExactSynonym obo:NCIT_C25150 "age")
AnnotationAssertion(oboInOwl:inSubset obo:NCIT_C25150 <http://purl.oboInOwlInOwllibrary.org/oboInOwlInOwl/NCIT_C118466>)
AnnotationAssertion(oboInOwl:inSubset obo:NCIT_C25150 <http://purl.oboInOwlInOwllibrary.org/oboInOwlInOwl/NCIT_C19752>)
AnnotationAssertion(oboInOwl:inSubset obo:NCIT_C25150 <http://purl.oboInOwlInOwllibrary.org/oboInOwlInOwl/NCIT_C54447>)
AnnotationAssertion(oboInOwl:inSubset obo:NCIT_C25150 <http://purl.oboInOwlInOwllibrary.org/oboInOwlInOwl/NCIT_C61410>)
AnnotationAssertion(oboInOwl:inSubset obo:NCIT_C25150 <http://purl.oboInOwlInOwllibrary.org/oboInOwlInOwl/NCIT_C77526>)
AnnotationAssertion(oboInOwl:inSubset obo:NCIT_C25150 <http://purl.oboInOwlInOwllibrary.org/oboInOwlInOwl/NCIT_C83187>)
AnnotationAssertion(oboInOwl:inSubset obo:NCIT_C25150 <http://purl.oboInOwlInOwllibrary.org/oboInOwlInOwl/NCIT_C83188>)
AnnotationAssertion(oboInOwl:inSubset obo:NCIT_C25150 <http://purl.oboInOwlInOwllibrary.org/oboInOwlInOwl/NCIT_C90007>)
AnnotationAssertion(oboInOwl:inSubset obo:NCIT_C25150 <http://purl.oboInOwlInOwllibrary.org/oboInOwlInOwl/NCIT_C90009>)
AnnotationAssertion(oboInOwl:inSubset obo:NCIT_C25150 <http://purl.oboInOwlInOwllibrary.org/oboInOwlInOwl/NCIT_C90259>)
AnnotationAssertion(rdfs:label obo:NCIT_C25150 "Age")
SubClassOf(obo:NCIT_C25150 obo:NCIT_C19332)

# Class: obo:NCIT_C25320 (Clinical Study Protocol)

AnnotationAssertion(obo:IAO_0000115 obo:NCIT_C25320 "A formal document that describes a complete plan of research activity in the framework of a clinical study; specifically, the study objective(s), design, methodology, eligibility requests for prospective subjects and controls; intervention regimen(s), proposed methods of analysis of data; statistical considerations, and organization of the study. The protocol usually also provides the background and rationale for the trial, but these could be represented in other protocol referenced documents.")
AnnotationAssertion(obo:IAO_0000412 obo:NCIT_C25320 obo:ncit.owl)
AnnotationAssertion(obo:NCIT_NHC0 obo:NCIT_C25320 "C25320")
AnnotationAssertion(obo:NCIT_P106 obo:NCIT_C25320 "Intellectual Product")
AnnotationAssertion(obo:NCIT_P108 obo:NCIT_C25320 "Clinical Study Protocol")
AnnotationAssertion(obo:NCIT_P207 obo:NCIT_C25320 "C1507394")
AnnotationAssertion(obo:NCIT_P322 obo:NCIT_C25320 "BRIDG")
AnnotationAssertion(obo:NCIT_P322 obo:NCIT_C25320 "CDISC-GLOSS")
AnnotationAssertion(obo:NCIT_P322 obo:NCIT_C25320 "CareLex")
AnnotationAssertion(obo:NCIT_P325 obo:NCIT_C25320 "A detailed plan of a scientific or medical experiment, treatment, or procedure. In clinical trials, it states what the study will do, how it will be done, and why it is being done. It explains how many people will be in the study, who is eligible to take part in it, what study drugs or other interventions will be given, what tests will be done and how often, and what information will be collected.")
AnnotationAssertion(obo:NCIT_P325 obo:NCIT_C25320 "A discrete, structured plan (that persists over time) of a formal investigation to assess the utility, impact, pharmacological, physiological, and/or psychological effects of a particular treatment, procedure, drug, device, biologic, food product, cosmetic, care plan, or subject characteristic. NOTE(S): The term \"protocol\" is somewhat overloaded and must be qualified to provide semantic context. Therefore the term \"study protocol\" was chosen to disambiguate it from other protocols. In previous versions of BRIDG, there was one class for StudyProtocol. However this too represented multiple distinct aspects of the semantics of study protocol, each of which have now been split into separate classes:- The StudyProtocol class represents the content of the study protocol and can exist even before the information is put into document form. - The details of the structured plan for the study protocol are represented by the StudyProtocolVersion, so named because any aspect of the definition can change from version to version. These details include, but are not limited to, the characteristics, specifications, objective(s), background, the pre-study/study/post-study portions of the plan (including the design, methodology, statistical considerations, organization).- The protocol and its versions can each be represented in document form, respectively StudyProtocolDocument and StudyProtocolDocumentVersion. A StudyProtocolDocument groups the various document versions (StudyProtocolDocumentVersions).- The conduct of a study based on a study protocol definition is represented by the StudyExecution class.")
AnnotationAssertion(obo:NCIT_P325 obo:NCIT_C25320 "A formal document that describes a complete plan of research activity in the framework of a clinical study; specifically, the study objective(s), design, methodology, eligibility requests for prospective subjects and controls; intervention regimen(s), proposed methods of analysis of data; statistical considerations, and organization of the study. The protocol usually also provides the background and rationale for the trial, but these could be represented in other protocol referenced documents. [NCI]")
AnnotationAssertion(obo:NCIT_P325 obo:NCIT_C25320 "See protocol.")
AnnotationAssertion(obo:NCIT_P366 obo:NCIT_C25320 "Protocol")
AnnotationAssertion(oboInOwl:hasExactSynonym obo:NCIT_C25320 "Clinical Study Protocol")
AnnotationAssertion(oboInOwl:hasExactSynonym obo:NCIT_C25320 "Clinical Trial Protocol")
AnnotationAssertion(oboInOwl:hasExactSynonym obo:NCIT_C25320 "Full Protocol")
AnnotationAssertion(oboInOwl:hasExactSynonym obo:NCIT_C25320 "Prot")
AnnotationAssertion(oboInOwl:hasExactSynonym obo:NCIT_C25320 "Protocol")
AnnotationAssertion(oboInOwl:hasExactSynonym obo:NCIT_C25320 "Protocol Amendment")
AnnotationAssertion(oboInOwl:hasExactSynonym obo:NCIT_C25320 "Study Protocol")
AnnotationAssertion(oboInOwl:hasExactSynonym obo:NCIT_C25320 "StudyProtocol")
AnnotationAssertion(oboInOwl:hasExactSynonym obo:NCIT_C25320 "Trial Protocol")
AnnotationAssertion(oboInOwl:hasExactSynonym obo:NCIT_C25320 "clinical protocol")
AnnotationAssertion(oboInOwl:hasExactSynonym obo:NCIT_C25320 "protocol")
AnnotationAssertion(oboInOwl:inSubset obo:NCIT_C25320 <http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C114548>)
AnnotationAssertion(oboInOwl:inSubset obo:NCIT_C25320 <http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C159501>)
AnnotationAssertion(oboInOwl:inSubset obo:NCIT_C25320 <http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C159503>)
AnnotationAssertion(oboInOwl:inSubset obo:NCIT_C25320 <http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C61410>)
AnnotationAssertion(oboInOwl:inSubset obo:NCIT_C25320 <http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C67497>)
AnnotationAssertion(rdfs:label obo:NCIT_C25320 "Clinical Study Protocol")
SubClassOf(obo:NCIT_C25320 obo:NCIT_C70817)
SubClassOf(obo:NCIT_C25320 ObjectSomeValuesFrom(obo:BFO_0000051 obo:CTO_0000008))
SubClassOf(obo:NCIT_C25320 ObjectSomeValuesFrom(obo:BFO_0000051 obo:CTO_0000035))

# Class: obo:NCIT_C48355 (Sponsor)

AnnotationAssertion(obo:IAO_0000115 obo:NCIT_C48355 "A person or organization that supports or champions something.")
AnnotationAssertion(obo:IAO_0000412 obo:NCIT_C48355 obo:ncit.owl)
AnnotationAssertion(obo:NCIT_NHC0 obo:NCIT_C48355 "C48355")
AnnotationAssertion(obo:NCIT_P106 obo:NCIT_C48355 "Human")
AnnotationAssertion(obo:NCIT_P108 obo:NCIT_C48355 "Sponsor")
AnnotationAssertion(obo:NCIT_P207 obo:NCIT_C48355 "C1711305")
AnnotationAssertion(obo:NCIT_P366 obo:NCIT_C48355 "Sponsor")
AnnotationAssertion(oboInOwl:hasExactSynonym obo:NCIT_C48355 "Applicant")
AnnotationAssertion(oboInOwl:hasExactSynonym obo:NCIT_C48355 "Sponsor")
AnnotationAssertion(rdfs:label obo:NCIT_C48355 "Sponsor")
SubClassOf(obo:NCIT_C48355 obo:NCBITaxon_9606)

# Class: obo:NCIT_C49653 (Diagnosis Study)

AnnotationAssertion(obo:IAO_0000115 obo:NCIT_C49653 "A type of study designed to evaluate method(s) aimed at identifying a disease or condition.")
AnnotationAssertion(Annotation(obo:IAO_0000119 "https://prsinfo.clinicaltrials.gov/definitions.html") obo:IAO_0000115 obo:NCIT_C49653 "One or more interventions are being evaluated for identifying a disease or health condition.")
AnnotationAssertion(obo:IAO_0000412 obo:NCIT_C49653 obo:ncit.owl)
AnnotationAssertion(obo:NCIT_NHC0 obo:NCIT_C49653 "C49653")
AnnotationAssertion(obo:NCIT_P106 obo:NCIT_C49653 "Research Activity")
AnnotationAssertion(obo:NCIT_P108 obo:NCIT_C49653 "Diagnosis Study")
AnnotationAssertion(obo:NCIT_P207 obo:NCIT_C49653 "C1704656")
AnnotationAssertion(obo:NCIT_P322 obo:NCIT_C49653 "CDISC")
AnnotationAssertion(obo:NCIT_P325 obo:NCIT_C49653 "A type of study designed to evaluate intervention(s) aimed at identifying a disease or condition.")
AnnotationAssertion(obo:NCIT_P366 obo:NCIT_C49653 "Diagnosis_Study")
AnnotationAssertion(oboInOwl:hasExactSynonym obo:NCIT_C49653 "DIAGNOSIS")
AnnotationAssertion(oboInOwl:hasExactSynonym obo:NCIT_C49653 "Diagnosis Study")
AnnotationAssertion(oboInOwl:hasExactSynonym obo:NCIT_C49653 "Diagnostic Study")
AnnotationAssertion(oboInOwl:inSubset obo:NCIT_C49653 <http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C132298>)
AnnotationAssertion(oboInOwl:inSubset obo:NCIT_C49653 <http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C61410>)
AnnotationAssertion(oboInOwl:inSubset obo:NCIT_C49653 <http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C66736>)
AnnotationAssertion(oboInOwl:inSubset obo:NCIT_C49653 <http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C66739>)
AnnotationAssertion(oboInOwl:inSubset obo:NCIT_C49653 <http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C66830>)
AnnotationAssertion(rdfs:label obo:NCIT_C49653 "Diagnosis Study")
SubClassOf(obo:NCIT_C49653 obo:NCIT_C147141)

# Class: obo:NCIT_C49656 (Treatment Study)

AnnotationAssertion(obo:IAO_0000115 obo:NCIT_C49656 "A type of study protocol designed to evaluate intervention(s) for disease treatment.")
AnnotationAssertion(Annotation(obo:IAO_0000119 "https://prsinfo.clinicaltrials.gov/definitions.html") obo:IAO_0000115 obo:NCIT_C49656 "One or more interventions are being evaluated for treating a disease, syndrome, or condition.")
AnnotationAssertion(obo:IAO_0000412 obo:NCIT_C49656 obo:ncit.owl)
AnnotationAssertion(obo:NCIT_NHC0 obo:NCIT_C49656 "C49656")
AnnotationAssertion(obo:NCIT_P106 obo:NCIT_C49656 "Research Activity")
AnnotationAssertion(obo:NCIT_P108 obo:NCIT_C49656 "Treatment Study")
AnnotationAssertion(obo:NCIT_P207 obo:NCIT_C49656 "C3161471")
AnnotationAssertion(obo:NCIT_P322 obo:NCIT_C49656 "CDISC")
AnnotationAssertion(obo:NCIT_P325 obo:NCIT_C49656 "A type of study designed to evaluate intervention(s) for treatment of disease, syndrome or condition.")
AnnotationAssertion(obo:NCIT_P366 obo:NCIT_C49656 "Treatment_Study")
AnnotationAssertion(oboInOwl:hasExactSynonym obo:NCIT_C49656 "TREATMENT")
AnnotationAssertion(oboInOwl:hasExactSynonym obo:NCIT_C49656 "Therapy Trial")
AnnotationAssertion(oboInOwl:hasExactSynonym obo:NCIT_C49656 "Treatment Study")
AnnotationAssertion(oboInOwl:inSubset obo:NCIT_C49656 <http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C132298>)
AnnotationAssertion(oboInOwl:inSubset obo:NCIT_C49656 <http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C61410>)
AnnotationAssertion(oboInOwl:inSubset obo:NCIT_C49656 <http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C66736>)
AnnotationAssertion(oboInOwl:inSubset obo:NCIT_C49656 <http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C66739>)
AnnotationAssertion(oboInOwl:inSubset obo:NCIT_C49656 <http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C66830>)
AnnotationAssertion(rdfs:label obo:NCIT_C49656 "Treatment Study")
SubClassOf(obo:NCIT_C49656 obo:NCIT_C147141)

# Class: obo:NCIT_C49657 (Prevention Study)

AnnotationAssertion(obo:IAO_0000115 obo:NCIT_C49657 "A type of study protocol designed to evaluate intervention(s) for disease prevention.")
AnnotationAssertion(Annotation(obo:IAO_0000119 "https://prsinfo.clinicaltrials.gov/definitions.html") obo:IAO_0000115 obo:NCIT_C49657 "One or more interventions are being assessed for preventing the development of a specific disease or health condition.")
AnnotationAssertion(obo:IAO_0000412 obo:NCIT_C49657 obo:ncit.owl)
AnnotationAssertion(obo:NCIT_NHC0 obo:NCIT_C49657 "C49657")
AnnotationAssertion(obo:NCIT_P106 obo:NCIT_C49657 "Research Activity")
AnnotationAssertion(obo:NCIT_P108 obo:NCIT_C49657 "Prevention Study")
AnnotationAssertion(obo:NCIT_P207 obo:NCIT_C49657 "C1706420")
AnnotationAssertion(obo:NCIT_P322 obo:NCIT_C49657 "CDISC")
AnnotationAssertion(obo:NCIT_P325 obo:NCIT_C49657 "A type of study designed to identify actions necessary to permanently eliminate or reduce the long-term risk to human life as a result of a particular medication or treatment regimen.")
AnnotationAssertion(obo:NCIT_P366 obo:NCIT_C49657 "Prevention_Study")
AnnotationAssertion(oboInOwl:hasExactSynonym obo:NCIT_C49657 "PREVENTION")
AnnotationAssertion(oboInOwl:hasExactSynonym obo:NCIT_C49657 "Prevention Study")
AnnotationAssertion(oboInOwl:hasExactSynonym obo:NCIT_C49657 "Preventive Clinical Trial")
AnnotationAssertion(oboInOwl:hasExactSynonym obo:NCIT_C49657 "Prophylaxis Study")
AnnotationAssertion(oboInOwl:inSubset obo:NCIT_C49657 <http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C132298>)
AnnotationAssertion(oboInOwl:inSubset obo:NCIT_C49657 <http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C61410>)
AnnotationAssertion(oboInOwl:inSubset obo:NCIT_C49657 <http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C66736>)
AnnotationAssertion(oboInOwl:inSubset obo:NCIT_C49657 <http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C66739>)
AnnotationAssertion(oboInOwl:inSubset obo:NCIT_C49657 <http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C66830>)
AnnotationAssertion(rdfs:label obo:NCIT_C49657 "Prevention Study")
SubClassOf(obo:NCIT_C49657 obo:NCIT_C147141)

# Class: obo:NCIT_C49692 (Planned Subject Number)

AnnotationAssertion(obo:IAO_0000115 obo:NCIT_C49692 "The number of subjects entered in a clinical trial.")
AnnotationAssertion(obo:IAO_0000412 obo:NCIT_C49692 obo:ncit.owl)
AnnotationAssertion(obo:NCIT_NHC0 obo:NCIT_C49692 "C49692")
AnnotationAssertion(obo:NCIT_P106 obo:NCIT_C49692 "Group Attribute")
AnnotationAssertion(obo:NCIT_P108 obo:NCIT_C49692 "Planned Subject Number")
AnnotationAssertion(obo:NCIT_P207 obo:NCIT_C49692 "C1709561")
AnnotationAssertion(obo:NCIT_P322 obo:NCIT_C49692 "CDISC")
AnnotationAssertion(obo:NCIT_P322 obo:NCIT_C49692 "CDISC-GLOSS")
AnnotationAssertion(obo:NCIT_P325 obo:NCIT_C49692 "The number of subjects in a class or group (including the total for the entire trial) intended to be enrolled in a trial to reach the planned sample size. Target enrollments are set so that statistical and scientific objectives of a trial will have a likelihood of being met as determined by agreement, algorithm, or other specified process.")
AnnotationAssertion(obo:NCIT_P325 obo:NCIT_C49692 "The planned number of subjects to be entered in a clinical trial. (NCI)")
AnnotationAssertion(obo:NCIT_P366 obo:NCIT_C49692 "Planned_Subject_Number")
AnnotationAssertion(oboInOwl:hasExactSynonym obo:NCIT_C49692 "Anticipated Enrollment")
AnnotationAssertion(oboInOwl:hasExactSynonym obo:NCIT_C49692 "PLANSUB")
AnnotationAssertion(oboInOwl:hasExactSynonym obo:NCIT_C49692 "Planned Enrollment")
AnnotationAssertion(oboInOwl:hasExactSynonym obo:NCIT_C49692 "Planned Number of Subjects")
AnnotationAssertion(oboInOwl:hasExactSynonym obo:NCIT_C49692 "Planned Subject Number")
AnnotationAssertion(oboInOwl:hasExactSynonym obo:NCIT_C49692 "Target Enrollment")
AnnotationAssertion(oboInOwl:hasExactSynonym obo:NCIT_C49692 "target enrollment")
AnnotationAssertion(oboInOwl:hasExactSynonym obo:NCIT_C49692 "target number")
AnnotationAssertion(oboInOwl:hasExactSynonym obo:NCIT_C49692 "target size")
AnnotationAssertion(oboInOwl:inSubset obo:NCIT_C49692 <http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C132298>)
AnnotationAssertion(oboInOwl:inSubset obo:NCIT_C49692 <http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C147066>)
AnnotationAssertion(oboInOwl:inSubset obo:NCIT_C49692 <http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C61410>)
AnnotationAssertion(oboInOwl:inSubset obo:NCIT_C49692 <http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C66738>)
AnnotationAssertion(oboInOwl:inSubset obo:NCIT_C49692 <http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C66830>)
AnnotationAssertion(oboInOwl:inSubset obo:NCIT_C49692 <http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C67152>)
AnnotationAssertion(oboInOwl:inSubset obo:NCIT_C49692 <http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C67497>)
AnnotationAssertion(rdfs:label obo:NCIT_C49692 "Planned Subject Number")
AnnotationAssertion(rdfs:seeAlso obo:NCIT_C49692 "https://prsinfo.clinicaltrials.gov/definitions.html")
AnnotationAssertion(rdfs:seeAlso obo:NCIT_C49692 "https://www.who.int/ictrp/network/trds/en/")
SubClassOf(obo:NCIT_C49692 obo:IAO_0000027)

# Class: obo:NCIT_C52580 (Allocation)

AnnotationAssertion(obo:IAO_0000115 obo:NCIT_C52580 "The distribution of resources over various time periods, products, operations, or investments.")
AnnotationAssertion(Annotation(obo:IAO_0000119 "https://prsinfo.clinicaltrials.gov/definitions.html") obo:IAO_0000115 obo:NCIT_C52580 "The method by which participants are assigned to arms in a clinical trial.")
AnnotationAssertion(obo:IAO_0000412 obo:NCIT_C52580 obo:ncit.owl)
AnnotationAssertion(obo:NCIT_NHC0 obo:NCIT_C52580 "C52580")
AnnotationAssertion(obo:NCIT_P106 obo:NCIT_C52580 "Activity")
AnnotationAssertion(obo:NCIT_P108 obo:NCIT_C52580 "Allocation")
AnnotationAssertion(obo:NCIT_P207 obo:NCIT_C52580 "C1706778")
AnnotationAssertion(obo:NCIT_P322 obo:NCIT_C52580 "CDISC")
AnnotationAssertion(obo:NCIT_P325 obo:NCIT_C52580 "The process of assigning subjects to particular treatment groups or cohorts in a clinical study.")
AnnotationAssertion(obo:NCIT_P366 obo:NCIT_C52580 "Allocation")
AnnotationAssertion(oboInOwl:hasExactSynonym obo:NCIT_C52580 "Allocation")
AnnotationAssertion(oboInOwl:hasExactSynonym obo:NCIT_C52580 "Subject Allocation")
AnnotationAssertion(oboInOwl:inSubset obo:NCIT_C52580 <http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C132298>)
AnnotationAssertion(oboInOwl:inSubset obo:NCIT_C52580 <http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C147066>)
AnnotationAssertion(oboInOwl:inSubset obo:NCIT_C52580 <http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C61410>)
AnnotationAssertion(rdfs:label obo:NCIT_C52580 "Allocation")
AnnotationAssertion(rdfs:seeAlso obo:NCIT_C52580 "https://www.clinicaltrials.gov/ct2/about-studies/glossary")
SubClassOf(obo:NCIT_C52580 obo:OBI_0000115)

# Class: obo:NCIT_C60776 (Contact Information)

AnnotationAssertion(obo:IAO_0000115 obo:NCIT_C60776 "Information regarding the means of contacting a person or group.")
AnnotationAssertion(obo:IAO_0000412 obo:NCIT_C60776 obo:ncit.owl)
AnnotationAssertion(obo:NCIT_NHC0 obo:NCIT_C60776 "C60776")
AnnotationAssertion(obo:NCIT_P106 obo:NCIT_C60776 "Conceptual Entity")
AnnotationAssertion(obo:NCIT_P108 obo:NCIT_C60776 "Contact Information")
AnnotationAssertion(obo:NCIT_P207 obo:NCIT_C60776 "C1880174")
AnnotationAssertion(obo:NCIT_P366 obo:NCIT_C60776 "Contact_Information")
AnnotationAssertion(oboInOwl:hasExactSynonym obo:NCIT_C60776 "Contact Info")
AnnotationAssertion(oboInOwl:hasExactSynonym obo:NCIT_C60776 "Contact Information")
AnnotationAssertion(rdfs:label obo:NCIT_C60776 "Contact Information")
SubClassOf(obo:NCIT_C60776 obo:IAO_0000300)

# Class: obo:NCIT_C70793 (Clinical Study Sponsor)

AnnotationAssertion(obo:IAO_0000115 obo:NCIT_C70793 "An entity such as an individual, company, institution, group, or organization which takes responsibility for the initiation, management, and/or financing of a clinical study. The sponsor does not actually conduct the investigation unless the sponsor is a sponsor-investigator. A person other than an individual (e.g., corporation or agency) that uses one or more of its own employees to conduct research it has initiated is considered to be a sponsor, and the employees are considered to be investigators. [21 CFR P.50.3(k)] [21 CFR P.50.102(j)] [21 CFR P.312.3]")
AnnotationAssertion(obo:IAO_0000412 obo:NCIT_C70793 obo:ncit.owl)
AnnotationAssertion(obo:NCIT_NHC0 obo:NCIT_C70793 "C70793")
AnnotationAssertion(obo:NCIT_P106 obo:NCIT_C70793 "Health Care Related Organization")
AnnotationAssertion(obo:NCIT_P108 obo:NCIT_C70793 "Clinical Study Sponsor")
AnnotationAssertion(obo:NCIT_P207 obo:NCIT_C70793 "C2347796")
AnnotationAssertion(obo:NCIT_P322 obo:NCIT_C70793 "CDISC")
AnnotationAssertion(obo:NCIT_P322 obo:NCIT_C70793 "CDISC-GLOSS")
AnnotationAssertion(obo:NCIT_P322 obo:NCIT_C70793 "CareLex")
AnnotationAssertion(obo:NCIT_P325 obo:NCIT_C70793 "An entity that is responsible for the initiation, management, and/or financing of a clinical study.")
AnnotationAssertion(obo:NCIT_P325 obo:NCIT_C70793 "An entity that is responsible for the initiation, management, and/or financing of a clinical study.[NCI]")
AnnotationAssertion(obo:NCIT_P325 obo:NCIT_C70793 "An individual, company, institution, or organization that takes responsibility for the initiation, management, and/or financing of a clinical trial. NOTE: If there is also a secondary sponsor, the responsible entity would be considered the primary sponsor. A corporation or agency whose employees conduct the investigation is considered a sponsor and the employees are considered investigators. [After ICH E6, WHO, 21 CFR 50.3 (e), and after IDMP] See also secondary sponsor.")
AnnotationAssertion(obo:NCIT_P366 obo:NCIT_C70793 "Clinical_Study_Sponsor")
AnnotationAssertion(oboInOwl:hasExactSynonym obo:NCIT_C70793 "CLINICAL STUDY SPONSOR")
AnnotationAssertion(oboInOwl:hasExactSynonym obo:NCIT_C70793 "Clinical Study Sponsor")
AnnotationAssertion(oboInOwl:hasExactSynonym obo:NCIT_C70793 "SPONSOR")
AnnotationAssertion(oboInOwl:hasExactSynonym obo:NCIT_C70793 "Sponsor")
AnnotationAssertion(oboInOwl:hasExactSynonym obo:NCIT_C70793 "Study Sponsor")
AnnotationAssertion(oboInOwl:hasExactSynonym obo:NCIT_C70793 "sponsor")
AnnotationAssertion(oboInOwl:inSubset obo:NCIT_C70793 <http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C114548>)
AnnotationAssertion(oboInOwl:inSubset obo:NCIT_C70793 <http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C132298>)
AnnotationAssertion(oboInOwl:inSubset obo:NCIT_C70793 <http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C154681>)
AnnotationAssertion(oboInOwl:inSubset obo:NCIT_C70793 <http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C61410>)
AnnotationAssertion(oboInOwl:inSubset obo:NCIT_C70793 <http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C66738>)
AnnotationAssertion(oboInOwl:inSubset obo:NCIT_C70793 <http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C66830>)
AnnotationAssertion(oboInOwl:inSubset obo:NCIT_C70793 <http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C67152>)
AnnotationAssertion(oboInOwl:inSubset obo:NCIT_C70793 <http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C67497>)
AnnotationAssertion(oboInOwl:inSubset obo:NCIT_C70793 <http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C78735>)
AnnotationAssertion(oboInOwl:inSubset obo:NCIT_C70793 <http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C83187>)
AnnotationAssertion(oboInOwl:inSubset obo:NCIT_C70793 <http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C83188>)
AnnotationAssertion(rdfs:label obo:NCIT_C70793 "Clinical Study Sponsor")
SubClassOf(obo:NCIT_C70793 obo:NCIT_C48355)

# Class: obo:NCIT_C70817 (Study Protocol)

AnnotationAssertion(obo:IAO_0000115 obo:NCIT_C70817 "The formal plan of an experiment or research activity, including the objective, rationale, design, materials and methods for the conduct of the study; intervention description, and method of data analysis.")
AnnotationAssertion(Annotation(obo:IAO_0000119 "https://prsinfo.clinicaltrials.gov/results_definitions.html") obo:IAO_0000115 obo:NCIT_C70817 "The written description of the clinical study, including objective(s), design, and methods. It may also include relevant scientific background and statistical considerations (if the protocol document includes the statistical analysis plan, use \"Study Protocol with SAP and/or ICF\" option). Note: All amendments approved by a human subjects protection review board (if applicable), before the time of submission and that apply to all clinical trial Facility Locations must be included.")
AnnotationAssertion(obo:IAO_0000412 obo:NCIT_C70817 obo:ncit.owl)
AnnotationAssertion(obo:NCIT_NHC0 obo:NCIT_C70817 "C70817")
AnnotationAssertion(obo:NCIT_P106 obo:NCIT_C70817 "Intellectual Product")
AnnotationAssertion(obo:NCIT_P108 obo:NCIT_C70817 "Study Protocol")
AnnotationAssertion(obo:NCIT_P207 obo:NCIT_C70817 "C2348563")
AnnotationAssertion(obo:NCIT_P322 obo:NCIT_C70817 "CDISC")
AnnotationAssertion(obo:NCIT_P325 obo:NCIT_C70817 "The formal plan of an experiment or research activity, including the objective, rationale, design, materials and methods for the conduct of the study, intervention description, and method of data analysis.")
AnnotationAssertion(obo:NCIT_P366 obo:NCIT_C70817 "Study_Protocol")
AnnotationAssertion(oboInOwl:hasExactSynonym obo:NCIT_C70817 "Protocol")
AnnotationAssertion(oboInOwl:hasExactSynonym obo:NCIT_C70817 "Study Protocol")
AnnotationAssertion(oboInOwl:inSubset obo:NCIT_C70817 <http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C132298>)
AnnotationAssertion(oboInOwl:inSubset obo:NCIT_C70817 <http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C132310>)
AnnotationAssertion(oboInOwl:inSubset obo:NCIT_C70817 <http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C61410>)
AnnotationAssertion(rdfs:label obo:NCIT_C70817 "Study Protocol")
AnnotationAssertion(rdfs:seeAlso obo:NCIT_C70817 "https://prsinfo.clinicaltrials.gov/definitions.html")
SubClassOf(obo:NCIT_C70817 obo:OBI_0000272)

# Class: obo:NCIT_C70840 (Blinded Clinical Study)

AnnotationAssertion(obo:IAO_0000115 obo:NCIT_C70840 "A clinical study that is designed using a procedure in which one or more parties to the study [subject(s), investigator(s), monitor, or/and data analyst(s)] are kept unaware of the treatment assignment(s).")
AnnotationAssertion(obo:IAO_0000412 obo:NCIT_C70840 obo:ncit.owl)
AnnotationAssertion(obo:NCIT_NHC0 obo:NCIT_C70840 "C70840")
AnnotationAssertion(obo:NCIT_P106 obo:NCIT_C70840 "Research Activity")
AnnotationAssertion(obo:NCIT_P108 obo:NCIT_C70840 "Blinded Clinical Study")
AnnotationAssertion(obo:NCIT_P207 obo:NCIT_C70840 "C2347038")
AnnotationAssertion(obo:NCIT_P322 obo:NCIT_C70840 "CDISC-GLOSS")
AnnotationAssertion(obo:NCIT_P325 obo:NCIT_C70840 "A study in which the subject, the investigator, or anyone assessing the outcome is unaware of the treatment assignment(s). NOTE: Blinding is used to reduce the potential for bias. [Modified ICH E6 Glossary] See also blinding/masking, double-blind study, single-blind study, triple-blind study; contrast with open-label or unblinded study.")
AnnotationAssertion(obo:NCIT_P325 obo:NCIT_C70840 "A type of study in which the patients (single-blinded) or the patients and their doctors (double-blinded) do not know which drug or treatment is being given. The opposite of a blinded study is an open label study.")
AnnotationAssertion(obo:NCIT_P366 obo:NCIT_C70840 "Blinded_Clinical_Study")
AnnotationAssertion(oboInOwl:hasExactSynonym obo:NCIT_C70840 "Blind Clinical Study")
AnnotationAssertion(oboInOwl:hasExactSynonym obo:NCIT_C70840 "Blinded Clinical Study")
AnnotationAssertion(oboInOwl:hasExactSynonym obo:NCIT_C70840 "Blinded Clinical Trial")
AnnotationAssertion(oboInOwl:hasExactSynonym obo:NCIT_C70840 "Masked Clinical Study")
AnnotationAssertion(oboInOwl:hasExactSynonym obo:NCIT_C70840 "blinded study")
AnnotationAssertion(oboInOwl:inSubset obo:NCIT_C70840 <http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C61410>)
AnnotationAssertion(oboInOwl:inSubset obo:NCIT_C70840 <http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C67497>)
AnnotationAssertion(rdfs:label obo:NCIT_C70840 "Blinded Clinical Study")
SubClassOf(obo:NCIT_C70840 obo:NCIT_C98388)

# Class: obo:NCIT_C71485 (Screening Study)

AnnotationAssertion(obo:IAO_0000115 obo:NCIT_C71485 "Clinical studies testing the efficacy of devices, techniques, procedures, or tests for the purpose of detecting the presence of disease, usually before there are any symptoms.")
AnnotationAssertion(Annotation(obo:IAO_0000119 "https://prsinfo.clinicaltrials.gov/definitions.html") obo:IAO_0000115 obo:NCIT_C71485 "One or more interventions are assessed or examined for identifying a condition, or risk factors for a condition, in people who are not yet known to have the condition or risk factor.")
AnnotationAssertion(obo:IAO_0000412 obo:NCIT_C71485 obo:ncit.owl)
AnnotationAssertion(obo:NCIT_NHC0 obo:NCIT_C71485 "C71485")
AnnotationAssertion(obo:NCIT_P106 obo:NCIT_C71485 "Research Activity")
AnnotationAssertion(obo:NCIT_P108 obo:NCIT_C71485 "Screening Study")
AnnotationAssertion(obo:NCIT_P207 obo:NCIT_C71485 "C2348164")
AnnotationAssertion(obo:NCIT_P322 obo:NCIT_C71485 "CDISC")
AnnotationAssertion(obo:NCIT_P322 obo:NCIT_C71485 "CDISC-GLOSS")
AnnotationAssertion(obo:NCIT_P325 obo:NCIT_C71485 "A type of study designed to assess or examine methods of identifying a condition (or risk factors for a condition) in people who are not yet known to have the condition (or risk factor). (Clinicaltrials.gov)")
AnnotationAssertion(obo:NCIT_P325 obo:NCIT_C71485 "Trials conducted to detect persons with early, mild, and asymptomatic disease.")
AnnotationAssertion(obo:NCIT_P366 obo:NCIT_C71485 "Screening_Study")
AnnotationAssertion(oboInOwl:hasExactSynonym obo:NCIT_C71485 "SCREENING")
AnnotationAssertion(oboInOwl:hasExactSynonym obo:NCIT_C71485 "Screening Study")
AnnotationAssertion(oboInOwl:hasExactSynonym obo:NCIT_C71485 "Screening Trial")
AnnotationAssertion(oboInOwl:hasExactSynonym obo:NCIT_C71485 "screening trials")
AnnotationAssertion(oboInOwl:inSubset obo:NCIT_C71485 <http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C132298>)
AnnotationAssertion(oboInOwl:inSubset obo:NCIT_C71485 <http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C61410>)
AnnotationAssertion(oboInOwl:inSubset obo:NCIT_C71485 <http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C66736>)
AnnotationAssertion(oboInOwl:inSubset obo:NCIT_C71485 <http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C66830>)
AnnotationAssertion(oboInOwl:inSubset obo:NCIT_C71485 <http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C67497>)
AnnotationAssertion(rdfs:label obo:NCIT_C71485 "Screening Study")
SubClassOf(obo:NCIT_C71485 obo:NCIT_C147141)

# Class: obo:NCIT_C71486 (Supportive Care Study)

AnnotationAssertion(obo:IAO_0000115 obo:NCIT_C71486 "Clinical studies intended to improve the comfort and quality of life for the patient using drugs, nutritional, dietary, behavioral or other interventions.")
AnnotationAssertion(Annotation(obo:IAO_0000119 "https://prsinfo.clinicaltrials.gov/definitions.html") obo:IAO_0000115 obo:NCIT_C71486 "One or more interventions are evaluated for maximizing comfort, minimizing side effects, or mitigating against a decline in the participant's health or function.")
AnnotationAssertion(obo:IAO_0000412 obo:NCIT_C71486 obo:ncit.owl)
AnnotationAssertion(obo:NCIT_NHC0 obo:NCIT_C71486 "C71486")
AnnotationAssertion(obo:NCIT_P106 obo:NCIT_C71486 "Research Activity")
AnnotationAssertion(obo:NCIT_P108 obo:NCIT_C71486 "Supportive Care Study")
AnnotationAssertion(obo:NCIT_P207 obo:NCIT_C71486 "C2348611")
AnnotationAssertion(obo:NCIT_P322 obo:NCIT_C71486 "CDISC")
AnnotationAssertion(obo:NCIT_P325 obo:NCIT_C71486 "A type of study designed to evaluate one or more interventions where the primary intent is to maximize comfort, minimize side effects or mitigate against a decline in the subject's health or function. In general, supportive care interventions are not intended to cure a disease. (ClinicalTrials.gov)")
AnnotationAssertion(obo:NCIT_P366 obo:NCIT_C71486 "Supportive_Care_Study")
AnnotationAssertion(oboInOwl:hasExactSynonym obo:NCIT_C71486 "SUPPORTIVE CARE")
AnnotationAssertion(oboInOwl:hasExactSynonym obo:NCIT_C71486 "Supportive Care Study")
AnnotationAssertion(oboInOwl:hasExactSynonym obo:NCIT_C71486 "Supportive Care Trial")
AnnotationAssertion(oboInOwl:inSubset obo:NCIT_C71486 <http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C132298>)
AnnotationAssertion(oboInOwl:inSubset obo:NCIT_C71486 <http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C61410>)
AnnotationAssertion(oboInOwl:inSubset obo:NCIT_C71486 <http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C66736>)
AnnotationAssertion(oboInOwl:inSubset obo:NCIT_C71486 <http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C66830>)
AnnotationAssertion(rdfs:label obo:NCIT_C71486 "Supportive Care Study")
SubClassOf(obo:NCIT_C71486 obo:NCIT_C147141)

# Class: obo:NCIT_C82638 (Factorial Study)

AnnotationAssertion(obo:IAO_0000115 obo:NCIT_C82638 "A type of clinical study in which two or more treatments are given alone and in combination, such that all possible combinations are represented across the treatment arms, and are compared in parallel against the study control group.")
AnnotationAssertion(Annotation(obo:IAO_0000119 "https://prsinfo.clinicaltrials.gov/definitions.html") obo:IAO_0000115 obo:NCIT_C82638 "Two or more interventions, each alone and in combination, are evaluated in parallel against a control group")
AnnotationAssertion(obo:IAO_0000412 obo:NCIT_C82638 obo:ncit.owl)
AnnotationAssertion(obo:NCIT_NHC0 obo:NCIT_C82638 "C82638")
AnnotationAssertion(obo:NCIT_P106 obo:NCIT_C82638 "Research Activity")
AnnotationAssertion(obo:NCIT_P108 obo:NCIT_C82638 "Factorial Study")
AnnotationAssertion(obo:NCIT_P207 obo:NCIT_C82638 "C2826344")
AnnotationAssertion(obo:NCIT_P322 obo:NCIT_C82638 "CDISC")
AnnotationAssertion(obo:NCIT_P325 obo:NCIT_C82638 "Two or more interventions, each alone or in combination, are evaluated in parallel against a control group. This study design allows for the comparison of active drug to placebo, presence of drug-drug interactions, and comparison of active drugs against each other.")
AnnotationAssertion(obo:NCIT_P366 obo:NCIT_C82638 "Factorial_Study")
AnnotationAssertion(oboInOwl:hasExactSynonym obo:NCIT_C82638 "FACTORIAL")
AnnotationAssertion(oboInOwl:hasExactSynonym obo:NCIT_C82638 "Factorial Study")
AnnotationAssertion(oboInOwl:inSubset obo:NCIT_C82638 <http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C132298>)
AnnotationAssertion(oboInOwl:inSubset obo:NCIT_C82638 <http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C61410>)
AnnotationAssertion(oboInOwl:inSubset obo:NCIT_C82638 <http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C66830>)
AnnotationAssertion(oboInOwl:inSubset obo:NCIT_C82638 <http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C77526>)
AnnotationAssertion(oboInOwl:inSubset obo:NCIT_C82638 <http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C89967>)
AnnotationAssertion(oboInOwl:inSubset obo:NCIT_C82638 <http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C99076>)
AnnotationAssertion(rdfs:label obo:NCIT_C82638 "Factorial Study")
SubClassOf(obo:NCIT_C82638 obo:NCIT_C98388)

# Class: obo:NCIT_C84336 (Collaborator)

AnnotationAssertion(obo:IAO_0000115 obo:NCIT_C84336 "Any of two or more parties working jointly towards a common goal.")
AnnotationAssertion(obo:IAO_0000412 obo:NCIT_C84336 obo:ncit.owl)
AnnotationAssertion(obo:NCIT_NHC0 obo:NCIT_C84336 "C84336")
AnnotationAssertion(obo:NCIT_P106 obo:NCIT_C84336 "Conceptual Entity")
AnnotationAssertion(obo:NCIT_P108 obo:NCIT_C84336 "Collaborator")
AnnotationAssertion(obo:NCIT_P207 obo:NCIT_C84336 "C2827395")
AnnotationAssertion(oboInOwl:hasExactSynonym obo:NCIT_C84336 "Collaborator")
AnnotationAssertion(rdfs:label obo:NCIT_C84336 "Collaborator")
SubClassOf(obo:NCIT_C84336 obo:NCBITaxon_9606)

# Class: obo:NCIT_C90467 (Test Facility Country)

AnnotationAssertion(obo:IAO_0000115 obo:NCIT_C90467 "The country in which the test is conducted.")
AnnotationAssertion(obo:IAO_0000412 obo:NCIT_C90467 obo:ncit.owl)
AnnotationAssertion(obo:NCIT_NHC0 obo:NCIT_C90467 "C90467")
AnnotationAssertion(obo:NCIT_P106 obo:NCIT_C90467 "Geographic Area")
AnnotationAssertion(obo:NCIT_P108 obo:NCIT_C90467 "Test Facility Country")
AnnotationAssertion(obo:NCIT_P207 obo:NCIT_C90467 "C2983675")
AnnotationAssertion(obo:NCIT_P322 obo:NCIT_C90467 "CDISC")
AnnotationAssertion(obo:NCIT_P325 obo:NCIT_C90467 "The country of the place in which a nonclinical laboratory study takes place, i.e., actually uses the test article in a test system. Testing facility includes any establishment required to register under section 510 of the act that conducts nonclinical laboratory studies and any consulting laboratory described in section 704 of the act that conducts such studies. Testing facility encompasses only those operational units that are being or have been used to conduct nonclinical laboratory studies. (FDA)")
AnnotationAssertion(oboInOwl:hasExactSynonym obo:NCIT_C90467 "TFCNTRY")
AnnotationAssertion(oboInOwl:hasExactSynonym obo:NCIT_C90467 "Test Facility Country")
AnnotationAssertion(oboInOwl:inSubset obo:NCIT_C90467 <http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C61410>)
AnnotationAssertion(oboInOwl:inSubset obo:NCIT_C90467 <http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C77526>)
AnnotationAssertion(oboInOwl:inSubset obo:NCIT_C90467 <http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C90007>)
AnnotationAssertion(oboInOwl:inSubset obo:NCIT_C90467 <http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C90009>)
AnnotationAssertion(rdfs:label obo:NCIT_C90467 "Test Facility Country")
SubClassOf(obo:NCIT_C90467 obo:NCIT_C60776)

# Class: obo:NCIT_C90468 (obo:NCIT_C90468)

SubClassOf(obo:NCIT_C90468 obo:NCIT_C60776)

# Class: obo:NCIT_C90469 (Test Facility Name)

AnnotationAssertion(obo:IAO_0000115 obo:NCIT_C90469 "The name of the place in which a test is conducted.")
AnnotationAssertion(obo:IAO_0000412 obo:NCIT_C90469 obo:ncit.owl)
AnnotationAssertion(obo:NCIT_NHC0 obo:NCIT_C90469 "C90469")
AnnotationAssertion(obo:NCIT_P106 obo:NCIT_C90469 "Intellectual Product")
AnnotationAssertion(obo:NCIT_P108 obo:NCIT_C90469 "Test Facility Name")
AnnotationAssertion(obo:NCIT_P207 obo:NCIT_C90469 "C2983677")
AnnotationAssertion(obo:NCIT_P322 obo:NCIT_C90469 "CDISC")
AnnotationAssertion(obo:NCIT_P325 obo:NCIT_C90469 "The name of the place in which a nonclinical laboratory study takes place, i.e., actually uses the test article in a test system. Testing facility includes any establishment required to register under section 510 of the act that conducts nonclinical laboratory studies and any consulting laboratory described in section 704 of the act that conducts such studies. Testing facility encompasses only those operational units that are being or have been used to conduct nonclinical laboratory studies. (FDA)")
AnnotationAssertion(oboInOwl:hasExactSynonym obo:NCIT_C90469 "TSTFNAM")
AnnotationAssertion(oboInOwl:hasExactSynonym obo:NCIT_C90469 "Test Facility Name")
AnnotationAssertion(oboInOwl:inSubset obo:NCIT_C90469 <http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C61410>)
AnnotationAssertion(oboInOwl:inSubset obo:NCIT_C90469 <http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C77526>)
AnnotationAssertion(oboInOwl:inSubset obo:NCIT_C90469 <http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C90007>)
AnnotationAssertion(oboInOwl:inSubset obo:NCIT_C90469 <http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C90009>)
AnnotationAssertion(rdfs:label obo:NCIT_C90469 "Test Facility Name")
SubClassOf(obo:NCIT_C90469 obo:NCIT_C60776)

# Class: obo:NCIT_C93360 (Study Condition)

AnnotationAssertion(obo:IAO_0000115 obo:NCIT_C93360 "A condition that is a focus of the study.")
AnnotationAssertion(obo:IAO_0000412 obo:NCIT_C93360 obo:ncit.owl)
AnnotationAssertion(obo:NCIT_NHC0 obo:NCIT_C93360 "C93360")
AnnotationAssertion(obo:NCIT_P106 obo:NCIT_C93360 "Qualitative Concept")
AnnotationAssertion(obo:NCIT_P108 obo:NCIT_C93360 "Study Condition")
AnnotationAssertion(obo:NCIT_P207 obo:NCIT_C93360 "C2985574")
AnnotationAssertion(obo:NCIT_P322 obo:NCIT_C93360 "BRIDG")
AnnotationAssertion(obo:NCIT_P325 obo:NCIT_C93360 "A condition that is a focus of the study.")
AnnotationAssertion(oboInOwl:hasExactSynonym obo:NCIT_C93360 "Study Condition")
AnnotationAssertion(oboInOwl:hasExactSynonym obo:NCIT_C93360 "StudyCondition")
AnnotationAssertion(oboInOwl:inSubset obo:NCIT_C93360 <http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C159501>)
AnnotationAssertion(oboInOwl:inSubset obo:NCIT_C93360 <http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C159503>)
AnnotationAssertion(rdfs:label obo:NCIT_C93360 "Study Condition")
SubClassOf(obo:NCIT_C93360 obo:PDRO_0000129)

# Class: obo:NCIT_C98388 (Interventional Study)

AnnotationAssertion(obo:IAO_0000115 obo:NCIT_C98388 "Studies in which individuals are assigned by an investigator based on a protocol to receive specific interventions. Subjects may receive diagnostic, therapeutic or other types of interventions. The assignment of the intervention may or may not be random. The individuals are then followed and biomedical and/or health outcomes are assessed.")
AnnotationAssertion(obo:IAO_0000412 obo:NCIT_C98388 obo:ncit.owl)
AnnotationAssertion(obo:NCIT_NHC0 obo:NCIT_C98388 "C98388")
AnnotationAssertion(obo:NCIT_P106 obo:NCIT_C98388 "Research Activity")
AnnotationAssertion(obo:NCIT_P108 obo:NCIT_C98388 "Interventional Study")
AnnotationAssertion(obo:NCIT_P207 obo:NCIT_C98388 "C3274035")
AnnotationAssertion(obo:NCIT_P322 obo:NCIT_C98388 "CDISC")
AnnotationAssertion(obo:NCIT_P322 obo:NCIT_C98388 "CDISC-GLOSS")
AnnotationAssertion(obo:NCIT_P325 obo:NCIT_C98388 "A trial which intervenes with the inviolability of the trial subject for the purpose of the investigation. For example, the administration of an investigational medical product to the trial subject or use of some extra means of intervention (i.e., samples, tests, or questionnaires) that would not otherwise be used. [Clinical Trial Directive EC/20/2001 definitions]")
AnnotationAssertion(obo:NCIT_P325 obo:NCIT_C98388 "Studies in which individuals are assigned by an investigator based on a protocol to receive specific interventions. Subjects may receive diagnostic, therapeutic or other types of interventions. The assignment of the intervention may or may not be random. The individuals are then followed and biomedical and/or health outcomes are assessed.")
AnnotationAssertion(oboInOwl:hasExactSynonym obo:NCIT_C98388 "INTERVENTIONAL")
AnnotationAssertion(oboInOwl:hasExactSynonym obo:NCIT_C98388 "Interventional Study")
AnnotationAssertion(oboInOwl:hasExactSynonym obo:NCIT_C98388 "interventional clinical trial")
AnnotationAssertion(oboInOwl:inSubset obo:NCIT_C98388 <http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C132298>)
AnnotationAssertion(oboInOwl:inSubset obo:NCIT_C98388 <http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C61410>)
AnnotationAssertion(oboInOwl:inSubset obo:NCIT_C98388 <http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C66830>)
AnnotationAssertion(oboInOwl:inSubset obo:NCIT_C98388 <http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C67497>)
AnnotationAssertion(oboInOwl:inSubset obo:NCIT_C98388 <http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C99077>)
AnnotationAssertion(rdfs:label obo:NCIT_C98388 "Interventional Study")
SubClassOf(obo:NCIT_C98388 obo:OPMI_0000418)

# Class: obo:NCIT_C98714 (Clinical Trial Registry Identifier)

AnnotationAssertion(obo:IAO_0000115 obo:NCIT_C98714 "A sequence of letters, numbers, or other characters that uniquely identifies a clinical trial within a clinical trial registry.")
AnnotationAssertion(obo:IAO_0000412 obo:NCIT_C98714 obo:ncit.owl)
AnnotationAssertion(obo:NCIT_NHC0 obo:NCIT_C98714 "C98714")
AnnotationAssertion(obo:NCIT_P106 obo:NCIT_C98714 "Intellectual Product")
AnnotationAssertion(obo:NCIT_P108 obo:NCIT_C98714 "Clinical Trial Registry Identifier")
AnnotationAssertion(obo:NCIT_P207 obo:NCIT_C98714 "C3274381")
AnnotationAssertion(obo:NCIT_P322 obo:NCIT_C98714 "CDISC")
AnnotationAssertion(obo:NCIT_P325 obo:NCIT_C98714 "Identification numbers assigned to the protocol by clinicaltrials.gov, EudraCT, or other registries.")
AnnotationAssertion(oboInOwl:hasExactSynonym obo:NCIT_C98714 "Clinical Trial Registry Identifier")
AnnotationAssertion(oboInOwl:hasExactSynonym obo:NCIT_C98714 "REGID")
AnnotationAssertion(oboInOwl:hasExactSynonym obo:NCIT_C98714 "Registry Identifier")
AnnotationAssertion(oboInOwl:hasExactSynonym obo:NCIT_C98714 "Trial Identifying Number")
AnnotationAssertion(oboInOwl:inSubset obo:NCIT_C98714 <http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C61410>)
AnnotationAssertion(oboInOwl:inSubset obo:NCIT_C98714 <http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C66738>)
AnnotationAssertion(oboInOwl:inSubset obo:NCIT_C98714 <http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C66830>)
AnnotationAssertion(oboInOwl:inSubset obo:NCIT_C98714 <http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C67152>)
AnnotationAssertion(rdfs:label obo:NCIT_C98714 "Clinical Trial Registry Identifier")
AnnotationAssertion(rdfs:seeAlso obo:NCIT_C98714 "https://www.who.int/ictrp/network/trds/en/")
SubClassOf(obo:NCIT_C98714 obo:IAO_0000578)

# Class: obo:NCIT_C98722 (Expanded Access Study)

AnnotationAssertion(obo:IAO_0000115 obo:NCIT_C98722 "Studies that provide a means for obtaining an experimental drug or device for patients who are not adequately treated by existing therapy, who do not meet the eligibility criteria for enrollment, or who are otherwise unable to participate in another clinical study. Expanded Access studies include individual-patient IND, treatment IND, compassionate use, emergency use or continued access.")
AnnotationAssertion(Annotation(obo:IAO_0000119 "https://prsinfo.clinicaltrials.gov/definitions.html") obo:IAO_0000116 obo:NCIT_C98722 "An investigational drug product (including biological product) available through expanded access for patients who do not qualify for enrollment in a clinical trial. Expanded Access includes all expanded access types under section 561 of the Federal Food, Drug, and Cosmetic Act: (1) for individual patients, including emergency use; (2) for intermediate-size patient populations; and (3) under a treatment IND or treatment protocol.")
AnnotationAssertion(obo:IAO_0000412 obo:NCIT_C98722 obo:ncit.owl)
AnnotationAssertion(obo:NCIT_NHC0 obo:NCIT_C98722 "C98722")
AnnotationAssertion(obo:NCIT_P106 obo:NCIT_C98722 "Research Activity")
AnnotationAssertion(obo:NCIT_P108 obo:NCIT_C98722 "Expanded Access Study")
AnnotationAssertion(obo:NCIT_P207 obo:NCIT_C98722 "C3274389")
AnnotationAssertion(obo:NCIT_P322 obo:NCIT_C98722 "CDISC")
AnnotationAssertion(obo:NCIT_P325 obo:NCIT_C98722 "Studies that provide a means for obtaining an experimental drug or device for patients who are not adequately treated by existing therapy, who do not meet the eligibility criteria for enrollment, or who are otherwise unable to participate in another clinical study. Expanded Access studies include individual-patient IND, treatment IND, compassionate use, emergency use or continued access.")
AnnotationAssertion(oboInOwl:hasExactSynonym obo:NCIT_C98722 "EXPANDED ACCESS")
AnnotationAssertion(oboInOwl:hasExactSynonym obo:NCIT_C98722 "Expanded Access Study")
AnnotationAssertion(oboInOwl:inSubset obo:NCIT_C98722 <http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C132298>)
AnnotationAssertion(oboInOwl:inSubset obo:NCIT_C98722 <http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C61410>)
AnnotationAssertion(oboInOwl:inSubset obo:NCIT_C98722 <http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C66830>)
AnnotationAssertion(oboInOwl:inSubset obo:NCIT_C98722 <http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C99077>)
AnnotationAssertion(rdfs:label obo:NCIT_C98722 "Expanded Access Study")
AnnotationAssertion(rdfs:seeAlso obo:NCIT_C98722 "https://prsinfo.clinicaltrials.gov/expanded_access_definitions.html")
SubClassOf(obo:NCIT_C98722 obo:OPMI_0000418)

# Class: obo:NCIT_C98747 (Intervention Type)

AnnotationAssertion(Annotation(obo:IAO_0000119 "https://prsinfo.clinicaltrials.gov/definitions.html") obo:IAO_0000115 obo:NCIT_C98747 "For each intervention studied in the clinical study, the general type of intervention.")
AnnotationAssertion(obo:IAO_0000115 obo:NCIT_C98747 "The kind of product or procedure studied in a trial.")
AnnotationAssertion(obo:IAO_0000412 obo:NCIT_C98747 obo:ncit.owl)
AnnotationAssertion(obo:NCIT_NHC0 obo:NCIT_C98747 "C98747")
AnnotationAssertion(obo:NCIT_P106 obo:NCIT_C98747 "Functional Concept")
AnnotationAssertion(obo:NCIT_P108 obo:NCIT_C98747 "Intervention Type")
AnnotationAssertion(obo:NCIT_P207 obo:NCIT_C98747 "C3274412")
AnnotationAssertion(obo:NCIT_P322 obo:NCIT_C98747 "CDISC")
AnnotationAssertion(obo:NCIT_P325 obo:NCIT_C98747 "The kind of product or procedure studied in a trial.")
AnnotationAssertion(oboInOwl:hasExactSynonym obo:NCIT_C98747 "INTTYPE")
AnnotationAssertion(oboInOwl:hasExactSynonym obo:NCIT_C98747 "Intervention Type")
AnnotationAssertion(Annotation(rdfs:seeAlso "http://www.icmje.org/recommendations/ 
http://www.who.int/ictrp/network/trds/en/index.html") oboInOwl:hasNarrowSynonym obo:NCIT_C98747 "intervention")
AnnotationAssertion(oboInOwl:inSubset obo:NCIT_C98747 <http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C61410>)
AnnotationAssertion(oboInOwl:inSubset obo:NCIT_C98747 <http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C66738>)
AnnotationAssertion(oboInOwl:inSubset obo:NCIT_C98747 <http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C66830>)
AnnotationAssertion(oboInOwl:inSubset obo:NCIT_C98747 <http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C67152>)
AnnotationAssertion(rdfs:label obo:NCIT_C98747 "Intervention Type")
SubClassOf(obo:NCIT_C98747 obo:OBI_0000011)

# Class: obo:NCIT_C98772 (Primary Outcome Measure)

AnnotationAssertion(obo:IAO_0000115 obo:NCIT_C98772 "The primary measurement(s) or observation(s) used to measure the effect of experimental variables in a study, or for observational studies, to describe patterns of diseases or traits or associations with exposures, risk factors or treatment. These are the outcome measures used to assess the primary objective(s).")
AnnotationAssertion(obo:IAO_0000412 obo:NCIT_C98772 obo:ncit.owl)
AnnotationAssertion(obo:NCIT_NHC0 obo:NCIT_C98772 "C98772")
AnnotationAssertion(obo:NCIT_P106 obo:NCIT_C98772 "Intellectual Product")
AnnotationAssertion(obo:NCIT_P108 obo:NCIT_C98772 "Primary Outcome Measure")
AnnotationAssertion(obo:NCIT_P207 obo:NCIT_C98772 "C3274433")
AnnotationAssertion(obo:NCIT_P322 obo:NCIT_C98772 "CDISC")
AnnotationAssertion(obo:NCIT_P325 obo:NCIT_C98772 "The primary measurement(s) or observation(s) used to measure the effect of experimental variables in a study, or for observational studies, to describe patterns of diseases or traits or associations with exposures, risk factors or treatment. These are the outcome measures used to assess the primary objective(s).")
AnnotationAssertion(oboInOwl:hasExactSynonym obo:NCIT_C98772 "OUTMSPRI")
AnnotationAssertion(oboInOwl:hasExactSynonym obo:NCIT_C98772 "PRIMARY OUTCOME MEASURE")
AnnotationAssertion(oboInOwl:hasExactSynonym obo:NCIT_C98772 "Primary Outcome Measure")
AnnotationAssertion(oboInOwl:inSubset obo:NCIT_C98772 <http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C117745>)
AnnotationAssertion(oboInOwl:inSubset obo:NCIT_C98772 <http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C61410>)
AnnotationAssertion(oboInOwl:inSubset obo:NCIT_C98772 <http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C66738>)
AnnotationAssertion(oboInOwl:inSubset obo:NCIT_C98772 <http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C66830>)
AnnotationAssertion(oboInOwl:inSubset obo:NCIT_C98772 <http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C67152>)
AnnotationAssertion(oboInOwl:inSubset obo:NCIT_C98772 <http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C81222>)
AnnotationAssertion(rdfs:label obo:NCIT_C98772 "Primary Outcome Measure")
SubClassOf(obo:NCIT_C98772 obo:CTO_0000104)

# Class: obo:NCIT_C98781 (Secondary Outcome Measure)

AnnotationAssertion(obo:IAO_0000115 obo:NCIT_C98781 "Other key measures that will be used to evaluate the intervention(s) or, for observational studies, that are a focus of the study. These are the outcome measures used to assess the secondary objective(s).")
AnnotationAssertion(obo:IAO_0000412 obo:NCIT_C98781 obo:ncit.owl)
AnnotationAssertion(obo:NCIT_NHC0 obo:NCIT_C98781 "C98781")
AnnotationAssertion(obo:NCIT_P106 obo:NCIT_C98781 "Intellectual Product")
AnnotationAssertion(obo:NCIT_P108 obo:NCIT_C98781 "Secondary Outcome Measure")
AnnotationAssertion(obo:NCIT_P207 obo:NCIT_C98781 "C3274440")
AnnotationAssertion(obo:NCIT_P322 obo:NCIT_C98781 "CDISC")
AnnotationAssertion(obo:NCIT_P325 obo:NCIT_C98781 "Secondary measures that will be used to evaluate the intervention(s) or, for observational studies, that are a focus of the study. These are the outcome measures used to assess the secondary objective(s).")
AnnotationAssertion(oboInOwl:hasExactSynonym obo:NCIT_C98781 "OUTMSSEC")
AnnotationAssertion(oboInOwl:hasExactSynonym obo:NCIT_C98781 "SECONDARY OUTCOME MEASURE")
AnnotationAssertion(oboInOwl:hasExactSynonym obo:NCIT_C98781 "Secondary Outcome Measure")
AnnotationAssertion(oboInOwl:inSubset obo:NCIT_C98781 <http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C117745>)
AnnotationAssertion(oboInOwl:inSubset obo:NCIT_C98781 <http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C61410>)
AnnotationAssertion(oboInOwl:inSubset obo:NCIT_C98781 <http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C66738>)
AnnotationAssertion(oboInOwl:inSubset obo:NCIT_C98781 <http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C66830>)
AnnotationAssertion(oboInOwl:inSubset obo:NCIT_C98781 <http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C67152>)
AnnotationAssertion(oboInOwl:inSubset obo:NCIT_C98781 <http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C81222>)
AnnotationAssertion(rdfs:label obo:NCIT_C98781 "Secondary Outcome Measure")
SubClassOf(obo:NCIT_C98781 obo:CTO_0000104)

# Class: obo:OAE_0000001 (adverse event)

AnnotationAssertion(Annotation(obo:IAO_0000119 "https://prsinfo.clinicaltrials.gov/results_definitions.html") obo:IAO_0000115 obo:OAE_0000001 "Any untoward or unfavorable medical occurrence in a participant, including any abnormal sign (for example, abnormal physical exam or laboratory finding), symptom, or disease, temporally associated with the participant’s participation in the research, whether or not considered related to the participant’s participation in the research")
AnnotationAssertion(obo:IAO_0000115 obo:OAE_0000001 "a pathological bodily process that occurs after a medical intervention. An adverse event is likely caused by the medical intervention; however, such a causal association is not required to be an adverse event.")
AnnotationAssertion(obo:IAO_0000116 obo:OAE_0000001 "Melanie Courtot and YH: More work is needed on how to restrict the scope of a term to be an 'adverse event', notably regarding temporal association. When is an appropirate time interval between a medical intervention and an adverse event observed? One week, one month, one year, or a lifetime? For some well-studied medical interventions (e.g., administration of many vaccines or drugs), we probably have a general idea. For many new interventions, we don't know much. In OAE, this issue is associated with defining the 'adverse event incubation time'.")
AnnotationAssertion(obo:IAO_0000116 obo:OAE_0000001 "YH: An adverse event is a process that has specified output of some adverse medical outcome (e.g., symptom, sign or accident) after a medical intervention (or process) (e.g., administration of drug or vaccine). The medical intervention can be an administration of a drug, a vaccine (i.e., vaccination), or a special nutritional product (for example, dietary supplement, infant formula, medical food), surgery, or usage of a medical device.")
AnnotationAssertion(obo:IAO_0000116 obo:OAE_0000001 "YH: An adverse event is possibly induced by the medical intervention. It can be caused by the medical intervention, or may not be caused by the medical intervention. One ultimate goal (or the goal in clinics) of study adverse events is to assess if the adverse event outcome is due to the medical intervention.")
AnnotationAssertion(obo:IAO_0000116 obo:OAE_0000001 "YH: In development of OAE, we initially use vaccine adverse event as our use case. A vaccine adverse event is associated with a vaccination (i.e. a medical intervention), regardless of whether it is considered vaccine-related, and includes any side effect, injury, toxicity, or sensitivity reaction or significant failure of immunization (i.e., a pharmacologic action).
Ref: Baylor NW and Midthum K. Regulation and testing of vaccines. In: Vaccines (Editors: Plotkin S, Orenstein W, and Offit P). 2008.  p1623.")
AnnotationAssertion(obo:IAO_0000116 obo:OAE_0000001 "YH: The current term 'adverse event' is different from the term definition shown in our paper: He Y, Xiang Z, Sarntivijai S, Toldo L, Ceusters W. OAE: a realism-based biomedical ontology for the representation of adverse events. Adverse Event Representation Workshop, International Conference on Biomedical Ontologies (ICBO), University at Buffalo, NY, July 26-30, 2011. Full lenghth conference proceeding paper.  

We  made the name changing in order to make OAE cover the broader sense of the 'adverse event' which does not assume definite causal effect between an adverse event and a medical intervention. In current definition, the adverse event emphasizes the time association and assumes a likelihood of such a causal association. This term 'adverse event' is stil under the OGMS:pathological bodily process.

The 'adverse event' defined in the above paper has now been changed to a new term: 'causal adverse event'. See more information in the new publication: Yongqun He Y, Sirarat Sarntivijai, Yu Lin, Zuoshuang Xiang, Abra Guo, Shelley Zhang, Desikan Jagannathan, Luca Toldo, Cui Tao and Barry Smith. OAE: The Ontology of Adverse Events. Journal of Biomedical Semantics. 2014, 5:29  doi:10.1186/2041-1480-5-29. PMID: 25093068.PMCID: PMC4120740.")
AnnotationAssertion(obo:IAO_0000116 obo:OAE_0000001 "YH: The main scope of OAE includes: (1) represent terms and relations in the area of adverse events, (2) assess possible associations between an adverse event and a medical intervention, particularly, identify any causal effect of a medical intervention to an adverse event; and (2) understand the mechanism (including molecular mechanisms) of causal adverse events.")
AnnotationAssertion(obo:IAO_0000116 obo:OAE_0000001 "YH: There has been discussion regarding whether the term 'side effect' is an alternative term for 'adverse event'. In AERO, the term 'AERO:adverse event' represents a subset of those adverse events for which causality has been established. In OAE, an adverse event for which causality has been established is called 'causal adverse event'.")
AnnotationAssertion(obo:IAO_0000117 obo:OAE_0000001 "Yongqun He")
AnnotationAssertion(obo:IAO_0000118 obo:OAE_0000001 "AE")
AnnotationAssertion(obo:IAO_0000118 obo:OAE_0000001 "adverse reaction")
AnnotationAssertion(obo:IAO_0000119 obo:OAE_0000001 "WEB: http://en.wikipedia.org/wiki/Adverse_event")
AnnotationAssertion(obo:IAO_0000119 obo:OAE_0000001 "WEB: http://www.fda.gov/Safety/MedWatch/HowToReport/ucm053087.htm")
AnnotationAssertion(obo:IAO_0000119 obo:OAE_0000001 "WEB: http://www.ncbi.nlm.nih.gov/pubmed/25093068")
AnnotationAssertion(obo:IAO_0000412 obo:OAE_0000001 obo:oae.owl)
AnnotationAssertion(rdfs:comment obo:OAE_0000001 "The OAE official website is: http://www.oae-ontology.org/.")
AnnotationAssertion(rdfs:label obo:OAE_0000001 "adverse event")
SubClassOf(obo:OAE_0000001 obo:OGMS_0000061)
SubClassOf(obo:OAE_0000001 ObjectSomeValuesFrom(obo:BFO_0000062 obo:OAE_0000002))

# Class: obo:OAE_0000002 (medical intervention)

AnnotationAssertion(Annotation(obo:IAO_0000119 "https://www.clinicaltrials.gov/ct2/about-studies/glossary") obo:IAO_0000115 obo:OAE_0000002 "A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.")
AnnotationAssertion(obo:IAO_0000115 obo:OAE_0000002 "medical intervention is a planned process that has the goal of diagnosing, preventing or relieving illness or injury. ")
AnnotationAssertion(obo:IAO_0000116 obo:OAE_0000002 "The act of intervening, interfering or interceding with the intent of modifying the outcome. In medicine, an intervention is usually undertaken to help treat or cure a condition. For example, \"Acupuncture as a therapeutic intervention is widely practiced in the United States,\"
Reference:
http://www.medterms.com/script/main/art.asp?articlekey=34214 . Some interventions can be used for diagnosis. ")
AnnotationAssertion(obo:IAO_0000116 obo:OAE_0000002 "The act of intervening, interfering or interceding with the intent of modifying the outcome. In medicine, an intervention is usually undertaken to help treat or cure a condition. For example, \"Acupuncture as a therapeutic intervention is widely practiced in the United States,\" 
Reference:
http://www.medterms.com/script/main/art.asp?articlekey=34214 . Some interventions can be used for diagnosis. ")
AnnotationAssertion(obo:IAO_0000117 obo:OAE_0000002 "YH")
AnnotationAssertion(obo:IAO_0000119 obo:OAE_0000002 "WEB: http://wiki.answers.com/Q/What_is_medical_intervention")
AnnotationAssertion(obo:IAO_0000412 obo:OAE_0000002 obo:oae.owl)
AnnotationAssertion(obo:IAO_0000412 obo:OAE_0000002 obo:omrse.owl)
AnnotationAssertion(obo:IAO_0000412 obo:OAE_0000002 obo:opmi.owl)
AnnotationAssertion(Annotation(rdfs:seeAlso "http://www.icmje.org/recommendations/ 
http://www.who.int/ictrp/network/trds/en/index.html") oboInOwl:hasExactSynonym obo:OAE_0000002 "Intervention(s)")
AnnotationAssertion(rdfs:label obo:OAE_0000002 "medical intervention")
AnnotationAssertion(rdfs:seeAlso obo:OAE_0000002 "https://prsinfo.clinicaltrials.gov/definitions.html")
SubClassOf(obo:OAE_0000002 obo:OBI_0000011)

# Class: obo:OAE_0000011 (drug administration)

AnnotationAssertion(obo:IAO_0000115 obo:OAE_0000011 "a medical intervention where a patient is administered with a drug")
AnnotationAssertion(obo:IAO_0000117 obo:OAE_0000011 "YH")
AnnotationAssertion(obo:IAO_0000412 obo:OAE_0000011 obo:oae.owl)
AnnotationAssertion(rdfs:label obo:OAE_0000011 "drug administration")
SubClassOf(obo:OAE_0000011 obo:OAE_0000002)

# Class: obo:OAE_0000094 (therapeutic intervention)

AnnotationAssertion(obo:IAO_0000115 obo:OAE_0000094 "a medical intervention that is used for therapeutic purpose")
AnnotationAssertion(obo:IAO_0000117 obo:OAE_0000094 "YH")
AnnotationAssertion(obo:IAO_0000412 obo:OAE_0000094 obo:oae.owl)
AnnotationAssertion(rdfs:label obo:OAE_0000094 "therapeutic intervention")
SubClassOf(obo:OAE_0000094 obo:OAE_0000002)

# Class: obo:OAE_0002807 (medical procedure)

AnnotationAssertion(obo:IAO_0000115 obo:OAE_0002807 "a medical intervention that refers to any series of pre-defined steps that should be followed to achieve a desired result.")
AnnotationAssertion(obo:IAO_0000117 obo:OAE_0002807 "YH, SS")
AnnotationAssertion(obo:IAO_0000119 obo:OAE_0002807 "WEB: http://www.wisegeekhealth.com/what-is-the-difference-between-a-surgery-and-a-procedure.htm")
AnnotationAssertion(obo:IAO_0000412 obo:OAE_0002807 obo:oae.owl)
AnnotationAssertion(rdfs:label obo:OAE_0002807 "medical procedure"@en)
SubClassOf(obo:OAE_0002807 obo:OAE_0000002)

# Class: obo:OBI_0000011 (planned process)

AnnotationAssertion(obo:IAO_0000111 obo:OBI_0000011 "planned process")
AnnotationAssertion(obo:IAO_0000111 obo:OBI_0000011 "planned process"@en)
AnnotationAssertion(obo:IAO_0000112 obo:OBI_0000011 "Injecting mice with a vaccine in order to test its efficacy")
AnnotationAssertion(obo:IAO_0000114 obo:OBI_0000011 obo:IAO_0000122)
AnnotationAssertion(obo:IAO_0000115 obo:OBI_0000011 "A processual entity that realizes a plan which is the concretization of a plan specification."@en)
AnnotationAssertion(obo:IAO_0000116 obo:OBI_0000011 "'Plan' includes a future direction sense. That can be problematic if plans are changed during their execution. There are however implicit contingencies for protocols that an agent has in his mind that can be considered part of the plan, even if the agent didn't have them in mind before. Therefore, a planned process can diverge from what the agent would have said the plan was before executing it, by adjusting to problems encountered during execution (e.g. choosing another reagent with equivalent properties, if the originally planned one has run out.)")
AnnotationAssertion(obo:IAO_0000116 obo:OBI_0000011 "We are only considering successfully completed planned processes. A plan may be modified, and details added during execution. For a given planned process, the associated realized plan specification is the one encompassing all changes made during execution. This means that all processes in which an agent acts towards achieving some
objectives is a planned process.")
AnnotationAssertion(obo:IAO_0000116 obo:OBI_0000011 "We are only considering successfully completed planned processes. A plan may be modified, and details added during execution. For a given planned process, the associated realized plan specification is the one encompassing all changes made during execution. This means that all processes in which an agent acts towards achieving some 
objectives is a planned process.")
AnnotationAssertion(obo:IAO_0000117 obo:OBI_0000011 "Bjoern Peters")
AnnotationAssertion(obo:IAO_0000119 obo:OBI_0000011 "branch derived")
AnnotationAssertion(obo:IAO_0000232 obo:OBI_0000011 "6/11/9: Edited at workshop. Used to include: is initiated by an agent")
AnnotationAssertion(obo:IAO_0000232 obo:OBI_0000011 "This class merges the previously separated objective driven process and planned process, as they the separation proved hard to maintain. (1/22/09, branch call)"@en)
AnnotationAssertion(obo:IAO_0000412 obo:OBI_0000011 obo:dron.owl)
AnnotationAssertion(obo:IAO_0000412 obo:OBI_0000011 obo:envo.owl)
AnnotationAssertion(obo:IAO_0000412 obo:OBI_0000011 obo:ico.owl)
AnnotationAssertion(obo:IAO_0000412 obo:OBI_0000011 obo:oae.owl)
AnnotationAssertion(obo:IAO_0000412 obo:OBI_0000011 obo:obi.owl)
AnnotationAssertion(obo:IAO_0000412 obo:OBI_0000011 obo:omrse.owl)
AnnotationAssertion(obo:IAO_0000412 obo:OBI_0000011 obo:opmi.owl)
AnnotationAssertion(obo:IAO_0000412 obo:OBI_0000011 obo:vo.owl)
AnnotationAssertion(obo:IAO_0000412 obo:OBI_0000011 "http://purl.obolibrary.org/obo/obi.owl")
AnnotationAssertion(rdfs:label obo:OBI_0000011 "planned process")
AnnotationAssertion(rdfs:label obo:OBI_0000011 "planned process"@en)
EquivalentClasses(obo:OBI_0000011 ObjectSomeValuesFrom(obo:BFO_0000055 ObjectSomeValuesFrom(obo:RO_0000059 obo:IAO_0000104)))
SubClassOf(obo:OBI_0000011 obo:BFO_0000015)

# Class: obo:OBI_0000066 (investigation)

AnnotationAssertion(obo:IAO_0000111 obo:OBI_0000066 "investigation"@en)
AnnotationAssertion(obo:IAO_0000112 obo:OBI_0000066 "Lung cancer investigation using expression profiling, a stem cell transplant investigation, biobanking is not an investigation, though it may be part of an investigation")
AnnotationAssertion(obo:IAO_0000114 obo:OBI_0000066 obo:IAO_0000122)
AnnotationAssertion(obo:IAO_0000115 obo:OBI_0000066 "a planned process that consists of parts: planning, study design execution, documentation and which produce conclusion(s)."@en)
AnnotationAssertion(obo:IAO_0000117 obo:OBI_0000066 "Bjoern Peters"@en)
AnnotationAssertion(obo:IAO_0000119 obo:OBI_0000066 "OBI branch derived"@en)
AnnotationAssertion(obo:IAO_0000232 obo:OBI_0000066 "Could add specific objective specification")
AnnotationAssertion(obo:IAO_0000232 obo:OBI_0000066 "Following OBI call November 2012,26th: it was decided there was no need for adding \"achieves objective of drawing conclusion\" as existing relations were providing equivalent ability. this note closes the issue and validates the class definition to be part of the OBI core
editor = PRS"@en)
AnnotationAssertion(obo:IAO_0000412 obo:OBI_0000066 obo:obi.owl)
AnnotationAssertion(obo:IAO_0000412 obo:OBI_0000066 obo:opmi.owl)
AnnotationAssertion(obo:OBI_0001847 obo:OBI_0000066 "study")
AnnotationAssertion(rdfs:label obo:OBI_0000066 "investigation"@en)
SubClassOf(obo:OBI_0000066 obo:OBI_0000011)

# Class: obo:OBI_0000070 (assay)

AnnotationAssertion(obo:IAO_0000111 obo:OBI_0000070 "assay"@en)
AnnotationAssertion(obo:IAO_0000112 obo:OBI_0000070 "Assay the wavelength of light emitted by excited Neon atoms. Count of geese flying over a house.")
AnnotationAssertion(obo:IAO_0000114 obo:OBI_0000070 obo:IAO_0000122)
AnnotationAssertion(obo:IAO_0000115 obo:OBI_0000070 "A planned process with the objective to produce information about the material entity that is the evaluant, by physically examining it or its proxies."@en)
AnnotationAssertion(obo:IAO_0000116 obo:OBI_0000070 "12/3/12: BP: the reference to the 'physical examination' is included to point out that a prediction is not an assay, as that does not require physical examiniation. ")
AnnotationAssertion(obo:IAO_0000117 obo:OBI_0000070 "PlanAndPlannedProcess Branch"@en)
AnnotationAssertion(obo:IAO_0000118 obo:OBI_0000070 "measuring"@en)
AnnotationAssertion(obo:IAO_0000118 obo:OBI_0000070 "scientific observation"@en)
AnnotationAssertion(obo:IAO_0000119 obo:OBI_0000070 "OBI branch derived"@en)
AnnotationAssertion(obo:IAO_0000412 obo:OBI_0000070 obo:obi.owl)
AnnotationAssertion(obo:OBI_0001847 obo:OBI_0000070 "study assay")
AnnotationAssertion(obo:OBI_9991118 obo:OBI_0000070 "any method")
AnnotationAssertion(rdfs:label obo:OBI_0000070 "assay"@en)
SubClassOf(obo:OBI_0000070 obo:OBI_0000011)

# Class: obo:OBI_0000102 (responsible party role)

AnnotationAssertion(obo:IAO_0000111 obo:OBI_0000102 "responsible party role")
AnnotationAssertion(obo:IAO_0000112 obo:OBI_0000102 "he THERAPIST has the ability to print a separate statement for the patient and each responsible party. http://www.beaverlog.com/therapist/ez_support/billing/responsible_party_statements.htm"@en)
AnnotationAssertion(obo:IAO_0000114 obo:OBI_0000102 obo:IAO_0000120)
AnnotationAssertion(obo:IAO_0000115 obo:OBI_0000102 "a study personnel role played by a party who is accountable for the execution of a study component and can make decisions about the conduct of the study"@en)
AnnotationAssertion(obo:IAO_0000117 obo:OBI_0000102 "Person: Jennifer Fostel"@en)
AnnotationAssertion(obo:IAO_0000118 obo:OBI_0000102 "responsible party")
AnnotationAssertion(obo:IAO_0000119 obo:OBI_0000102 "OBI"@en)
AnnotationAssertion(obo:IAO_0000412 obo:OBI_0000102 obo:obi.owl)
AnnotationAssertion(rdfs:label obo:OBI_0000102 "responsible party role"@en)
SubClassOf(obo:OBI_0000102 obo:OBI_0000202)

# Class: obo:OBI_0000115 (intervention design)

AnnotationAssertion(obo:IAO_0000111 obo:OBI_0000115 "intervention design")
AnnotationAssertion(obo:IAO_0000112 obo:OBI_0000115 "PMID: 18208636.Br J Nutr. 2008 Jan 22;:1-11.Effect of vitamin D supplementation on bone and vitamin D status among Pakistani immigrants in Denmark: a randomised double-blinded placebo-controlled intervention study.")
AnnotationAssertion(obo:IAO_0000114 obo:OBI_0000115 obo:IAO_0000125)
AnnotationAssertion(Annotation(obo:IAO_0000119 "https://prsinfo.clinicaltrials.gov/definitions.html") obo:IAO_0000115 obo:OBI_0000115 "A description of the manner in which the clinical trial will be conducted.")
AnnotationAssertion(obo:IAO_0000115 obo:OBI_0000115 "An intervention design is a study design in which a controlled process applied to the subjects (the intervention) serves as the independent variable manipulated by the experimentalist. The treatment (perturbation or intervention) defined can be defined as a combination of values taken by independent variable manipulated by the experimentalists are applied to the recruited subjects assigned (possibly by applying specific methods) to treatment groups. The specificity of intervention design is the fact that independent variables are being manipulated and a response of the biological system is evaluated via response variables as monitored by possibly a series of assays.")
AnnotationAssertion(obo:IAO_0000117 obo:OBI_0000115 "Philppe Rocca-Serra")
AnnotationAssertion(obo:IAO_0000119 obo:OBI_0000115 "OBI branch derived")
AnnotationAssertion(obo:IAO_0000412 obo:OBI_0000115 obo:obi.owl)
AnnotationAssertion(oboInOwl:hasExactSynonym obo:OBI_0000115 "Interventional Study Design")
AnnotationAssertion(oboInOwl:hasExactSynonym obo:OBI_0000115 "intervention model")
AnnotationAssertion(rdfs:label obo:OBI_0000115 "intervention design")
SubClassOf(obo:OBI_0000115 obo:OBI_0500000)

# Class: obo:OBI_0000202 (investigation agent role)

AnnotationAssertion(obo:IAO_0000111 obo:OBI_0000202 "investigation agent role")
AnnotationAssertion(obo:IAO_0000112 obo:OBI_0000202 "The person perform microarray experiments and submit microarray results (including raw data, processed data) with experiment description to ArrayExpress."@en)
AnnotationAssertion(obo:IAO_0000114 obo:OBI_0000202 obo:IAO_0000122)
AnnotationAssertion(obo:IAO_0000115 obo:OBI_0000202 "A role borne by an entity and that is realized in a process that is part of an investigation in which an objective is achieved. These processes include, among others: planning, overseeing, funding, reviewing."@en)
AnnotationAssertion(obo:IAO_0000116 obo:OBI_0000202 "Implementing a study means carrying out or performing the study and providing reagents or other materials used in the study and other tasks without which the study would not happen.")
AnnotationAssertion(obo:IAO_0000116 obo:OBI_0000202 "Philly2013: Historically, this role would have been borne only by humans or organizations. However, we now also want to enable representing investigations run by robot scientists such as ADAM (King et al, Science, 2009)")
AnnotationAssertion(obo:IAO_0000117 obo:OBI_0000202 "GROUP:  Role Branch"@en)
AnnotationAssertion(obo:IAO_0000118 obo:OBI_0000202 "investigator")
AnnotationAssertion(obo:IAO_0000119 obo:OBI_0000202 "OBI"@en)
AnnotationAssertion(obo:IAO_0000232 obo:OBI_0000202 "Feb 10, 2009.  changes after discussion at OBI Consortium Workshop Feb 2-6, 2009.  accepted as core term.")
AnnotationAssertion(obo:IAO_0000412 obo:OBI_0000202 obo:obi.owl)
AnnotationAssertion(obo:IAO_0000412 obo:OBI_0000202 obo:opmi.owl)
AnnotationAssertion(obo:OBI_0001847 obo:OBI_0000202 "study person role")
AnnotationAssertion(rdfs:comment obo:OBI_0000202 "Philly2013: Historically, this role would have been borne only by humans or organizations. However, we now also want to enable investigations run by robot scientists such as ADAM (King et al, Science, 2009)")
AnnotationAssertion(rdfs:label obo:OBI_0000202 "investigation agent role")
SubClassOf(obo:OBI_0000202 obo:BFO_0000023)

# Class: obo:OBI_0000243 (sponsor role)

AnnotationAssertion(obo:IAO_0000111 obo:OBI_0000243 "sponsor role"@en)
AnnotationAssertion(obo:IAO_0000114 obo:OBI_0000243 obo:IAO_0000120)
AnnotationAssertion(obo:IAO_0000115 obo:OBI_0000243 "a responsible party role involved with any of the following activities:  initiating, managing and funding a study"@en)
AnnotationAssertion(obo:IAO_0000117 obo:OBI_0000243 "Person: Jennifer Fostel"@en)
AnnotationAssertion(obo:IAO_0000118 obo:OBI_0000243 "sponsor")
AnnotationAssertion(obo:IAO_0000232 obo:OBI_0000243 "CDISC definition: sponsor. 1. An individual, company, institution, or organization that takes responsibility for the initiation, management, and/or financing of a clinical trial. 2. A corporation or agency whose employees conduct the investigation is considered a sponsor; employees are considered investigators"@en)
AnnotationAssertion(obo:IAO_0000412 obo:OBI_0000243 obo:obi.owl)
AnnotationAssertion(obo:IAO_0000412 obo:OBI_0000243 obo:opmi.owl)
AnnotationAssertion(rdfs:label obo:OBI_0000243 "sponsor role"@en)
SubClassOf(obo:OBI_0000243 obo:OBI_0000102)

# Class: obo:OBI_0000245 (organization)

AnnotationAssertion(obo:IAO_0000111 obo:OBI_0000245 "organization"@en)
AnnotationAssertion(obo:IAO_0000112 obo:OBI_0000245 "PMID: 16353909.AAPS J. 2005 Sep 22;7(2):E274-80. Review. The joint food and agriculture organization of the United Nations/World Health Organization Expert Committee on Food Additives and its role in the evaluation of the safety of veterinary drug residues in foods."@en)
AnnotationAssertion(obo:IAO_0000114 obo:OBI_0000245 obo:IAO_0000122)
AnnotationAssertion(obo:IAO_0000115 obo:OBI_0000245 "An entity that can bear roles, has members, and has a set of organization rules. Members of organizations are either organizations themselves or individual people. Members can bear specific organization member roles that are determined in the organization rules. The organization rules also determine how decisions are made on behalf of the organization by the organization members."@en)
AnnotationAssertion(obo:IAO_0000116 obo:OBI_0000245 "BP: The definition summarizes long email discussions on the OBI developer, roles, biomaterial and denrie branches. It leaves open if an organization is a material entity or a dependent continuant, as no consensus was reached on that.  The current placement as material is therefore temporary, in order to move forward with development. Here is the entire email summary, on which the definition is based:

1) there are organization_member_roles (president, treasurer, branch
editor), with individual persons as bearers

2) there are organization_roles (employer, owner, vendor, patent holder)

3) an organization has a charter / rules / bylaws, which specify what roles
there are, how they should be realized, and how to modify the
charter/rules/bylaws themselves.

It is debatable what the organization itself is (some kind of dependent
continuant or an aggregate of people). This also determines who/what the
bearer of organization_roles' are. My personal favorite is still to define
organization as a kind of 'legal entity', but thinking it through leads to
all kinds of questions that are clearly outside the scope of OBI.

Interestingly enough, it does not seem to matter much where we place
organization itself, as long as we can subclass it (University, Corporation,
Government Agency, Hospital), instantiate it (Affymetrix, NCBI, NIH, ISO,
W3C, University of Oklahoma), and have it play roles.

This leads to my proposal: We define organization through the statements 1 -
3 above, but without an 'is a' statement for now. We can leave it in its
current place in the is_a hierarchy (material entity) or move it up to
'continuant'. We leave further clarifications to BFO, and close this issue
for now."@en)
AnnotationAssertion(obo:IAO_0000117 obo:OBI_0000245 "PERSON: Alan Ruttenberg")
AnnotationAssertion(obo:IAO_0000117 obo:OBI_0000245 "PERSON: Bjoern Peters")
AnnotationAssertion(obo:IAO_0000117 obo:OBI_0000245 "PERSON: Philippe Rocca-Serra")
AnnotationAssertion(obo:IAO_0000117 obo:OBI_0000245 "PERSON: Susanna Sansone")
AnnotationAssertion(obo:IAO_0000119 obo:OBI_0000245 "GROUP: OBI")
AnnotationAssertion(obo:IAO_0000412 obo:OBI_0000245 obo:obi.owl)
AnnotationAssertion(rdfs:label obo:OBI_0000245 "organization"@en)
SubClassOf(obo:OBI_0000245 obo:BFO_0000040)

# Class: obo:OBI_0000272 (protocol)

AnnotationAssertion(obo:IAO_0000111 obo:OBI_0000272 "protocol"@en)
AnnotationAssertion(obo:IAO_0000112 obo:OBI_0000272 "PCR protocol, has objective specification, amplify DNA fragment of interest, and has action specification describes the amounts of experimental reagents used (e..g. buffers, dNTPS, enzyme), and the temperature and cycle time settings for running the PCR."@en)
AnnotationAssertion(obo:IAO_0000114 obo:OBI_0000272 obo:IAO_0000122)
AnnotationAssertion(obo:IAO_0000115 obo:OBI_0000272 "A plan specification which has sufficient level of detail and quantitative information to communicate it between investigation agents, so that different investigation agents will reliably be able to independently reproduce the process."@en)
AnnotationAssertion(obo:IAO_0000117 obo:OBI_0000272 "PlanAndPlannedProcess Branch"@en)
AnnotationAssertion(obo:IAO_0000119 obo:OBI_0000272 "OBI branch derived + wikipedia (http://en.wikipedia.org/wiki/Protocol_%28natural_sciences%29)"@en)
AnnotationAssertion(obo:IAO_0000412 obo:OBI_0000272 obo:obi.owl)
AnnotationAssertion(obo:OBI_0001847 obo:OBI_0000272 "study protocol")
AnnotationAssertion(rdfs:label obo:OBI_0000272 "protocol"@en)
SubClassOf(obo:OBI_0000272 obo:IAO_0000104)

# Class: obo:OBI_0000810 (informed consent process)

AnnotationAssertion(obo:IAO_0000111 obo:OBI_0000810 "informed consent process")
AnnotationAssertion(obo:IAO_0000114 obo:OBI_0000810 obo:IAO_0000122)
AnnotationAssertion(obo:IAO_0000115 obo:OBI_0000810 "A planned process in which a person or their legal representative is informed about key facts about potential risks and benefits of a process and makes a documented decision as to whether the person in question will participate.")
AnnotationAssertion(obo:IAO_0000116 obo:OBI_0000810 "09/28/2009 Alan Ruttenberg: This is made a subclass of the higher level processual entity in BFO because I don't want to take a stand on whether it is a process aggregate. Analogous to the situation with Material entity.")
AnnotationAssertion(obo:IAO_0000117 obo:OBI_0000810 "Person:Alan Ruttenberg")
AnnotationAssertion(obo:IAO_0000119 obo:OBI_0000810 "http://clinicaltrials.gov/ct2/info/glossary#informed")
AnnotationAssertion(obo:IAO_0000232 obo:OBI_0000810 "2009/09/28 Alan Ruttenberg. Fucoidan-use-case")
AnnotationAssertion(obo:IAO_0000412 obo:OBI_0000810 obo:obi.owl)
AnnotationAssertion(rdfs:label obo:OBI_0000810 "informed consent process")
SubClassOf(obo:OBI_0000810 obo:OBI_0000011)
SubClassOf(obo:OBI_0000810 ObjectSomeValuesFrom(obo:OBI_0000293 obo:NCBITaxon_9606))
SubClassOf(obo:OBI_0000810 ObjectSomeValuesFrom(obo:RO_0000057 ObjectSomeValuesFrom(obo:RO_0000087 obo:OBI_0000202)))

# Class: obo:OBI_0000968 (device)

AnnotationAssertion(obo:IAO_0000111 obo:OBI_0000968 "device")
AnnotationAssertion(obo:IAO_0000112 obo:OBI_0000968 "A voltmeter is a measurement device which is intended to perform some measure function.")
AnnotationAssertion(obo:IAO_0000112 obo:OBI_0000968 "An autoclave is a device that sterlizes instruments or contaminated waste by applying high temperature and pressure.")
AnnotationAssertion(obo:IAO_0000114 obo:OBI_0000968 obo:IAO_0000122)
AnnotationAssertion(obo:IAO_0000115 obo:OBI_0000968 "A material entity that is designed to perform a function in a scientific investigation, but is not a reagent.")
AnnotationAssertion(obo:IAO_0000116 obo:OBI_0000968 "2012-12-17 JAO: In common lab usage, there is a distinction made between devices and reagents that is difficult to model. Therefore we have chosen to specifically exclude reagents from the definition of \"device\", and are enumerating the types of roles that a reagent can perform.

2013-6-5 MHB: The following clarifications are outcomes of the May 2013 Philly Workshop. Reagents are distinguished from devices that also participate in scientific techniques by the fact that reagents are chemical or biological in nature and necessarily participate in some chemical interaction or reaction during the realization of their experimental role. By contrast, devices do not participate in such chemical reactions/interactions.  Note that there are cases where devices use reagent components during their operation, where the reagent-device distinction is less clear.  For example:

(1) An HPLC machine is considered a device, but has a column that holds a stationary phase resin as an operational component.  This resin qualifies as a device if it participates purely in size exclusion, but bears a reagent role that is realized in the running of a column if it interacts electrostatically or chemically with the evaluant. The container the resin is in (“the column”) considered alone is a device. So the entire column as well as the entire HPLC machine are devices that have a reagent as an operating part.

(2) A pH meter is a device, but its electrode component bears a reagent role in virtue of its interacting directly with the evaluant in execution of an assay.

(3) A gel running  box  is a device that has a metallic lead as a component that participates in a chemical reaction with the running buffer when a charge is passed through it.  This metallic lead is considered to have a reagent role as a component of this device realized in the running of a gel.

In the examples above, a reagent is an operational component of a device, but the device itself does not realize a reagent role (as bearing a reagent role is not transitive across the part_of relation).  In this way, the asserted disjointness between a reagent and device holds, as both roles are never realized in the same bearer during execution of an assay.  ")
AnnotationAssertion(obo:IAO_0000117 obo:OBI_0000968 "PERSON: Helen Parkinson")
AnnotationAssertion(obo:IAO_0000118 obo:OBI_0000968 "instrument")
AnnotationAssertion(obo:IAO_0000119 obo:OBI_0000968 "OBI development call 2012-12-17.")
AnnotationAssertion(obo:IAO_0000412 obo:OBI_0000968 obo:obi.owl)
AnnotationAssertion(rdfs:label obo:OBI_0000968 "device")
SubClassOf(obo:OBI_0000968 obo:BFO_0000040)

# Class: obo:OBI_0001627 (country name)

AnnotationAssertion(obo:IAO_0000111 obo:OBI_0001627 "country name"@en)
AnnotationAssertion(obo:IAO_0000114 obo:OBI_0001627 obo:IAO_0000120)
AnnotationAssertion(obo:IAO_0000115 obo:OBI_0001627 "A textual entity that denotes a geographic location that is a site or part of a site that is identified as a country in the political geography."@en)
AnnotationAssertion(obo:IAO_0000117 obo:OBI_0001627 "Person: Chris Stoeckert, Jie Zheng"@en)
AnnotationAssertion(obo:IAO_0000119 obo:OBI_0001627 "NIAID GSCID-BRC metadata working group"@en)
AnnotationAssertion(obo:IAO_0000119 obo:OBI_0001627 "Website: http://en.wikipedia.org/wiki/Country"@en)
AnnotationAssertion(obo:IAO_0000412 obo:OBI_0001627 obo:obi.owl)
AnnotationAssertion(obo:OBI_0001886 obo:OBI_0001627 "Specimen Collection Location - Country")
AnnotationAssertion(dc:source obo:OBI_0001627 "NIAID GSCID-BRC")
AnnotationAssertion(rdfs:label obo:OBI_0001627 "country name"@en)
SubClassOf(obo:OBI_0001627 obo:IAO_0000300)

# Class: obo:OBI_0001755 (selection criterion)

AnnotationAssertion(obo:IAO_0000111 obo:OBI_0001755 "selection criterion"@en)
AnnotationAssertion(obo:IAO_0000112 obo:OBI_0001755 "rats should be aged between 6 and 8 weeks and weight between 180-250grams"@en)
AnnotationAssertion(obo:IAO_0000114 obo:OBI_0001755 obo:IAO_0000122)
AnnotationAssertion(obo:IAO_0000115 obo:OBI_0001755 "A directive information entity which defines and states a principle of standard by which selection process may take place."@en)
AnnotationAssertion(obo:IAO_0000117 obo:OBI_0001755 "Person: Philippe Rocca-Serra"@en)
AnnotationAssertion(obo:IAO_0000118 obo:OBI_0001755 "selection rule"@en)
AnnotationAssertion(obo:IAO_0000119 obo:OBI_0001755 "OBI discussion summarized under the following tracker item : http://sourceforge.net/p/obi/obi-terms/678/"@en)
AnnotationAssertion(obo:IAO_0000412 obo:OBI_0001755 obo:obi.owl)
AnnotationAssertion(rdfs:label obo:OBI_0001755 "selection criterion"@en)
SubClassOf(obo:OBI_0001755 obo:IAO_0000033)

# Class: obo:OBI_0001928 (selection)

AnnotationAssertion(obo:IAO_0000111 obo:OBI_0001928 "selection"@en)
AnnotationAssertion(obo:IAO_0000112 obo:OBI_0001928 "PMID: 24023800.  In this study, a set of eleven genes (VATP16, 60 S, UQCC, SMD3, EF1α, UBQ, SAND, GAPDH, ACT, PsaB, PTB2) was evaluated to identify reference genes during the first hours of interaction (6, 12, 18 and 24 hpi) between two V. vinifera genotypes and P. viticola. Two analyses were used for the selection of reference genes: direct comparison of susceptible, Trincadeira, and resistant, Regent, V. vinifera cultivars at 0 h, 6, 12, 18 and 24 hours post inoculation with P. viticola (genotype effect); and comparison of each genotype with mock inoculated samples during inoculation time-course (biotic stress effect). Three statistical methods were used, GeNorm, NormFinder, and BestKeeper, allowing to identify UBQ, EF1α and GAPDH as the most stable genes for the genotype effect."@en)
AnnotationAssertion(obo:IAO_0000114 obo:OBI_0001928 obo:IAO_0000122)
AnnotationAssertion(obo:IAO_0000115 obo:OBI_0001928 "A planned process which results in the creation of group of entity from a larger group by the application of predefined criteria."@en)
AnnotationAssertion(obo:IAO_0000116 obo:OBI_0001928 "this term refers to  a planned process and therefore is distinct from the notion of 'natural selection', a process covering the operation of natural causes by which those individuals of a species that are best adapted to the environment tend to be preserved and to transmit their characters, while those less adapted die out, so that in the course of generations the degree of adaptation to the environment tends progressively to increase. (as defined by Oxford English Dictionary)"@en)
AnnotationAssertion(obo:IAO_0000117 obo:OBI_0001928 "Person: Philippe Rocca-Serra"@en)
AnnotationAssertion(obo:IAO_0000118 obo:OBI_0001928 "selection process"@en)
AnnotationAssertion(obo:IAO_0000119 obo:OBI_0001928 "OBI"@en)
AnnotationAssertion(obo:IAO_0000412 obo:OBI_0001928 obo:obi.owl)
AnnotationAssertion(rdfs:label obo:OBI_0001928 "selection"@en)
SubClassOf(obo:OBI_0001928 obo:OBI_0000011)

# Class: obo:OBI_0001933 (value specification)

AnnotationAssertion(obo:IAO_0000111 obo:OBI_0001933 "value specification")
AnnotationAssertion(obo:IAO_0000112 obo:OBI_0001933 "The value of 'positive' in a classification scheme of \"positive or negative\"; the value of '20g' on the quantitative scale of mass.")
AnnotationAssertion(obo:IAO_0000114 obo:OBI_0001933 obo:IAO_0000122)
AnnotationAssertion(obo:IAO_0000115 obo:OBI_0001933 "An information content entity that specifies a value within a classification scheme or on a quantitative scale.")
AnnotationAssertion(obo:IAO_0000116 obo:OBI_0001933 "This term is currently a descendant of 'information content entity', which requires that it 'is about' something. A value specification of '20g' for a measurement data item of the mass of a particular mouse 'is about' the mass of that mouse. However there are cases where a value specification is not clearly about any particular. In the future we may change 'value specification' to remove the 'is about' requirement.")
AnnotationAssertion(obo:IAO_0000117 obo:OBI_0001933 "PERSON:Bjoern Peters")
AnnotationAssertion(obo:IAO_0000412 obo:OBI_0001933 obo:obi.owl)
AnnotationAssertion(rdfs:label obo:OBI_0001933 "value specification")
SubClassOf(obo:OBI_0001933 obo:IAO_0000030)

# Class: obo:OBI_0002555 (age group inclusion criterion)

AnnotationAssertion(obo:IAO_0000111 obo:OBI_0002555 "age group inclusion criterion"@en)
AnnotationAssertion(obo:IAO_0000112 obo:OBI_0002555 "\"18-33 years old\""@en)
AnnotationAssertion(obo:IAO_0000114 obo:OBI_0002555 obo:IAO_0000123)
AnnotationAssertion(Annotation(obo:IAO_0000119 "https://clinicaltrials.gov/ct2/about-studies/glossary") obo:IAO_0000115 obo:OBI_0002555 "A type of eligibility criteria that indicates the age a person must be to participate in a clinical study. This may be indicated by a specific age or the following age groups. The age groups are: Child (birth-17), Adult (18-64), Older Adult (65+).")
AnnotationAssertion(obo:IAO_0000115 obo:OBI_0002555 "An inclusion criterion that defines and states an age bracket which, if met, makes an entity suitable for a given task or participation in a given process.")
AnnotationAssertion(obo:IAO_0000117 obo:OBI_0002555 "Mathias Brochhausen")
AnnotationAssertion(obo:IAO_0000233 obo:OBI_0002555 "#839")
AnnotationAssertion(obo:IAO_0000412 obo:OBI_0002555 obo:obi.owl)
AnnotationAssertion(oboInOwl:hasExactSynonym obo:OBI_0002555 "ages eligible for study")
AnnotationAssertion(rdfs:label obo:OBI_0002555 "age group inclusion criterion"@en)
AnnotationAssertion(rdfs:seeAlso obo:OBI_0002555 "https://www.who.int/ictrp/network/trds/en/")
SubClassOf(obo:OBI_0002555 obo:OBI_0500027)
SubClassOf(obo:OBI_0002555 ObjectIntersectionOf(ObjectSomeValuesFrom(obo:BFO_0000051 obo:OBI_0002556) ObjectSomeValuesFrom(obo:BFO_0000051 obo:OBI_0002557)))

# Class: obo:OBI_0002556 (minimum age value specification)

AnnotationAssertion(obo:IAO_0000111 obo:OBI_0002556 "minimum age value specification"@en)
AnnotationAssertion(obo:IAO_0000114 obo:OBI_0002556 obo:IAO_0000123)
AnnotationAssertion(obo:IAO_0000115 obo:OBI_0002556 "A value specifcation that specifies the youngest age when specifying an age range."@en)
AnnotationAssertion(Annotation(obo:IAO_0000119 "https://prsinfo.clinicaltrials.gov/definitions.html") obo:IAO_0000115 obo:OBI_0002556 "The numerical value, if any, for the minimum age a potential participant must meet to be eligible for the clinical study.")
AnnotationAssertion(obo:IAO_0000117 obo:OBI_0002556 "Mathias Brochhausen"@en)
AnnotationAssertion(obo:IAO_0000412 obo:OBI_0002556 obo:obi.owl)
AnnotationAssertion(oboInOwl:hasExactSynonym obo:OBI_0002556 "minimum age")
AnnotationAssertion(rdfs:label obo:OBI_0002556 "minimum age value specification"@en)
SubClassOf(obo:OBI_0002556 obo:OBI_0001933)

# Class: obo:OBI_0002557 (maximum age value specification)

AnnotationAssertion(obo:IAO_0000111 obo:OBI_0002557 "maximum age value specification"@en)
AnnotationAssertion(obo:IAO_0000114 obo:OBI_0002557 obo:IAO_0000123)
AnnotationAssertion(obo:IAO_0000115 obo:OBI_0002557 "A value specifcation that specifies the oldest age when specifying an age range."@en)
AnnotationAssertion(Annotation(obo:IAO_0000119 "https://prsinfo.clinicaltrials.gov/definitions.html") obo:IAO_0000115 obo:OBI_0002557 "The numerical value, if any, for the maximum age a potential participant can be to be eligible for the clinical study.")
AnnotationAssertion(obo:IAO_0000117 obo:OBI_0002557 "Mathias Brochhausen"@en)
AnnotationAssertion(obo:IAO_0000412 obo:OBI_0002557 obo:obi.owl)
AnnotationAssertion(oboInOwl:hasExactSynonym obo:OBI_0002557 "maximum age")
AnnotationAssertion(rdfs:label obo:OBI_0002557 "maximum age value specification"@en)
SubClassOf(obo:OBI_0002557 obo:OBI_0001933)

# Class: obo:OBI_0002561 (sex inclusion criterion)

AnnotationAssertion(obo:IAO_0000111 obo:OBI_0002561 "sex inclusion criterion"@en)
AnnotationAssertion(obo:IAO_0000112 obo:OBI_0002561 "\"included males and females\", \"included male patients\""@en)
AnnotationAssertion(obo:IAO_0000114 obo:OBI_0002561 obo:IAO_0000123)
AnnotationAssertion(Annotation(obo:IAO_0000119 "https://clinicaltrials.gov/ct2/about-studies/glossary") obo:IAO_0000115 obo:OBI_0002561 "A type of eligibility criteria that indicates the sex of people who may participate in a clinical study (all, female, male). Sex is a person's classification as female or male based on biological distinctions. Sex is distinct from gender-based eligibility.")
AnnotationAssertion(obo:IAO_0000115 obo:OBI_0002561 "An inclusion criterion that defines and states one or more sexes which, if met, makes an entity suitable for a given task or participation in a given process."@en)
AnnotationAssertion(obo:IAO_0000117 obo:OBI_0002561 "Mathias Brochhausen"@en)
AnnotationAssertion(obo:IAO_0000412 obo:OBI_0002561 obo:obi.owl)
AnnotationAssertion(oboInOwl:hasExactSynonym obo:OBI_0002561 "sexes eligible for study")
AnnotationAssertion(rdfs:label obo:OBI_0002561 "sex inclusion criterion"@en)
AnnotationAssertion(rdfs:seeAlso obo:OBI_0002561 "https://www.who.int/ictrp/network/trds/en/")
SubClassOf(obo:OBI_0002561 obo:OBI_0500027)

# Class: obo:OBI_0002624 (case-control study design)

AnnotationAssertion(obo:IAO_0000111 obo:OBI_0002624 "case-control study design")
AnnotationAssertion(obo:IAO_0000114 obo:OBI_0002624 obo:IAO_0000120)
AnnotationAssertion(obo:IAO_0000115 obo:OBI_0002624 "A study design that entails the creation of two types of roles, such that each participant under investigation bears one or the other. What distinguishes the two types of roles is an 'outcome', which is associated with participants that have the case role but not associated with participants that have the control role. A case-control study examines the hypothesis that the presence of the outcome in case participants is associated with an 'exposure' that is not associated with control participants.")
AnnotationAssertion(obo:IAO_0000117 obo:OBI_0002624 "John Judkins, Bjoern Peters")
AnnotationAssertion(obo:IAO_0000119 obo:OBI_0002624 "Wikipedia, OBI")
AnnotationAssertion(obo:IAO_0000412 obo:OBI_0002624 obo:obi.owl)
AnnotationAssertion(rdfs:label obo:OBI_0002624 "case-control study design")
SubClassOf(obo:OBI_0002624 obo:OBI_0500000)

# Class: obo:OBI_0300311 (observation design)

AnnotationAssertion(obo:IAO_0000111 obo:OBI_0300311 "observation design")
AnnotationAssertion(obo:IAO_0000112 obo:OBI_0300311 "PMID: 12387964.Lancet. 2002 Oct 12;360(9340):1144-9.Deficiency of antibacterial peptides in patients with morbus Kostmann: an observation study.")
AnnotationAssertion(obo:IAO_0000114 obo:OBI_0300311 obo:IAO_0000125)
AnnotationAssertion(obo:IAO_0000115 obo:OBI_0300311 "observation design is a study design in which subjects are monitored in the absence of any active intervention by experimentalists.")
AnnotationAssertion(obo:IAO_0000117 obo:OBI_0300311 "Philippe Rocca-Serra")
AnnotationAssertion(obo:IAO_0000119 obo:OBI_0300311 "OBI branch derived")
AnnotationAssertion(obo:IAO_0000412 obo:OBI_0300311 obo:obi.owl)
AnnotationAssertion(rdfs:label obo:OBI_0300311 "observation design")
AnnotationAssertion(rdfs:seeAlso obo:OBI_0300311 "https://prsinfo.clinicaltrials.gov/definitions.html")
SubClassOf(obo:OBI_0300311 obo:OBI_0500000)

# Class: obo:OBI_0500000 (study design)

AnnotationAssertion(obo:IAO_0000111 obo:OBI_0500000 "study design"@en)
AnnotationAssertion(obo:IAO_0000112 obo:OBI_0500000 "a matched pairs study design describes criteria by which subjects are identified as pairs which then undergo the same protocols, and the data generated is analyzed by comparing the differences between the paired subjects, which constitute the results of the executed study design."@en)
AnnotationAssertion(obo:IAO_0000114 obo:OBI_0500000 obo:IAO_0000122)
AnnotationAssertion(obo:IAO_0000115 obo:OBI_0500000 "A plan specification comprised of protocols (which may specify how and what kinds of data will be gathered) that are executed as part of an investigation and is realized during a study design execution.")
AnnotationAssertion(obo:IAO_0000116 obo:OBI_0500000 "Editor note: there is at least an implicit restriction on the kind of data transformations that can be done based on the measured data available.")
AnnotationAssertion(obo:IAO_0000117 obo:OBI_0500000 "PERSON: Chris Stoeckert")
AnnotationAssertion(obo:IAO_0000118 obo:OBI_0500000 "experimental design"@en)
AnnotationAssertion(obo:IAO_0000232 obo:OBI_0500000 "rediscussed at length (MC/JF/BP). 12/9/08). The definition was clarified to differentiate it from protocol."@en)
AnnotationAssertion(obo:IAO_0000412 obo:OBI_0500000 obo:obi.owl)
AnnotationAssertion(obo:IAO_0000412 obo:OBI_0500000 obo:omiabis.owl)
AnnotationAssertion(rdfs:label obo:OBI_0500000 "study design"@en)
AnnotationAssertion(rdfs:seeAlso obo:OBI_0500000 "https://prsinfo.clinicaltrials.gov/definitions.html")
AnnotationAssertion(rdfs:seeAlso obo:OBI_0500000 "https://www.who.int/ictrp/network/trds/en/")
SubClassOf(obo:OBI_0500000 obo:IAO_0000104)

# Class: obo:OBI_0500002 (repeated measure design)

AnnotationAssertion(obo:IAO_0000111 obo:OBI_0500002 "repeated measure design")
AnnotationAssertion(obo:IAO_0000112 obo:OBI_0500002 "PMID: 10959922.J Biopharm Stat. 2000 Aug;10(3):433-45.Equivalence in test assay method comparisons for the repeated-measure, matched-pair design in medical device studies: statistical considerations.")
AnnotationAssertion(obo:IAO_0000114 obo:OBI_0500002 obo:IAO_0000120)
AnnotationAssertion(obo:IAO_0000115 obo:OBI_0500002 "a study design which use the same individuals and exposure them to a set of conditions. The effect of order and practice can be confounding factor in such designs")
AnnotationAssertion(obo:IAO_0000117 obo:OBI_0500002 "PlanAndPlannedProcess Branch")
AnnotationAssertion(obo:IAO_0000119 obo:OBI_0500002 "http://www.holah.karoo.net/experimentaldesigns.htm")
AnnotationAssertion(obo:IAO_0000412 obo:OBI_0500002 obo:obi.owl)
AnnotationAssertion(rdfs:label obo:OBI_0500002 "repeated measure design")
SubClassOf(obo:OBI_0500002 obo:OBI_0000115)

# Class: obo:OBI_0500003 (cross over design)

AnnotationAssertion(obo:IAO_0000111 obo:OBI_0500003 "cross over design")
AnnotationAssertion(obo:IAO_0000112 obo:OBI_0500003 "PMID: 17601993-Objective: HIV-infected patients with lipodystrophy (HIV-lipodystrophy) are insulin resistant and have elevated plasma free fatty acid (FFA) concentrations. We aimed to explore the mechanisms underlying FFA-induced insulin resistance in patients with HIV-lipodystrophy. Research Design and Methods: Using a randomized placebo-controlled cross-over design, we studied the effects of an overnight acipimox-induced suppression of FFA on glucose and FFA metabolism by using stable isotope labelled tracer techniques during basal conditions and a two-stage euglycemic, hyperinsulinemic clamp (20 mU insulin/m(2)/min; 50 mU insulin/m(2)/min) in nine patients with nondiabetic HIV-lipodystrophy. All patients received antiretroviral therapy. Biopsies from the vastus lateralis muscle were obtained during each stage of the clamp. Results: Acipimox treatment reduced basal FFA rate of appearance by 68.9% (52.6%-79.5%) and decreased plasma FFA concentration by 51.6 % (42.0%-58.9%), (both, P < 0.0001). Endogenous glucose production was not influenced by acipimox. During the clamp the increase in glucose-uptake was significantly greater after acipimox treatment compared to placebo (acipimox: 26.85 (18.09-39.86) vs placebo: 20.30 (13.67-30.13) mumol/kg/min; P < 0.01). Insulin increased phosphorylation of Akt (Thr(308)) and GSK-3beta (Ser(9)), decreased phosphorylation of glycogen synthase (GS) site 3a+b and increased GS-activity (I-form) in skeletal muscle (P < 0.01). Acipimox decreased phosphorylation of GS (site 3a+b) (P < 0.02) and increased GS-activity (P < 0.01) in muscle. Conclusion: The present study provides direct evidence that suppression of lipolysis in patients with HIV-lipodystrophy improves insulin-stimulated peripheral glucose-uptake. The increased glucose-uptake may in part be explained by increased dephosphorylation of GS (site 3a+b) resulting in increased GS activity.")
AnnotationAssertion(obo:IAO_0000114 obo:OBI_0500003 obo:IAO_0000120)
AnnotationAssertion(Annotation(obo:IAO_0000119 "https://prsinfo.clinicaltrials.gov/definitions.html") obo:IAO_0000115 obo:OBI_0500003 "Participants receive one of two (or more) alternative interventions during the initial phase of the study and receive the other intervention during the second phase of the study")
AnnotationAssertion(obo:IAO_0000115 obo:OBI_0500003 "a repeated measure design which ensures that experimental units receive, in sequence, the treatment (or the control), and then, after a specified time interval (aka *wash-out periods*), switch to the control (or treatment). In this design, subjects (patients in human context) serve as their own controls, and randomization may be used to determine the ordering which a subject receives the treatment and control")
AnnotationAssertion(obo:IAO_0000117 obo:OBI_0500003 "Philippe Rocca-Serra")
AnnotationAssertion(obo:IAO_0000119 obo:OBI_0500003 "(source: http://www.sbu.se/Filer/Content0/publikationer/1/literaturesearching_1993/glossary.html)")
AnnotationAssertion(obo:IAO_0000412 obo:OBI_0500003 obo:obi.owl)
AnnotationAssertion(rdfs:label obo:OBI_0500003 "cross over design")
SubClassOf(obo:OBI_0500003 obo:OBI_0500002)

# Class: obo:OBI_0500004 (n-to-1 design)

AnnotationAssertion(obo:IAO_0000111 obo:OBI_0500004 "n-to-1 design")
AnnotationAssertion(obo:IAO_0000114 obo:OBI_0500004 obo:IAO_0000125)
AnnotationAssertion(obo:IAO_0000115 obo:OBI_0500004 "N-of-1 design is a cross-over design in which the same patient is repeatedly randomised to receive either the experimental treatment or its control (Senn, 1993).")
AnnotationAssertion(obo:IAO_0000117 obo:OBI_0500004 "Philippe Rocca-Serra")
AnnotationAssertion(obo:IAO_0000119 obo:OBI_0500004 "Adapted from  http://www.childrens-mercy.org/stats/definitions/crossover.htm and source:http://symptomresearch.nih.gov/chapter_6/sec1/csss1pg1.htm)")
AnnotationAssertion(obo:IAO_0000412 obo:OBI_0500004 obo:obi.owl)
AnnotationAssertion(rdfs:label obo:OBI_0500004 "n-to-1 design")
SubClassOf(obo:OBI_0500004 obo:OBI_0500003)

# Class: obo:OBI_0500006 (parallel group design)

AnnotationAssertion(obo:IAO_0000111 obo:OBI_0500006 "parallel group design")
AnnotationAssertion(obo:IAO_0000112 obo:OBI_0500006 "PMID: 17408389-Purpose: Proliferative vitreoretinopathy (PVR) is the most important reason for blindness following retinal detachment. Presently, vitreous tamponades such as gas or silicone oil cannot contact the lower part of the retina. A heavier-than-water tamponade displaces the inflammatory and PVR-stimulating environment from the inferior area of the retina. The Heavy Silicone Oil versus Standard Silicone Oil Study (HSO Study) is designed to answer the question of whether a heavier-than-water tamponade improves the prognosis of eyes with PVR of the lower retina. Methods: The HSO Study is a multicentre, randomized, prospective controlled clinical trial comparing two endotamponades within a two-arm parallel group design. Patients with inferiorly and posteriorly located PVR are randomized to either heavy silicone oil or standard silicone oil as a tamponading agent. Three hundred and fifty consecutive patients are recruited per group. After intraoperative re-attachment, patients are randomized to either standard silicone oil (1000 cSt or 5000 cSt) or Densiron((R)) as a tamponading agent. The main endpoint criteria are complete retinal attachment at 12 months and change of visual acuity (VA) 12 months postoperatively compared with the preoperative VA. Secondary endpoints include complete retinal attachment before endotamponade removal, quality of life analysis and the number of retina affecting re-operation within 1 year of follow-up. Results: The design and early recruitment phase of the study are described. Conclusions: The results of this study will uncover whether or not heavy silicone oil improves the prognosis of eyes with PVR.")
AnnotationAssertion(obo:IAO_0000114 obo:OBI_0500006 obo:IAO_0000125)
AnnotationAssertion(obo:IAO_0000115 obo:OBI_0500006 "A parallel group design or independent measure design is a study design which uses unique experimental unit each experimental group, in other word no two individuals are shared between experimental groups, hence also known as parallel group design. Subjects of a treatment group receive a unique combination of independent variable values making up a treatment")
AnnotationAssertion(Annotation(obo:IAO_0000119 "https://prsinfo.clinicaltrials.gov/definitions.html") obo:IAO_0000115 obo:OBI_0500006 "Participants are assigned to one of two or more groups in parallel for the duration of the study")
AnnotationAssertion(obo:IAO_0000117 obo:OBI_0500006 "Philippe Rocca-Serra")
AnnotationAssertion(obo:IAO_0000118 obo:OBI_0500006 "independent measure design")
AnnotationAssertion(obo:IAO_0000119 obo:OBI_0500006 "http://www.holah.karoo.net/experimentaldesigns.htm")
AnnotationAssertion(obo:IAO_0000412 obo:OBI_0500006 obo:obi.owl)
AnnotationAssertion(rdfs:label obo:OBI_0500006 "parallel group design")
SubClassOf(obo:OBI_0500006 obo:OBI_0500000)

# Class: obo:OBI_0500014 (factorial design)

AnnotationAssertion(obo:IAO_0000111 obo:OBI_0500014 "factorial design")
AnnotationAssertion(obo:IAO_0000112 obo:OBI_0500014 "PMID: 17582121-Our objective was to examine the effects of dietary cation-anion difference (DCAD) with different concentrations of dietary crude protein (CP) on performance and acid-base status in early lactation cows. Six lactating Holstein cows averaging 44 d in milk were used in a 6 x 6 Latin square design with a 2 x 3 factorial arrangement of treatments: DCAD of -3, 22, or 47 milliequivalents (Na + K - Cl - S)/100 g of dry matter (DM), and 16 or 19% CP on a DM basis. Linear increases with DCAD occurred in DM intake, milk fat percentage, 4% fat-corrected milk production, milk true protein, milk lactose, and milk solids-not-fat. Milk production itself was unaffected by DCAD. Jugular venous blood pH, base excess and HCO3(-) concentration, and urine pH increased, but jugular venous blood Cl- concentration, urine titratable acidity, and net acid excretion decreased linearly with increasing DCAD. An elevated ratio of coccygeal venous plasma essential AA to nonessential AA with increasing DCAD indicated that N metabolism in the rumen was affected, probably resulting in more microbial protein flowing to the small intestine. Cows fed 16% CP had lower urea N in milk than cows fed 19% CP; the same was true for urea N in coccygeal venous plasma and urine. Dry matter intake, milk production, milk composition, and acid-base status did not differ between the 16 and 19% CP treatments. It was concluded that DCAD affected DM intake and performance of dairy cows in early lactation. Feeding 16% dietary CP to cows in early lactation, compared with 19% CP, maintained lactation performance while reducing urea N excretion in milk and urine.")
AnnotationAssertion(obo:IAO_0000114 obo:OBI_0500014 obo:IAO_0000125)
AnnotationAssertion(Annotation(obo:IAO_0000119 "https://prsinfo.clinicaltrials.gov/definitions.html") obo:IAO_0000115 obo:OBI_0500014 "Two or more interventions, each alone and in combination, are evaluated in parallel against a control group")
AnnotationAssertion(obo:IAO_0000115 obo:OBI_0500014 "factorial design is_a study design which is used to evaluate two or more factors simultaneously. The treatments are combinations of levels of the factors. The advantages of factorial designs over one-factor-at-a-time experiments is that they are more efficient and they allow interactions to be detected. In statistics, a factorial design experiment is an experiment whose design consists of two or more factors, each with discrete possible values or levels, and whose experimental units take on all possible combinations of these levels across all such factors. Such an experiment allows studying the effect of each factor on the response variable, as well as the effects of interactions between factors on the response variable.")
AnnotationAssertion(obo:IAO_0000117 obo:OBI_0500014 "Philippe Rocca-Serra")
AnnotationAssertion(obo:IAO_0000119 obo:OBI_0500014 "http://www.stats.gla.ac.uk/steps/glossary/anova.html#facdes And from wikipedia (01/03/2007): http://en.wikipedia.org/wiki/Factorial_experiment)")
AnnotationAssertion(obo:IAO_0000412 obo:OBI_0500014 obo:obi.owl)
AnnotationAssertion(rdfs:label obo:OBI_0500014 "factorial design")
SubClassOf(obo:OBI_0500014 obo:OBI_0500000)

# Class: obo:OBI_0500026 (eligibility criterion)

AnnotationAssertion(obo:IAO_0000111 obo:OBI_0500026 "eligibility criterion"@en)
AnnotationAssertion(obo:IAO_0000112 obo:OBI_0500026 "PMID: 17579629 -Eligibility criteria included: untreated ED-SCLC; age >/=70 and performance status 0-2, or age <70 and PS 3."@en)
AnnotationAssertion(obo:IAO_0000114 obo:OBI_0500026 obo:IAO_0000122)
AnnotationAssertion(Annotation(obo:IAO_0000119 "https://prsinfo.clinicaltrials.gov/definitions.html") obo:IAO_0000115 obo:OBI_0500026 "A limited list of criteria for selection of participants in the clinical study, provided in terms of inclusion and exclusion criteria and suitable for assisting potential participants in identifying clinical studies of interest.")
AnnotationAssertion(Annotation(obo:IAO_0000119 "https://clinicaltrials.gov/ct2/about-studies/glossary") obo:IAO_0000115 obo:OBI_0500026 "The key requirements that people who want to participate in a clinical study must meet or the characteristics they must have. Eligibility criteria consist of both inclusion criteria (which are required for a person to participate in the study) and exclusion criteria (which prevent a person from participating). Types of eligibility criteria include whether a study accepts healthy volunteers, has age or age group requirements, or is limited by sex")
AnnotationAssertion(obo:IAO_0000115 obo:OBI_0500026 "an eligibility criterion (rule) is_a selection criterion which 
defines and states the requirements (positive or negative) for an entity to be considered as suitable for a given task or participation in a process.
"@en)
AnnotationAssertion(obo:IAO_0000117 obo:OBI_0500026 "Person: Philippe Rocca-Serra"@en)
AnnotationAssertion(obo:IAO_0000118 obo:OBI_0500026 "eligibility rule"@en)
AnnotationAssertion(obo:IAO_0000119 obo:OBI_0500026 "Adapted from Clinical Research Glossary Version 4.0 CDICS glossary group"@en)
AnnotationAssertion(obo:IAO_0000412 obo:OBI_0500026 obo:obi.owl)
AnnotationAssertion(rdfs:label obo:OBI_0500026 "eligibility criterion"@en)
SubClassOf(obo:OBI_0500026 obo:OBI_0001755)

# Class: obo:OBI_0500027 (inclusion criterion)

AnnotationAssertion(obo:IAO_0000111 obo:OBI_0500027 "inclusion criterion"@en)
AnnotationAssertion(obo:IAO_0000112 obo:OBI_0500027 "PMID: 23979341-The major inclusion criterion was patients in whom severe cerebral embolism was diagnosed at age 75 or younger (more than 9 in the NIHSS score on day 7 after the onset of stroke) ."@en)
AnnotationAssertion(obo:IAO_0000114 obo:OBI_0500027 obo:IAO_0000125)
AnnotationAssertion(Annotation(obo:IAO_0000119 "https://clinicaltrials.gov/ct2/about-studies/glossary") obo:IAO_0000115 obo:OBI_0500027 "A type of eligibility criteria. These are the reasons that a person is allowed to participate in a clinical study.")
AnnotationAssertion(obo:IAO_0000115 obo:OBI_0500027 "an inclusion criterion (rule) is_a *eligibility criterion*  which defines and states a condition which, if met, makes an entity suitable for a given task or participation in a given process. For instance, in a study protocol, inclusion criteria indicate the conditions that prospective subjects MUST meet to be eligible for participation in a study."@en)
AnnotationAssertion(obo:IAO_0000117 obo:OBI_0500027 "Person: Philippe Rocca-Serra"@en)
AnnotationAssertion(obo:IAO_0000118 obo:OBI_0500027 "inclusion condition"@en)
AnnotationAssertion(obo:IAO_0000118 obo:OBI_0500027 "inclusion rule"@en)
AnnotationAssertion(obo:IAO_0000119 obo:OBI_0500027 "Adapted from Clinical Research Glossary Version 4.0 CDICS glossary group"@en)
AnnotationAssertion(obo:IAO_0000412 obo:OBI_0500027 obo:obi.owl)
AnnotationAssertion(Annotation(obo:IAO_0000119 "http://www.icmje.org/recommendations/ 
https://www.who.int/ictrp/network/trds/en/") oboInOwl:hasExactSynonym obo:OBI_0500027 "key inclusion criteria")
AnnotationAssertion(rdfs:label obo:OBI_0500027 "inclusion criterion"@en)
SubClassOf(obo:OBI_0500027 obo:OBI_0500026)

# Class: obo:OBI_0500028 (exclusion criterion)

AnnotationAssertion(obo:IAO_0000111 obo:OBI_0500028 "exclusion rule"@en)
AnnotationAssertion(obo:IAO_0000112 obo:OBI_0500028 "PMID: 17600285-Exclusion criteria included the use of any topical ophthalmic or topical oral medication and/or history of ocular or oral surgery within the past six months."@en)
AnnotationAssertion(obo:IAO_0000114 obo:OBI_0500028 obo:IAO_0000125)
AnnotationAssertion(Annotation(obo:IAO_0000119 "https://clinicaltrials.gov/ct2/about-studies/glossary") obo:IAO_0000115 obo:OBI_0500028 "A type of eligibility criteria. These are reasons that a person is not allowed to participate in a clinical study.")
AnnotationAssertion(obo:IAO_0000115 obo:OBI_0500028 "an exclusion criterion (rule) is_a *eligibility criterion*  which defines and states a condition which, if met, makes an entity unsuitable for a given task or participation in a given process. For instance, in a study protocol, exclusion criteria indicate the conditions that prospective subjects SHOULD NOT meet to be eligible for participation in a study"@en)
AnnotationAssertion(obo:IAO_0000117 obo:OBI_0500028 "Person: Philippe Rocca-Serra"@en)
AnnotationAssertion(obo:IAO_0000119 obo:OBI_0500028 "Adapted from Clinical Research Glossary Version 4.0 CDICS glossary group"@en)
AnnotationAssertion(obo:IAO_0000412 obo:OBI_0500028 obo:obi.owl)
AnnotationAssertion(Annotation(obo:IAO_0000119 "http://www.icmje.org/recommendations/ 
https://www.who.int/ictrp/network/trds/en/") oboInOwl:hasExactSynonym obo:OBI_0500028 "key exclusion criteria")
AnnotationAssertion(rdfs:label obo:OBI_0500028 "exclusion criterion"@en)
SubClassOf(obo:OBI_0500028 obo:OBI_0500026)

# Class: obo:OBI_0600004 (human subject enrollment)

AnnotationAssertion(obo:IAO_0000111 obo:OBI_0600004 "human subject enrollment"@en)
AnnotationAssertion(obo:IAO_0000112 obo:OBI_0600004 "enlisting familiy members of HIV patients into a study"@en)
AnnotationAssertion(obo:IAO_0000114 obo:OBI_0600004 obo:IAO_0000122)
AnnotationAssertion(obo:IAO_0000115 obo:OBI_0600004 "A planned process with the objective to obtain a population of human subjects to participate in an investigation by determining eligibility of subjects and obtaining informed consent."@en)
AnnotationAssertion(obo:IAO_0000116 obo:OBI_0600004 "As with group assignment, should the specified output here be an organism which bears a role")
AnnotationAssertion(obo:IAO_0000117 obo:OBI_0600004 "Bjoern Peters"@en)
AnnotationAssertion(obo:IAO_0000119 obo:OBI_0600004 "IEDB"@en)
AnnotationAssertion(obo:IAO_0000232 obo:OBI_0600004 "criteria come from plan / clinical trial branch"@en)
AnnotationAssertion(obo:IAO_0000412 obo:OBI_0600004 obo:obi.owl)
AnnotationAssertion(rdfs:label obo:OBI_0600004 "human subject enrollment"@en)
SubClassOf(obo:OBI_0600004 obo:OBI_0001928)

# Class: obo:OGMS_0000014 (clinical finding)

AnnotationAssertion(obo:IAO_0000115 obo:OGMS_0000014 "A representation that is either the output of a clinical history taking or a physical examination or an image finding, or some combination thereof."@en)
AnnotationAssertion(obo:IAO_0000117 obo:OGMS_0000014 "Albert Goldfain")
AnnotationAssertion(obo:IAO_0000119 obo:OGMS_0000014 "http://ontology.buffalo.edu/medo/Disease_and_Diagnosis.pdf")
AnnotationAssertion(obo:IAO_0000232 obo:OGMS_0000014 "creation date: 2010-07-19T10:18:02Z")
AnnotationAssertion(obo:IAO_0000412 obo:OGMS_0000014 obo:ogms.owl)
AnnotationAssertion(rdfs:label obo:OGMS_0000014 "clinical finding")
SubClassOf(obo:OGMS_0000014 obo:IAO_0000027)

# Class: obo:OGMS_0000015 (clinical history)

AnnotationAssertion(obo:IAO_0000115 obo:OGMS_0000015 "A series of statements representing health-relevant qualities of a patient and of a patient's family."@en)
AnnotationAssertion(obo:IAO_0000117 obo:OGMS_0000015 "Albert Goldfain")
AnnotationAssertion(obo:IAO_0000119 obo:OGMS_0000015 "http://ontology.buffalo.edu/medo/Disease_and_Diagnosis.pdf")
AnnotationAssertion(obo:IAO_0000232 obo:OGMS_0000015 "creation date: 2010-07-19T10:18:59Z")
AnnotationAssertion(obo:IAO_0000412 obo:OGMS_0000015 obo:ogms.owl)
AnnotationAssertion(rdfs:label obo:OGMS_0000015 "clinical history")
SubClassOf(obo:OGMS_0000015 obo:IAO_0000027)

# Class: obo:OGMS_0000019 (preclinical finding)

AnnotationAssertion(obo:IAO_0000115 obo:OGMS_0000019 "A representation of a quality of a patient that is (1) recorded by a clinician because the quality is hypothesized to be of clinical significance and (2) refers to qualities obtaining in the patient prior to their becoming detectable in a clinical history taking or physical examination."@en)
AnnotationAssertion(obo:IAO_0000117 obo:OGMS_0000019 "Albert Goldfain")
AnnotationAssertion(obo:IAO_0000119 obo:OGMS_0000019 "http://ontology.buffalo.edu/medo/Disease_and_Diagnosis.pdf")
AnnotationAssertion(obo:IAO_0000232 obo:OGMS_0000019 "creation date: 2009-06-23T10:22:44Z")
AnnotationAssertion(obo:IAO_0000412 obo:OGMS_0000019 obo:ogms.owl)
AnnotationAssertion(rdfs:label obo:OGMS_0000019 "preclinical finding")
SubClassOf(obo:OGMS_0000019 obo:IAO_0000027)

# Class: obo:OGMS_0000031 (disease)

AnnotationAssertion(obo:IAO_0000115 obo:OGMS_0000031 "A disposition (i) to undergo pathological processes that (ii) exists in an organism because of one or more disorders in that organism."@en)
AnnotationAssertion(obo:IAO_0000117 obo:OGMS_0000031 "Albert Goldfain")
AnnotationAssertion(obo:IAO_0000119 obo:OGMS_0000031 "http://ontology.buffalo.edu/medo/Disease_and_Diagnosis.pdf")
AnnotationAssertion(obo:IAO_0000232 obo:OGMS_0000031 "creation date: 2009-06-23T11:21:20Z")
AnnotationAssertion(obo:IAO_0000412 obo:OGMS_0000031 obo:ogms.owl)
AnnotationAssertion(rdfs:label obo:OGMS_0000031 "disease")
SubClassOf(obo:OGMS_0000031 obo:BFO_0000016)

# Class: obo:OGMS_0000060 (bodily process)

AnnotationAssertion(obo:IAO_0000117 obo:OGMS_0000060 "Albert Goldfain")
AnnotationAssertion(obo:IAO_0000232 obo:OGMS_0000060 "creation date: 2009-06-23T11:53:49Z")
AnnotationAssertion(obo:IAO_0000412 obo:OGMS_0000060 obo:oae.owl)
AnnotationAssertion(obo:IAO_0000412 obo:OGMS_0000060 obo:ogms.owl)
AnnotationAssertion(rdfs:label obo:OGMS_0000060 "bodily process")
SubClassOf(obo:OGMS_0000060 obo:BFO_0000015)

# Class: obo:OGMS_0000061 (pathological bodily process)

AnnotationAssertion(obo:IAO_0000115 obo:OGMS_0000061 "A bodily process that is clinically abnormal."@en)
AnnotationAssertion(obo:IAO_0000117 obo:OGMS_0000061 "Albert Goldfain")
AnnotationAssertion(obo:IAO_0000119 obo:OGMS_0000061 "http://ontology.buffalo.edu/medo/Disease_and_Diagnosis.pdf")
AnnotationAssertion(obo:IAO_0000232 obo:OGMS_0000061 "creation date: 2009-06-23T11:54:29Z")
AnnotationAssertion(obo:IAO_0000412 obo:OGMS_0000061 obo:oae.owl)
AnnotationAssertion(obo:IAO_0000412 obo:OGMS_0000061 obo:ogms.owl)
AnnotationAssertion(rdfs:label obo:OGMS_0000061 "pathological bodily process")
SubClassOf(obo:OGMS_0000061 obo:OGMS_0000060)

# Class: obo:OGMS_0000073 (diagnosis)

AnnotationAssertion(Annotation(obo:IAO_0000119 "https://www.clinicaltrialsregister.eu/doc/EU_Clinical_Trials_Register_Glossary.pdf") obo:IAO_0000115 obo:OGMS_0000073 "1. the determination of the nature of a case of disease.
2. the art of distinguishing one disease from another.")
AnnotationAssertion(obo:IAO_0000115 obo:OGMS_0000073 "The representation of a conclusion of a diagnostic process."@en)
AnnotationAssertion(obo:IAO_0000117 obo:OGMS_0000073 "Albert Goldfain")
AnnotationAssertion(obo:IAO_0000119 obo:OGMS_0000073 "http://ontology.buffalo.edu/medo/Disease_and_Diagnosis.pdf")
AnnotationAssertion(obo:IAO_0000232 obo:OGMS_0000073 "creation date: 2009-06-23T12:42:23Z")
AnnotationAssertion(obo:IAO_0000412 obo:OGMS_0000073 obo:ogms.owl)
AnnotationAssertion(rdfs:label obo:OGMS_0000073 "diagnosis")
SubClassOf(obo:OGMS_0000073 obo:IAO_0000027)

# Class: obo:OMIABIS_0001019 (longitudinal study design)

AnnotationAssertion(obo:IAO_0000115 obo:OMIABIS_0001019 "A study design that involves repeated observations of the same entity over time. In the biobank context, longitudinal studies sample a group of people in a given time period, and study them at intervals by the acquisition and analyses of data and/or samples over time."@en)
AnnotationAssertion(obo:IAO_0000117 obo:OMIABIS_0001019 "Alice Nzinga"@en)
AnnotationAssertion(obo:IAO_0000412 obo:OMIABIS_0001019 obo:omiabis.owl)
AnnotationAssertion(rdfs:label obo:OMIABIS_0001019 "longitudinal study design"@en)
SubClassOf(obo:OMIABIS_0001019 obo:OBI_0500000)

# Class: obo:OMIABIS_0001020 (cohort study design)

AnnotationAssertion(obo:IAO_0000115 obo:OMIABIS_0001020 "A longitudinal study that aims to study a case-defined population who presently have a certain condition or recepient of a particular treatment that are followed over time and are compared with a similar group who do not have condition."@en)
AnnotationAssertion(obo:IAO_0000412 obo:OMIABIS_0001020 obo:omiabis.owl)
AnnotationAssertion(rdfs:label obo:OMIABIS_0001020 "cohort study design"@en)
SubClassOf(obo:OMIABIS_0001020 obo:OMIABIS_0001019)

# Class: obo:OMRSE_00000024 (role in human social processes)

AnnotationAssertion(obo:IAO_0000115 obo:OMRSE_00000024 "A role inhering in an entity realized by social interactions in human society."@en)
AnnotationAssertion(obo:IAO_0000117 obo:OMRSE_00000024 "Mathias Brochhausen"@en)
AnnotationAssertion(obo:IAO_0000412 obo:OMRSE_00000024 obo:omrse.owl)
AnnotationAssertion(rdfs:comment obo:OMRSE_00000024 "Previous definition: A role played by an entity in human social processes."@en)
AnnotationAssertion(rdfs:label obo:OMRSE_00000024 "role in human social processes"@en)
SubClassOf(obo:OMRSE_00000024 obo:BFO_0000023)

# Class: obo:OMRSE_00000038 (legal person role)

AnnotationAssertion(obo:IAO_0000115 obo:OMRSE_00000038 "A role borne by a human individual or by a collection of humans regarded as possessing rights and duties enforeable at law."@en)
AnnotationAssertion(obo:IAO_0000117 obo:OMRSE_00000038 "Mathias Brochhausen")
AnnotationAssertion(obo:IAO_0000119 obo:OMRSE_00000038 "Malcolm N. Shaw: International Law. Cambridge University Press, Cambridge, 2008.")
AnnotationAssertion(obo:IAO_0000412 obo:OMRSE_00000038 obo:omrse.owl)
AnnotationAssertion(rdfs:comment obo:OMRSE_00000038 "We are aware of the fact that Wikipedia's definition differs from ours by saying that \"Legal personality (...) is the characteristic of a non-living entity regarded by law to have the status of personhood\" (http://en.wikipedia.org/wiki/Legal_personality) 
However, Shaw explicates:
\"In any legal system, certain entities, whether they be individuals or companies, will be regarded as possessing rights and duties enforceable at law. Thus an individual may prosecute or be prosecuted for assault and a company can sue for breach of contract. They are able to do this because the law recognises them as 'legal persons' possessing the capacity to have and to maintain certain rights, and being subject to perform specific duties. (...) In municipal law individuals, limited companies and public corporations are recognized as each possessing a distinct legal personality, the terms of which are circumscribed by the relevant legislation\" (Shaw MN: International Law. Sixth Edition. Cambridge University Press, Cambridge, 2008).                We hold that Shaw's position is ontological more prolific since it not only allows to explain how groups of individuals become recognized as unities at law, but also how different individuals can hold different legal personality roles (always against the context of one legal system). The latter will proof useful when dealing with the representing comatous patients or minorsat law in ontologies."@en)
AnnotationAssertion(rdfs:label obo:OMRSE_00000038 "legal person role"@en)
SubClassOf(obo:OMRSE_00000038 obo:OMRSE_00000024)

# Class: obo:OPMI_0000112 (telephone number)

AnnotationAssertion(obo:IAO_0000115 obo:OPMI_0000112 "A telephone number is a sequence of digits assigned to a fixed-line telephone subscriber station connected to a telephone line or to a wireless electronic telephony device, such as a radio telephone or a mobile telephone, or to other devices for data transmission via the public switched telephone network (PSTN) or other public and private networks.")
AnnotationAssertion(obo:IAO_0000117 obo:OPMI_0000112 "Oliver He")
AnnotationAssertion(obo:IAO_0000118 obo:OPMI_0000112 "phone number")
AnnotationAssertion(obo:IAO_0000119 obo:OPMI_0000112 "https://en.wikipedia.org/wiki/Telephone_number")
AnnotationAssertion(obo:IAO_0000412 obo:OPMI_0000112 obo:opmi.owl)
AnnotationAssertion(rdfs:label obo:OPMI_0000112 "telephone number"@en)
SubClassOf(obo:OPMI_0000112 obo:OPMI_0000397)

# Class: obo:OPMI_0000223 (contact name)

AnnotationAssertion(obo:IAO_0000115 obo:OPMI_0000223 "The textual name of the contact person or organization")
AnnotationAssertion(obo:IAO_0000412 obo:OPMI_0000223 obo:opmi.owl)
AnnotationAssertion(rdfs:label obo:OPMI_0000223 "contact name"@en)
SubClassOf(obo:OPMI_0000223 obo:NCIT_C60776)

# Class: obo:OPMI_0000282 (medical condition)

AnnotationAssertion(obo:IAO_0000115 obo:OPMI_0000282 "The medical state or condition of a patient")
AnnotationAssertion(obo:IAO_0000117 obo:OPMI_0000282 "Oliver He, Edison Ong")
AnnotationAssertion(obo:IAO_0000118 obo:OPMI_0000282 "medical state")
AnnotationAssertion(obo:IAO_0000119 obo:OPMI_0000282 "https://en.wikipedia.org/wiki/Medical_state")
AnnotationAssertion(obo:IAO_0000412 obo:OPMI_0000282 obo:opmi.owl)
AnnotationAssertion(rdfs:label obo:OPMI_0000282 "medical condition"@en)
SubClassOf(obo:OPMI_0000282 obo:BFO_0000017)

# Class: obo:OPMI_0000293 (investigator)

AnnotationAssertion(obo:IAO_0000115 obo:OPMI_0000293 "A person who performs an investigation task and takes the role of an investigator role.")
AnnotationAssertion(obo:IAO_0000412 obo:OPMI_0000293 obo:opmi.owl)
AnnotationAssertion(rdfs:label obo:OPMI_0000293 "investigator"@en)
SubClassOf(obo:OPMI_0000293 obo:NCBITaxon_9606)

# Class: obo:OPMI_0000294 (clinical investigator)

AnnotationAssertion(obo:IAO_0000115 obo:OPMI_0000294 "An investigator who is involved in a clinical trial and is responsible for ensuring that an investigation is conducted according to the signed investigator statement, the investigational plan, and applicable regulations; for protecting the rights, safety, and welfare of subjects under the investigator's care; and for the control of drugs under investigation.")
AnnotationAssertion(obo:IAO_0000117 obo:OPMI_0000294 "Oliver He")
AnnotationAssertion(obo:IAO_0000119 obo:OPMI_0000294 "https://en.wikipedia.org/wiki/Clinical_investigator")
AnnotationAssertion(obo:IAO_0000412 obo:OPMI_0000294 obo:opmi.owl)
AnnotationAssertion(rdfs:label obo:OPMI_0000294 "clinical investigator"@en)
SubClassOf(obo:OPMI_0000294 obo:OPMI_0000293)

# Class: obo:OPMI_0000296 (clinical trial start date)

AnnotationAssertion(obo:IAO_0000115 obo:OPMI_0000296 "The (estimated) date on which the clinical study is open for recruitment of participants, or the actual date on which the first participant is enrolled.")
AnnotationAssertion(obo:IAO_0000119 obo:OPMI_0000296 "https://prsinfo.clinicaltrials.gov/definitions.html")
AnnotationAssertion(obo:IAO_0000412 obo:OPMI_0000296 obo:opmi.owl)
AnnotationAssertion(Annotation(rdfs:seeAlso "http://www.icmje.org/recommendations/ 
http://www.who.int/ictrp/network/trds/en/index.html") oboInOwl:hasExactSynonym obo:OPMI_0000296 "date of first enrollment")
AnnotationAssertion(oboInOwl:hasExactSynonym obo:OPMI_0000296 "study start")
AnnotationAssertion(rdfs:label obo:OPMI_0000296 "clinical trial start date"@en)
SubClassOf(obo:OPMI_0000296 obo:CTO_0000214)

# Class: obo:OPMI_0000297 (study completion date)

AnnotationAssertion(obo:IAO_0000115 obo:OPMI_0000297 "The date on which a study completes")
AnnotationAssertion(Annotation(obo:IAO_0000119 "https://prsinfo.clinicaltrials.gov/definitions.html") obo:IAO_0000115 obo:OPMI_0000297 "The date the final participant was examined or received an intervention for purposes of final collection of data for the primary and secondary outcome measures and adverse events (for example, last participant’s last visit), whether the clinical study concluded according to the pre-specified protocol or was terminated.")
AnnotationAssertion(obo:IAO_0000117 obo:OPMI_0000297 "Oliver He")
AnnotationAssertion(obo:IAO_0000412 obo:OPMI_0000297 obo:opmi.owl)
AnnotationAssertion(Annotation(rdfs:seeAlso "http://www.icmje.org/recommendations/ 
http://www.who.int/ictrp/network/trds/en/index.html") oboInOwl:hasExactSynonym obo:OPMI_0000297 "Completion Date")
AnnotationAssertion(oboInOwl:hasExactSynonym obo:OPMI_0000297 "study completion")
AnnotationAssertion(rdfs:label obo:OPMI_0000297 "study completion date"@en)
SubClassOf(obo:OPMI_0000297 obo:BFO_0000148)

# Class: obo:OPMI_0000302 (date of registration)

AnnotationAssertion(Annotation(obo:IAO_0000119 "https://www.clinicaltrials.gov/ct2/about-studies/glossary") obo:IAO_0000115 obo:OPMI_0000302 "The date on which the study sponsor or investigator first submitted a study record to ClinicalTrials.gov. There is typically a delay of a few days between the first submitted date and the record's availability on ClinicalTrials.gov (the first posted date).")
AnnotationAssertion(obo:IAO_0000115 obo:OPMI_0000302 "a date when a registration occurs")
AnnotationAssertion(obo:IAO_0000412 obo:OPMI_0000302 obo:opmi.owl)
AnnotationAssertion(oboInOwl:hasExactSynonym obo:OPMI_0000302 "First submitted")
AnnotationAssertion(Annotation(rdfs:seeAlso "https://www.who.int/ictrp/network/trds/en/") oboInOwl:hasExactSynonym obo:OPMI_0000302 "date of registration in primary registry")
AnnotationAssertion(rdfs:label obo:OPMI_0000302 "date of registration"@en)
SubClassOf(obo:OPMI_0000302 obo:BFO_0000148)

# Class: obo:OPMI_0000304 (recruitment status)

AnnotationAssertion(obo:IAO_0000115 obo:OPMI_0000304 "The current stage of a clinical study and whether it is or will be open for enrollment")
AnnotationAssertion(Annotation(obo:IAO_0000119 "https://prsinfo.clinicaltrials.gov/definitions.html") obo:IAO_0000115 obo:OPMI_0000304 "The recruitment status for the clinical study as a whole, based upon the status of the individual sites. If at least one facility in a multi-site clinical study has an Individual Site Status of \"Recruiting,\" then the Overall Recruitment Status for the study must be \"Recruiting.\"")
AnnotationAssertion(obo:IAO_0000117 obo:OPMI_0000304 "Oliver He")
AnnotationAssertion(obo:IAO_0000119 obo:OPMI_0000304 "https://clinicaltrials.gov/ct2/help/glossary/recruitment-status")
AnnotationAssertion(obo:IAO_0000412 obo:OPMI_0000304 obo:opmi.owl)
AnnotationAssertion(rdfs:label obo:OPMI_0000304 "recruitment status"@en)
AnnotationAssertion(rdfs:seeAlso obo:OPMI_0000304 "http://www.icmje.org/recommendations/ 
http://www.who.int/ictrp/network/trds/en/index.html")
SubClassOf(obo:OPMI_0000304 obo:OPMI_0000326)

# Class: obo:OPMI_0000326 (status)

AnnotationAssertion(obo:IAO_0000117 obo:OPMI_0000326 "Oliver He, Edison Ong")
AnnotationAssertion(obo:IAO_0000412 obo:OPMI_0000326 obo:opmi.owl)
AnnotationAssertion(rdfs:label obo:OPMI_0000326 "status"@en)
SubClassOf(obo:OPMI_0000326 obo:BFO_0000017)

# Class: obo:OPMI_0000327 (study status)

AnnotationAssertion(obo:IAO_0000115 obo:OPMI_0000327 "The current stage of a clinical study and whether it is or will be open for enrollment")
AnnotationAssertion(obo:IAO_0000117 obo:OPMI_0000327 "Oliver He")
AnnotationAssertion(obo:IAO_0000119 obo:OPMI_0000327 "https://clinicaltrials.gov/ct2/help/glossary/recruitment-status")
AnnotationAssertion(obo:IAO_0000412 obo:OPMI_0000327 obo:opmi.owl)
AnnotationAssertion(rdfs:label obo:OPMI_0000327 "study status"@en)
SubClassOf(obo:OPMI_0000327 obo:OPMI_0000326)

# Class: obo:OPMI_0000365 (combinational intervention)

AnnotationAssertion(Annotation(obo:IAO_0000119 "https://prsinfo.clinicaltrials.gov/definitions.html") obo:IAO_0000115 obo:OPMI_0000365 "Combining a drug and device, a biological product and device; a drug and biological product; or a drug, biological product, and device")
AnnotationAssertion(obo:IAO_0000117 obo:OPMI_0000365 "Leon Li, Asiyah Lin, Oliver He")
AnnotationAssertion(obo:IAO_0000412 obo:OPMI_0000365 obo:opmi.owl)
AnnotationAssertion(rdfs:label obo:OPMI_0000365 "combinational intervention"@en)
SubClassOf(obo:OPMI_0000365 obo:OAE_0000002)

# Class: obo:OPMI_0000376 (behavioral intervention)

AnnotationAssertion(obo:IAO_0000115 obo:OPMI_0000376 "A medical intervention that involves a behavioral process to control, prevent, or treat a behavior problem.")
AnnotationAssertion(obo:IAO_0000117 obo:OPMI_0000376 "Leon Li, Asiyah Lin, Oliver He")
AnnotationAssertion(obo:IAO_0000119 obo:OPMI_0000376 "https://www.understood.org/en/learning-attention-issues/treatments-approaches/educational-strategies/behavior-intervention-plans-what-you-need-to-know")
AnnotationAssertion(obo:IAO_0000412 obo:OPMI_0000376 obo:opmi.owl)
AnnotationAssertion(Annotation(rdfs:seeAlso "https://prsinfo.clinicaltrials.gov/definitions.html") oboInOwl:hasExactSynonym obo:OPMI_0000376 "behavioral")
AnnotationAssertion(rdfs:label obo:OPMI_0000376 "behavioral intervention"@en)
SubClassOf(obo:OPMI_0000376 obo:OAE_0000002)

# Class: obo:OPMI_0000381 (human subject)

AnnotationAssertion(obo:IAO_0000412 obo:OPMI_0000381 obo:opmi.owl)
AnnotationAssertion(rdfs:label obo:OPMI_0000381 "human subject"@en)
SubClassOf(obo:OPMI_0000381 obo:NCBITaxon_9606)

# Class: obo:OPMI_0000383 (contact person)

AnnotationAssertion(obo:IAO_0000112 obo:OPMI_0000383 "In clinicaltrials.gov, contact information character limits:
First Name: 62 characters
Last Name: 62 characters
Degree: 30 characters
Phone: 30 characters
Phone Ext: 14 characters
Email: 254 characters
Citation: https://prsinfo.clinicaltrials.gov/definitions.html#StudyOfficials")
AnnotationAssertion(obo:IAO_0000115 obo:OPMI_0000383 "A person who serves as a contact role and has disclosed specified information to be reached. Usually the contact information, such as email and phone number, is provided.,")
AnnotationAssertion(obo:IAO_0000116 obo:OPMI_0000383 "Leon, Asiyah, Oliver: Since each contact needs to provide some contact information, we may need to define the contact information.")
AnnotationAssertion(obo:IAO_0000117 obo:OPMI_0000383 "Leon Li, Asiyah Lin, Oliver He")
AnnotationAssertion(obo:IAO_0000119 obo:OPMI_0000383 "https://prsinfo.clinicaltrials.gov/definitions.html#StudyOfficials")
AnnotationAssertion(obo:IAO_0000412 obo:OPMI_0000383 obo:opmi.owl)
AnnotationAssertion(rdfs:label obo:OPMI_0000383 "contact person"@en)
SubClassOf(obo:OPMI_0000383 obo:NCBITaxon_9606)

# Class: obo:OPMI_0000384 (facility contact)

AnnotationAssertion(obo:IAO_0000115 obo:OPMI_0000384 "A contact person for each facility participating in a study.")
AnnotationAssertion(obo:IAO_0000117 obo:OPMI_0000384 "Leon Li, Asiyah Lin, Oliver He")
AnnotationAssertion(obo:IAO_0000119 obo:OPMI_0000384 "https://prsinfo.clinicaltrials.gov/definitions.html")
AnnotationAssertion(obo:IAO_0000412 obo:OPMI_0000384 obo:opmi.owl)
AnnotationAssertion(rdfs:label obo:OPMI_0000384 "facility contact"@en)
SubClassOf(obo:OPMI_0000384 obo:OPMI_0000383)

# Class: obo:OPMI_0000389 (contact of scientific queries)

AnnotationAssertion(obo:IAO_0000117 obo:OPMI_0000389 "Leon Li, Asiyah Lin, Oliver He")
AnnotationAssertion(obo:IAO_0000119 obo:OPMI_0000389 "https://prsinfo.clinicaltrials.gov/definitions.html#StudyOfficials")
AnnotationAssertion(obo:IAO_0000412 obo:OPMI_0000389 obo:opmi.owl)
AnnotationAssertion(rdfs:label obo:OPMI_0000389 "contact of scientific queries"@en)
SubClassOf(obo:OPMI_0000389 obo:OPMI_0000383)

# Class: obo:OPMI_0000390 (investigator role)

AnnotationAssertion(obo:IAO_0000115 obo:OPMI_0000390 "An investigation agent role that is taken by a human individual")
AnnotationAssertion(obo:IAO_0000117 obo:OPMI_0000390 "Leon Li, Asiyah Lin, Oliver He")
AnnotationAssertion(obo:IAO_0000118 obo:OPMI_0000390 "human investigator role")
AnnotationAssertion(obo:IAO_0000412 obo:OPMI_0000390 obo:opmi.owl)
AnnotationAssertion(rdfs:label obo:OPMI_0000390 "investigator role"@en)
SubClassOf(obo:OPMI_0000390 obo:OBI_0000202)

# Class: obo:OPMI_0000391 (contact person role)

AnnotationAssertion(obo:IAO_0000115 obo:OPMI_0000391 "a role taken by a person who serves as a contact for some process.")
AnnotationAssertion(obo:IAO_0000117 obo:OPMI_0000391 "Leon Li, Asiyah Lin, Oliver He")
AnnotationAssertion(obo:IAO_0000412 obo:OPMI_0000391 obo:opmi.owl)
AnnotationAssertion(rdfs:label obo:OPMI_0000391 "contact person role"@en)
SubClassOf(obo:OPMI_0000391 obo:BFO_0000023)

# Class: obo:OPMI_0000393 (contact for public queries)

AnnotationAssertion(obo:IAO_0000117 obo:OPMI_0000393 "Leon Li, Asiyah Lin, Oliver He")
AnnotationAssertion(obo:IAO_0000119 obo:OPMI_0000393 "https://prsinfo.clinicaltrials.gov/definitions.html#StudyOfficials")
AnnotationAssertion(obo:IAO_0000412 obo:OPMI_0000393 obo:opmi.owl)
AnnotationAssertion(rdfs:label obo:OPMI_0000393 "contact for public queries"@en)
SubClassOf(obo:OPMI_0000393 obo:OPMI_0000383)

# Class: obo:OPMI_0000395 (central contact person of study)

AnnotationAssertion(obo:IAO_0000115 obo:OPMI_0000395 "A person to whom questions concerning enrollment at any location of the study can be addressed.")
AnnotationAssertion(obo:IAO_0000117 obo:OPMI_0000395 "Leon Li, Asiyah Lin, Oliver He")
AnnotationAssertion(obo:IAO_0000118 obo:OPMI_0000395 "central contact person")
AnnotationAssertion(obo:IAO_0000119 obo:OPMI_0000395 "https://prsinfo.clinicaltrials.gov/definitions.html")
AnnotationAssertion(obo:IAO_0000412 obo:OPMI_0000395 obo:opmi.owl)
AnnotationAssertion(rdfs:label obo:OPMI_0000395 "central contact person of study"@en)
SubClassOf(obo:OPMI_0000395 obo:OPMI_0000383)

# Class: obo:OPMI_0000397 (contact person information)

AnnotationAssertion(obo:IAO_0000115 obo:OPMI_0000397 "information content entity about a contact person")
AnnotationAssertion(obo:IAO_0000117 obo:OPMI_0000397 "Leon Li, Asiyah Lin, Oliver He")
AnnotationAssertion(obo:IAO_0000412 obo:OPMI_0000397 obo:opmi.owl)
AnnotationAssertion(rdfs:label obo:OPMI_0000397 "contact person information"@en)
SubClassOf(obo:OPMI_0000397 obo:IAO_0000030)

# Class: obo:OPMI_0000398 (primary sponsor role)

AnnotationAssertion(obo:IAO_0000115 obo:OPMI_0000398 "A sponsor role taken by an individual, organization, group or other legal entity which takes responsibility for initiating, managing and/or financing a study. The Primary Sponsor is responsible for ensuring that the trial is properly registered. The Primary Sponsor may or may not be the main funder.")
AnnotationAssertion(obo:IAO_0000117 obo:OPMI_0000398 "Leon Li, Asiyah Lin, Oliver He")
AnnotationAssertion(obo:IAO_0000119 obo:OPMI_0000398 "https://www.who.int/ictrp/network/trds/en/")
AnnotationAssertion(obo:IAO_0000412 obo:OPMI_0000398 obo:opmi.owl)
AnnotationAssertion(rdfs:label obo:OPMI_0000398 "primary sponsor role"@en)
SubClassOf(obo:OPMI_0000398 obo:OBI_0000243)

# Class: obo:OPMI_0000399 (secondary sponsor role)

AnnotationAssertion(obo:IAO_0000115 obo:OPMI_0000399 "A sponsor role taken by an additional individual, organization or another legal person, if any, that has agreed with the primary sponsor to take on responsibilities of sponsorship.")
AnnotationAssertion(obo:IAO_0000117 obo:OPMI_0000399 "Leon Li, Asiyah Lin, Oliver He")
AnnotationAssertion(obo:IAO_0000118 obo:OPMI_0000399 "collaborator role")
AnnotationAssertion(obo:IAO_0000119 obo:OPMI_0000399 "https://www.who.int/ictrp/network/trds/en/")
AnnotationAssertion(obo:IAO_0000412 obo:OPMI_0000399 obo:opmi.owl)
AnnotationAssertion(rdfs:comment obo:OPMI_0000399 "A secondary sponsor may have agreed to:
- take on all the responsibilities of sponsorship jointly with the primary sponsor; or
- form a group with the Primary Sponsor in which the responsibilities of sponsorship are allocated among the members of the group; or
- act as the Primary Sponsor’s legal representative in relation to some or all of the trial sites.
by WHO (https://www.who.int/ictrp/network/trds/en/)")
AnnotationAssertion(rdfs:comment obo:OPMI_0000399 "In clinicaltrials.gov, the secondary sponsor role can be taken by a project collaborator (Reference: https://prsinfo.clinicaltrials.gov/trainTrainer/WHO-ICMJE-ClinTrialsgov-Cross-Ref.pdf). However, a secondary sponsor may serve as a collaborator role, but a collaborator may not serve as a secondary sponsor role.")
AnnotationAssertion(rdfs:label obo:OPMI_0000399 "secondary sponsor role"@en)
SubClassOf(obo:OPMI_0000399 obo:OBI_0000243)

# Class: obo:OPMI_0000400 (principal investigator role)

AnnotationAssertion(obo:IAO_0000115 obo:OPMI_0000400 "An investigator role taken by an individual who is designated as responsible party by the sponsor")
AnnotationAssertion(obo:IAO_0000117 obo:OPMI_0000400 "Leon Li, Asiyah Lin, Oliver He")
AnnotationAssertion(obo:IAO_0000119 obo:OPMI_0000400 "https://prsinfo.clinicaltrials.gov/definitions.html")
AnnotationAssertion(obo:IAO_0000412 obo:OPMI_0000400 obo:opmi.owl)
AnnotationAssertion(rdfs:label obo:OPMI_0000400 "principal investigator role"@en)
SubClassOf(obo:OPMI_0000400 obo:OPMI_0000390)

# Class: obo:OPMI_0000401 (sponsor investigator role)

AnnotationAssertion(obo:IAO_0000115 obo:OPMI_0000401 "An investigator role taken by an individual who both initiates and conducts the study")
AnnotationAssertion(obo:IAO_0000117 obo:OPMI_0000401 "Leon Li, Asiyah Lin, Oliver He")
AnnotationAssertion(obo:IAO_0000119 obo:OPMI_0000401 "https://prsinfo.clinicaltrials.gov/definitions.html")
AnnotationAssertion(obo:IAO_0000412 obo:OPMI_0000401 obo:opmi.owl)
AnnotationAssertion(rdfs:label obo:OPMI_0000401 "sponsor investigator role"@en)
SubClassOf(obo:OPMI_0000401 obo:OPMI_0000390)

# Class: obo:OPMI_0000402 (investigation collaborator role)

AnnotationAssertion(obo:IAO_0000115 obo:OPMI_0000402 "An investigation agent role taken by an agent (an individual, organization, group or another legal entity) who provides support to an investigation. The support may include funding, design, implementation, data analysis or reporting. The responsible party is responsible for confirming all collaborators before listing them.")
AnnotationAssertion(obo:IAO_0000117 obo:OPMI_0000402 "Leon Li, Asiyah Li, Oliver He")
AnnotationAssertion(obo:IAO_0000118 obo:OPMI_0000402 "collaborator role")
AnnotationAssertion(obo:IAO_0000119 obo:OPMI_0000402 "https://prsinfo.clinicaltrials.gov/definitions.html#Collaborators")
AnnotationAssertion(obo:IAO_0000119 obo:OPMI_0000402 "https://www.who.int/ictrp/network/trds/en/")
AnnotationAssertion(obo:IAO_0000412 obo:OPMI_0000402 obo:opmi.owl)
AnnotationAssertion(rdfs:comment obo:OPMI_0000402 "A secondary sponsor may serve as a collaborator role. However, a  collaborator may not serve as a secondary sponsor role.")
AnnotationAssertion(rdfs:label obo:OPMI_0000402 "investigation collaborator role"@en)
SubClassOf(obo:OPMI_0000402 obo:OBI_0000202)

# Class: obo:OPMI_0000418 (human subject study)

AnnotationAssertion(obo:IAO_0000115 obo:OPMI_0000418 "A systematic, scientific investigation that can be either interventional or observational and involves human beings as research subjects. Human subject research can be either medical (clinical) research or non-medical (e.g., social science) research.")
AnnotationAssertion(obo:IAO_0000117 obo:OPMI_0000418 "Oliver He")
AnnotationAssertion(obo:IAO_0000118 obo:OPMI_0000418 "human investigation")
AnnotationAssertion(obo:IAO_0000118 obo:OPMI_0000418 "human study")
AnnotationAssertion(obo:IAO_0000119 obo:OPMI_0000418 "https://en.wikipedia.org/wiki/Human_subject_research")
AnnotationAssertion(obo:IAO_0000412 obo:OPMI_0000418 obo:opmi.owl)
AnnotationAssertion(rdfs:label obo:OPMI_0000418 "human subject study"@en)
SubClassOf(obo:OPMI_0000418 obo:OBI_0000066)

# Class: obo:PATO_0000047 (biological sex)

AnnotationAssertion(obo:IAO_0000115 obo:PATO_0000047 "An organismal quality inhering in a bearer by virtue of the bearer's ability to undergo sexual reproduction in order to differentiate the individuals or types involved.")
AnnotationAssertion(obo:IAO_0000412 obo:PATO_0000047 obo:pato.owl)
AnnotationAssertion(oboInOwl:hasOBONamespace obo:PATO_0000047 "quality")
AnnotationAssertion(oboInOwl:id obo:PATO_0000047 "PATO:0000047")
AnnotationAssertion(oboInOwl:inSubset obo:PATO_0000047 <http://purl.oboInOwllibrary.org/oboInOwl/pato#attribute_slim>)
AnnotationAssertion(rdfs:label obo:PATO_0000047 "biological sex")
SubClassOf(obo:PATO_0000047 obo:PATO_0001995)

# Class: obo:PATO_0000383 (female)

AnnotationAssertion(obo:IAO_0000115 obo:PATO_0000383 "A biological sex quality inhering in an individual or a population that only produces gametes that can be fertilised by male gametes.")
AnnotationAssertion(obo:IAO_0000412 obo:PATO_0000383 obo:pato.owl)
AnnotationAssertion(oboInOwl:hasOBONamespace obo:PATO_0000383 "quality")
AnnotationAssertion(oboInOwl:id obo:PATO_0000383 "PATO:0000383")
AnnotationAssertion(oboInOwl:inSubset obo:PATO_0000383 <http://purl.oboInOwllibrary.org/oboInOwl/pato#mpath_slim>)
AnnotationAssertion(oboInOwl:inSubset obo:PATO_0000383 <http://purl.oboInOwllibrary.org/oboInOwl/pato#value_slim>)
AnnotationAssertion(rdfs:label obo:PATO_0000383 "female")
SubClassOf(obo:PATO_0000383 obo:PATO_0001894)

# Class: obo:PATO_0000384 (male)

AnnotationAssertion(obo:IAO_0000115 obo:PATO_0000384 "A biological sex quality inhering in an individual or a population whose sex organs contain only male gametes.")
AnnotationAssertion(obo:IAO_0000412 obo:PATO_0000384 obo:pato.owl)
AnnotationAssertion(oboInOwl:hasOBONamespace obo:PATO_0000384 "quality")
AnnotationAssertion(oboInOwl:id obo:PATO_0000384 "PATO:0000384")
AnnotationAssertion(oboInOwl:inSubset obo:PATO_0000384 <http://purl.oboInOwllibrary.org/oboInOwl/pato#mpath_slim>)
AnnotationAssertion(oboInOwl:inSubset obo:PATO_0000384 <http://purl.oboInOwllibrary.org/oboInOwl/pato#value_slim>)
AnnotationAssertion(rdfs:label obo:PATO_0000384 "male")
SubClassOf(obo:PATO_0000384 obo:PATO_0001894)

# Class: obo:PATO_0001236 (process quality)

AnnotationAssertion(obo:IAO_0000115 obo:PATO_0001236 "A quality which inheres in an process.")
AnnotationAssertion(obo:IAO_0000412 obo:PATO_0001236 obo:pato.owl)
AnnotationAssertion(oboInOwl:hasAlternativeId obo:PATO_0001236 "PATO:0001239")
AnnotationAssertion(oboInOwl:hasAlternativeId obo:PATO_0001236 "PATO:0001240")
AnnotationAssertion(oboInOwl:hasExactSynonym obo:PATO_0001236 "quality of a process")
AnnotationAssertion(oboInOwl:hasExactSynonym obo:PATO_0001236 "quality of occurrent")
AnnotationAssertion(oboInOwl:hasExactSynonym obo:PATO_0001236 "quality of process")
AnnotationAssertion(oboInOwl:hasExactSynonym obo:PATO_0001236 "relational quality of occurrent")
AnnotationAssertion(oboInOwl:hasOBONamespace obo:PATO_0001236 "quality")
AnnotationAssertion(oboInOwl:id obo:PATO_0001236 "PATO:0001236")
AnnotationAssertion(rdfs:comment obo:PATO_0001236 "See comments of relational quality of a physical entity.")
AnnotationAssertion(rdfs:label obo:PATO_0001236 "process quality")
SubClassOf(obo:PATO_0001236 obo:BFO_0000019)

# Class: obo:PATO_0001241 (physical object quality)

AnnotationAssertion(obo:IAO_0000115 obo:PATO_0001241 "A quality which inheres in a continuant.")
AnnotationAssertion(obo:IAO_0000412 obo:PATO_0001241 obo:pato.owl)
AnnotationAssertion(oboInOwl:hasAlternativeId obo:PATO_0001241 "PATO:0001237")
AnnotationAssertion(oboInOwl:hasAlternativeId obo:PATO_0001241 "PATO:0001238")
AnnotationAssertion(oboInOwl:hasDbXref obo:PATO_0001241 "snap:Quality")
AnnotationAssertion(oboInOwl:hasExactSynonym obo:PATO_0001241 "monadic quality of a continuant")
AnnotationAssertion(oboInOwl:hasExactSynonym obo:PATO_0001241 "multiply inhering quality of a physical entity")
AnnotationAssertion(oboInOwl:hasExactSynonym obo:PATO_0001241 "quality of a continuant")
AnnotationAssertion(oboInOwl:hasExactSynonym obo:PATO_0001241 "quality of a single physical entity")
AnnotationAssertion(oboInOwl:hasExactSynonym obo:PATO_0001241 "quality of an object")
AnnotationAssertion(oboInOwl:hasExactSynonym obo:PATO_0001241 "quality of continuant")
AnnotationAssertion(oboInOwl:hasNarrowSynonym obo:PATO_0001241 "monadic quality of an object")
AnnotationAssertion(oboInOwl:hasNarrowSynonym obo:PATO_0001241 "monadic quality of continuant")
AnnotationAssertion(oboInOwl:hasOBONamespace obo:PATO_0001241 "quality")
AnnotationAssertion(oboInOwl:id obo:PATO_0001241 "PATO:0001241")
AnnotationAssertion(rdfs:comment obo:PATO_0001241 "Relational qualities are qualities that hold between multiple entities. Normal (monadic) qualities such as the shape of a eyeball exist purely as a quality of that eyeball. A relational quality such as sensitivity to light is a quality of that eyeball (and connecting nervous system) as it relates to incoming light waves/particles.")
AnnotationAssertion(rdfs:label obo:PATO_0001241 "physical object quality")
SubClassOf(obo:PATO_0001241 obo:BFO_0000019)

# Class: obo:PATO_0001894 (phenotypic sex)

AnnotationAssertion(obo:IAO_0000115 obo:PATO_0001894 "An organismal quality inhering in a bearer by virtue of the bearer's physical expression of sexual characteristics.")
AnnotationAssertion(obo:IAO_0000412 obo:PATO_0001894 obo:pato.owl)
AnnotationAssertion(oboInOwl:hasOBONamespace obo:PATO_0001894 "quality")
AnnotationAssertion(oboInOwl:id obo:PATO_0001894 "PATO:0001894")
AnnotationAssertion(oboInOwl:inSubset obo:PATO_0001894 <http://purl.oboInOwllibrary.org/oboInOwl/pato#attribute_slim>)
AnnotationAssertion(rdfs:label obo:PATO_0001894 "phenotypic sex")
SubClassOf(obo:PATO_0001894 obo:PATO_0000047)

# Class: obo:PATO_0001995 (organismal quality)

AnnotationAssertion(obo:IAO_0000115 obo:PATO_0001995 "A quality that inheres in an entire organism or part of an organism.")
AnnotationAssertion(obo:IAO_0000412 obo:PATO_0001995 obo:pato.owl)
AnnotationAssertion(oboInOwl:hasOBONamespace obo:PATO_0001995 "quality")
AnnotationAssertion(oboInOwl:id obo:PATO_0001995 "PATO:0001995")
AnnotationAssertion(rdfs:label obo:PATO_0001995 "organismal quality")
SubClassOf(obo:PATO_0001995 obo:PATO_0001241)

# Class: obo:PDRO_0000129 (condition)

AnnotationAssertion(obo:IAO_0000114 obo:PDRO_0000129 obo:IAO_0000123)
AnnotationAssertion(obo:IAO_0000115 obo:PDRO_0000129 "An information content entity that describes some relationships between some entities and whose truthfullness is a prerequisite for something."@en)
AnnotationAssertion(obo:IAO_0000115 obo:PDRO_0000129 "Une entité de contenu informationnel qui décrit des relations entre certaines entités et dont la véracité est un prérequis pour quelque chose."@fr)
AnnotationAssertion(obo:IAO_0000412 obo:PDRO_0000129 obo:pdro.owl)
AnnotationAssertion(rdfs:label obo:PDRO_0000129 "condition"@en)
AnnotationAssertion(rdfs:label obo:PDRO_0000129 "condition"@fr)
SubClassOf(obo:PDRO_0000129 obo:IAO_0000030)

# Class: obo:VO_0000002 (vaccination)

AnnotationAssertion(obo:IAO_0000115 obo:VO_0000002 "a medical intervention that involves in adding vaccine into a host (e.g., human, mouse) in vivo with the intent to invoke an adaptive immune response.")
AnnotationAssertion(obo:IAO_0000412 obo:VO_0000002 obo:oae.owl)
AnnotationAssertion(obo:IAO_0000412 obo:VO_0000002 obo:vo.owl)
AnnotationAssertion(rdfs:label obo:VO_0000002 "vaccination")
AnnotationAssertion(rdfs:seeAlso obo:VO_0000002 "https://prsinfo.clinicaltrials.gov/definitions.html")
SubClassOf(obo:VO_0000002 obo:OAE_0000002)

# Class: obo:VO_0000427 (phase 1 vaccine trial)

AnnotationAssertion(obo:IAO_0000115 obo:VO_0000427 "A vaccine clinical trial that investigates the safety profile of a vaccine in a small group (10-50) of healthy volunteers.")
AnnotationAssertion(obo:IAO_0000117 obo:VO_0000427 "YH")
AnnotationAssertion(obo:IAO_0000412 obo:VO_0000427 obo:vo.owl)
AnnotationAssertion(rdfs:label obo:VO_0000427 "phase 1 vaccine trial")
SubClassOf(obo:VO_0000427 obo:VO_0000596)

# Class: obo:VO_0000428 (phase 2 vaccine trial)

AnnotationAssertion(obo:IAO_0000115 obo:VO_0000428 "A vaccine clinical trial that studies vaccine efficacy with a target population (numbering 50-100). Different dosage levels will also be explored at this stage to determine the optimum dose.")
AnnotationAssertion(obo:IAO_0000117 obo:VO_0000428 "YH")
AnnotationAssertion(obo:IAO_0000412 obo:VO_0000428 obo:vo.owl)
AnnotationAssertion(rdfs:label obo:VO_0000428 "phase 2 vaccine trial")
SubClassOf(obo:VO_0000428 obo:VO_0000596)

# Class: obo:VO_0000429 (phase 3 vaccine trial)

AnnotationAssertion(obo:IAO_0000115 obo:VO_0000429 "A vaccine clinical trial that takes the trial to a large-scale safety and efficacy study in a relevant patient population, usually in excess of 3,000.")
AnnotationAssertion(obo:IAO_0000117 obo:VO_0000429 "YH")
AnnotationAssertion(obo:IAO_0000412 obo:VO_0000429 obo:vo.owl)
AnnotationAssertion(rdfs:label obo:VO_0000429 "phase 3 vaccine trial")
SubClassOf(obo:VO_0000429 obo:VO_0000596)

# Class: obo:VO_0000430 (phase 4 vaccine trial)

AnnotationAssertion(obo:IAO_0000115 obo:VO_0000430 "The final stage of vaccine clinical evaluation. Phase IV occurs after a vaccine or therapy is licensed and is being used by large numbers of people. These studies are not always required or completed.")
AnnotationAssertion(obo:IAO_0000117 obo:VO_0000430 "YH")
AnnotationAssertion(obo:IAO_0000412 obo:VO_0000430 obo:vo.owl)
AnnotationAssertion(rdfs:label obo:VO_0000430 "phase 4 vaccine trial")
SubClassOf(obo:VO_0000430 obo:VO_0000596)

# Class: obo:VO_0000596 (vaccine clinical trial)

AnnotationAssertion(obo:IAO_0000115 obo:VO_0000596 "A processual entity by which a vaccine is tested clinically for safety and effectiveness. Clinical trials are conducted in phases. Classically, clinical trials unfold in three phases in order to gather data and information about a vaccine and its performance. This will form the basis of a dossier submitted to regulatory authorities by way of an application for licensure. After a vaccine is licensed and is being used by large numbers of people, a Phase IV study may or may not be taken for vaccine clinical evaluation.")
AnnotationAssertion(obo:IAO_0000116 obo:VO_0000596 "Most vaccines against a pathogen (e.g., HIV) are not tested by vaccinating people and then deliberately exposing them to virulent pathogen (e.g., HIV). This strategy is never for a vaccine against a disease as serious as HIV.
The best way to determine if a vaccine is effective is to test it in a randomized, controlled, double-blind clinical trial. This type of trial is often referred to as the gold standard in medical research and provides the strongest evidence for the efficacy of a vaccine.")
AnnotationAssertion(obo:IAO_0000117 obo:VO_0000596 "YH")
AnnotationAssertion(obo:IAO_0000412 obo:VO_0000596 obo:vo.owl)
AnnotationAssertion(rdfs:label obo:VO_0000596 "vaccine clinical trial")
SubClassOf(obo:VO_0000596 obo:CTO_0000220)


############################
#   Named Individuals
############################

# Individual: obo:IAO_0000122 (ready for release)

AnnotationAssertion(rdfs:label obo:IAO_0000122 "ready for release"@en)
ClassAssertion(obo:IAO_0000078 obo:IAO_0000122)
ClassAssertion(owl:Thing obo:IAO_0000122)

# Individual: obo:IAO_0000123 (metadata incomplete)

AnnotationAssertion(rdfs:label obo:IAO_0000123 "metadata incomplete"@en)
ClassAssertion(obo:IAO_0000078 obo:IAO_0000123)
ClassAssertion(owl:Thing obo:IAO_0000123)

# Individual: obo:IAO_0000125 (pending final vetting)

AnnotationAssertion(rdfs:label obo:IAO_0000125 "pending final vetting"@en)
ClassAssertion(obo:IAO_0000078 obo:IAO_0000125)
ClassAssertion(owl:Thing obo:IAO_0000125)


AnnotationAssertion(Annotation(obo:IAO_0000119 "https://prsinfo.clinicaltrials.gov/definitions.html") obo:IAO_0000115 obo:ERO_0000348 "single group of individuals with specific characteristics.")
AnnotationAssertion(rdfs:label obo:omrse.owl "The Ontology of Medically Related Social Entities"@en)
AnnotationAssertion(Annotation(obo:IAO_0000119 "https://prsinfo.clinicaltrials.gov/definitions.html") obo:IAO_0000115 <http://purl.org/net/OCRe/research.owl#Case_control_study> "Group of individuals with specific characteristics (for example, conditions or exposures) compared to group(s) with different characteristics, but otherwise similar.")
AnnotationAssertion(Annotation(obo:IAO_0000119 "https://prsinfo.clinicaltrials.gov/definitions.html") obo:IAO_0000115 <http://purl.org/net/OCRe/research.owl#Case_crossover_study> "Characteristics of case immediately prior to disease onset (sometimes called the hazard period) compared to characteristics of same case at a prior time (that is, control period).")
AnnotationAssertion(Annotation(obo:IAO_0000119 "https://prsinfo.clinicaltrials.gov/definitions.html") obo:IAO_0000115 <http://purl.org/net/OCRe/research.owl#Cohort_study> "Group of individuals, initially defined and composed, with common characteristics (for example, condition, birth year), who are examined or traced over a given time period.")
AnnotationAssertion(Annotation(obo:IAO_0000119 "https://prsinfo.clinicaltrials.gov/definitions.html") obo:IAO_0000115 <http://purl.org/net/OCRe/research.owl#Parallel_group_study> "Participants are assigned to one of two or more groups in parallel for the duration of the study")
AnnotationAssertion(Annotation(obo:IAO_0000119 "https://prsinfo.clinicaltrials.gov/definitions.html") obo:IAO_0000115 <http://purl.org/net/OCRe/study_design.owl#Crossover_study> "Participants receive one of two (or more) alternative interventions during the initial phase of the study and receive the other intervention during the second phase of the study")
AnnotationAssertion(Annotation(obo:IAO_0000119 "https://prsinfo.clinicaltrials.gov/definitions.html") obo:IAO_0000115 <http://purl.org/net/OCRe/study_design.owl#Single_group_study> "Clinical trials with a single arm")
AnnotationAssertion(obo:IAO_0000115 <obo:CTO_0000021> "A centrally registered identifier that is assigned for a specific clinical trial registered in the Korean Clinical Research Information Service (CRIS). The format for the registry number is “KCT” followed by a 7-digit number, e.g., KCT0004537.")
AnnotationAssertion(oboInOwl:hasExactSynonym <obo:CTO_0000021> "CRIS identifier")
AnnotationAssertion(rdfs:label <obo:CTO_0000021> "Korean clinical trial registry identifier")
AnnotationAssertion(rdfs:seeAlso <obo:CTO_0000021> "http://cris.nih.go.kr/cris/en/use_guide/cris_introduce.jsp")
AnnotationAssertion(obo:IAO_0000115 <obo:CTO_0000027> "A centrally registered identifier that is assigned for a specific clinical trial registered in the Sri Lanka clinical trials registry (SLCTR ). The format for the registry number is “SLCTR /” followed  by a 4-digit number, followed by a slash, followed a 3-digit number, e.g., SLCTR/2020/010")
AnnotationAssertion(oboInOwl:hasExactSynonym <obo:CTO_0000027> "SLCTR identifier")
AnnotationAssertion(rdfs:label <obo:CTO_0000027> "Sri Lanka clinical trials registry identifier")
AnnotationAssertion(rdfs:seeAlso <obo:CTO_0000027> "https://slctr.lk/")
AnnotationAssertion(obo:IAO_0000115 <obo:CTO_0000029> "The jRTC (Japan Registry of Clinical Trials) clinical trial registry is a primary clinical trial registry recognised by WHO and ICMJE that enables the registration of clinical trials.")
AnnotationAssertion(oboInOwl:hasExactSynonym <obo:CTO_0000029> "Japan Registry of Clinical Trials")
AnnotationAssertion(oboInOwl:hasExactSynonym <obo:CTO_0000029> "jRTC")
AnnotationAssertion(rdfs:label <obo:CTO_0000029> "jRTC clinical trials register")
AnnotationAssertion(rdfs:seeAlso <obo:CTO_0000029> "https://jrct.niph.go.jp/")
AnnotationAssertion(rdfs:seeAlso <obo:CTO_0000029> "https://rctportal.niph.go.jp/en/")
AnnotationAssertion(obo:IAO_0000115 <obo:CTO_0000042> "The international standard randomised controlled trial register is a primary clinical trial registry recognised by WHO and ICMJE that enables the registration of clinical trials.")
AnnotationAssertion(oboInOwl:hasExactSynonym <obo:CTO_0000042> "ISRCTN")
AnnotationAssertion(rdfs:label <obo:CTO_0000042> "International standard randomised controlled trial register")
AnnotationAssertion(rdfs:seeAlso <obo:CTO_0000042> "http://www.isrctn.com/")
AnnotationAssertion(obo:IAO_0000412 _:genid2147483648 obo:obi.owl)
AnnotationAssertion(obo:IAO_0000412 _:genid2147483649 obo:omrse.owl)
)